<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Endocrinol (Lausanne)</journal-id><journal-id journal-id-type="iso-abbrev">Front Endocrinol (Lausanne)</journal-id><journal-id journal-id-type="publisher-id">Front. Endocrinol.</journal-id><journal-title-group><journal-title>Frontiers in Endocrinology</journal-title></journal-title-group><issn pub-type="epub">1664-2392</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5687125</article-id><article-id pub-id-type="doi">10.3389/fendo.2017.00298</article-id><article-categories><subj-group subj-group-type="heading"><subject>Endocrinology</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>From Sea to Shining Sea and the Great Plains to Patagonia: A Review on Current Knowledge of Diabetes Mellitus in Hispanics/Latinos in the US and Latin America</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Avil&#x000e9;s-Santa</surname><given-names>M. Larissa</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1">*</xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/423618"/></contrib><contrib contrib-type="author"><name><surname>Col&#x000f3;n-Ramos</surname><given-names>Uriyo&#x000e1;n</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/441649"/></contrib><contrib contrib-type="author"><name><surname>Lindberg</surname><given-names>Nangel M.</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/487484"/></contrib><contrib contrib-type="author"><name><surname>Mattei</surname><given-names>Josiemer</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/440738"/></contrib><contrib contrib-type="author"><name><surname>Pasquel</surname><given-names>Francisco J.</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/473410"/></contrib><contrib contrib-type="author"><name><surname>P&#x000e9;rez</surname><given-names>Cynthia M.</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/490436"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>National Heart, Lung, and Blood Institute at the National Institutes of Health</institution>, <addr-line>Bethesda, MD</addr-line>, <country>United States</country></aff><aff id="aff2"><sup>2</sup><institution>Department of Global Health, Milken Institute School of Public Health, George Washington University</institution>, <addr-line>Washington, DC</addr-line>, <country>United States</country></aff><aff id="aff3"><sup>3</sup><institution>Kaiser Permanente Center for Health Research</institution>, <addr-line>Portland, OR</addr-line>, <country>United States</country></aff><aff id="aff4"><sup>4</sup><institution>Department of Nutrition, Harvard TH Chan School of Public Health</institution>, <addr-line>Boston, MA</addr-line>, <country>United States</country></aff><aff id="aff5"><sup>5</sup><institution>Department of Medicine, Emory University School of Medicine</institution>, <addr-line>Atlanta, GA</addr-line>, <country>United States</country></aff><aff id="aff6"><sup>6</sup><institution>University of Puerto Rico Graduate School of Public Health</institution>, <addr-line>San Juan</addr-line>, <country>Puerto Rico</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: MariaRosario (Happy) Araneta, University of California, San Diego, United States</p></fn><fn fn-type="edited-by"><p>Reviewed by: Jan Bro&#x0017e;, Charles University, Czechia; Cecilia B. Rosales, University of Arizona, United States</p></fn><corresp content-type="corresp" id="cor1">*Correspondence: M. Larissa Avil&#x000e9;s-Santa, <email>avilessantal@nhlbi.nih.gov</email></corresp><fn fn-type="other" id="fn002"><p>Specialty section: This article was submitted to Diabetes, a section of the journal Frontiers in Endocrinology</p></fn></author-notes><pub-date pub-type="epub"><day>10</day><month>11</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>8</volume><elocation-id>298</elocation-id><history><date date-type="received"><day>19</day><month>5</month><year>2017</year></date><date date-type="accepted"><day>16</day><month>10</month><year>2017</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2017 Avil&#x000e9;s-Santa, Col&#x000f3;n-Ramos, Lindberg, Mattei, Pasquel and P&#x000e9;rez.</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Avil&#x000e9;s-Santa, Col&#x000f3;n-Ramos, Lindberg, Mattei, Pasquel and P&#x000e9;rez</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>The past two decades have witnessed many advances in the prevention, treatment, and control of diabetes mellitus (DM) and its complications. Increased screening has led to a greater recognition of type 2 diabetes mellitus (type 2 DM) and prediabetes; however, Hispanics/Latinos, the largest minority group in the US, have not fully benefited from these advances. The Hispanic/Latino population is highly diverse in ancestries, birth places, cultures, languages, and socioeconomic backgrounds, and it populates most of the Western Hemisphere. In the US, the prevalence of DM varies among Hispanic/Latino heritage groups, being higher among Mexicans, Puerto Ricans, and Dominicans, and lower among South Americans. The risk and prevalence of diabetes among Hispanics/Latinos are significantly higher than in non-Hispanic Whites, and nearly 40% of Hispanics/Latinos with diabetes have not been formally diagnosed. Despite these striking facts, the representation of Hispanics/Latinos in pharmacological and non-pharmacological clinical trials has been suboptimal, while the prevalence of diabetes in these populations continues to rise. This review will focus on the epidemiology, etiology and prevention of type 2 DM in populations of Latin American origin. We will set the stage by defining the terms <italic>Hispanic, Latino</italic>, and <italic>Latin American</italic>, explaining the challenges identifying Hispanics/Latinos in the scientific literature and databases, describing the epidemiology of diabetes&#x02014;including type 2 DM and gestational diabetes mellitus (GDM)&#x02014;and cardiovascular risk factors in Hispanics/Latinos in the US and Latin America, and discussing trends, and commonalities and differences across studies and populations, including methodology to ascertain diabetes. We will discuss studies on mechanisms of disease, and research on prevention of type 2 DM in Hispanics/Latinos, including women with GDM, youth and adults; and finalize with a discussion on lessons learned and opportunities to enhance research, and, consequently, clinical care oriented toward preventing type 2 DM in Hispanics/Latinos in the US and Latin America.</p></abstract><kwd-group><kwd>type 2 diabetes mellitus</kwd><kwd>gestational diabetes</kwd><kwd>prevention of diabetes</kwd><kwd>Latinos</kwd><kwd>Latin America</kwd><kwd>epidemiology of type 2 diabetes</kwd><kwd>Hispanics</kwd></kwd-group><counts><fig-count count="2"/><table-count count="7"/><equation-count count="0"/><ref-count count="444"/><page-count count="35"/><word-count count="30476"/></counts></article-meta></front><body><sec sec-type="introduction" id="S1"><title>Introduction</title><disp-quote><p>Poverty is the best cure for diabetes.</p><p>La pobreza es el mejor remedio contra la diabetes.</p><attrib>-Gabriel Garc&#x000ed;a M&#x000e1;rquez (<xref rid="B1" ref-type="bibr">1</xref>)</attrib></disp-quote><p>Diabetes mellitus (DM) has been documented in the medical history of some Latin American countries since the late 1800s and early 1900s (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B3" ref-type="bibr">3</xref>). Although not a common disease at that time, type 1 DM was highlighted by medical societies in the Americas due to its dramatic presentation and fast clinical deterioration. In contrast, type 2 diabetes mellitus (type 2 DM) and its long-term complications only gained attention in the mid-twentieth century (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B3" ref-type="bibr">3</xref>). Over the next decades, type 2 DM would become recognized not just as a common chronic disease but also as one of the leading causes of death worldwide (<xref rid="B4" ref-type="bibr">4</xref>).</p><sec id="S1-1"><title>Why Is It Important to Understand Type 2 Diabetes in Hispanics/Latinos in the US and in Latin Americans?</title><p>Hispanics/Latinos in the US mainland constitute 17.6% of the population (<xref rid="B5" ref-type="bibr">5</xref>), and are the largest US minority group. It is projected that by year 2060, 29% of the US population will be of Hispanic/Latino descent (<xref rid="B6" ref-type="bibr">6</xref>). Compared to other US populations, the Hispanic/Latino population is younger, with nearly half of the US-born Hispanics/Latinos under age 18 (<xref rid="B7" ref-type="bibr">7</xref>). The prevalence of diabetes among Hispanics/Latinos in the US is 22.6%, and twice as high as that of non-Hispanic Whites (NHWs) (11.3%) (<xref rid="B8" ref-type="bibr">8</xref>). Diabetes has also become a leading cause of death in Latin America (<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B10" ref-type="bibr">10</xref>).</p><p>Understanding type 2 DM among Hispanics/Latinos in the US and in Latin America poses several challenges. A long-standing assumption in the US is that Hispanics/Latinos are a demographically and ancestrally homogeneous group. However, as we will explain, Hispanics/Latinos are a highly heterogeneous group, and in fact, the prevalence of diabetes varies widely among different US Hispanic/Latino heritage groups (<xref rid="B11" ref-type="bibr">11</xref>&#x02013;<xref rid="B13" ref-type="bibr">13</xref>). These differences in prevalence may be mediated by differences in ancestry, as well as differences in socioeconomic factors, cultural norms, dietary and physical activity (PA) patterns, and history of environmental exposures&#x02014;among others&#x02014;experienced in both the country of origin and the US.</p><p>As the foundations for precision and personalized medicine are built, it is clear that adequate prevention, diagnosis, and treatment of type 2 DM among Hispanics/Latinos in the US and in Latin America require deep understanding of its etiology, manifestations, and response to interventions across populations. Whereas diabetes has become a seemingly unavoidable outcome for many Hispanics/Latinos, it does not have to be so.</p><p>In this expert review, we will describe the epidemiology of type 2 DM and gestational diabetes mellitus (GDM) and traditional cardiovascular (CV) risk factors in Hispanics/Latinos in the US and Latin America based on selected studies. We will also discuss studies on the etiology of type 2 DM and GDM in Hispanic/Latino populations. Given the increasing prevalence of type 2 DM across the continent, and especially at younger ages, we considered imperative to focus on research dedicated to disease prevention in Hispanics/Latinos in the US and in Latin America. We will also highlight opportunities to enhance our knowledge through research within a holistic framework of multidimensional and transdisciplinary strategies; a framework that is also applicable to the clinical care of Hispanics/Latinos at risk of type 2 DM.</p><p>In this review, the term type 2 DM will be used throughout most of the text, and specially within the context of etiology and prevention. The term diabetes will be used within the context of epidemiology or when there is no distinction between type 1 and type 2 DM. As a reference, we have also included a list of acronyms and abbreviations used throughout the text (see <xref ref-type="app" rid="A1">Appendix</xref>).</p></sec><sec id="S1-2"><title>Who Are the Hispanics/Latinos in the US and Latin Americans?</title><p>The Office of Management and Budget (OMB) and the US Census Bureau define Hispanic or Latino as &#x0201c;a person of Cuban, Mexican, Puerto Rican, South or Central American, or other Spanish culture regardless of race&#x0201d; (<xref rid="B14" ref-type="bibr">14</xref>). The racial and ethnic categories defined by the OMB have been challenged and are under revision (<xref rid="B15" ref-type="bibr">15</xref>). Figure <xref ref-type="fig" rid="F1">1</xref> (<xref rid="B16" ref-type="bibr">16</xref>) illustrates where the largest Hispanic/Latino heritage groups live in the US and Puerto Rico based on the 2010 US Census.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>2010 US Census Map&#x02014;Largest Detailed Hispanic Origin Group by State: 2010. This is Figure 4 from Ennis et al. (<xref rid="B16" ref-type="bibr">16</xref>).</p></caption><graphic xlink:href="fendo-08-00298-g001"/></fig><p>The terms Hispanic and Latino have different meanings in the US and abroad. Place of residence (<xref rid="B17" ref-type="bibr">17</xref>), ancestry group (<xref rid="B18" ref-type="bibr">18</xref>), or immigrant generation (<xref rid="B18" ref-type="bibr">18</xref>) may influence individuals&#x02019; preference for the term Hispanic, Latino, both, or neither. In this review, the term Hispanic/Latino refers to persons of Latin American descent who live in the US or in Latin America; that is, those who self-identify or trace their roots to countries in the Americas where Spanish, Portuguese, and French are the predominant languages (<xref rid="B19" ref-type="bibr">19</xref>, <xref rid="B20" ref-type="bibr">20</xref>), excluding persons from Spain. The term Latin Americans refers to persons or populations in Latin America (<xref rid="B19" ref-type="bibr">19</xref>, <xref rid="B20" ref-type="bibr">20</xref>).</p></sec><sec id="S1-3"><title>Sociodemographic and Economic Characteristics of the Hispanic/Latino Population in the US and in Latin America</title><p>According to the US Census Bureau, Hispanics/Latinos have become the US largest minority group. This population increased nearly fourfold between 1980 and 2015, rising from 14.8 million (6.5%) to 56.6 million (17.6%) (<xref rid="B21" ref-type="bibr">21</xref>&#x02013;<xref rid="B23" ref-type="bibr">23</xref>). The Hispanic/Latino population is projected to increase to 119 million, or nearly 29% of the population in 2060 (<xref rid="B6" ref-type="bibr">6</xref>), with growth attributed to high rates of immigration and fertility, and low overall mortality (<xref rid="B24" ref-type="bibr">24</xref>). In 2015, Hispanics/Latinos of Mexican origin were the largest Hispanic/Latino heritage group (63%), followed by Puerto Ricans (10%), Salvadorans (4%), Cubans (4%), and Dominicans (3%) (<xref rid="B21" ref-type="bibr">21</xref>).</p><p>As a group, Hispanics/Latinos are younger than other racial/ethnic groups in the US (median 28.7&#x02009;years) and lag behind other groups in educational attainment (<xref rid="B21" ref-type="bibr">21</xref>) (Table <xref ref-type="table" rid="T1">1</xref>). At 67%, the percentage of Hispanics/Latinos age 25 or older with a high school education or higher is significantly lower than that of NHWs (91.8%) (<xref rid="B25" ref-type="bibr">25</xref>). Poverty rates are significantly higher among Hispanics/Latinos (21.4%) than NHWs (9.1%) (<xref rid="B26" ref-type="bibr">26</xref>). In the US, unemployment among the population aged 16&#x02009;years and older was highest among non-Hispanic Blacks (11.3%) and islander Puerto Ricans (8.4%), and lowest among NHWs (5%) and Hispanics/Latinos (4.9%). Islander Puerto Ricans continue to have higher poverty rates (46.1%) than other Hispanics/Latino groups in the US (22.6%), non-Hispanic Blacks (25.4%), and NHWs (10.4%) (<xref rid="B21" ref-type="bibr">21</xref>).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Selected socioeconomic indicators for Hispanics/Latinos in the US by heritage group, 2015.<xref ref-type="table-fn" rid="tfn2"><sup>a</sup></xref></p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Race/ethnic group</th><th valign="top" align="center" rowspan="1" colspan="1">Median age (years)</th><th valign="top" align="center" rowspan="1" colspan="1">Percent of population &#x02265;25&#x02009;years who are high school graduate or higher</th><th valign="top" align="center" rowspan="1" colspan="1">Percent of population &#x02265;16&#x02009;years who is unemployed</th><th valign="top" align="center" rowspan="1" colspan="1">Percent of people whose income in the past 12&#x02009;months is below the poverty level</th><th valign="top" align="center" rowspan="1" colspan="1">Median family income</th><th valign="top" align="center" rowspan="1" colspan="1">Percent of civilian noninstitutionalized population with no health insurance coverage</th></tr></thead><tbody><tr><td align="left" valign="top" colspan="7" rowspan="1"><bold>US Mainland</bold></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hispanic/Latino</td><td align="center" valign="top" rowspan="1" colspan="1">28.7</td><td align="center" valign="top" rowspan="1" colspan="1">66.0</td><td align="center" valign="top" rowspan="1" colspan="1">4.9</td><td align="center" valign="top" rowspan="1" colspan="1">22.6</td><td align="center" valign="top" rowspan="1" colspan="1">$46,690</td><td align="center" valign="top" rowspan="1" colspan="1">19.5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Mexican</td><td align="center" valign="top" rowspan="1" colspan="1">26.9</td><td align="center" valign="top" rowspan="1" colspan="1">60.9</td><td align="center" valign="top" rowspan="1" colspan="1">4.9</td><td align="center" valign="top" rowspan="1" colspan="1">23.5</td><td align="center" valign="top" rowspan="1" colspan="1">$45,616</td><td align="center" valign="top" rowspan="1" colspan="1">21.5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Puerto Rican</td><td align="center" valign="top" rowspan="1" colspan="1">29.5</td><td align="center" valign="top" rowspan="1" colspan="1">78.9</td><td align="center" valign="top" rowspan="1" colspan="1">5.9</td><td align="center" valign="top" rowspan="1" colspan="1">24.6</td><td align="center" valign="top" rowspan="1" colspan="1">$45,693</td><td align="center" valign="top" rowspan="1" colspan="1">8.5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Cuban</td><td align="center" valign="top" rowspan="1" colspan="1">40.8</td><td align="center" valign="top" rowspan="1" colspan="1">79.2</td><td align="center" valign="top" rowspan="1" colspan="1">3.9</td><td align="center" valign="top" rowspan="1" colspan="1">17.6</td><td align="center" valign="top" rowspan="1" colspan="1">$51,105</td><td align="center" valign="top" rowspan="1" colspan="1">13.9</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Dominican</td><td align="center" valign="top" rowspan="1" colspan="1">30.1</td><td align="center" valign="top" rowspan="1" colspan="1">68.1</td><td align="center" valign="top" rowspan="1" colspan="1">6.4</td><td align="center" valign="top" rowspan="1" colspan="1">26.7</td><td align="center" valign="top" rowspan="1" colspan="1">$39,762</td><td align="center" valign="top" rowspan="1" colspan="1">12.3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Central American</td><td align="center" valign="top" rowspan="1" colspan="1">30.1</td><td align="center" valign="top" rowspan="1" colspan="1">56.0</td><td align="center" valign="top" rowspan="1" colspan="1">4.6</td><td align="center" valign="top" rowspan="1" colspan="1">22.2</td><td align="center" valign="top" rowspan="1" colspan="1">$43,570</td><td align="center" valign="top" rowspan="1" colspan="1">28.2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;South American</td><td align="center" valign="top" rowspan="1" colspan="1">35.6</td><td align="center" valign="top" rowspan="1" colspan="1">85.2</td><td align="center" valign="top" rowspan="1" colspan="1">4.3</td><td align="center" valign="top" rowspan="1" colspan="1">14.4</td><td align="center" valign="top" rowspan="1" colspan="1">$60,169</td><td align="center" valign="top" rowspan="1" colspan="1">17.0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Other</td><td align="center" valign="top" rowspan="1" colspan="1">31.7</td><td align="center" valign="top" rowspan="1" colspan="1">70.8</td><td align="center" valign="top" rowspan="1" colspan="1">4.7</td><td align="center" valign="top" rowspan="1" colspan="1">20.0</td><td align="center" valign="top" rowspan="1" colspan="1">$49,812</td><td align="center" valign="top" rowspan="1" colspan="1">19.5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Non-Hispanic White</td><td align="center" valign="top" rowspan="1" colspan="1">43.3</td><td align="center" valign="top" rowspan="1" colspan="1">92.3</td><td align="center" valign="top" rowspan="1" colspan="1">5.0</td><td align="center" valign="top" rowspan="1" colspan="1">10.4</td><td align="center" valign="top" rowspan="1" colspan="1">$77,072</td><td align="center" valign="top" rowspan="1" colspan="1">6.3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Non-Hispanic Black</td><td align="center" valign="top" rowspan="1" colspan="1">33.7</td><td align="center" valign="top" rowspan="1" colspan="1">84.7</td><td align="center" valign="top" rowspan="1" colspan="1">11.3</td><td align="center" valign="top" rowspan="1" colspan="1">25.4</td><td align="center" valign="top" rowspan="1" colspan="1">$45,014</td><td align="center" valign="top" rowspan="1" colspan="1">11.0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Puerto Rico</bold></td><td align="center" valign="top" rowspan="1" colspan="1">40.0</td><td align="center" valign="top" rowspan="1" colspan="1">74.7</td><td align="center" valign="top" rowspan="1" colspan="1">8.4</td><td align="center" valign="top" rowspan="1" colspan="1">46.1</td><td align="center" valign="top" rowspan="1" colspan="1">$22,428</td><td align="center" valign="top" rowspan="1" colspan="1">5.7</td></tr></tbody></table><table-wrap-foot><fn id="tfn2"><p><italic><sup>a</sup>Source: US Census Bureau, 2015 American Community Survey 1-Year Estimates</italic>.</p></fn></table-wrap-foot></table-wrap><p>Hispanics/Latinos of any race are disproportionately affected by lack of health insurance compared to all other groups (<xref rid="B27" ref-type="bibr">27</xref>). While only approximately 10% of NHWs did not have healthcare insurance, nearly 20% of Hispanics/Latinos of any race lack health insurance. Within Hispanic/Latino subgroups, the percentage of uninsured individuals varied considerably, from 8.5% in Puerto Ricans to 28.2% in Central Americans (<xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B29" ref-type="bibr">29</xref>).</p><p>The population in Latin America and the Caribbean is projected to grow from 646 million currently to 784 million in 2050 (<xref rid="B30" ref-type="bibr">30</xref>). This population is relatively young with a median age of 29.2&#x02009;years (<xref rid="B31" ref-type="bibr">31</xref>) (Table <xref ref-type="table" rid="T2">2</xref>). Enrollment in secondary and tertiary education remains unequal in the region, ranging from 21.2% in Honduras to 88.6% in Chile. The percentage of the population classified as poor is highly variable, from 4.3% in Argentina to over 60% in Guatemala and Honduras.</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Selected socioeconomic indicators for Hispanics/Latinos in Latin America, 2014&#x02013;2015.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Country</th><th valign="top" align="center" rowspan="1" colspan="1">Median age (years), 2015<xref ref-type="table-fn" rid="tfn3"><sup>a</sup></xref></th><th valign="top" align="center" rowspan="1" colspan="1">Gross enrollment rate in secondary and tertiary education, 2014<xref ref-type="table-fn" rid="tfn4"><sup>b</sup></xref></th><th valign="top" align="center" rowspan="1" colspan="1">Economic participation rate in population aged&#x02009;&#x02265;&#x02009;15, 2015<xref ref-type="table-fn" rid="tfn4"><sup>b</sup></xref></th><th valign="top" align="center" rowspan="1" colspan="1">Percentage of population classified as poor, 2014<xref ref-type="table-fn" rid="tfn4"><sup>b</sup></xref></th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Argentina</td><td align="center" valign="top" rowspan="1" colspan="1">30.8</td><td align="center" valign="top" rowspan="1" colspan="1">88.2/NA</td><td align="center" valign="top" rowspan="1" colspan="1">59.6</td><td align="center" valign="top" rowspan="1" colspan="1">4.3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Bolivia</td><td align="center" valign="top" rowspan="1" colspan="1">24.1</td><td align="center" valign="top" rowspan="1" colspan="1">75.7/NA</td><td align="center" valign="top" rowspan="1" colspan="1">69.6</td><td align="center" valign="top" rowspan="1" colspan="1">32.7</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Brazil</td><td align="center" valign="top" rowspan="1" colspan="1">31.3</td><td align="center" valign="top" rowspan="1" colspan="1">NA</td><td align="center" valign="top" rowspan="1" colspan="1">66.6</td><td align="center" valign="top" rowspan="1" colspan="1">16.5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Chile</td><td align="center" valign="top" rowspan="1" colspan="1">34.4</td><td align="center" valign="top" rowspan="1" colspan="1">88.3/88.6</td><td align="center" valign="top" rowspan="1" colspan="1">57.4</td><td align="center" valign="top" rowspan="1" colspan="1">7.8</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Colombia</td><td align="center" valign="top" rowspan="1" colspan="1">30.0</td><td align="center" valign="top" rowspan="1" colspan="1">78.6/51.3</td><td align="center" valign="top" rowspan="1" colspan="1">69.4</td><td align="center" valign="top" rowspan="1" colspan="1">28.6</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Costa Rica</td><td align="center" valign="top" rowspan="1" colspan="1">31.4</td><td align="center" valign="top" rowspan="1" colspan="1">78.1/53.0</td><td align="center" valign="top" rowspan="1" colspan="1">59.6</td><td align="center" valign="top" rowspan="1" colspan="1">18.6</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cuba</td><td align="center" valign="top" rowspan="1" colspan="1">41.2</td><td align="center" valign="top" rowspan="1" colspan="1">NA/41.0</td><td align="center" valign="top" rowspan="1" colspan="1">NA</td><td align="center" valign="top" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Dominican Republic</td><td align="center" valign="top" rowspan="1" colspan="1">26.1</td><td align="center" valign="top" rowspan="1" colspan="1">65.5/47.5</td><td align="center" valign="top" rowspan="1" colspan="1">58.8</td><td align="center" valign="top" rowspan="1" colspan="1">37.2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Ecuador</td><td align="center" valign="top" rowspan="1" colspan="1">26.6</td><td align="center" valign="top" rowspan="1" colspan="1">NA</td><td align="center" valign="top" rowspan="1" colspan="1">64.4</td><td align="center" valign="top" rowspan="1" colspan="1">29.8</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">El Salvador</td><td align="center" valign="top" rowspan="1" colspan="1">26.7</td><td align="center" valign="top" rowspan="1" colspan="1">70.2/28.9</td><td align="center" valign="top" rowspan="1" colspan="1">61.6</td><td align="center" valign="top" rowspan="1" colspan="1">41.6</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Guatemala</td><td align="center" valign="top" rowspan="1" colspan="1">21.2</td><td align="center" valign="top" rowspan="1" colspan="1">46.7/NA</td><td align="center" valign="top" rowspan="1" colspan="1">62.2</td><td align="center" valign="top" rowspan="1" colspan="1">67.7</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Honduras</td><td align="center" valign="top" rowspan="1" colspan="1">23.4</td><td align="center" valign="top" rowspan="1" colspan="1">49.3/21.2</td><td align="center" valign="top" rowspan="1" colspan="1">61.6</td><td align="center" valign="top" rowspan="1" colspan="1">74.3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">M&#x000e9;xico</td><td align="center" valign="top" rowspan="1" colspan="1">27.4</td><td align="center" valign="top" rowspan="1" colspan="1">NA/29.9</td><td align="center" valign="top" rowspan="1" colspan="1">63.2</td><td align="center" valign="top" rowspan="1" colspan="1">41.2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Nicaragua</td><td align="center" valign="top" rowspan="1" colspan="1">25.2</td><td align="center" valign="top" rowspan="1" colspan="1">NA</td><td align="center" valign="top" rowspan="1" colspan="1">62.4</td><td align="center" valign="top" rowspan="1" colspan="1">58.3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Panama</td><td align="center" valign="top" rowspan="1" colspan="1">28.7</td><td align="center" valign="top" rowspan="1" colspan="1">NA</td><td align="center" valign="top" rowspan="1" colspan="1">64.0</td><td align="center" valign="top" rowspan="1" colspan="1">21.4</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Paraguay</td><td align="center" valign="top" rowspan="1" colspan="1">24.9</td><td align="center" valign="top" rowspan="1" colspan="1">NA</td><td align="center" valign="top" rowspan="1" colspan="1">68.6</td><td align="center" valign="top" rowspan="1" colspan="1">42.3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Per&#x000fa;</td><td align="center" valign="top" rowspan="1" colspan="1">27.5</td><td align="center" valign="top" rowspan="1" colspan="1">78.4/NA</td><td align="center" valign="top" rowspan="1" colspan="1">71.8</td><td align="center" valign="top" rowspan="1" colspan="1">22.7</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Uruguay</td><td align="center" valign="top" rowspan="1" colspan="1">34.9</td><td align="center" valign="top" rowspan="1" colspan="1">NA</td><td align="center" valign="top" rowspan="1" colspan="1">65.8</td><td align="center" valign="top" rowspan="1" colspan="1">4.4</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Venezuela</td><td align="center" valign="top" rowspan="1" colspan="1">27.4</td><td align="center" valign="top" rowspan="1" colspan="1">74.8/NA</td><td align="center" valign="top" rowspan="1" colspan="1">64.8</td><td align="center" valign="top" rowspan="1" colspan="1">32.1</td></tr></tbody></table><table-wrap-foot><fn id="tfn3"><p><italic><sup>a</sup>Source: United Nations, Department of Economic and Social Affairs, Population Division (2015). World Population Prospects: The 2015 Revision, Key Findings and Advance Tables. Working Paper No. ESA/P/WP.241</italic>.</p></fn><fn id="tfn4"><p><italic><sup>b</sup>Source: Economic Commission for Latin America and the Caribbean (ECLAC), Statistical Yearbook for Latin America and the Caribbean, 2016 (LC/PUB.2017/2-P), Santiago, 2016. Data correspond to the most recent available year</italic>.</p></fn></table-wrap-foot></table-wrap></sec><sec id="S1-4"><title>Challenges in Identifying Hispanics/Latinos in US Government Reports and the Scientific Literature</title><sec id="S1-4-1"><title>Demographic Terminology</title><p>From the late 1800s and through most of the twentieth century, several terms have been used in the Census data and the medical literature to attempt to identify persons of Mexican origin, and later other Hispanics/Latinos (<xref rid="B32" ref-type="bibr">32</xref>, <xref rid="B33" ref-type="bibr">33</xref>). Not surprisingly, the terms failed to accurately identify this elusive and complex mosaic of populations.</p><p>Through several modifications to the US Census since 1970 (<xref rid="B33" ref-type="bibr">33</xref>), blanket demographic terms such as &#x0201c;Hispanic&#x0201d; and &#x0201c;Latino&#x0201d; have been used to attempt to capture the specific cultural identities within the &#x0201c;Hispanic or Latino&#x0201d; populations. Despite the population&#x02019;s diversity in virtually every element, this conglomerate of races, nationalities, and cultures is still regarded by many as a monolith.</p></sec><sec id="S1-4-2"><title>Publications on US Hispanic/Latino Health</title><p>The earliest scientific reports on the health of any US Hispanic/Latino heritage group date from 1929 or earlier (<xref rid="B34" ref-type="bibr">34</xref>), and focused on tuberculosis in Mexican immigrants. Subsequent studies published from the 1950s to the 1970s addressed farm laborers&#x02019; health (<xref rid="B35" ref-type="bibr">35</xref>), folk medicine (<xref rid="B36" ref-type="bibr">36</xref>), sociological, psychiatric, and behavioral issues (<xref rid="B37" ref-type="bibr">37</xref>&#x02013;<xref rid="B42" ref-type="bibr">42</xref>), hematologic and gastrointestinal disorders (<xref rid="B43" ref-type="bibr">43</xref>&#x02013;<xref rid="B46" ref-type="bibr">46</xref>), infectious and tropical diseases (<xref rid="B47" ref-type="bibr">47</xref>&#x02013;<xref rid="B49" ref-type="bibr">49</xref>), and women&#x02019;s fertility (<xref rid="B50" ref-type="bibr">50</xref>), among other topics, and focused on Mexican immigrants, Puerto Rican migrants, and Puerto Rico. Thus, for most of the twentieth century, health-related studies in Hispanics/Latinos were isolated and did not address chronic diseases; furthermore, the manner in which Hispanics/Latinos were classified was inconsistent. Although the Framingham Heart Study was initiated in 1948 (<xref rid="B51" ref-type="bibr">51</xref>), and its first analyses on the incidence of cardiovascular disease (CVD) and associated risk factors were published between 1957 and 1959 (<xref rid="B52" ref-type="bibr">52</xref>, <xref rid="B53" ref-type="bibr">53</xref>), the study of chronic diseases, in particular CV morbidity and mortality, in Hispanics/Latinos in the US did not start until the 1960s (<xref rid="B54" ref-type="bibr">54</xref>).</p><p>As we will describe, differences and similarities in the prevalence of diabetes and CV risk factors between Hispanics/Latinos and other racial/ethnic groups, and among Hispanic/Latino heritage groups would gradually be documented by various studies across the US. Understanding these differences and similarities could shed light on the interaction among various health determinants, and diabetes risk across populations. These differences and similarities are still being investigated.</p></sec></sec></sec><sec id="S2"><title>Epidemiology of DM in Hispanics/Latinos in the US and Latin America</title><sec id="S2-1"><title>Diabetes in Hispanics/Latinos in the US</title><p>During the past three decades of the twentieth century, reports about chronic diseases&#x02014;including diabetes&#x02014;in the US Hispanic/Latino population started to be generated and disseminated through several epidemiological studies, including but not limited to the Puerto Rico Heart Health Program (<xref rid="B54" ref-type="bibr">54</xref>, <xref rid="B55" ref-type="bibr">55</xref>), the Laredo Project (<xref rid="B56" ref-type="bibr">56</xref>), the San Antonio Heart Study (SAHS) (<xref rid="B57" ref-type="bibr">57</xref>, <xref rid="B58" ref-type="bibr">58</xref>), the Hispanic Health and Nutrition Examination Survey (Hispanic HANES) (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B59" ref-type="bibr">59</xref>, <xref rid="B60" ref-type="bibr">60</xref>), the San Luis Valley Diabetes Study (<xref rid="B61" ref-type="bibr">61</xref>), and later the National Health Interview Survey (NHIS) (<xref rid="B28" ref-type="bibr">28</xref>), the Behavioral Risk Factor Surveillance Survey (BRFSS) (<xref rid="B62" ref-type="bibr">62</xref>), and the National Health and Nutrition Examination Survey (NHANES) (<xref rid="B63" ref-type="bibr">63</xref>). However, most of the studies were cross-sectional and focused on one Hispanic/Latino heritage group or specific region of the US. Of these, the Hispanic HANES, conducted from 1982 to 1984, was the first epidemiological study to describe the prevalence of some chronic diseases, including diabetes, in the three largest Hispanic/Latino heritage groups at the time: Mexicans, Puerto Ricans, and Cubans (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B59" ref-type="bibr">59</xref>, <xref rid="B60" ref-type="bibr">60</xref>). However, the Hispanic HANES was a one-time cross-sectional study. In 2006, the Hispanic Community Health Study/Study of Latinos (HCHS/SOL), a prospective study, was established to describe the prevalence of chronic diseases (especially CV and pulmonary), identify their risk or protective factors, and correlate them with future health outcomes in a cohort of US Hispanics/Latinos from diverse origins in a cohort of over 16,000 Hispanic/Latino adults from Central American, Cuban, Dominican, Mexican, Puerto Rican, and South American heritage living in San Diego, Chicago, Miami, and New York (<xref rid="B64" ref-type="bibr">64</xref>, <xref rid="B65" ref-type="bibr">65</xref>).</p><p>There are important differences in these studies that make comparisons across them difficult: methodological variations in selection of study populations, diagnostic criteria to determine diabetes, lack of assessment to distinguish between type 1 and type 2 DM, proposed diagnostic cut points (<xref rid="B66" ref-type="bibr">66</xref>&#x02013;<xref rid="B68" ref-type="bibr">68</xref>), and time-period of analysis. Further caution must be taken when interpreting data gathered across studies, because the lack of confirmatory testing of diagnostic criteria in some studies could result in an inaccurate estimate of the prevalence (<xref rid="B66" ref-type="bibr">66</xref>). Since some surveys restrict their sampling to specific geographic areas, generalizability of the findings to all Hispanics/Latinos living in the US or Latin America is reduced.</p><p>Table <xref ref-type="table" rid="T3">3</xref> lists selected US epidemiological studies focused on or that have included Hispanics/Latinos, and that have estimated diabetes prevalence (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B11" ref-type="bibr">11</xref>&#x02013;<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B54" ref-type="bibr">54</xref>&#x02013;<xref rid="B61" ref-type="bibr">61</xref>, <xref rid="B64" ref-type="bibr">64</xref>, <xref rid="B65" ref-type="bibr">65</xref>, <xref rid="B69" ref-type="bibr">69</xref>&#x02013;<xref rid="B95" ref-type="bibr">95</xref>). An analysis of the 2011&#x02013;2012 NHANES cycle showed that the unadjusted prevalence of total diabetes based on ADA criteria (2-h OGTT, FPG, or HbA1c) was 14.3% (9.1% for diagnosed diabetes and 5.2% for undiagnosed diabetes) and 38.0% for prediabetes (<xref rid="B8" ref-type="bibr">8</xref>). The prevalence of total diabetes for those of Hispanic/Latino heritage was twice as high (22.6%) than for NHWs (11.3%) and higher than the other racial/ethnic groups included in the study. The age-standardized prevalence of undiagnosed diabetes among Hispanic/Latino adults (49.0%) was significantly higher than that for NHWs (32.3%), and slightly lower than that for non-Hispanic Asians (50.9%) (<xref rid="B8" ref-type="bibr">8</xref>).</p><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Prevalence of type 2 diabetes and prediabetes among Hispanic/Latino populations in the US (selected studies).</p></caption><table frame="hsides" rules="rows"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Study (reference)</th><th valign="top" align="center" rowspan="1" colspan="1">Study period</th><th valign="top" align="left" rowspan="1" colspan="1">Sample size</th><th valign="top" align="center" rowspan="1" colspan="1">Age range (years)</th><th valign="top" align="left" rowspan="1" colspan="1">Glycemic criteria</th><th valign="top" align="left" rowspan="1" colspan="1">Key findings</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Puerto Rico Heart Health Program (<xref rid="B54" ref-type="bibr">54</xref>, <xref rid="B55" ref-type="bibr">55</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">1965&#x02013;1980</td><td align="left" valign="top" rowspan="1" colspan="1">2,567 rural and 6,190 urban Puerto Rican men</td><td align="center" valign="top" rowspan="1" colspan="1">45&#x02013;64</td><td align="left" valign="top" rowspan="1" colspan="1">FPG&#x02009;&#x02265;&#x02009;126&#x02009;mg/dL, self-reports of physician-diagnosed diabetes, or use of insulin or hypoglycemic agents</td><td align="left" valign="top" rowspan="1" colspan="1">3.6% in rural men and 9% in urban men</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Laredo Project (<xref rid="B56" ref-type="bibr">56</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">1979</td><td align="left" valign="top" rowspan="1" colspan="1">389 Mexican Americans</td><td align="center" valign="top" rowspan="1" colspan="1">40&#x02013;74</td><td align="left" valign="top" rowspan="1" colspan="1">Fasting hyperglycemia defined as FPG&#x02009;&#x0003e;&#x02009;140&#x02009;mg/dL</td><td align="left" valign="top" rowspan="1" colspan="1">Age-adjusted prevalence was 10.9% in men and 10.1% in women</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Starr County Study, Texas (<xref rid="B69" ref-type="bibr">69</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">1981</td><td align="left" valign="top" rowspan="1" colspan="1">2,498 Mexican Americans</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;15</td><td align="left" valign="top" rowspan="1" colspan="1">Zero-hour (fasting) plasma glucose level &#x02265;140&#x02009;mg/dL or a 2-h level &#x02265;200&#x02009;mg/dL.</td><td align="left" valign="top" rowspan="1" colspan="1">6.9% males and 6.7% females</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Albuquerque, New Mexico (<xref rid="B70" ref-type="bibr">70</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">1984&#x02013;1985</td><td align="left" valign="top" rowspan="1" colspan="1">1,175 Hispanics</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;18</td><td align="left" valign="top" rowspan="1" colspan="1">Self-reported diagnosis</td><td align="left" valign="top" rowspan="1" colspan="1"><list list-type="simple"><list-item><p>Prevalence increased with age: men: 1.9% in 25&#x02013;34 to 13.8% in &#x02265;75.</p></list-item><list-item><p>Women: 0.6% in 25&#x02013;34 to 16.1% in &#x02265;75</p></list-item></list>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">San Luis Valley Diabetes Study, Colorado (<xref rid="B61" ref-type="bibr">61</xref>, <xref rid="B71" ref-type="bibr">71</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">1984</td><td align="left" valign="top" rowspan="1" colspan="1"><list list-type="simple"><list-item><p>607 Hispanics without prior history of DM</p></list-item><list-item><p>343 Hispanics with previously diagnosed DM</p></list-item></list></td><td align="center" valign="top" rowspan="1" colspan="1">20&#x02013;74</td><td align="left" valign="top" rowspan="1" colspan="1">History of previously diagnosed DM with confirmation using FPG&#x02009;&#x02265;&#x02009;140&#x02009;mg/dL or 2-h OGTT&#x02009;&#x02265;&#x02009;200&#x02009;mg/dL</td><td align="left" valign="top" rowspan="1" colspan="1"><list list-type="simple"><list-item><p>Age-adjusted prevalence of previously diagnosed DM: 3.3% in men and 4.9% in women</p></list-item><list-item><p>Newly diagnosed DM: 2.2% in men and 4.3% in women</p></list-item></list>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">San Antonio Heart Study, Texas (<xref rid="B57" ref-type="bibr">57</xref>, <xref rid="B58" ref-type="bibr">58</xref>, <xref rid="B72" ref-type="bibr">72</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">First phase: 1979&#x02013;1982<break/>Second phase: 1984&#x02013;1988</td><td align="left" valign="top" rowspan="1" colspan="1">3,302 Mexican Americans</td><td align="center" valign="top" rowspan="1" colspan="1">25&#x02013;64</td><td align="left" valign="top" rowspan="1" colspan="1">2-h OGTT</td><td align="left" valign="top" rowspan="1" colspan="1"><list list-type="simple"><list-item><p>Age-adjusted prevalence for men was 14.0% in the barrio vs. 6.5% in the suburbs and for men was 18.0% in the barrio vs. 4.3% in the suburbs.</p></list-item><list-item><p>Prevalence was two to three times higher in Mexican Americans than in NHWs.</p></list-item></list>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Puerto Rico Household Health Interview Survey (<xref rid="B73" ref-type="bibr">73</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">1975&#x02013;1986</td><td align="left" valign="top" rowspan="1" colspan="1">Minimum sample size of 2,696 in 1983<break/>Maximum sample size of 12,212 in 1976</td><td align="center" valign="top" rowspan="1" colspan="1">All ages</td><td align="left" valign="top" rowspan="1" colspan="1">Self-reported diagnosis</td><td align="left" valign="top" rowspan="1" colspan="1">3.1% in 1975 to 5.1% in 1986<break/>4.5% of males and 5.8% of females reported a history of DM</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HHANES (<xref rid="B11" ref-type="bibr">11</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">1982&#x02013;1984</td><td align="left" valign="top" rowspan="1" colspan="1">6,588 Hispanics</td><td align="center" valign="top" rowspan="1" colspan="1">20&#x02013;74&#x02009;years</td><td align="left" valign="top" rowspan="1" colspan="1">OGTT administered to subsample of 1,326</td><td align="left" valign="top" rowspan="1" colspan="1"><list list-type="simple"><list-item><p>Cubans 45&#x02013;74: 15.8%</p></list-item><list-item><p>Mexican Americans 45&#x02013;74: 23.9%</p></list-item><list-item><p>Puerto Ricans 45&#x02013;74: 26.1%</p></list-item><list-item><p>Cubans 20&#x02013;44: 2.4%</p></list-item><list-item><p>Mexican Americans 20&#x02013;44: 3.8%</p></list-item><list-item><p>Puerto Ricans 20&#x02013;44: 4.1%</p></list-item></list>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mexico City Diabetes Study (<xref rid="B74" ref-type="bibr">74</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">1979&#x02013;1982</td><td align="left" valign="top" rowspan="1" colspan="1">2,282 individuals of Mexican descent in San Antonio, and Mexicans in Mexico City</td><td align="center" valign="top" rowspan="1" colspan="1">35&#x02013;64</td><td align="left" valign="top" rowspan="1" colspan="1">FPG&#x02009;&#x02265;&#x02009;126&#x02009;mg/dL</td><td align="left" valign="top" rowspan="1" colspan="1"><list list-type="simple"><list-item><p>San Antonio: 17.8% in men and 23% in women</p></list-item><list-item><p>Mexico City: 12.3% in men and 18.5% in women</p></list-item></list>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NHANES (<xref rid="B75" ref-type="bibr">75</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">1999&#x02013;2000</td><td align="left" valign="top" rowspan="1" colspan="1">915<break/>Mexican Americans, NHBs, and NHWs</td><td align="center" valign="top" rowspan="1" colspan="1">12&#x02013;19</td><td align="left" valign="top" rowspan="1" colspan="1">IFG: 100&#x02013;125&#x02009;mg/dL</td><td align="left" valign="top" rowspan="1" colspan="1">Prevalence of IFG was 13.0, 4.2, and 7% in Mexican Americans, NHBs, and NHWs, respectively</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NHANES (<xref rid="B76" ref-type="bibr">76</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">1999&#x02013;2002</td><td align="left" valign="top" rowspan="1" colspan="1">1,802 adolescents without DM (672 Mexican American)</td><td align="center" valign="top" rowspan="1" colspan="1">12&#x02013;19</td><td align="left" valign="top" rowspan="1" colspan="1">HOMA-IR</td><td align="left" valign="top" rowspan="1" colspan="1">Mexican American children had higher HOMA-IR levels than white children</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NHANES (<xref rid="B77" ref-type="bibr">77</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">1988&#x02013;1994<break/>1999&#x02013;2002</td><td align="left" valign="top" rowspan="1" colspan="1">1988&#x02013;1994: 31,638 Mexican American, NHW and NHB adults<break/>1999&#x02013;2002: 17,217 Mexican American, NHW and NHB adults</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;20</td><td align="left" valign="top" rowspan="1" colspan="1"><list list-type="simple"><list-item><p>Previously diagnosed DM</p></list-item><list-item><p>Undiagnosed DM: FPG&#x02009;&#x02265;&#x02009;126&#x02009;mg/dL</p></list-item><list-item><p>IFG: 100&#x02013;125&#x02009;mg/dL</p></list-item></list>
</td><td align="left" valign="top" rowspan="1" colspan="1"><list list-type="simple"><list-item><p>Among Mexican Americans:</p></list-item><list-item><p>Previously diagnosed DM: 9.6 and 10.6%</p></list-item><list-item><p>Undiagnosed DM: 4.7 and 3.5%</p></list-item><list-item><p>IFG: 32.9 and 33.0%</p></list-item></list>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MESA (<xref rid="B78" ref-type="bibr">78</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">2000&#x02013;2002</td><td align="left" valign="top" rowspan="1" colspan="1">1,437 Hispanics</td><td align="center" valign="top" rowspan="1" colspan="1">45&#x02013;84</td><td align="left" valign="top" rowspan="1" colspan="1">FPG&#x02009;&#x02265;&#x02009;126&#x02009;mg/dL or use of hypoglycemic medication</td><td align="left" valign="top" rowspan="1" colspan="1"><list list-type="simple"><list-item><p>Age-adjusted prevalence of diabetes</p></list-item><list-item><p>Mexican Americans: 22.3%</p></list-item><list-item><p>Dominicans: 16.1%</p></list-item><list-item><p>Puerto Ricans: 19.7%</p></list-item><list-item><p>Other Hispanics: 15.2%</p></list-item></list>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NHANES (<xref rid="B79" ref-type="bibr">79</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">2005&#x02013;2006</td><td align="left" valign="top" rowspan="1" colspan="1">2,806 Mexican American, NHW and NHB adults</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;20</td><td align="left" valign="top" rowspan="1" colspan="1">FPG, OGTT</td><td align="left" valign="top" rowspan="1" colspan="1"><list list-type="simple"><list-item><p>Mexican Americans</p></list-item><list-item><p>Diagnosed DM: 12.6%</p></list-item><list-item><p>Undiagnosed DM: 7.5%</p></list-item><list-item><p>Total DM: 20.1%</p></list-item><list-item><p>Percent undiagnosed DM: 35.9%</p></list-item><list-item><p>Prediabetes: 32.0%</p></list-item><list-item><p>Prediabetes/DM: 52.0%</p></list-item></list></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NHANES (<xref rid="B80" ref-type="bibr">80</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">2005&#x02013;2006</td><td align="left" valign="top" rowspan="1" colspan="1">277 Mexican Americans<break/>257 NHBs<break/>198 NHWs</td><td align="center" valign="top" rowspan="1" colspan="1">12&#x02013;19</td><td align="left" valign="top" rowspan="1" colspan="1">FPG and 2-h OGTT<break/>ADA 1998</td><td align="left" valign="top" rowspan="1" colspan="1">Prevalence of IFG, IFT, and prediabetes among Mexican Americans were 14.3, 3.5, and 16.9%, respectively</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Study of Women&#x02019;s Health Across the Nation (SWAN) (<xref rid="B81" ref-type="bibr">81</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">1996&#x02013;1997</td><td align="left" valign="top" rowspan="1" colspan="1">3,302 women in seven sites; analysis based on 420 women recruited in the New Jersey site</td><td align="center" valign="top" rowspan="1" colspan="1">42&#x02013;52</td><td align="left" valign="top" rowspan="1" colspan="1">FPG&#x02009;&#x02265;&#x02009;126&#x02009;mg/dL or self-reported use of insulin</td><td align="left" valign="top" rowspan="1" colspan="1">3.3% in Caucasians, 5.9% in Dominicans, 8.3% in Central Americans, 9.8% in Cubans, 13.5% in Puerto Ricans, 15.6% in South Americans</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Phase I of the US&#x02013;Mexico Border Diabetes Prevention and Control Project (<xref rid="B82" ref-type="bibr">82</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">2001&#x02013;2002</td><td align="left" valign="top" rowspan="1" colspan="1">4,027: 2,120 Hispanics from Mexico, 1,437 Hispanics from the US, and 470 non-Hispanics from the US.</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;18</td><td align="left" valign="top" rowspan="1" colspan="1">Self-reported diagnosis<break/>FPG&#x02009;&#x02265;&#x02009;126&#x02009;mg/dL</td><td align="left" valign="top" rowspan="1" colspan="1">Age-adjusted prevalence of self-reported and unrecognized DM was 16.6% of the Mexican side and 14.7% on the US side; age-adjusted prevalence of IFG was similar on both sides of the border (14.1% on the Mexican side and 13.6% on the US side)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BRFSS (<xref rid="B83" ref-type="bibr">83</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">1995&#x02013;2010</td><td align="left" valign="top" rowspan="1" colspan="1"><list list-type="simple"><list-item><p>1995: 1,193 in Montana to 5,107 in Maryland</p></list-item><list-item><p>2010: 1,964 in Alaska to 35,109 in Florida</p></list-item></list>
</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;18</td><td align="left" valign="top" rowspan="1" colspan="1">Self-reported diagnosis</td><td align="left" valign="top" rowspan="1" colspan="1"><list list-type="simple"><list-item><p>In 1995, age-adjusted prevalence was &#x0003e;6% in only three states, Washington, DC, and Puerto Rico.</p></list-item><list-item><p>In 2010, age-adjusted prevalence was highest (&#x0003e;10%) in Alabama, Mississippi, Puerto Rico, South Carolina, Tennessee, Texas, and West Virginia.</p></list-item></list>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NHANES (<xref rid="B85" ref-type="bibr">85</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">1999&#x02013;2008</td><td align="left" valign="top" rowspan="1" colspan="1">22,621 Mexican American, NHW and NHB adults, of whom 551 had undiagnosed DM</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;20</td><td align="left" valign="top" rowspan="1" colspan="1">Undiagnosed DM was defined as HbA1c&#x02009;&#x02265;&#x02009;6.5% without a self-report of physician-diagnosed DM</td><td align="left" valign="top" rowspan="1" colspan="1">Overall prevalence of undiagnosed DM of 1.5% in NHWs, 3.1% in NHBs, and 2.7% in Mexican Americans<break/>Overall prevalence of diagnosed DM of 6.7% in NHWs, 11.3% in NHBs, and 7.6% in Mexican Americans</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">California Health Interview Survey (<xref rid="B86" ref-type="bibr">86</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">2001, 2003, 2005, and 2007</td><td align="left" valign="top" rowspan="1" colspan="1">33,633 Hispanics and 126,488 NHWs</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;18</td><td align="left" valign="top" rowspan="1" colspan="1">Self-report of physician-diagnosed DM</td><td align="left" valign="top" rowspan="1" colspan="1"><list list-type="simple"><list-item><p>Mexicans: 9%</p></list-item><list-item><p>Central Americans: 1%</p></list-item><list-item><p>South Americans: 0.5%</p></list-item><list-item><p>2 or more countries of origin: 7%</p></list-item><list-item><p>Other Hispanics: 13%</p></list-item><list-item><p>NHWs: 7%</p></list-item></list>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NHANES (<xref rid="B87" ref-type="bibr">87</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">1999&#x02013;2002<break/>2003&#x02013;2006<break/>2007&#x02013;2010</td><td align="left" valign="top" rowspan="1" colspan="1">19,182 Mexican American, NHW and NHB adults</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;12</td><td align="left" valign="top" rowspan="1" colspan="1">HbA1c: 5.7&#x02013;6.4%<break/>FPG: 100&#x02013;125&#x02009;mg/dL</td><td align="left" valign="top" rowspan="1" colspan="1">Prevalence of prediabetes among Mexican Americans: 34.4, 30.3, and 37.8%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HCHS/SOL (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B84" ref-type="bibr">84</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">2008&#x02013;2011</td><td align="left" valign="top" rowspan="1" colspan="1">16,415 Hispanics</td><td align="center" valign="top" rowspan="1" colspan="1">18&#x02013;74</td><td align="left" valign="top" rowspan="1" colspan="1">FPG, 2-h OGTT, HbA1c</td><td align="left" valign="top" rowspan="1" colspan="1"><list list-type="simple"><list-item><p>Overall prevalence of DM was 16.9%</p></list-item><list-item><p>South Americans: 10.2%</p></list-item><list-item><p>Cubans: 13.4%</p></list-item><list-item><p>Central Americans: 17.7%</p></list-item><list-item><p>Dominicans: 18.1%</p></list-item><list-item><p>Puerto Ricans: 18.1%</p></list-item><list-item><p>Mexicans/Mexican Americans: 18.3%</p></list-item></list>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">SEARCH Study (<xref rid="B88" ref-type="bibr">88</xref>, <xref rid="B89" ref-type="bibr">89</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">2001&#x02013;2009</td><td align="left" valign="top" rowspan="1" colspan="1">3,345,783 youths in 2001 and 3,458,974 in 2009</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;20</td><td align="left" valign="top" rowspan="1" colspan="1">Physician-diagnosed DM</td><td align="left" valign="top" rowspan="1" colspan="1">Prevalence of type 2 DM among Hispanic youth aged 10&#x02013;19&#x02009;years was 0.45 per 1,000 in 2001 and 0.79 per 1,000 in 2009, representing a relative increase of 76% over the 8-year period</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NHANES (<xref rid="B90" ref-type="bibr">90</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">1988&#x02013;1994<break/>1999&#x02013;2004<break/>2005&#x02013;2010</td><td align="left" valign="top" rowspan="1" colspan="1">1988&#x02013;1994: 4,201<break/>1999&#x02013;2004: 2,860<break/>2005&#x02013;2010: 2,765<break/>Mexican Americans</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;20</td><td align="left" valign="top" rowspan="1" colspan="1">Based on HbA1c</td><td align="left" valign="top" rowspan="1" colspan="1"><list list-type="simple"><list-item><p>Diagnosed DM: 7.6 (0.57), 8.8 (1.06), 11.9 (1.01)</p></list-item><list-item><p>Undiagnosed DM: 1.8 (0.17), 2.3 (0.40), 2.9 (0.32)</p></list-item><list-item><p>Prediabetes: 5.6 (0.64), 10.6 (0.68), 12.7 (0.76)</p></list-item></list>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NHANES (<xref rid="B8" ref-type="bibr">8</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">1988&#x02013;2012</td><td align="left" valign="top" rowspan="1" colspan="1">2011&#x02013;2012: 2,623 (561 All Hispanics)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;20</td><td align="left" valign="top" rowspan="1" colspan="1">Self-reported diagnosis<break/>Undiagnosed DM based on FPG, 2-h OGTT, HbA1c</td><td align="left" valign="top" rowspan="1" colspan="1"><list list-type="simple"><list-item><p>All Hispanics</p></list-item><list-item><p>Total DM: 22.6%</p></list-item><list-item><p>Diagnosed DM: 12.5%</p></list-item><list-item><p>Undiagnosed DM: 10.1%</p></list-item><list-item><p>Prediabetes: 36.8%</p></list-item><list-item><p>Mexican Americans</p></list-item><list-item><p>Total DM: 23.8%</p></list-item><list-item><p>Diagnosed DM: 14.4%</p></list-item><list-item><p>Undiagnosed DM: 9.4%</p></list-item><list-item><p>Prediabetes: 38.0%</p></list-item></list>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NHIS (<xref rid="B91" ref-type="bibr">91</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">1997&#x02013;2012</td><td align="left" valign="top" rowspan="1" colspan="1">427,975 (367,292 non-Hispanics and 60,683 Hispanics)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;18</td><td align="left" valign="top" rowspan="1" colspan="1">Self-reported diagnosis</td><td align="left" valign="top" rowspan="1" colspan="1"><list list-type="simple"><list-item><p>Less than high school education: 17.6% for Puerto Ricans, 13.4% for Cubans, and 9.7% for Mexicans</p></list-item><list-item><p>High school diploma/GED: 9.8% for Puerto Ricans, 8.2% for Cubans, and 6.3% for Mexicans</p></list-item><list-item><p>More than high school education: 6.8% for Puerto Ricans, 6.0% for Cubans, and 6.7% for Mexicans</p></list-item></list>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HCHS/SOL (<xref rid="B13" ref-type="bibr">13</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">2008&#x02013;2011</td><td align="left" valign="top" rowspan="1" colspan="1">15,507 Hispanics</td><td align="center" valign="top" rowspan="1" colspan="1">18&#x02013;74</td><td align="left" valign="top" rowspan="1" colspan="1">FPG, 2-h OGTT, HbA1c</td><td align="left" valign="top" rowspan="1" colspan="1">6.7% met at least one diagnostic criterion of probable DM &#x02013; 39.4% of total DM (self-reported plus probable DM)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HCHS/SOL (<xref rid="B92" ref-type="bibr">92</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">2012&#x02013;2014</td><td align="left" valign="top" rowspan="1" colspan="1">1,466 Hispanics</td><td align="center" valign="top" rowspan="1" colspan="1">8&#x02013;16</td><td align="left" valign="top" rowspan="1" colspan="1">FPG and HbA1c<break/>ADA 2015</td><td align="left" valign="top" rowspan="1" colspan="1">Prevalence of prediabetes/DM was 16.5%, being higher in boys (20.9%) than in girls (11.8%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Starr County, Texas (<xref rid="B93" ref-type="bibr">93</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">2002&#x02013;2014</td><td align="left" valign="top" rowspan="1" colspan="1">5,230 Mexican American adults</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;20</td><td align="left" valign="top" rowspan="1" colspan="1">FPG, OGTT, HbA1c</td><td align="left" valign="top" rowspan="1" colspan="1"><list list-type="simple"><list-item><p>Previously identified DM: 11.8% in men and 14.4% in women</p></list-item><list-item><p>Newly identified DM: 11.9% in men and 12.3% in women</p></list-item><list-item><p>Total DM: 23.7% in men and 26.7% in women</p></list-item><list-item><p>Prediabetes: 32.8% in men and 31.9% in women</p></list-item></list>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NHANES (<xref rid="B94" ref-type="bibr">94</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">2005&#x02013;2014</td><td align="left" valign="top" rowspan="1" colspan="1">2,606 NHWs, NHBs, and Hispanics</td><td align="center" valign="top" rowspan="1" colspan="1">12&#x02013;19</td><td align="left" valign="top" rowspan="1" colspan="1">FPG, 2-h OGTT, HbA1c</td><td align="left" valign="top" rowspan="1" colspan="1"><list list-type="simple"><list-item><p>Prevalence of total DM, prediabetes, and percent undiagnosed DM:</p></list-item><list-item><p>All Hispanics: 0.76, 22.9, and 39.5%</p></list-item><list-item><p>Mexican Americans: 0.85, 22.4, and 43.9%</p></list-item></list>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HCHS/SOL (<xref rid="B95" ref-type="bibr">95</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">2008&#x02013;2011</td><td align="left" valign="top" rowspan="1" colspan="1">15,507 Hispanics</td><td align="center" valign="top" rowspan="1" colspan="1">18&#x02013;74</td><td align="left" valign="top" rowspan="1" colspan="1">FPG, 2-h OGTT, HbA1c</td><td align="left" valign="top" rowspan="1" colspan="1"><list list-type="simple"><list-item><p>Prediabetes: 36.3%</p></list-item><list-item><p>Total IFG: 18.1%</p></list-item><list-item><p>Total IGT: 15.4%</p></list-item><list-item><p>Total impaired HbA1c: 21.2%</p></list-item><list-item><p>IFG&#x02009;+&#x02009;impaired HbA1c: 8.6%</p></list-item><list-item><p>IFG&#x02009;+&#x02009;IGT&#x02009;+&#x02009;impaired HbA1c: 3.8%</p></list-item></list>
</td></tr></tbody></table></table-wrap><p>The baseline examination of the HCHS/SOL (2008&#x02013;2011) showed that the prevalence of diabetes ranged from 10.2% in South Americans to 18.1% in Dominicans and Puerto Ricans and 18.3% in Mexicans (<xref rid="B12" ref-type="bibr">12</xref>). Prevalence by sex ranged from a low of 10.6% for South American men to a high of 18.7% for Mexican men, and from 9.8% in South American women to 19.5% in Puerto Rican women. Diabetes prevalence increased significantly with age and BMI but was inversely associated with years of education and household income (<xref rid="B12" ref-type="bibr">12</xref>). Although the prevalence of diabetes also increased significantly with length of residence in the US, it was similar among US-born participants and foreign-born participants residing in the US for fewer than 5&#x02009;years. However, the prevalence was significantly higher among foreign-born participants with longer than 10&#x02009;years of residence in the US. Nearly half of Hispanics/Latinos (48%) had adequate glycemic control, a rate slightly lower than those for NHWs (52.9%) and non-Hispanic Blacks (52.6%) who participated in the 1988&#x02013;2010 NHANES cycles (<xref rid="B96" ref-type="bibr">96</xref>). Preliminary data from the second examination of the HCHS/SOL (2014&#x02013;2017) demonstrated an overall increase in prevalence of diabetes, which is still higher among Mexicans, Dominicans, and Puerto Ricans and lower among Cubans (<xref rid="B97" ref-type="bibr">97</xref>).</p><p>The HCHS/SOL also determined that nearly 40% of Hispanics/Latinos with diabetes met at least one ADA criterion of undiagnosed diabetes (<xref rid="B13" ref-type="bibr">13</xref>). This finding is consistent with a recent NHANES data analysis that showed that Mexican Americans and other Hispanic women were more likely to be unaware of their diabetes status (<xref rid="B98" ref-type="bibr">98</xref>).</p><p>An additional analysis of HCHS/SOL baseline data found that 36.3% of the target population met at least one of the ADA criteria for prediabetes (<xref rid="B97" ref-type="bibr">97</xref>). Prevalence of prediabetes varied by age, sex, Hispanic/Latino heritage groups, and BMI categories, but was similar across place of birth and years living in the US. In the 2011&#x02013;2012 NHANES cycle, the overall prevalence of prediabetes was 38.0%, and 36.8% for all Hispanics/Latinos (<xref rid="B8" ref-type="bibr">8</xref>).</p><p>Although there is a paucity of studies examining the prevalence of type 2 DM among children and adolescents, evidence suggests that prediabetes is highly prevalent among Hispanic/Latino adolescents in the US. In a recent analysis based on the 2005&#x02013;2014 NHANES cycles, the prevalence of prediabetes (based on FPG, 2hPG, or HbA1c) among all Hispanic/Latino adolescents (aged 12&#x02013;19&#x02009;years) was 22.9%. Among Mexican Americans it was 22.4%, significantly higher (<italic>P</italic>&#x02009;=&#x02009;0.001) than in NHWs (15.1%) (<xref rid="B94" ref-type="bibr">94</xref>). Recent data from the Study of Latino Youth, a population-based cross-sectional study of 1,466 Hispanic/Latino youth aged 8&#x02013;16&#x02009;years, found a combined prevalence of prediabetes and diabetes (based on FPG and HbA1c) of 16.5% (<xref rid="B92" ref-type="bibr">92</xref>), with boys having a higher prevalence compared with girls (20.9 vs. 11.8%, respectively). However, the study did not assess differences by Hispanic/Latino heritage group nor was OGTT available.</p><p>The limited number of studies examining the incidence of type 2 DM in Hispanic/Latinos (<xref rid="B99" ref-type="bibr">99</xref>&#x02013;<xref rid="B106" ref-type="bibr">106</xref>) indicates that the incidence has been higher than in NHWs across all age groups (<xref rid="B99" ref-type="bibr">99</xref>&#x02013;<xref rid="B101" ref-type="bibr">101</xref>) (Table <xref ref-type="table" rid="T4">4</xref>). A recent analysis of type 2 DM in children examined in five study centers in the U.S (<xref rid="B105" ref-type="bibr">105</xref>) reported an annual rate increase significantly greater for Hispanics/Latinos (3.1%) compared to NHWs (0.6%), but significantly lower than Native Americans (8.9%). However, a recent analysis based on NHANES 2005&#x02013;2014 cycle did not reveal an increase in incidence in this age group (<xref rid="B94" ref-type="bibr">94</xref>).</p><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>Incidence of type 2 diabetes among Hispanic/Latino populations in the US (selected studies).</p></caption><table frame="hsides" rules="rows"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Study and reference</th><th valign="top" align="center" rowspan="1" colspan="1">Study period</th><th valign="top" align="left" rowspan="1" colspan="1">Sample size</th><th valign="top" align="center" rowspan="1" colspan="1">Age range (years)</th><th valign="top" align="left" rowspan="1" colspan="1">Glycemic criteria</th><th valign="top" align="left" rowspan="1" colspan="1">Key findings</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">San Antonio Heart Study, Texas (<xref rid="B99" ref-type="bibr">99</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">1979&#x02013;1992</td><td align="left" valign="top" rowspan="1" colspan="1">3,302 Mexican Americans</td><td align="center" valign="top" rowspan="1" colspan="1">25&#x02013;64</td><td align="left" valign="top" rowspan="1" colspan="1">2-h OGTT</td><td align="left" valign="top" rowspan="1" colspan="1">8-year incidence was 8.7% among Mexican Americans in the low-income barrio neighborhoods; 8.4% among Mexican Americans in the transitional neighborhoods; and 3.4% among Mexican Americans in the suburban neighborhoods</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">San Luis Valley Diabetes Study, Colorado (<xref rid="B100" ref-type="bibr">100</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">1983&#x02013;1988</td><td align="left" valign="top" rowspan="1" colspan="1">607 Hispanics without prior history of DM<break/>343 Hispanics with previously diagnosed DM</td><td align="center" valign="top" rowspan="1" colspan="1">20&#x02013;74</td><td align="left" valign="top" rowspan="1" colspan="1">History of previously diagnosed DM with confirmation using FPG&#x02009;&#x02265;&#x02009;140&#x02009;mg/dL or 2-h OGTT&#x02009;&#x02265;&#x02009;200&#x02009;mg/dL</td><td align="left" valign="top" rowspan="1" colspan="1">6-year incidence for Hispanic men and women was 4.3/1,000 and 5.3/1,000, respectively; incidence was 2.4 (95% CI: 1.6&#x02013;3.6) times higher in Hispanic men than in NHW men; incidence in Hispanic women was 3.6 (95% CI: 2.4&#x02013;5.4) times higher.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">San Antonio Heart Study, Texas (<xref rid="B101" ref-type="bibr">101</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">1987&#x02013;1996</td><td align="left" valign="top" rowspan="1" colspan="1">1,995 Mexican Americans<break/>1,231 NHWs</td><td align="center" valign="top" rowspan="1" colspan="1">25&#x02013;64</td><td align="left" valign="top" rowspan="1" colspan="1">2-h OGTT&#x02009;&#x02265;&#x02009;200&#x02009;mg/dL<break/>FPG&#x02009;&#x02265;&#x02009;126&#x02009;mg/dL<break/>History of DM and receiving treatment with insulin or oral hypoglycemic agents</td><td align="left" valign="top" rowspan="1" colspan="1">7- to 8-year incidence increased from 5.7% for Mexican Americans enrolled in 1979 to 15.7% for participants enrolled in 1988.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">San Antonio Heart Study, and Mexico City Diabetes Study (<xref rid="B102" ref-type="bibr">102</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">1987&#x02013;1996</td><td align="left" valign="top" rowspan="1" colspan="1">1,995 Mexican Americans<break/>1,231 NHWs</td><td align="center" valign="top" rowspan="1" colspan="1">35&#x02013;64</td><td align="left" valign="top" rowspan="1" colspan="1">2-h OGTT&#x02009;&#x02265;&#x02009;200&#x02009;mg/dL<break/>FPG&#x02009;&#x02265;&#x02009;126&#x02009;mg/dL<break/>History of DM and receiving treatment with insulin or oral hypoglycemic agents</td><td align="left" valign="top" rowspan="1" colspan="1">6- to 8-year crude incidence was 90% higher in Mexican Americans men living in San Antonio than Mexicans in Mexico City: 2.70/100 versus 1.42/100; in women, the crude incidence was more than twofold higher in San Antonio than in Mexico City: 2.86/100 versus 1.21/100. Incidence remained significantly higher in San Antonio than in Mexico City after adjusting for several confounders.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">SEARCH for Diabetes in Youth Study, US (<xref rid="B103" ref-type="bibr">103</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">2002&#x02013;2005</td><td align="left" valign="top" rowspan="1" colspan="1">635 incident cases from 3,207,005 Hispanic person-years at risk</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;20</td><td align="left" valign="top" rowspan="1" colspan="1">Physician-diagnosed DM</td><td align="left" valign="top" rowspan="1" colspan="1">Incidence of type 1 DM for youth aged&#x02009;&#x02264;&#x02009;14&#x02009;years was 15.0/100,000 for females and 16.2/100,000 for males. Among youth aged&#x02009;&#x02264;&#x02009;17&#x02009;years, the rates of type 1 DM were 14.1/100,000 for females and 15.6/100,000 for males. For type 2 DM, the rates were 6.9/100,000 for females and 4.8/100,000 for males.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Puerto Rico Heart Health Program (<xref rid="B104" ref-type="bibr">104</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">1965&#x02013;1975</td><td align="left" valign="top" rowspan="1" colspan="1">4,685 Puerto Ricans</td><td align="center" valign="top" rowspan="1" colspan="1">35&#x02013;79</td><td align="left" valign="top" rowspan="1" colspan="1">FPG&#x02009;&#x02265;&#x02009;126&#x02009;mg/dL and self-reports of physician-diagnosed diabetes or use of insulin or hypoglycemic agents</td><td align="left" valign="top" rowspan="1" colspan="1">Crude rate of 11% over a median follow-up period of 2.6&#x02009;years (range: 2&#x02013;7&#x02009;years), for an incidence rate of 42.6/1,000 person-years.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">New York City Community Health Survey (<xref rid="B105" ref-type="bibr">105</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">2002, 2004, and 2008</td><td align="left" valign="top" rowspan="1" colspan="1">24,384</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;18</td><td align="left" valign="top" rowspan="1" colspan="1">Self-reported DM</td><td align="left" valign="top" rowspan="1" colspan="1">Age-adjusted incidence of DM per 1,000 population was 9.4 in 2002, 11.9 in 2004, and 8.6 in 2008. DM incidence was significantly associated with being aged 45 or older, being Black or Hispanic, being overweight or obese, and having less than a high school diploma.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">SEARCH for Diabetes in Youth Study, US (<xref rid="B106" ref-type="bibr">106</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">2002&#x02013;2012</td><td align="left" valign="top" rowspan="1" colspan="1">11,245 youths aged&#x02009;&#x0003c;&#x02009;20 with type 1 DM and 2,846 youth aged 10&#x02013;19 with type 2 diabetes</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;20</td><td align="left" valign="top" rowspan="1" colspan="1">Physician-diagnosed DM</td><td align="left" valign="top" rowspan="1" colspan="1">Annual rate of increase in type 1 DM was greater among Hispanics than among NHWs (4.2 vs. 1.2%, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001). Annual rate of increase in type 2 DM among Hispanics differed significantly from that among Native Americans (3.1% vs. 8.9%, <italic>P</italic>&#x02009;=&#x02009;0.01).</td></tr></tbody></table></table-wrap><p>A few studies have estimated GDM in Hispanics/Latinos (<xref rid="B107" ref-type="bibr">107</xref>&#x02013;<xref rid="B114" ref-type="bibr">114</xref>) (Table <xref ref-type="table" rid="T5">5</xref>). One of the early studies examining the epidemiology of GDM in an ethnically diverse cohort of over 10,000 women at the Mount Sinai Medical Center in New York City between 1987 and 1990 found a prevalence of 3.2% (<xref rid="B107" ref-type="bibr">107</xref>). After controlling for traditional risk factors, first-generation Hispanic/Latino women had a 59% increased risk for GDM compared to NHW women. Kim et al. (<xref rid="B112" ref-type="bibr">112</xref>) found that among Hispanic/Latino women, the prevalence of GDM varied by heritage group, from 5.5% among Cubans to 8.7% among Mexicans. Nearly 45% of GDM cases among Hispanic/Latino women were attributable to overweight and obesity, which ranged from 38.5% among Central/South American women to 65.7% among Cuban women. In a recent study of prevalence trends in GDM by race/ethnicity for 19 states, the GDM prevalence increased significantly from 3.71 per 100 deliveries in 2000 to 5.77 per 100 deliveries in 2010 (<xref rid="B113" ref-type="bibr">113</xref>). Prevalence of GDM among deliveries increased significantly among all racial/ethnic groups, particularly Hispanics/Latinas, who experienced the highest relative increase (66%).</p><table-wrap id="T5" position="float"><label>Table 5</label><caption><p>Incidence or prevalence of gestational diabetes mellitus among Hispanic/Latino populations in the US.</p></caption><table frame="hsides" rules="rows"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Study and reference</th><th valign="top" align="center" rowspan="1" colspan="1">Study period</th><th valign="top" align="left" rowspan="1" colspan="1">Sample size</th><th valign="top" align="center" rowspan="1" colspan="1">Age range (years)</th><th valign="top" align="left" rowspan="1" colspan="1">Glycemic criteria</th><th valign="top" align="left" rowspan="1" colspan="1">Key findings</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">New York City (<xref rid="B107" ref-type="bibr">107</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">1987&#x02013;1989</td><td align="left" valign="top" rowspan="1" colspan="1">10,187 (328 with GDM; of these 112 Hispanic)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;20 to &#x02265;40</td><td align="left" valign="top" rowspan="1" colspan="1">FPG and OGTT according to National Diabetes Data Group</td><td align="left" valign="top" rowspan="1" colspan="1">Prevalence of 4.1% among Hispanics Excess risk for Hispanic women born in Puerto Rico or elsewhere outside of the US</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Nurses&#x02019; Health Study II (<xref rid="B108" ref-type="bibr">108</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">1990&#x02013;1994</td><td align="left" valign="top" rowspan="1" colspan="1">14,613 (224 Hispanic)</td><td align="center" valign="top" rowspan="1" colspan="1">25&#x02013;42</td><td align="left" valign="top" rowspan="1" colspan="1">Self-reported GDM, validated by medical record review in a subset</td><td align="left" valign="top" rowspan="1" colspan="1">4.7% Whites, 10.6% AAs, 7.6% Hispanics, and 10.5% Asians</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Northern California Kaiser Permanente Medical Care Program (<xref rid="B109" ref-type="bibr">109</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">1991&#x02013;2000</td><td align="left" valign="top" rowspan="1" colspan="1">267,051 pregnancies screened for GDM</td><td align="center" valign="top" rowspan="1" colspan="1">15&#x02013;49</td><td align="left" valign="top" rowspan="1" colspan="1">Physician diagnosis or ADA criteria</td><td align="left" valign="top" rowspan="1" colspan="1">Age- and race/ethnicity-adjusted yearly prevalence increased from 5.1% in 1991 to 7.4% in 1997, being significantly higher among Asians (7.2&#x02013;11.0%) and Hispanics (7.2&#x02013;9.8%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">New York City (<xref rid="B110" ref-type="bibr">110</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">1995&#x02013;2003</td><td align="left" valign="top" rowspan="1" colspan="1">951,920</td><td align="center" valign="top" rowspan="1" colspan="1">15&#x02013;44</td><td align="left" valign="top" rowspan="1" colspan="1">Diagnostic codes ICD&#x02013;9 648.81&#x02013;648.82</td><td align="left" valign="top" rowspan="1" colspan="1"><list list-type="simple"><list-item><p>Overall risk of 5.2%</p></list-item><list-item><p>7.2% North African</p></list-item><list-item><p>5.9% Sub-Saharan Africa</p></list-item><list-item><p>6.2% East Asia</p></list-item><list-item><p>8.6% South-East Asia and Pacific Islands</p></list-item><list-item><p>14.3% South Central Asia</p></list-item><list-item><p>6.8% Non-Hispanic Caribbean</p></list-item><list-item><p>4.9% Hispanic Caribbean</p></list-item><list-item><p>6.3% Mexico</p></list-item><list-item><p>4.9% Central American</p></list-item><list-item><p>6.6% South American</p></list-item><list-item><p>34.3% African-American</p></list-item><list-item><p>3.6% NHWs</p></list-item></list>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">19 US states (<xref rid="B111" ref-type="bibr">111</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">2005&#x02013;2006</td><td align="left" valign="top" rowspan="1" colspan="1">3,108,877 births</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;20 to &#x02265;40</td><td align="left" valign="top" rowspan="1" colspan="1">Documented in birth certificate</td><td align="left" valign="top" rowspan="1" colspan="1">3.8% NHWs, 3.5% NHBs, 3.6% Hispanics, 6.3% Asian, and Pacific Islanders</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">California (<xref rid="B112" ref-type="bibr">112</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">2007&#x02013;2009</td><td align="left" valign="top" rowspan="1" colspan="1">1,228,265 records</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;20</td><td align="left" valign="top" rowspan="1" colspan="1">ICD-9-CM codes for pregestational DM (250) or DM (648.0)<break/>GDM was defined as glucose intolerance complicating pregnancy, childbirth, or postpartum (ICD-9-CM code 648.8).</td><td align="left" valign="top" rowspan="1" colspan="1">11.9% Asian and Pacific Islands, 7.6% American Indians, 5.6% Black Americans, 8.4% Hispanics, 6.6% others, and 5.4% NHWs<break/>Among Hispanic women: Mexican (8.7%), Central/South American (7.4%), Puerto Rican (6.6%), and Cuban (5.5%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GDM among hospital deliveries in 19 US states (<xref rid="B113" ref-type="bibr">113</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">2000&#x02013;2010</td><td align="left" valign="top" rowspan="1" colspan="1">75,212 in 2000 to 119,229 in 2010</td><td align="center" valign="top" rowspan="1" colspan="1">15&#x02013;44</td><td align="left" valign="top" rowspan="1" colspan="1">ICD-9-CM 648.8x, DRG codes 767&#x02013;768, 774&#x02013;775, and 765&#x02013;766 (2008&#x02013;2010), or DRG codes 370&#x02013;375 (2000&#x02013;2007)</td><td align="left" valign="top" rowspan="1" colspan="1">Age-standardized prevalence increased from 3.71% in 2000 to 5.77% in 2010<break/>Largest relative increase in prevalence was highest among Hispanics (66%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Prepregnancy diabetes among deliveries in 19 US states (<xref rid="B114" ref-type="bibr">114</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">2000&#x02013;2010</td><td align="left" valign="top" rowspan="1" colspan="1">13,217 in 2000 to 18,168 in 2010</td><td align="center" valign="top" rowspan="1" colspan="1">15&#x02013;44</td><td align="left" valign="top" rowspan="1" colspan="1">ICD-9-CM 648.0x. 250.xx, or 249.xx or DRG codes 767&#x02013;768, 774&#x02013;775, and 765&#x02013;766 (2007&#x02013;2010) or DRG codes 372&#x02013;375 (2000&#x02013;2007)</td><td align="left" valign="top" rowspan="1" colspan="1">Age-standardized prevalence of deliveries with prepregnancy DM among Hispanics ranged from 0.74 in 2000 to 0.94 in 2010<break/>NHBs, followed by Hispanics, had the highest absolute change in age-standardized rates (0.20 per 100 deliveries) and throughout the time period had the highest rates of prepregnancy DM</td></tr></tbody></table><table-wrap-foot><p><italic>ICD-9, International Classification of Diseases, Ninth Version; ICD-9-CM, International Classification of Diseases, Ninth Version, Clinical Modification. DRG, Diagnosis-Related Group</italic>.</p></table-wrap-foot></table-wrap></sec><sec id="S2-2"><title>Diabetes in Latin America</title><p>Table <xref ref-type="table" rid="T6">6</xref> illustrates selected studies assessing diabetes in Latin America (<xref rid="B115" ref-type="bibr">115</xref>&#x02013;<xref rid="B139" ref-type="bibr">139</xref>). The prevalence of diabetes varies by date in which the studies were performed, methods of assessing prevalence, region and age group (<xref rid="B140" ref-type="bibr">140</xref>, <xref rid="B141" ref-type="bibr">141</xref>).</p><table-wrap id="T6" position="float"><label>Table 6</label><caption><p>Prevalence of type 2 diabetes and prediabetes among Hispanic/Latino populations in Latin America (selected studies).</p></caption><table frame="hsides" rules="rows"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Study and reference</th><th valign="top" align="center" rowspan="1" colspan="1">Study period</th><th valign="top" align="left" rowspan="1" colspan="1">Sample size</th><th valign="top" align="center" rowspan="1" colspan="1">Age range (years)</th><th valign="top" align="left" rowspan="1" colspan="1">Glycemic criteria</th><th valign="top" align="left" rowspan="1" colspan="1">Key findings</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">The Brazilian Cooperative Group on the Study of Diabetes Prevalence (<xref rid="B115" ref-type="bibr">115</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">1986&#x02013;1988</td><td align="left" valign="top" rowspan="1" colspan="1">21,847 from nine large cities</td><td align="center" valign="top" rowspan="1" colspan="1">30&#x02013;69</td><td align="left" valign="top" rowspan="1" colspan="1">2-h OGTT<break/>WHO 1985</td><td align="left" valign="top" rowspan="1" colspan="1">Overall prevalence was 7.6 and 7.8% for diabetes and IGT, respectively. DM prevalence increased from 2.7% in the 30&#x02013;39-year age-group to 17.4% in the 60&#x02013;69-year age-group</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">The Cooperative Group for the Study of Diabetes Prevalence in Rio de Janeiro, Brazil (<xref rid="B116" ref-type="bibr">116</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">1988&#x02013;1989</td><td align="left" valign="top" rowspan="1" colspan="1">2,051</td><td align="center" valign="top" rowspan="1" colspan="1">30&#x02013;69</td><td align="left" valign="top" rowspan="1" colspan="1">2-h OGTT<break/>WHO 1985</td><td align="left" valign="top" rowspan="1" colspan="1">Age-adjusted prevalence rates for DM and IGT were 7.1 and 9.0%, respectively</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Bolivia (<xref rid="B117" ref-type="bibr">117</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">1998</td><td align="left" valign="top" rowspan="1" colspan="1">2,948 from four Bolivian cities: La Paz, El Alto, Santa Cruz, and Cochabamba</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;25</td><td align="left" valign="top" rowspan="1" colspan="1">2-h OGTT<break/>WHO 1997</td><td align="left" valign="top" rowspan="1" colspan="1">Overall prevalence of DM was 7.2% and of IGT was 7.8%.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Brazilian Multicenter Study, Ribeir&#x000e3;o Preto, S&#x000e3;o Paulo, Brazil (<xref rid="B118" ref-type="bibr">118</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">1986&#x02013;1988</td><td align="left" valign="top" rowspan="1" colspan="1">1,473</td><td align="center" valign="top" rowspan="1" colspan="1">30&#x02013;69</td><td align="left" valign="top" rowspan="1" colspan="1">2-h OGTT<break/>WHO 1997</td><td align="left" valign="top" rowspan="1" colspan="1">The overall rates of DM and IGT were 12.1 and 7.7%, respectively</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mexican National Health Survey 2000 (<xref rid="B119" ref-type="bibr">119</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">2000</td><td align="left" valign="top" rowspan="1" colspan="1">42,886 from 400 cities in Mexico</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;20</td><td align="left" valign="top" rowspan="1" colspan="1">2-h OGTT<break/>FBG<break/>ADA 1997</td><td align="left" valign="top" rowspan="1" colspan="1">Age-adjusted prevalence 8.2%, of which 2,878 (80%) had previously been diagnosed.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Argentina (<xref rid="B120" ref-type="bibr">120</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">1995&#x02013;1998</td><td align="left" valign="top" rowspan="1" colspan="1">2,397</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;20</td><td align="left" valign="top" rowspan="1" colspan="1">2-h OGTT<break/>WHO 1999</td><td align="left" valign="top" rowspan="1" colspan="1">Age-standardized prevalence rates for diabetes ranged between 6.5 and 7.7%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mexican National Health Survey 2000 (<xref rid="B121" ref-type="bibr">121</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">2000</td><td align="left" valign="top" rowspan="1" colspan="1">12,856 men and 28,332 women</td><td align="center" valign="top" rowspan="1" colspan="1">20&#x02013;69</td><td align="left" valign="top" rowspan="1" colspan="1">2-h OGTT<break/>FBG<break/>ADA 1997</td><td align="left" valign="top" rowspan="1" colspan="1">DM rates of 5.6% in men and 9.7% in women</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">The Health Wellbeing and Aging (SABE) Project and NHANES (<xref rid="B123" ref-type="bibr">123</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">1999&#x02013;2004</td><td align="left" valign="top" rowspan="1" colspan="1">10,518</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;60</td><td align="left" valign="top" rowspan="1" colspan="1">Self-reported diagnosis</td><td align="left" valign="top" rowspan="1" colspan="1"><list list-type="simple"><list-item><p>13.0% in Santiago, 13.8% in Montevideo, 14.7% in Havana, 17.7% in S&#x000e3;o Paulo, 21.3% in Mexico City, 21.7% in Bridgetown</p></list-item><list-item><p>US Whites 13.8%</p></list-item><list-item><p>US Blacks 25.5%</p></list-item><list-item><p>US Mexican Americans 26.4%</p></list-item></list>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">The Health Wellbeing and Aging (SABE) Project (<xref rid="B124" ref-type="bibr">124</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">1999&#x02013;2000</td><td align="left" valign="top" rowspan="1" colspan="1">13,753</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;60</td><td align="left" valign="top" rowspan="1" colspan="1">Self-reported diagnosis</td><td align="left" valign="top" rowspan="1" colspan="1">Prevalence of diagnosed diabetes was highest in US Blacks and Mexican Americans, followed by Bridgetown and Mexico City (22% for each) and lowest in Santiago, Montevideo, Havana, and US Whites (13&#x02013;15%).</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">The FRIMEX Study (<xref rid="B125" ref-type="bibr">125</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">2001&#x02013;2002</td><td align="left" valign="top" rowspan="1" colspan="1">140,017 from 6 Mexican cities: Mexico City, Guadalajara, Monterrey, Puebla, Leon, and Tijuana</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;18</td><td align="left" valign="top" rowspan="1" colspan="1">FBG&#x02009;&#x0003e;&#x02009;126&#x02009;mg/dL<break/>Random&#x02009;&#x0003e;&#x02009;200&#x02009;mg/dL</td><td align="left" valign="top" rowspan="1" colspan="1">Prevalence of 10.4%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PREVENCION<break/>Peruvian Study of the Prevalence of Cardiovascular Diseases (<xref rid="B126" ref-type="bibr">126</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">2004&#x02013;2006</td><td align="left" valign="top" rowspan="1" colspan="1">1,878 adults in Arequipa, Peru</td><td align="center" valign="top" rowspan="1" colspan="1">20&#x02013;80</td><td align="left" valign="top" rowspan="1" colspan="1">FPG&#x02009;&#x02265;&#x02009;100&#x02009;mg/dL or current antidiabetic medication (insulin or oral agents)</td><td align="left" valign="top" rowspan="1" colspan="1">Age-standardized prevalence was 6.3% in men and 5.9% in women</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Pelotas, Rio Grande do Sul State, Brazil (<xref rid="B127" ref-type="bibr">127</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">2003</td><td align="left" valign="top" rowspan="1" colspan="1">3,100 men and women</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;20</td><td align="left" valign="top" rowspan="1" colspan="1">Self-reported diagnosis</td><td align="left" valign="top" rowspan="1" colspan="1">Prevalence of DM of 6.3%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CARMELA Study (<xref rid="B128" ref-type="bibr">128</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">2003&#x02013;2005</td><td align="left" valign="top" rowspan="1" colspan="1">11,550 in 7 Latin American countries</td><td align="center" valign="top" rowspan="1" colspan="1">25&#x02013;64</td><td align="left" valign="top" rowspan="1" colspan="1">FPG&#x02009;&#x02265;&#x02009;126&#x02009;mg/dL or self-reported diagnosis</td><td align="left" valign="top" rowspan="1" colspan="1">Prevalence of DM was 7% (range: 4&#x02013;9%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CARMELA Study (<xref rid="B129" ref-type="bibr">129</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">2003&#x02013;2005</td><td align="left" valign="top" rowspan="1" colspan="1">11,502 in 7 Latin American countries</td><td align="center" valign="top" rowspan="1" colspan="1">25&#x02013;64</td><td align="left" valign="top" rowspan="1" colspan="1">FPG&#x02009;&#x02265;&#x02009;110&#x02009;mg/dL or self-reported diagnosis</td><td align="left" valign="top" rowspan="1" colspan="1">31.2% had glucose abnormalities (32.6% of men and 30.1% of women)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mexico City Prospective Study (<xref rid="B130" ref-type="bibr">130</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">1998&#x02013;2004</td><td align="left" valign="top" rowspan="1" colspan="1">52,584 men and 106,962 women</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;35</td><td align="left" valign="top" rowspan="1" colspan="1">Self-reported diagnosis</td><td align="left" valign="top" rowspan="1" colspan="1">4.8% in men and 3.9% in women</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Chile (<xref rid="B131" ref-type="bibr">131</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">2000&#x02013;2005</td><td align="left" valign="top" rowspan="1" colspan="1">486 overweight and obese adolescents</td><td align="center" valign="top" rowspan="1" colspan="1">6&#x02013;15</td><td align="left" valign="top" rowspan="1" colspan="1">FPG&#x02009;&#x02265;&#x02009;100&#x02009;mg/dL</td><td align="left" valign="top" rowspan="1" colspan="1"><list list-type="simple"><list-item><p>2% in males Tanner stage I-II</p></list-item><list-item><p>1% in females Tanner stage I-II</p></list-item><list-item><p>9% in males Tanner stage III-V</p></list-item><list-item><p>6% in females Tanner stage III-V</p></list-item></list></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">The Latin American Consortium of Studies in Obesity (LASO) (<xref rid="B133" ref-type="bibr">133</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">1998&#x02013;2007</td><td align="left" valign="top" rowspan="1" colspan="1">31,009<break/>Argentina, Chile, Colombia, Costa Rica, Dominican Republic, Per&#x000fa;, Puerto Rico, and Venezuela</td><td align="center" valign="top" rowspan="1" colspan="1">20&#x02013;85</td><td align="left" valign="top" rowspan="1" colspan="1">FPG&#x02009;&#x02265;&#x02009;126&#x02009;mg/dL or self-reported current pharmacological treatment</td><td align="left" valign="top" rowspan="1" colspan="1">Average prevalence of 5%, 4.8% in women and 5.1% in men<break/>Puerto Rico had a significantly higher prevalence of DM</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) (<xref rid="B135" ref-type="bibr">135</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">2008&#x02013;2010</td><td align="left" valign="top" rowspan="1" colspan="1">15,105</td><td align="center" valign="top" rowspan="1" colspan="1">35&#x02013;74</td><td align="left" valign="top" rowspan="1" colspan="1">Self-reported diagnosis, medication use, FPG&#x02009;&#x02265;&#x02009;126&#x02009;mg/dL, 2-h post-OGTT&#x02009;&#x02265;&#x02009;200&#x02009;mg/dL, or HbA1c&#x02009;&#x02265;&#x02009;6.5%</td><td align="left" valign="top" rowspan="1" colspan="1">Prevalence of DM was 19.7%<break/>Proportion of previously diagnosed DM was 50.4%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CESCAS [<italic>Centro de Excelencia en Salud Cardiovascular para el Cono Sur</italic>] I Study (<xref rid="B136" ref-type="bibr">136</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">2010&#x02013;2011</td><td align="left" valign="top" rowspan="1" colspan="1">7,524<break/>Argentina, Chile, and Uruguay</td><td align="center" valign="top" rowspan="1" colspan="1">35&#x02013;74</td><td align="left" valign="top" rowspan="1" colspan="1">FPG&#x02009;&#x02265;&#x02009;126&#x02009;mg/dL or self-reported history of diabetes</td><td align="left" valign="top" rowspan="1" colspan="1">Prevalence of DM of 12.4%, 10.6% in men, and 14% in women</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Panama Survey of Life and Health Quality (ENSCAVI) and Survey of Risk Factors Associated with Cardiovascular Diseases (PREFREC) (<xref rid="B137" ref-type="bibr">137</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">2007<break/>2010&#x02013;2011</td><td align="left" valign="top" rowspan="1" colspan="1">25,748<break/>3,590</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;18<break/>&#x02265;18</td><td align="left" valign="top" rowspan="1" colspan="1">Self-reported diagnosis of diabetes<break/>FPG&#x02009;&#x02265;&#x02009;126&#x02009;mg/dL and HbA1c&#x02009;&#x02265;&#x02009;6.5%</td><td align="left" valign="top" rowspan="1" colspan="1">Prevalence of DM of 5.4%<break/>Prevalence of previously diagnosed DM of 7.3% and combined prevalence of DM of 9.5% based on FPG and HbA1c</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Multiethnic Study of Pre-Diabetes and Diabetes in LMIC (<xref rid="B138" ref-type="bibr">138</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">2010&#x02013;2011</td><td align="left" valign="top" rowspan="1" colspan="1">23,496<break/>Southern Cone of Latin America, Peru, South Asia, and South Africa.</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;20</td><td align="left" valign="top" rowspan="1" colspan="1">Diabetes: FPG&#x02009;&#x02265;&#x02009;126&#x02009;mg/dL<break/>Prediabetes: 100&#x02013;125&#x02009;mg/dL</td><td align="left" valign="top" rowspan="1" colspan="1">Prevalence of DM and prediabetes was 14.0 and 17.8%, respectively, in the Southern Cone of Latin America; estimates were 9.8 and 17.1%, respectively, in Per&#x000fa;.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CRONICAS<break/>Centro de Excelencia de Enfermedades Cr&#x000f3;nicas Cohort Study (<xref rid="B139" ref-type="bibr">139</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">2010&#x02013;2013</td><td align="left" valign="top" rowspan="1" colspan="1">3,135<break/>Four Peruvian sites</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;35</td><td align="left" valign="top" rowspan="1" colspan="1">FPG&#x02009;&#x02265;&#x02009;126&#x02009;mg/dL or self-reported current pharmacological treatment</td><td align="left" valign="top" rowspan="1" colspan="1">Overall prevalence of 7.1%</td></tr></tbody></table><table-wrap-foot><p><italic>FBG, fasting blood glucose</italic>.</p></table-wrap-foot></table-wrap><p>According to a 2015 International Diabetes Federation report, the prevalence of type 2 DM in Latin America was highest in Mexico (14.7%) and lowest in Argentina (6.2%); however, over one-quarter of the Latin American and Caribbean population remained undiagnosed (<xref rid="B141" ref-type="bibr">141</xref>). The Cardiovascular Risk Factor Multiple Evaluation in Latin America (CARMELA) Study (conducted between 2003 and 2005) (<xref rid="B128" ref-type="bibr">128</xref>) reported an age-adjusted prevalence of diabetes of 7.0% in seven urban populations in Latin America (<xref rid="B129" ref-type="bibr">129</xref>). The prevalence was highest in Mexico City, Mexico (8.9%) and Bogot&#x000e1;, Colombia (8.1%) and lowest in Lima, Per&#x000fa; (4.4%); it increased with age in all cities, and tended to be higher among women than men. Prevalence of undiagnosed diabetes occurred in 20% of adults with diabetes. The Latin American Consortium of Studies in Obesity (LASO) (which included 11 studies conducted in eight countries between 1999 and 2008) (<xref rid="B132" ref-type="bibr">132</xref>) reported an average prevalence of 5%, which increased from 0.9% in participants aged 20&#x02013;29&#x02009;years to 16.4% in those aged 70 or older (<xref rid="B133" ref-type="bibr">133</xref>). However, the prevalence of diabetes in Latin America and the Caribbean was similar to the US population (NHANES, 1999&#x02013;2004), after accounting for differences in the age distribution. Puerto Rico had the highest prevalence among the countries included in the analysis.</p><p>More recent Latin American studies include the <italic>Estudo Longitudinal de Sa&#x000fa;de do Adulto</italic> (ELSA-Brasil) (<xref rid="B134" ref-type="bibr">134</xref>), which reported a prevalence of 19.7% (based on self-report or FPG, 2hPG and HbA1c), of which about half was undiagnosed (<xref rid="B135" ref-type="bibr">135</xref>); the <italic>Centro de Excelencia en Salud Cardiovascular para el Cono Sur I</italic> (CESCAS I), which reported an overall prevalence (based on FPG only) of 12.4% across four sites in Argentina, Chile, and Uruguay (<xref rid="B136" ref-type="bibr">136</xref>); and the <italic>Centro de Excelencia de Enfermedades Cr&#x000f3;nicas</italic> (CRONICAS), which reported an overall prevalence of 7.1% (based on FPG only) across four regions in Per&#x000fa; (<xref rid="B139" ref-type="bibr">139</xref>).</p><p>One of the few studies in Latin America and the Caribbean that estimated the incidence of type 2 DM is the Mexico City Diabetes Study, which focused on the population aged 35&#x02013;64&#x02009;years over 18&#x02009;years of follow-up (<xref rid="B143" ref-type="bibr">143</xref>) (Table <xref ref-type="table" rid="T7">7</xref>). Cumulative incidence rates of type 2 DM for men and women were 14.4/1,000 and 13.7/1,000, respectively. Incidence was 15.8, 15.7, and 12.7 per 1,000 person-years for the follow-up studies conducted in 1994, 1998, and 2008, respectively. These figures suggest that this population has one of the highest diabetes incidence rates worldwide, and that incidence rates have remained fairly stable.</p><table-wrap id="T7" position="float"><label>Table 7</label><caption><p>Incidence of type 2 diabetes and gestational diabetes mellitus among Hispanic/Latino populations in Latin America.</p></caption><table frame="hsides" rules="rows"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Study and reference</th><th valign="top" align="center" rowspan="1" colspan="1">Study period</th><th valign="top" align="center" rowspan="1" colspan="1">Sample size</th><th valign="top" align="center" rowspan="1" colspan="1">Age range (years)</th><th valign="top" align="left" rowspan="1" colspan="1">Glycemic criteria</th><th valign="top" align="left" rowspan="1" colspan="1">Key findings</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Brazilian Gestational Diabetes Study (<xref rid="B142" ref-type="bibr">142</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">1991&#x02013;1995</td><td align="center" valign="top" rowspan="1" colspan="1">4,977</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;20&#x02009;years</td><td align="left" valign="top" rowspan="1" colspan="1">OGTT<break/>ADA 2000<break/>WHO 1999</td><td align="left" valign="top" rowspan="1" colspan="1">2.4% presented with GDM by ADA criteria and 7.2% by WHO criteria.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mexico City Diabetes Study (<xref rid="B143" ref-type="bibr">143</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">1990&#x02013;2008</td><td align="center" valign="top" rowspan="1" colspan="1">1,939</td><td align="center" valign="top" rowspan="1" colspan="1">35&#x02013;64</td><td align="left" valign="top" rowspan="1" colspan="1">OGTT<break/>ADA criteria</td><td align="left" valign="top" rowspan="1" colspan="1">Cumulative incidence was 14.4/1,000 and 13.7/1,000 for men and women, respectively.<break/>Incidence was 15.8/1,000, 15.7/1,000, and 12.7/1,000 for the second (1994), third (1998), and fourth (2008) follow-up phases, respectively.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CRONICAS Cohort Study (<xref rid="B139" ref-type="bibr">139</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">2010&#x02013;2013</td><td align="center" valign="top" rowspan="1" colspan="1">3,135<break/>Four Peruvian sites</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02265;35</td><td align="left" valign="top" rowspan="1" colspan="1">FPG&#x02009;&#x02265;&#x02009;126&#x02009;mg/dL or self-reported current pharmacological treatment</td><td align="left" valign="top" rowspan="1" colspan="1">Overall incidence of 1.95 per 100 person-years.<break/>1.97 per 100 person-years in women and 1.93 per 100 person-years in men.</td></tr></tbody></table></table-wrap></sec><sec id="S2-3"><title>Other CV Risk Factors in Hispanics/Latinos</title><sec id="S2-3-1"><title>Overweight/Obesity</title><p>In the most recent NHANES examination (2013&#x02013;2014 cycle), the age-adjusted prevalence of obesity in adults (&#x0003e;20&#x02009;years) was 37.1% for NHWs and 42.7% for Hispanics/Latinos, with Hispanic/Latino men and women having 21% and 33% increased odds of obesity compared to NHWs, respectively (<xref rid="B144" ref-type="bibr">144</xref>). In the most current NHANES examination, the prevalence of obesity in children was 14.7% for NHWs and 21.9% in Hispanics/Latinos, and extreme obesity was 4.4% in NHWs and 7.6% in Hispanics/Latinos (<xref rid="B145" ref-type="bibr">145</xref>). In the baseline examination (2008&#x02013;2011) of the HCHS/SOL, 77% of participants had overweight or obesity, and the age-adjusted prevalence of obesity ranged from 26.8% in South American men to 51.4% in Puerto Rican women (<xref rid="B84" ref-type="bibr">84</xref>). However, enlarged waist circumference (&#x02265;102&#x02009;cm in men and &#x02265;88&#x02009;cm in women) was highly prevalent among men (73%) and women (96%), independent of the heritage group (<xref rid="B146" ref-type="bibr">146</xref>). A higher prevalence of overall obesity in women compared to men, and high prevalence of abdominal obesity have also been described in Puerto Rico (<xref rid="B147" ref-type="bibr">147</xref>, <xref rid="B148" ref-type="bibr">148</xref>).</p><p>The CARMELA study reported an overall obesity prevalence of 23%, ranging from 16% in Quito, Ecuador to 31% in Mexico City, Mexico (<xref rid="B128" ref-type="bibr">128</xref>). The LASO reported that overall obesity ranged from 13.8% in men to 18.4% in women, and that abdominal obesity ranged from 15.4% in men to 55.5% in women (<xref rid="B133" ref-type="bibr">133</xref>). CESCAS I reported a prevalence of 35.7% obesity and 52.9% central obesity (<xref rid="B136" ref-type="bibr">136</xref>), whereas CRONICAS reported a prevalence of 44.0% overweight and 26.0% obesity among individuals without diabetes, and 40.8% overweight and 39.9% obesity among those with diabetes; and enlarged waist circumference in 71.5% without diabetes and 88.5% with diabetes (<xref rid="B139" ref-type="bibr">139</xref>); and in ELSA-Brasil, 40.2 and 22.9% had overweight and obesity, respectively (<xref rid="B149" ref-type="bibr">149</xref>). Although the prevalence of obesity in some regions of Latin America has been lower than that of Hispanics/Latinos in the US, in others it is comparable.</p><p>A systematic review of studies published between 2008 and 2013 estimated that the prevalence of overweight and obesity for children and adolescents throughout Latin America ranged from 18.9 to 36.9% in children aged 5&#x02013;11 and 16.6 to 35.8% in adolescents aged 12&#x02013;19 (<xref rid="B150" ref-type="bibr">150</xref>). An obesity trend analysis from Mexico (2012) revealed a significant increase during the same time frame in which obesity increased in the US (<xref rid="B145" ref-type="bibr">145</xref>, <xref rid="B151" ref-type="bibr">151</xref>). The prevalence of overweight/obesity also increased in Colombia from 38.2% in 2000 to 43.1% in 2010 (<xref rid="B152" ref-type="bibr">152</xref>).</p></sec><sec id="S2-3-2"><title>Hypertension</title><p>In the 2009&#x02013;2010 NHANES cycle, the age-adjusted prevalence of hypertension among US adults was 29.8% for NHW men, 26.9% for NHW women, 26.3% for Mexican American men, and 27.7% for Mexican American women (<xref rid="B153" ref-type="bibr">153</xref>). In the HCHS/SOL, the age-adjusted prevalence of hypertension was 25.5% (<xref rid="B154" ref-type="bibr">154</xref>).</p><p>In CARMELA, hypertension prevalence ranged from 7.2% (men) and 10.1% (women) in Ecuador to 37.7% (men) and 21.7% (women) in Argentina (<xref rid="B155" ref-type="bibr">155</xref>). LASO reported a mean prevalence of 20.2% (<xref rid="B133" ref-type="bibr">133</xref>). CRONICAS reported a prevalence of 23.9% for individuals without diabetes, and 50.9% for individuals with diabetes (<xref rid="B139" ref-type="bibr">139</xref>). ELSA-Brasil reported a mean prevalence of 25.7% in women and 34.5% in men (<xref rid="B149" ref-type="bibr">149</xref>). In CESCAS I hypertension prevalence ranged from 36.9% in Temuco, Chile to 45.3% in Bariloche, Argentina, and a mean of 40.8% in Chile, Argentina, and Uruguay (<xref rid="B136" ref-type="bibr">136</xref>).</p></sec><sec id="S2-3-3"><title>Dyslipidemia</title><p>In the 2011&#x02013;2012 NHANES cycle, prevalence of high total cholesterol was 13.5% in NHWs and 14.2% in Hispanics/Latinos, and the prevalence of low high-density lipoprotein cholesterol (HDL-C) was 17.1% in NHWs and 21.8% in Hispanics/Latinos (<xref rid="B156" ref-type="bibr">156</xref>). In the HCHS/SOL, the prevalence of elevated total cholesterol was 13.9% in women and 14.3% in men, elevated low-density lipoprotein cholesterol (LDL-C) was 34% in women and 38.2% in men, triglycerides (TGs)&#x02009;&#x0003e;&#x02009;200&#x02009;mg/dL was 10.2% in women and 19.8% in men, and low HDL-C was 47.9% in women and 34.3% in men (<xref rid="B157" ref-type="bibr">157</xref>).</p><p>In CARMELA, the prevalence of hypercholesterolemia ranged from 5.7% in Barquisimeto, Venezuela to 20.2% in Quito, Ecuador (<xref rid="B128" ref-type="bibr">128</xref>). CESCAS I reported an overall prevalence of hypercholesterolemia of 24.4% (which ranged from 20.8% in Bariloche, Argentina to 31.0% in Barros Blancos, Uruguay), high LDL-C of 23.1%, low HDL-C of 34.1%, and hypertriglyceridemia of 22.1% (<xref rid="B136" ref-type="bibr">136</xref>). LASO reported an overall prevalence of 8.9% of elevated total cholesterol, 8.5% of high LDL-C, 53.3% of low HDL-C, and 26.5% of high TGs (<xref rid="B133" ref-type="bibr">133</xref>). ELSA-Brasil reported a mean prevalence of hypercholesterolemia of 68.2% in women and 65.5% in men (<xref rid="B149" ref-type="bibr">149</xref>). Although the prevalence of lipid and lipoprotein abnormalities varies by region and study, it seems like low HDL-C is highly prevalent across Hispanic/Latino populations in the US and Latin America.</p></sec><sec id="S2-3-4"><title>Tobacco Use</title><p>The prevalence of smoking among US adults is 16.7% for men and 13.6% for women, with distinct racial/ethnic differences (<xref rid="B158" ref-type="bibr">158</xref>). The prevalence among NHWs is 20.2%, and 10.1% for Hispanics/Latinos, nationwide. However, the HCHS/SOL demonstrated a higher overall prevalence of daily smoking (16.9% in men and 10.7% in women) and significant differences among heritage groups with higher prevalence of daily smokers in Puerto Rican men (27.0%), Cuban men (26.2%) and Puerto Rican women (24.2%), and lower smoking prevalence in Dominican men (8.8%) and Mexican women (4.4%) (<xref rid="B159" ref-type="bibr">159</xref>).</p><p>In Latin America, the CARMELA reported a prevalence of current smoking that ranged from 21.8% in Barquisimeto, Venezuela to 45.4% Santiago, Chile (<xref rid="B128" ref-type="bibr">128</xref>). LASO reported a mean prevalence of 25.8% (<xref rid="B133" ref-type="bibr">133</xref>), and CESCAS I reported a mean prevalence of 29.7% in Argentina, Chile, and Uruguay (<xref rid="B136" ref-type="bibr">136</xref>). ELSA-Brasil reported a mean prevalence of current smoking of 15.5% in women and 16.7% in men (<xref rid="B149" ref-type="bibr">149</xref>). In contrast, CRONICAS reported a prevalence of daily smoking of 3.3% among individuals without diabetes, and 2.7% among those with diabetes in Per&#x000fa; (<xref rid="B139" ref-type="bibr">139</xref>).</p></sec><sec id="S2-3-5"><title>Behavioral Risk Factors</title><p>Cardiometabolic factors are influenced by modifiable behavioral risk factors, namely physical activity (PA), and dietary intake. The 2010 Racial and Ethnic Approaches to Community Health Risk Factor Survey estimated approximately one-third of Hispanic/Latino men and women met PA recommendations (<xref rid="B160" ref-type="bibr">160</xref>). Moreover, using objective measures, the HCHS/SOL reported that Hispanic/Latino adults spent 11.9&#x02009;h/day, or 74% of their monitored time, in sedentary behaviors, with less time for Mexicans and more for Dominicans (<xref rid="B161" ref-type="bibr">161</xref>). CESCAS I reported a prevalence of physical inactivity of 35.2% (<xref rid="B136" ref-type="bibr">136</xref>); ELSA-Brasil reported a mean prevalence of physical inactivity of 79.8% in women and 70.9% in men (<xref rid="B149" ref-type="bibr">149</xref>).</p><p>In the HCHS/SOL, differences in total energy, macronutrient, and nutrient-dense intakes were observed among the different heritage groups (<xref rid="B162" ref-type="bibr">162</xref>), with higher total energy and macronutrient intakes by Cubans, higher fiber intake by Mexicans, lower fiber intake by Puerto Ricans and lowest total energy intake by Dominicans. Evaluations of the dietary intake and quality based on the 2010 Alternate Health Eating Index and the Dietary Approaches to Stop Hypertension (DASH) revealed overall low scores for intakes of whole grains, and fruit and vegetables with lower dietary quality for Puerto Ricans and higher quality for Mexicans (<xref rid="B163" ref-type="bibr">163</xref>, <xref rid="B164" ref-type="bibr">164</xref>).</p><p>Dietary patterns in Latin America have been gradually shifting toward increased consumption of sugars and meat, and decreased consumption of fruit and cereals across the continent (<xref rid="B165" ref-type="bibr">165</xref>, <xref rid="B166" ref-type="bibr">166</xref>). In CESCAS I, 85.5% of participants reported low intake of fruits and vegetables (<xref rid="B136" ref-type="bibr">136</xref>). CRONICAS reported that 3.8% of individuals without diabetes and 9.5% with diabetes consumed 5 or more servings of fruits/vegetables per day (<xref rid="B139" ref-type="bibr">139</xref>). ELSA-Brasil reported low health dietary scores (1.23&#x02013;1.38 out of 5) (<xref rid="B149" ref-type="bibr">149</xref>).</p></sec></sec></sec><sec id="S3"><title>Etiology of Type 2 DM in Hispanics/Latinos</title><p>Multiple factors contribute to type 2 DM risk including: genetic variations, demographic characteristics, and behavior- and lifestyle-related risk factors (<xref rid="B167" ref-type="bibr">167</xref>). Among the pathophysiologic defects in type 2 DM, insulin resistance along with &#x003b2;-cell failure are considered major defects (<xref rid="B168" ref-type="bibr">168</xref>). Alterations in the adipose tissue (endocrine organ), the gut incretin-system (enteroinsular axis), renal reabsorption of glucose, and brain insulin response also play important roles in the development of glucose intolerance and type 2 DM (<xref rid="B169" ref-type="bibr">169</xref>). In addition, alterations in the crosstalk between immune and metabolic pathways are closely linked to obesity and diabetes (<xref rid="B170" ref-type="bibr">170</xref>). Inflammation is also recognized as a common pathway for the major complications of atherosclerosis, stroke, and ischemic heart disease, commonly observed in persons with diabetes (<xref rid="B171" ref-type="bibr">171</xref>). Some of these aspects have been studied in Hispanics/Latinos.</p><sec id="S3-1"><title>Obesity and Insulin Resistance</title><p>As reported in other ethnic groups, type 2 DM is associated with obesity in Hispanics/Latinos (<xref rid="B172" ref-type="bibr">172</xref>). However, obesity does not explain the excess diabetes prevalence among Hispanics/Latinos compared to NHWs (<xref rid="B172" ref-type="bibr">172</xref>). For instance, 29.3% of participants of HCHS/SOL with prediabetes had normal weight (<xref rid="B95" ref-type="bibr">95</xref>). On the other hand, duration of obesity or earlier age of onset has been associated with increased risk of developing type 2 DM (<xref rid="B173" ref-type="bibr">173</xref>&#x02013;<xref rid="B175" ref-type="bibr">175</xref>).</p><p>In addition to overweight or obesity, the distribution of the adipose tissue has been associated with increased risk for type 2 DM and CVD. Non-alcoholic hepatic steatosis, for example, has been described in some Hispanic/Latino groups, and has been linked to increased insulin resistance and other cardiometabolic abnormalities (<xref rid="B176" ref-type="bibr">176</xref>, <xref rid="B177" ref-type="bibr">177</xref>).</p><p>Data from the SAHS showed that insulin resistance measured by several insulin resistance surrogates accounts for a significant proportion of the excess type 2 DM risk in Mexican-Americans compared to NHWs (<xref rid="B178" ref-type="bibr">178</xref>). This study also showed evidence of higher all-cause and CV mortality among Hispanics/Latinos born in the US (<xref rid="B179" ref-type="bibr">179</xref>).</p></sec><sec id="S3-2"><title>Adipokines, Hypercoagulability, Inflammation, and Endothelial Dysfunction Biomarkers</title><p>Several adipokines and inflammation and hypercoagulability mediators, such as leptin, intercellular adhesion molecule-1, tissue plasminogen activator, inhibitor of plasminogen activator-1, high-sensitivity C-reactive protein (CRP), macrophage chemoattractant protein 1 (MCP-1), tumor necrosis factor (TNF)-&#x003b1;, and interleukin-6 (IL-6) have been found to be elevated in young Hispanics/Latinos at high risk of developing type 2 DM (<xref rid="B180" ref-type="bibr">180</xref>&#x02013;<xref rid="B189" ref-type="bibr">189</xref>) and individuals from different racial/ethnic groups&#x02014;including Hispanics/Latinos&#x02014;with type 2 DM (<xref rid="B189" ref-type="bibr">189</xref>&#x02013;<xref rid="B194" ref-type="bibr">194</xref>). Elevated IL-6, leptin, CRP, and TNF-&#x003b1; have been observed in Mexican Americans with type 2 DM, and the elevation IL-6 and leptin in particular was linearly associated with increasing glycemia (<xref rid="B194" ref-type="bibr">194</xref>).</p><p>For example, in a prospective study of Hispanic/Latino adolescents with obesity, higher baseline MCP-1 or IL-6 levels at prepubertal age were associated with a 16 and 21% greater decline in insulin sensitivity during puberty (<xref rid="B195" ref-type="bibr">195</xref>). However, this relationship between proinflammatory/endothelial dysfunction markers and insulin sensitivity has been shown to vary with adipose tissue distribution, and may differ across racial/ethnic groups (<xref rid="B188" ref-type="bibr">188</xref>, <xref rid="B192" ref-type="bibr">192</xref>). Adiponectin, a collagen-like protein secreted from adipose tissue has been inversely correlated with both insulin sensitivity and adiposity (<xref rid="B196" ref-type="bibr">196</xref>&#x02013;<xref rid="B198" ref-type="bibr">198</xref>), and increased risk of developing type 2 DM in Hispanic/Latino adults (<xref rid="B199" ref-type="bibr">199</xref>). Adiponectin inversely correlates with CV risk factors in older adults (<xref rid="B200" ref-type="bibr">200</xref>), and appears to predict progression to glycemic failure in adolescents with type 2 DM from different ethnic groups (<xref rid="B200" ref-type="bibr">200</xref>, <xref rid="B201" ref-type="bibr">201</xref>). A cautionary note: Most of these studies have been small, and the representation of Hispanic/Latino heritage groups has been very limited.</p></sec><sec id="S3-3"><title>Other Factors</title><p><italic>Maternal factors</italic> such as fasting indexes of total triiodothyronine, insulin, leptin, and ghrelin have been associated with excessive weight gain in Hispanic/Latino children (<xref rid="B202" ref-type="bibr">202</xref>&#x02013;<xref rid="B204" ref-type="bibr">204</xref>). Women who experience GDM are at high risk of developing GDM in subsequent pregnancies (<xref rid="B205" ref-type="bibr">205</xref>, <xref rid="B206" ref-type="bibr">206</xref>) and type 2 DM (<xref rid="B205" ref-type="bibr">205</xref>). In addition, children born to women with GDM are at increased risk of obesity and glycometabolic disease later in life (<xref rid="B204" ref-type="bibr">204</xref>&#x02013;<xref rid="B214" ref-type="bibr">214</xref>). Increased proinflammatory markers have also been identified in women with GDM (<xref rid="B215" ref-type="bibr">215</xref>). Research studies involving Hispanic/Latino women in the US or in Latin America have described increased proinflammatory markers (e.g., proinflammatory cytokines and/or natural killer cells) at the placental level (<xref rid="B216" ref-type="bibr">216</xref>&#x02013;<xref rid="B218" ref-type="bibr">218</xref>), and at both the placental and fetal level (<xref rid="B219" ref-type="bibr">219</xref>) associated with maternal hyperglycemia during pregnancy. In Mexican women, prepregnancy overweight and obesity have been associated with increased oxidative stress in the newborn (<xref rid="B220" ref-type="bibr">220</xref>). In Chile, in women with overweight or obesity and GDM, maternal elevated TGs were associated with increased infant&#x02019;s birth weight (BW), despite good maternal glucose control (<xref rid="B221" ref-type="bibr">221</xref>). Maternal hyperglycemia, whether due to preexisting diabetes or GDM, has been associated with increased oxidative stress and maternal DNA damage (<xref rid="B222" ref-type="bibr">222</xref>, <xref rid="B223" ref-type="bibr">223</xref>), and both placental and umbilical cord DNA damage (<xref rid="B222" ref-type="bibr">222</xref>, <xref rid="B223" ref-type="bibr">223</xref>). However, the number of patients in these studies has been small, and the interaction of obesity or other proinflammatory factors cannot be separated from hyperglycemia. Whether these changes could be prevented or reversed is unknown.</p><p>Low BW, like maternal GDM, has been inversely associated with glucose intolerance and insulin sensitivity during childhood and increased risk for CVD later in life. This susceptibility to adult chronic diseases may be a response to exposures <italic>in utero</italic>&#x02014;known as fetal programming&#x02014;or early malnutrition in extra uterine life (<xref rid="B224" ref-type="bibr">224</xref>, <xref rid="B225" ref-type="bibr">225</xref>). Several studies in Latin America have documented the inverse association between BW and insulin sensitivity later in life (<xref rid="B226" ref-type="bibr">226</xref>), malnutrition during the first year of life and insulin sensitivity, glucose tolerance and metabolic syndrome later in life (<xref rid="B227" ref-type="bibr">227</xref>&#x02013;<xref rid="B229" ref-type="bibr">229</xref>); and being exclusively or predominantly breastfed&#x02009;&#x0003e;&#x02009;12&#x02009;months and lower adiposity and serum cholesterol during childhood (<xref rid="B230" ref-type="bibr">230</xref>).</p><p><italic>Chronic malnutrition</italic> is associated with alterations in glucose metabolism and insulin sensitivity (<xref rid="B231" ref-type="bibr">231</xref>). Decades ago, a malnutrition-modulated diabetes or tropical diabetes was described in developing countries (<xref rid="B232" ref-type="bibr">232</xref>, <xref rid="B233" ref-type="bibr">233</xref>). Some investigators hypothesized that consumption of cassava (manioc or tapioca) could lead to diabetes in malnourished subjects, due to cyanogenic glycosides leading to chronic pancreatitis; however, the theories remained largely speculative (<xref rid="B232" ref-type="bibr">232</xref>). Others postulated that chronic protein energy malnutrition would cause persistent insulin deficiency and glucose intolerance without ketosis, among other clinical features (<xref rid="B234" ref-type="bibr">234</xref>&#x02013;<xref rid="B236" ref-type="bibr">236</xref>).</p><p>A link between plasma <italic>branched-chain amino acids</italic> (BCAAs) and insulin clearance has been observed in recent years. Overweight persons exposed to a diet high in saturated fat have been found to have a significant inverse correlation between plasma BCAAs and insulin clearance. This association has also been observed in Hispanics/Latinos (<xref rid="B237" ref-type="bibr">237</xref>).</p><p>Atypical forms of diabetes such as <italic>ketosis prone diabetes</italic> (KPD) have also been described in Hispanics/Latinos. KPD affects 20&#x02013;50% of African-American and Hispanic/Latino patients with new diagnoses of diabetic ketoacidosis (<xref rid="B238" ref-type="bibr">238</xref>). Hispanics/Latinos with KPD also appear to be disproportionally affected by KPD characterized by an absence of autoantibodies and presence of &#x003b2;-cell functional reserve (<xref rid="B239" ref-type="bibr">239</xref>, <xref rid="B240" ref-type="bibr">240</xref>).</p><p>Sleep disruptions characteristic of <italic>obstructive sleep apnea (OSA)</italic> and that alter sleep duration and timing may promote behavioral, metabolic, and/or hormonal changes associated with changes in weight (<xref rid="B241" ref-type="bibr">241</xref>&#x02013;<xref rid="B244" ref-type="bibr">244</xref>). OSA is independently associated with insulin resistance (<xref rid="B245" ref-type="bibr">245</xref>) and predicts subsequent risk for type 2 DM (<xref rid="B246" ref-type="bibr">246</xref>). In the HCHS/SOL, both quantity and quality of sleep were associated with higher odds of having type 2 DM (<xref rid="B247" ref-type="bibr">247</xref>, <xref rid="B248" ref-type="bibr">248</xref>) and impaired glucose tolerance (IGT) (<xref rid="B247" ref-type="bibr">247</xref>) with the greatest odds among those with short sleep duration and insomnia (<xref rid="B249" ref-type="bibr">249</xref>). Three loci have been found to be significantly associated with OSA traits in a large genome-wide association study of 12,558 Hispanics/Latinos (<xref rid="B250" ref-type="bibr">250</xref>). The association of fasting blood glucose and OSA was weaker among Hispanics/Latinos in MESA compared to African Americans (AA) and NHWs (<xref rid="B251" ref-type="bibr">251</xref>).</p><p>In recent years, <italic>Alzheimer</italic>&#x02019;<italic>s disease</italic> (AD) has been considered as a metabolic disease mediated by alterations in brain insulin responsiveness, glucose utilization, and energy metabolism that can lead to increased oxidative stress, inflammation, and worsening insulin resistance (<xref rid="B252" ref-type="bibr">252</xref>). The association between type 2 DM and AD has been called type 3 diabetes (<xref rid="B253" ref-type="bibr">253</xref>). Mexican American elders with diabetes are at almost twofold increased risk of dementia than those without diabetes (<xref rid="B254" ref-type="bibr">254</xref>). Also, longer duration of diabetes has been associated with a faster rate of cognitive decline in this age group (<xref rid="B255" ref-type="bibr">255</xref>). Further research is needed to examine the interaction of type 2 DM and AD in this vulnerable group, and among other Hispanic/Latino groups.</p><p>Other emerging risk factors for type 2 DM and CVD include the gut microbiome (<xref rid="B256" ref-type="bibr">256</xref>&#x02013;<xref rid="B258" ref-type="bibr">258</xref>), gallbladder disease (<xref rid="B259" ref-type="bibr">259</xref>), environmental exposures (<xref rid="B260" ref-type="bibr">260</xref>&#x02013;<xref rid="B262" ref-type="bibr">262</xref>), and the impact of sugar-sweetened beverages intake on satiety (<xref rid="B263" ref-type="bibr">263</xref>). Research on these emerging factors in Hispanics/Latinos has been limited.</p></sec><sec id="S3-4"><title>Genetics and Type 2 DM in Hispanics/Latinos</title><p>The polygenic nature of type 2 DM is well established and more than 100 loci for type 2 DM and glycemic traits have been identified through genome-wide association studies (GWAS) of common and rare variation in populations of diverse ancestral origins (<xref rid="B264" ref-type="bibr">264</xref>).</p><p>Genetic variations in the gene encoding for transcription factor 7-like 2 (TCF7L2) have been associated with type 2 DM in different populations (<xref rid="B265" ref-type="bibr">265</xref>). The T allele of single nucleotide polymorphism (SNP) rs7903146 of TCF7L2 strongly predicts the development of type 2 DM (<xref rid="B265" ref-type="bibr">265</xref>, <xref rid="B266" ref-type="bibr">266</xref>). TCF7L2 has been associated with GDM and type 2 DM in Hispanics/Latinos of Mexican descent (<xref rid="B267" ref-type="bibr">267</xref>, <xref rid="B268" ref-type="bibr">268</xref>), and polymorphisms of this gene have been associated with reduced acute insulin response in this heritage group (<xref rid="B269" ref-type="bibr">269</xref>). This gene has also been associated with diabetes in the HCHS/SOL (<xref rid="B270" ref-type="bibr">270</xref>). TCF7L2 polymorphism rs7903146 has also been associated with coronary artery disease (<xref rid="B271" ref-type="bibr">271</xref>, <xref rid="B272" ref-type="bibr">272</xref>) and stroke (<xref rid="B273" ref-type="bibr">273</xref>) among patients with long standing history of type 2 DM.</p><p>A haplotype containing four missense SNPs, all in SLC16A11, conferring 20% increased risk for type 2 DM was identified through GWAS in Mexican and other Latin American samples in the SIGMA type 2 DM Consortium (<xref rid="B274" ref-type="bibr">274</xref>). A newly identified African ancestry-specific allele at KCNQ1 was associated diabetes in HCHS/SOL (<xref rid="B270" ref-type="bibr">270</xref>), however, the mechanisms leading to type 2 DM due to alterations in this allele are less well understood (<xref rid="B275" ref-type="bibr">275</xref>).</p><p>Whole-exome sequencing in 3756 individuals of Mexican and Mexican American ancestry identified a rare variant (p.E508K) in HNF1A that had significant association (fivefold increase) with type 2 DM (<xref rid="B276" ref-type="bibr">276</xref>). HNF1A is the gene responsible for MODY3, a monogenic, early-onset form of type 2 DM, however carriers of p.E508K did not show early-onset of type 2 DM and were indistinguishable from the wider type 2 DM population, thus not fulfilling the classical diagnostic criteria for MODY3 (<xref rid="B276" ref-type="bibr">276</xref>).</p><p>The Genetics Underlying Diabetes in Hispanics/Latinos (GUARDIAN) Consortium (<xref rid="B277" ref-type="bibr">277</xref>) conducted a GWAS in multiple Mexican-ancestry cohorts with highly detailed glucose homeostasis measures. Nonparametric meta-analysis of the Discovery and Translation cohorts identified a significant relationship with type 2 DM phenotype at 6p24 (SLC35B3/TFAP2A) in association with glucose effectiveness, 11p15 (KCNQ1) with disposition index, and 6p22 (CDKAL1) and 11q14 (MTNR1B) with acute insulin response (<xref rid="B277" ref-type="bibr">277</xref>).</p><p>Genetic studies of GDM in Latin American women have yielded varied findings. In Brazilian women, GDM has been associated with the glucokinase gene (<xref rid="B278" ref-type="bibr">278</xref>), the MTNR1B gene polymorphism rs10830963 (<xref rid="B279" ref-type="bibr">279</xref>), LGALSI polymorphism (<xref rid="B280" ref-type="bibr">280</xref>) and IRS-1 (<xref rid="B281" ref-type="bibr">281</xref>). In Mexican women, GDM has been associated with polymorphisms of the HNF4A gene (<xref rid="B282" ref-type="bibr">282</xref>), the TNF-&#x003b1; gene promoter (<xref rid="B283" ref-type="bibr">283</xref>), the MTNR1B gene (<xref rid="B284" ref-type="bibr">284</xref>), the CENTD2 gene (<xref rid="B284" ref-type="bibr">284</xref>), the KCNQ1 haplotype (<xref rid="B284" ref-type="bibr">284</xref>), and the TCF7L2 gene (<xref rid="B284" ref-type="bibr">284</xref>, <xref rid="B285" ref-type="bibr">285</xref>). However, polymorphisms of the fat mass and obesity-associated (FTO) and the TCF7L2 genes have not been associated with GDM in Brazilian women (<xref rid="B286" ref-type="bibr">286</xref>), and SLC16A11 locus was not associated with GDM in Mexican women (<xref rid="B284" ref-type="bibr">284</xref>).</p><p>Among Mexican American subjects recruited in the San Antonio Family Heart Study, DNA methylation levels at five CpG sites, mapping to three well-characterized genes (TXNIP, ABCG1, and SAMD12) independently explained 7.8% of the heritability of type 2 DM (<xref rid="B287" ref-type="bibr">287</xref>). In the same population, individuals with the hypertriglyceridemic waist phenotype [waist circumference &#x02265;95&#x02009;cm in men and &#x02265;80&#x02009;cm in women] combined with high serum TG concentration (&#x02265;2.0&#x02009;mmol/L in men and &#x02265;1.5&#x02009;mmol/L in women) were found to have epigenetic changes (DNA methylation) in genes involved in &#x003b2; oxidation of long-chain fatty acids (CPT1A) and triglyceride storage (ABCG1) (<xref rid="B288" ref-type="bibr">288</xref>).</p><p>In summary, these findings have shown the broad complexity of the pathophysiology of metabolic disease and research focused on Hispanics/Latinos. Broader attention to different heritages should be considered in future studies to better stratify subjects at risk for type 2 DM and develop intervention strategies according to different genotypic and phenotypic traits.</p></sec></sec><sec id="S4"><title>Interventions to Prevent Type 2 DM among Hispanics/Latinos</title><sec id="S4-1"><title>Lifestyle Interventions to Prevent Type 2 DM in Hispanic/Latino Women with History of GDM</title><p>The increasing prevalence of obesity and metabolic disease in young Hispanics/Latinos (and other racial/ethnic groups) has raised thought-provoking questions about the role of maternal health and the intrauterine environment on the child&#x02019;s future risk for type 2 DM and obesity. As previously described, women who experience GDM are at high risk of developing GDM in subsequent pregnancies and type 2 DM, and their children are at increased risk of metabolic disease.</p><p>The quality of dietary fat intake (<xref rid="B289" ref-type="bibr">289</xref>) and PA (<xref rid="B290" ref-type="bibr">290</xref>&#x02013;<xref rid="B293" ref-type="bibr">293</xref>) during mid-pregnancy have been as proposed factors that could influence the risk of GDM in Latin American women. However, clinical studies evaluating the effect of exercise training on pregnancy outcomes have yielded inconsistent or even conflictive results (<xref rid="B292" ref-type="bibr">292</xref>, <xref rid="B294" ref-type="bibr">294</xref>). In a systematic review by Perales et al., the authors concluded that the combination of aerobic and resistance training during pregnancy seemed to produce the most favorable effect on different maternal health parameters, but that this combination (or either type of exercise separately) yielded an overall weak effect on reducing GDM (<xref rid="B294" ref-type="bibr">294</xref>). Previous history of GDM, preexisting overweight or obesity, gestational weight gain, intensity, frequency, duration, and timing of exercise, and adherence to the PA regime may be factors impacting program efficacy (<xref rid="B292" ref-type="bibr">292</xref>, <xref rid="B294" ref-type="bibr">294</xref>).</p><p>Research focused on preventing GDM or type 2 DM in women with a history of GDM&#x02014;especially Hispanics/Latinas&#x02014;has been scarce. Some studies have evaluated PA and weight gain/retention during pregnancy or postpartum (<xref rid="B295" ref-type="bibr">295</xref>&#x02013;<xref rid="B297" ref-type="bibr">297</xref>). In the Behaviors Affecting Baby and You Study (<italic>n</italic>&#x02009;=&#x02009;110 women at risk of GDM, 60% Hispanic/Latina) participants were randomized to either a 12-week tailored PA intervention or usual wellness care (<xref rid="B295" ref-type="bibr">295</xref>). Women on the tailored exercise intervention had smaller decrease in postpartum PA than the control group (&#x02212;1.0 MET-hours/week versus &#x02212;10.0 MET-hours/week). In the Diet Exercise and Breastfeeding Intervention Study (<italic>n</italic>&#x02009;=&#x02009;116, 35.5% Hispanic/Latina), pregnant women with GDM were randomized to either a Diabetes Prevention Program (DPP)-modeled intervention that started during pregnancy and continued postpartum, or usual care to determine feasibility and changes in metabolic parameters (<xref rid="B296" ref-type="bibr">296</xref>). In a subsample of 72 participants, women who had lost&#x02009;&#x0003e;&#x02009;2&#x02009;kg experienced lower increases in fasting glucose, 2h-glucose and homeostasis model assessment of insulin resistance (HOMA-IR) at 12&#x02009;months postpartum. Hispanic/Latino women were more likely to maintain or gain weight postpartum than women from other racial/ethnic groups (<xref rid="B296" ref-type="bibr">296</xref>).</p><p>In the Gestational Diabetes&#x02019; Effects on Moms Study (<italic>n</italic>&#x02009;=&#x02009;2,280 women with GDM, 22.2% Hispanic/Latina), a DPP-modeled intervention between 6&#x02009;weeks and 6&#x02009;months postpartum was compared to a usual care (mailed recommendations only) (<xref rid="B297" ref-type="bibr">297</xref>). The intervention arm had 28% higher odds of meeting postpartum weight goals than usual care. A greater proportion of women on the intervention arm had less weight retention at 6&#x02009;weeks (25.5 vs. 22.4%) and 6&#x02009;months postpartum (30.6 vs. 23.9%, mean weight lost&#x02009;=&#x02009;1.89 vs. 0.94&#x02009;kg) compared to the women in usual care. However, the difference was no longer significant at 12&#x02009;months (33.0 vs. 28.0%, mean weight lost&#x02009;=&#x02009;1.19 vs. 0.50&#x02009;kg). Also, at 6&#x02009;months postpartum, the intervention arm had a greater increase in vigorous-intensity PA (mean 15.4&#x02009;min/week) than usual care.</p><p>In the Parish Nurse Intervention Program (<xref rid="B298" ref-type="bibr">298</xref>), 100 Mexican American women with GDM were randomized to an interview-based intervention assessing health-promoting behaviors and lifestyle or to usual care. At postpartum, intervention participants reported higher scores on health-promoting behaviors than women receiving usual care. While promising, there were no significant differences in blood glucose, HbA1c, macrosomia, and other biometric parameters. In the Dulce Mothers Project, 84 Hispanic/Latino women with previous GDM were randomized to a shortened 8-week DPP-modeled intervention, or usual care (<xref rid="B299" ref-type="bibr">299</xref>). After 6&#x02009;months, intervention participants reported a significantly higher PA and lower fat intake, but there were no changes in body weight or BMI. Although changes in HbA1c% (5.73&#x02013;5.82%), total cholesterol (180&#x02013;169.9&#x02009;mg/dL), LDL-C (107.8&#x02013;100.4&#x02009;mg/dL), and TGs (124&#x02013;110.3&#x02009;mg/dL) were statistically significant, they were not clinically significant. In the Estudio Vida (<xref rid="B300" ref-type="bibr">300</xref>), 68 pregnant Hispanic/Latino women of unspecified ancestry were randomized to a 6-month culturally and linguistically modified lifestyle intervention (monthly in-person behavioral counseling, and five telephone-delivered booster sessions, plus follow-up 6&#x02009;weeks postpartum) or to usual care, to compare PA, gestational weight gain, infant BW, and biomarkers of insulin resistance postpartum. Although the intervention was shown to be feasible, no changes were observed in any of the outcomes (<xref rid="B300" ref-type="bibr">300</xref>).</p><p>Some of the studies described above did not report the Hispanic/Latino heritage group of the participants and/or assess cardiometabolic markers. In addition, it is unknown whether the follow-up of participants continued beyond the intervention period, and whether the risk for future GDM or type 2 DM was reduced. Other interventions focused on Hispanic/Latino women with history of or at risk of GDM and involving lifestyle intervention have been proposed (<xref rid="B301" ref-type="bibr">301</xref>, <xref rid="B302" ref-type="bibr">302</xref>) have been proposed or initiated. However, results have not yet been published.</p></sec><sec id="S4-2"><title>Lifestyle Interventions to Prevent Type 2 DM in Hispanic/Latino Youth in the US and Latin America</title><p>Little information is available of type 2 DM prevention efforts focusing on the youth (<xref rid="B303" ref-type="bibr">303</xref>). To date, no published investigations are available to address type 2 DM prevention in Hispanic/Latino youth with prediabetes. Although programs designed to prevent childhood and youth obesity have been extensively reviewed, these seldom assess blood pressure, lipids and lipoproteins and other metabolic markers, or adiposity (<xref rid="B304" ref-type="bibr">304</xref>&#x02013;<xref rid="B311" ref-type="bibr">311</xref>). The effectiveness trials for prevention of type 2 DM among youth are further challenged by a lack of consensus on parameters for disease risk indicators (adiposity, CV risk markers, resting energy expenditure), especially during puberty, and its associated changes in body composition, insulin sensitivity and or insulin secretion (<xref rid="B312" ref-type="bibr">312</xref>&#x02013;<xref rid="B317" ref-type="bibr">317</xref>).</p><sec id="S4-2-1"><title>Weight Loss and Obesity Prevention Trials</title><p>Weight loss interventions focusing on children with overweight or obese have resulted in improved metabolic outcomes such as insulin sensitivity, lipids and adiposity measures (<xref rid="B318" ref-type="bibr">318</xref>&#x02013;<xref rid="B324" ref-type="bibr">324</xref>). Most of these trials involved medium to high-intensity interventions focusing on physical activity (PA) and dietary intake (<xref rid="B309" ref-type="bibr">309</xref>, <xref rid="B311" ref-type="bibr">311</xref>, <xref rid="B325" ref-type="bibr">325</xref>). Interventions delivered in schools with home involvement (PA-only interventions), or with home and community components (diet and PA interventions) have produced the strongest evidence of the metabolic benefits of weight loss and, consequently, childhood obesity prevention in the US and Latin America (<xref rid="B310" ref-type="bibr">310</xref>, <xref rid="B325" ref-type="bibr">325</xref>, <xref rid="B326" ref-type="bibr">326</xref>).</p><p>While promising, there are few weight gain prevention interventions specifically focusing on Hispanics/Latinos in the US and Latin America (<xref rid="B304" ref-type="bibr">304</xref>, <xref rid="B308" ref-type="bibr">308</xref>, <xref rid="B327" ref-type="bibr">327</xref>). Reviews of childhood obesity interventions in Latin America and the Caribbean report encouraging trends in childhood obesity prevention and treatment programs in schools (<xref rid="B328" ref-type="bibr">328</xref>), healthcare (<xref rid="B329" ref-type="bibr">329</xref>), and settings such as home, summer camps and family clinics (<xref rid="B330" ref-type="bibr">330</xref>). However, these studies were mostly carried out in Mexico and Brazil, only three were randomized clinical trials (RCTs), and most did not include appropriate pediatric measures for BMI or participants&#x02019; ages (<xref rid="B327" ref-type="bibr">327</xref>). In the US, evaluations of community-based interventions targeting multiple predictors of childhood obesity are underway <italic>via</italic> the CDC-funded Childhood Obesity Research Demonstration Projects (CORD) (<xref rid="B331" ref-type="bibr">331</xref>&#x02013;<xref rid="B334" ref-type="bibr">334</xref>). Two of the sites will focus specifically on Hispanic/Latino populations.</p><sec id="S4-2-1-1"><title>Dietary Considerations</title><p>Although there is no prescribed diet for diabetes prevention among youth, reductions of saturated fats and sugars and increases in fruits, vegetables, and fiber are expected to prevent overweight among children (<xref rid="B335" ref-type="bibr">335</xref>, <xref rid="B336" ref-type="bibr">336</xref>) and therefore are also used in weight loss intervention trials. However, some argue that diets for type 2 DM prevention among youth should instead focus on low-glycemic foods (<xref rid="B337" ref-type="bibr">337</xref>). Small trials that test the safety and efficacy of intense diet modifications suggest that low-glycemic food choices decrease waist circumference, BMI z-score, and insulin resistance&#x02014;assessed through the HOMA-IR&#x02014;compared to higher glycemic food choices (<xref rid="B323" ref-type="bibr">323</xref>, <xref rid="B325" ref-type="bibr">325</xref>, <xref rid="B337" ref-type="bibr">337</xref>&#x02013;<xref rid="B341" ref-type="bibr">341</xref>). Some authors argue that these diets lead to greater decreases in adipose tissue compared to low-energy and low-fat diets (<xref rid="B338" ref-type="bibr">338</xref>, <xref rid="B342" ref-type="bibr">342</xref>). In terms of metabolic effects of these diets specifically among Hispanics/Latinos, evidence is still emerging (<xref rid="B325" ref-type="bibr">325</xref>).</p></sec><sec id="S4-2-1-2"><title>Physical Activity Considerations</title><p>Intervention trials involving exercise only (without diet restrictions) among youth and adults have shown effects on metabolic outcomes and cardiorespiratory fitness without affecting weight or fat mass (<xref rid="B343" ref-type="bibr">343</xref>&#x02013;<xref rid="B349" ref-type="bibr">349</xref>). Data specific to Hispanics/Latinos are limited, but in Mexico, Mac&#x000ed;as-Cervantes et al. observed a significant decrease in insulin and HOMA-IR after a randomized trial of a 12-week exercise training intervention in a RCT of 76 children, aged 6&#x02013;9&#x02009;years, with no significant changes in BMI or diet between control and intervention groups (<xref rid="B347" ref-type="bibr">347</xref>). Of note, the ADA recommends that children engage in 60&#x02009;minutes of exercise per day most days, and that they limit time in front of a screen to less than 2&#x02009;hours a day as a type 2 DM prevention strategy in children (<xref rid="B336" ref-type="bibr">336</xref>).</p></sec></sec><sec id="S4-2-2"><title>Preventing Prediabetes in School-Aged Children</title><p>DPPs in school settings have been somewhat successful at increasing PA (and sometimes improving diet) <italic>via</italic> education and hands-on activities. However, their effects on BMI, adiposity measures, and lipids have been inconsistent (<xref rid="B305" ref-type="bibr">305</xref>, <xref rid="B350" ref-type="bibr">350</xref>&#x02013;<xref rid="B353" ref-type="bibr">353</xref>). Results are difficult to compare due to the range of both the cardiometabolic risk indicators assessed and the age of the children included in the studies.</p><p>Lifestyle intervention trials have been conducted in schools with large (&#x0003e;50%) Hispanic/Latino populations to achieve change in metabolic and anthropometric outcomes among normal-weight students. These interventions have often involved PA and healthful nutrition education components and activities that are incorporated into the schools&#x02019; curricula (regular and PA classes) and cafeteria. After 4&#x02013;7 month interventions involving elementary- and middle-school children, several studies reported significant improvements in behavioral or metabolic outcomes, without an effect on anthropometrics (<xref rid="B354" ref-type="bibr">354</xref>&#x02013;<xref rid="B356" ref-type="bibr">356</xref>). Two additional studies with similar school-based programs reported improvements in metabolic and anthropometric parameters in the US and Brazil (<xref rid="B350" ref-type="bibr">350</xref>, <xref rid="B357" ref-type="bibr">357</xref>), yet, not all studies have yielded significant results. For example, the HEALTHY study, a larger school RCT in seven centers in the US in which children in middle school (sixth to eighth grade, 54.2% Hispanics/Latinos) were followed, did not observe significant decreases in overweight/obesity, lipid, hypertension, or other metabolic markers among Hispanics/Latinos (<xref rid="B358" ref-type="bibr">358</xref>, <xref rid="B359" ref-type="bibr">359</xref>).</p><p>Studies that focus on older Hispanic/Latino youth (aged 14&#x02013;17&#x02009;years) are less consistent in their findings. A small RCT in Brazil (<xref rid="B360" ref-type="bibr">360</xref>) reported that a high-intensity exercise intervention for 43 adolescents with obesity did not improve BMI, waist circumference, blood glucose, physical fitness, HDL-C, or lipids. Other studies in older Hispanic/Latino teenagers (14&#x02013;17&#x02009;years) with obesity in the US or Mexico used similar dietary intake-targeted interventions for an average 4-month period. Although they reported significant changes in some anthropometric measures, physical inactivity, diet, and cardiometabolic risk factors, they were insufficiently powered and did not include controls (<xref rid="B361" ref-type="bibr">361</xref>&#x02013;<xref rid="B363" ref-type="bibr">363</xref>).</p></sec></sec><sec id="S4-3"><title>Lifestyle Interventions to Prevent Type 2 DM in Hispanic/Latino Adults in the US and Latin America</title><p>The evidence for successful type 2 DM prevention interventions among adults is growing. However, the increasing prevalence and incidence of type 2 DM among Hispanic/Latino adults suggest that preventive programs have not caught up with the needs of this population.</p><sec id="S4-3-1"><title>The DPP</title><p>The DPP is a seminal type 2 DM prevention trial (<xref rid="B364" ref-type="bibr">364</xref>). It recruited an ethnically diverse (<italic>N</italic>&#x02009;=&#x02009;3,234, 16% Hispanics/Latinos) cohort and established a multisite program that demonstrated that a lifestyle intervention targeting 7% body weight reduction and increase in PA (goal&#x02009;=&#x02009;150&#x02009;minutes per week) effectively reduced by 58% (compared to placebo) the incidence of type 2 DM among persons at high risk, and compared to 31% reduction with metformin (<xref rid="B364" ref-type="bibr">364</xref>, <xref rid="B365" ref-type="bibr">365</xref>). The reduction of diabetes incidence was similar among race/ethnic groups, including Hispanics/Latinos (<xref rid="B364" ref-type="bibr">364</xref>). The percent of weight loss achieved by Hispanics/Latinos in the lifestyle intervention arm (women 7.3%, men 7.7%) was close to that of NHWs (women 7.9%, men 8.5%) (<xref rid="B366" ref-type="bibr">366</xref>).</p></sec><sec id="S4-3-2"><title>Lifestyle Interventions Modeled after the DPP in Hispanics/Latinos in the US</title><p>The success of the DPP has sparked numerous attempts to modify this individual-based intervention for delivery in various community settings serving culturally diverse groups (<xref rid="B367" ref-type="bibr">367</xref>&#x02013;<xref rid="B379" ref-type="bibr">379</xref>). Many of these translations appear to be effective for weight loss and improvement in cardiometabolic parameters (<xref rid="B368" ref-type="bibr">368</xref>, <xref rid="B379" ref-type="bibr">379</xref>), although questions remain as to appropriate dosage that makes interventions both accessible and cost-effective, as well as the way in which these interventions have been culturally adapted to different populations.</p><p>A recent review identified only five RCTs designed to evaluate lifestyle interventions aimed to reduce risk of type 2 DM in Hispanics/Latinos (measured by reduction of weight or HbA1c) (<xref rid="B380" ref-type="bibr">380</xref>), and only two were deemed to have a strong quality rating. These two studies were conducted in women only (<xref rid="B370" ref-type="bibr">370</xref>) or mostly (&#x0003e;70%) (<xref rid="B368" ref-type="bibr">368</xref>), and only one of them reported a significant reduction in HbA1c (<xref rid="B368" ref-type="bibr">368</xref>).</p><p>Most studies designed for type 2 DM prevention among Hispanics/Latinos culturally tailor their programs to the population of interest (<xref rid="B367" ref-type="bibr">367</xref>&#x02013;<xref rid="B369" ref-type="bibr">369</xref>, <xref rid="B371" ref-type="bibr">371</xref>, <xref rid="B381" ref-type="bibr">381</xref>). A recent review of culturally tailored type 2 DM prevention interventions in US Hispanic/Latino adults described the varied approaches to cultural tailoring, which ranged from use of bilingual materials to community input on program content (<xref rid="B380" ref-type="bibr">380</xref>). As is the case in virtually all culturally adapted studies, none assessed the relative importance of various cultural adaptation elements, did not compare culturally adapted interventions and non-adapted approaches (<xref rid="B380" ref-type="bibr">380</xref>), and did not specify participants&#x02019; ancestry or country of origin. While budgetary limitations often present barriers to these analyses, it would be important to ascertain the usefulness of elements of cultural adaptation, as well as to determine the variability of health-related behaviors by cultural origin (<xref rid="B84" ref-type="bibr">84</xref>, <xref rid="B163" ref-type="bibr">163</xref>, <xref rid="B382" ref-type="bibr">382</xref>&#x02013;<xref rid="B384" ref-type="bibr">384</xref>). There is a critical need for culturally adapted interventions to provide more detailed information on the methodology followed in the cultural adaptations, beyond the translation of materials, as well as to address the linguistic needs of many Latin American immigrants from indigenous communities, for whom Spanish is not a first language.</p><p>In Latin America, there seem to be no published studies modeled after the DPP, but several RCTs have evaluated the effect of lifestyle interventions on weight and metabolic outcomes among adults in Mexico and Brazil (<xref rid="B384" ref-type="bibr">384</xref>). The RCTs varied in size (<italic>N</italic>&#x02009;=&#x02009;51&#x02013;241), intervention dosage (weekly to monthly), duration (6&#x02013;12&#x02009;months), and specific intervention components. The dietary interventions included the DASH diet (<xref rid="B385" ref-type="bibr">385</xref>), low-glycemic diets (<xref rid="B386" ref-type="bibr">386</xref>), or diets recommending olive oil, fruits, and vegetables (<xref rid="B387" ref-type="bibr">387</xref>). The studies reported significant changes in body weight loss and/or metabolic markers, including fasting blood glucose, HbA1c, and lipids (<xref rid="B386" ref-type="bibr">386</xref>&#x02013;<xref rid="B390" ref-type="bibr">390</xref>).</p></sec></sec><sec id="S4-4"><title>Pharmacological Interventions to Prevent Type 2 DM in Hispanic/Latino Adults in the US and Latin America</title><p>A few pharmacological interventions focused on preventing or delaying type 2 DM in Hispanics/Latinos have been published (<xref rid="B391" ref-type="bibr">391</xref>&#x02013;<xref rid="B395" ref-type="bibr">395</xref>). The PPAR &#x003b3; agonists troglitazone (<xref rid="B391" ref-type="bibr">391</xref>) and pioglitazone (<xref rid="B392" ref-type="bibr">392</xref>) have demonstrated long-term preservation of &#x003b2;-cell function in Hispanic/Latino women with a history of GDM. Troglitazone significantly reduced the annual incidence rate of type 2 DM (5.4 versus 12.1% for placebo) over a median 30-month follow-up (<xref rid="B391" ref-type="bibr">391</xref>), and pioglitazone demonstrated a significant decrease over 1-year period (<xref rid="B392" ref-type="bibr">392</xref>).</p><p>Boyko et al. reported a significant and greater reduction in diabetes incidence (hazard ratio&#x02009;=&#x02009;0.18 over approximately 5&#x02009;years, <italic>P</italic>&#x02009;=&#x02009;0.0242) in Latinos taking rosiglitazone, another PPAR &#x003b3; agonist, and South Asians showing the lowest reduction (<xref rid="B393" ref-type="bibr">393</xref>). De Fronzo et al. reported a similar effect of pioglitazone at reducing diabetes incidence (hazard ratio&#x02009;=&#x02009;0.28 over 2.4&#x02009;years, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001) among NHWs, AAs and Hispanics/Latinos compared to placebo (<xref rid="B394" ref-type="bibr">394</xref>).</p><p>O&#x02019;Brien et al. (<xref rid="B395" ref-type="bibr">395</xref>) compared a 12-month intensive lifestyle intervention (DPP-modeled) led by <italic>promotoras</italic> to metformin, and to usual care in a group of 85 Hispanic/Latino women (aged&#x02009;&#x02265;&#x02009;20&#x02009;years) with prediabetes (IFG and/or HbA1c 5.7&#x02013;6.4%). The investigators observed a significant reduction in weight (&#x02212;4.0&#x02009;kg or 5.0%, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001) as well as in BMI in women on the lifestyle intervention compared to the other groups. However, no significant changes in blood pressure, biochemical parameters, or HOMA-IR were observed. Of note, the mean adherence to metformin was 66.4%.</p><sec id="S4-4-1"><title>Pharmacological Interventions for Cardiometabolic Risk Factors in Hispanic/Latino Adults in the US and Latin America</title><p>Pharmacological interventions specifically designed to improve cardiometabolic risk factors in Hispanics/Latinos at high risk of type 2 DM are limited. Despite this limitation, we would like to highlight some key findings.</p><p>Four RCTs (<xref rid="B396" ref-type="bibr">396</xref>&#x02013;<xref rid="B400" ref-type="bibr">400</xref>) designed to compare the effectiveness of combinations of angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs) on blood pressure reduction and/or prevention of CV events with other antihypertensive medications reported that Hispanics/Latinos demonstrated good response to the therapies and maintenance of blood pressure control, similar or even superior than that observed in NHWs (<xref rid="B396" ref-type="bibr">396</xref>&#x02013;<xref rid="B399" ref-type="bibr">399</xref>). In one of the trials, the addition of trandolapril to the treatment was associated with a lower incidence of diabetes and CV events among Hispanics/Latinos than in non-Hispanic participants (<xref rid="B398" ref-type="bibr">398</xref>). This observation is consistent with previous clinical trials (in which Hispanics/Latinos had not been included) that reported a lower incidence of type 2 DM associated with ACE inhibitors and ARBs (<xref rid="B401" ref-type="bibr">401</xref>, <xref rid="B402" ref-type="bibr">402</xref>). Also, a secondary data analysis on one of the trials revealed that a significantly larger percent (75%) of Hispanic/Latino women (<italic>n</italic>&#x02009;=&#x02009;5,017) reached blood pressure goals compared to 68% of NHW women (<italic>n</italic>&#x02009;=&#x02009;4,710), and that Hispanic/Latino women experienced fewer CV events (5.7 versus 12.3%) (<xref rid="B403" ref-type="bibr">403</xref>). In addition, Punzi et al. reported a significant reduction in blood pressure in Hispanics/Latinos with Stage I-II hypertension associated with nebivolol (&#x003b2; blocker) (<xref rid="B404" ref-type="bibr">404</xref>). Blood pressure control was achieved by 32&#x02013;71% of participants depending on the dose. Some of these studies reported the Hispanic/Latino heritage group of the participants or the Latin American countries where the studies were conducted. Other studies did not report nationalities or heritage group.</p><p>The results of the studies described above suggest Hispanics/Latinos experienced similar or better response to antihypertensive therapy than patients from other demographic groups (<xref rid="B405" ref-type="bibr">405</xref>). In contrast, Yi et al. did not observe an increased blood pressure control with self-blood pressure monitoring in a low-income urban setting (<xref rid="B406" ref-type="bibr">406</xref>). Thus, the good response to hypertensive medications observed among Hispanics/Latinos in clinical trials may be both physiological and dependent on a controlled research setting. Future research may address underlying self-efficacy and contextual barriers that impeded the success of the self-monitoring and blood pressure control outside of clinical trials.</p><p>Various clinical trials evaluating the efficacy of lipid-lowering agents have reported significant reductions of total cholesterol and LDL-C, or CRP in US Hispanics/Latinos or Latin Americans (<xref rid="B407" ref-type="bibr">407</xref>&#x02013;<xref rid="B410" ref-type="bibr">410</xref>), and comparable to reductions experienced by NHWs (<xref rid="B407" ref-type="bibr">407</xref>, <xref rid="B408" ref-type="bibr">408</xref>). These studies have also reported good medication tolerance.</p></sec></sec><sec id="S4-5"><title>Policies and Priorities and Diabetes Prevention Research in Latin America</title><p>Countries throughout Latin America and the Caribbean are starting to raise awareness about chronic disease, including type 2 DM treatment and prevention. For example, the Latin American Association for Diabetes published guidelines about the treatment and management of type 2 DM across medical associations in 17 countries (<xref rid="B411" ref-type="bibr">411</xref>). During the 2016 Pan American Health Organization (PAHO) symposium on Diabetes in the Americas, various countries described the epidemiology of diabetes in terms of incidence, prevalence, mortality, and risk factors. The review discussed policies or public awareness programs in place or designed to raise awareness of diabetes management focused mostly on nutrition education and physical activities (<xref rid="B412" ref-type="bibr">412</xref>).</p><p>Increased activities about prevention and treatment of type 2 DM, such as those described during the PAHO Diabetes in the Americas symposium, can be leveraged to increase our understanding of whether strategies designed to target type 2 DM risk factors (i.e., prediabetes, hypertension, and obesity) can actually lead to lower disease risk. As of May 2015, Chile and Mexico had implemented national-level taxes on sodas, and evaluations for these programs are underway (<xref rid="B413" ref-type="bibr">413</xref>). Various Latin American countries have set strategies, which have not yet been evaluated, to increase awareness about the harmful effects of transfatty acids (<xref rid="B414" ref-type="bibr">414</xref>) and of high salt intake (<xref rid="B415" ref-type="bibr">415</xref>&#x02013;<xref rid="B419" ref-type="bibr">419</xref>). Other population-level initiatives include the creation of guidelines for healthful eating and PA; the creation of <italic>Ciclov&#x000ed;a-Recreov&#x000ed;a</italic> in Colombia (<xref rid="B420" ref-type="bibr">420</xref>), additional training of health care professionals to improve diabetes care, and diabetes screening initiatives in Chile, Argentina, and Honduras, nutrition labeling in Ecuador, and the ban of unhealthful foods in schools in Costa Rica, Per&#x000fa; and Guatemala (<xref rid="B418" ref-type="bibr">418</xref>). These new strategies present a unique opportunity to evaluate the process of implementation, the role of stakeholders in their design and implementation, and their eventual impact on anthropometric, lipids, and metabolic indicators or diabetes prevalence and treatment.</p></sec></sec><sec id="S5"><title>Preventing Type 2 DM in Hispanics/Latinos&#x02014;A Holistic Framework</title><p>The epidemiology, etiology, and interventions studies selected for this review provide important insights on the magnitude of the prevalence, the complexity of potential mechanisms of disease, and the approaches toward preventing type 2 DM in Hispanics/Latinos. Based on these insights, it is evident that the successful prevention of type 2 DM in Hispanic/Latino populations in the US and Latin America would need a fundamentally radical transformation. In the era of personalized medicine, this transformation would require a holistic mission and a multidisciplinary approach.</p><p>This holistic framework integrates key domains that interact with each other (Figure <xref ref-type="fig" rid="F2">2</xref>). Within each domain we have identified areas that represent opportunities for enhancing the prevention of type 2 DM in Hispanic/Latino populations&#x02014;whether as a part of a research program or clinical care intervention. The Hispanic/Latino individual is at the center, and representing the most important element of the framework.</p><fig id="F2" position="float"><label>Figure 2</label><caption><p>Framework of opportunities to enhance research and clinical care oriented toward preventing type 2 diabetes in Hispanics/Latinos in the US and Latin America.</p></caption><graphic xlink:href="fendo-08-00298-g002"/></fig><p>Our understanding of the burden of diabetes (type 1 and type 2) in Hispanic/Latino populations remains insufficient and should be prioritized. The development of effective type 2 DM preventive efforts requires continued surveillance of the burden of disease and its risk factors using disaggregated data on Hispanic/Latino subgroups. Adequate representation of diverse populations would enhance the identification of different phenotypes, and potential disease mediators and interactions. More detailed epidemiologic data at the country level in Latin America are urgently needed.</p><p>Consistency and standardization of methodology to assess the prevalence of diabetes in Hispanic/Latino populations would more accurately estimate its prevalence within and among countries and ethnic/heritage groups, and enhance comparison across studies. The need for consistency of methodology and for detailed disaggregated data could be addressed through the creation of repositories of deidentified data, and consortia (including representatives from research study groups, academic centers, medical societies, health authorities, and others) that would strategize the harmonization and/or standardization of methodology for data collection and analysis.</p><p>The identification of Hispanics/Latinos and Latin Americans in health-related research is inconsistent. Although the concept of a Hispanic/Latino monolith is slowly changing, the continued use of umbrella terms like &#x0201c;Hispanic&#x0201d; or &#x0201c;Latino&#x0201d; limits the ability of public health and clinical researchers to evaluate and address type 2 DM risk factors that may impact or manifest differently across Hispanic/Latino heritage groups; and this in turns delays the development of effective preventive strategies.</p><p>The etiology of type 2 DM is complex, and the research studies discussed in this review demonstrated areas in which further research could be developed. In this regard, it is not completely understood whether the oxidative stress, inflammatory and endothelial changes described in placental and umbilical cord tissue of pregnancies in which the mother had obesity or GDM could be prevented or reverted during pregnancy, and the impact that such reduction would have on the child. At the same time, although GDM has been associated with increased risk for maternal type 2 DM, it is not clear whether GDM increases the mother&#x02019;s risk for CVD. Determining GDM risk (i.e., a predictive profile) for Hispanic/Latino women might identify those at risk early in pregnancy or before conception, so preventive interventions are tailored and initiated earlier.</p><p>Although obesity is associated with increased risk for type 2 DM, the distribution of adipose tissue (i.e., steatosis) has been associated to specific metabolic (<xref rid="B421" ref-type="bibr">421</xref>, <xref rid="B422" ref-type="bibr">422</xref>) and cardiac structural abnormalities (<xref rid="B423" ref-type="bibr">423</xref>, <xref rid="B424" ref-type="bibr">424</xref>). The study of other type 2 DM risk factors previously mentioned (e.g., sleep-disordered breathing, gut microbiome, environmental exposures) could uncover new mechanisms of disease, which can be turned into additional opportunities for interventions in Hispanic/Latino populations.</p><p>As the field of genetics/epigenetics/genomics continues evolving, additional insights on the gene-environment interaction (e.g., chronic stress, environmental endocrine disruptors, other environmental exposures) and the differences in susceptibility to type 2 DM experienced by different Hispanic/Latino heritage groups in the US and Latin America might be uncovered. Thus, the inclusion of Hispanics/Latinos in these research studies needs to improve.</p><p>The clinical assessment of Hispanics/Latinos at risk of developing type 2 DM needs to be comprehensive. The medical history needs to account underlying medical, nutritional, physical fitness, emotional, behavioral, cultural, and social factors. A detailed family history will uncover heredity patterns that could be relevant in the decision-making regarding therapy or genetic testing. The individuals&#x02019; family dynamics and social network may also uncover dietary habits and values (<xref rid="B425" ref-type="bibr">425</xref>&#x02013;<xref rid="B427" ref-type="bibr">427</xref>) that could impact the disease risk, the need for pharmacological therapy, and the effectiveness of the intervention. Socioeconomic factors will influence both type 2 DM risk and the success of any prevention strategy (<xref rid="B368" ref-type="bibr">368</xref>&#x02013;<xref rid="B371" ref-type="bibr">371</xref>, <xref rid="B427" ref-type="bibr">427</xref>&#x02013;<xref rid="B431" ref-type="bibr">431</xref>). Access, availability and quality of food; social and family responsibilities, social network and support; stressors; of the built environment, neighborhood safety, transportation, and access to recreational activities; availability and access to health services, health insurance type, and coverage; access to and utilization of medications and medical services; formal education attained and health literacy; and occupation(s), work shift, and occupational safety are some of the factors that will influence the success of the intervention. Incorporating these factors into the clinical assessment could uncover obstacles requiring alternative or additional interventions.</p><p>As previously discussed, Hispanics/Latinos at risk of type 2 DM often also have other cardiometabolic factors that increase the risk for developing type 2 DM or CVD (<xref rid="B95" ref-type="bibr">95</xref>, <xref rid="B146" ref-type="bibr">146</xref>, <xref rid="B148" ref-type="bibr">148</xref>, <xref rid="B432" ref-type="bibr">432</xref>, <xref rid="B433" ref-type="bibr">433</xref>). While lifestyle intervention would ideally be recommended to every patient at risk, some patients would also need pharmacological therapy to control other cardiometabolic factors (<xref rid="B66" ref-type="bibr">66</xref>, <xref rid="B434" ref-type="bibr">434</xref>). Prevention of use of tobacco or its cessation should also be addressed, when applicable.</p><p>The difference in prevalence of diabetes across Hispanic/Latino heritage groups presents an opportunity to study potential genetic, biological and environmental interactions that lead to different manifestations of the disease. Deep metabolic phenotyping, (i.e., assessment of glucose homeostasis, insulin sensitivity, insulin secretion, &#x003b1;-cell and &#x003b2;-cell function, adipose tissue distribution) along with a comprehensive clinical assessment (including age, sex, clinical presentation of the disease, detailed medical history, etc.) may uncover important differences or similarities in type 2 DM phenotypes among Hispanic/Latino heritage groups, and biological or health determinants that could influence type 2 DM risk. Given the diversity of the Hispanic/Latino population, the feasibility of such enterprise could be addressed through collaborations like those mentioned above, exploring the use of clinical databases, and creating patient/data registries, among other potential collective efforts.</p><p>Type 2 diabetes mellitus preventive strategies have mostly focused on weight reduction, and have produced promising results. However, given the increasing prevalence of obesity in the Hispanic/Latino populations, type 2 DM diabetes and obesity preventive efforts may require even more intensive approaches, perhaps through risk stratification. Preventive efforts focusing on those at higher risk due to age, health status, medications, sedentary lifestyle, family history of type 2 DM or GDM might be different than the strategies for those who have lower susceptibility. The timing of prevention should also be considered. Earlier onset of obesity has been associated with higher risk of developing type 2 DM (<xref rid="B173" ref-type="bibr">173</xref>&#x02013;<xref rid="B175" ref-type="bibr">175</xref>), for example. Also, risk stratification should be carefully determined and considering all factors mentioned above. For instance, the DPP reported that over a 10-year follow-up period from randomization, the initial differences in incident diabetes among treatment arms, including the lifestyle intervention, began to narrow (<xref rid="B435" ref-type="bibr">435</xref>). Through a retrospective analysis, the investigators examined participants&#x02019; susceptibility to type 2 DM, including genetic risk scores (GRSs) (<xref rid="B435" ref-type="bibr">435</xref>, <xref rid="B436" ref-type="bibr">436</xref>). The investigators concluded that although clinical and genetic susceptibility could influence risk to develop type 2 DM, GRS alone did not determine the success of the lifestyle intervention; at the highest quartile of GRS, intensive lifestyle intervention was effective at reducing risk (<xref rid="B435" ref-type="bibr">435</xref>, <xref rid="B436" ref-type="bibr">436</xref>).</p><p>Few behaviors are as closely tied to culture as diet and self-care. What, when, and how much we eat, as well as our notions of health and disease, including whose advice we seek, are firmly grounded in the cultural context which shapes us. It may influence beliefs about what causes diabetes, whether to engage in type 2 DM risk-reduction activities, seek advice regarding the disease, and decide which treatment options are followed. Despite their impact on health and disease management, cultural considerations are often an afterthought in the development and implementation of preventive or treatment interventions targeting type 2 DM in Hispanic/Latino populations. A recent review found only 12 published studies on behavioral interventions aimed at reduction of type 2 DM and specifically designed for Hispanic/Latino adults (<xref rid="B380" ref-type="bibr">380</xref>). All interventions were offered in Spanish and took place in community settings, and nine included materials for individuals of low literacy. However, only two included Hispanic/Latino foods or recipes, community input in the intervention content, and addressed cultural beliefs regarding diabetes. Thus, it appears that for most studies, the process of infusing culture into interventions remains at the surface structures (language and setting in which intervention is delivered), without fully incorporating cultural values and elements into intervention messages, materials, design, and implementation (<xref rid="B437" ref-type="bibr">437</xref>). Given the evidence that culturally coherent behavioral interventions for diabetes prevention/management among Hispanic/Latino groups are more effective than usual care in improving HbA1c, weight/body mass index, lipid, blood pressure, dietary intake, PA, and diabetes knowledge (<xref rid="B438" ref-type="bibr">438</xref>), there is a strong case for ensuring the presence of cultural-competency components in every diabetes-related healthcare service intervention. Cultural competence must be at the core of clinical care and the design and implementation of research studies and large-scale interventions.</p><p>Lifestyle intervention studies to prevent type 2 DM in Hispanics/Latinos have mostly been focused on short-term goals of weight reduction, and increasing PA. While they have demonstrated modest success at meeting these goals, follow-up periods have been insufficiently long to demonstrate prevention or delay of type 2 DM. Initiating lifestyle interventions before pregnancy (to prevent GDM, for example), and improving representation of women of various Hispanic/Latino heritage groups, should be seriously considered. Studies focused on children and adolescents could explore the impact of factors, such as maternal health, prenatal care, and child&#x02019;s development on preventive interventions. Advances in the field will require funding opportunities that allow for longer follow-up periods, permit the examination of interventions and outcomes for different Hispanic/Latino populations, and allow for comparisons of various elements of cultural adaptation. On the other hand, integrating research interventions within established clinical settings or health systems could be resource-efficient way to implement research studies on type 2 DM prevention, including the follow-up of research study participants.</p><p>Quality of life and savings in disability-adjusted life years resulting from delaying the onset of type 2 DM should be quantified and qualified, especially among high-risk populations like Hispanics/Latinos. Also, the evaluation of type 2 DM risk prevention in multilevel community studies to prevent childhood obesity (<xref rid="B331" ref-type="bibr">331</xref>, <xref rid="B332" ref-type="bibr">332</xref>), coupled with mass media campaigns to increase awareness of type 2 DM prevention (<xref rid="B336" ref-type="bibr">336</xref>, <xref rid="B439" ref-type="bibr">439</xref>), and other risk factors for diabetes, is warranted.</p><p>The success of large culturally tailored interventions, such as those modeled after the DPP, underscore the promise that such interventions might result in improved quality of life, higher productivity, and reduced morbidity and mortality for Hispanic/Latino populations. However, it is critical to remain aware that the vast heterogeneity in the Hispanic/Latino population requires clinicians and researchers alike to avoid relying on vague and largely unexamined concepts, such as <italic>familism</italic> and <italic>marianism</italic> without first verifying their relevance in the population of interest. Often, the uncritical acceptance of these values as omnipresent in individuals of Hispanic/Latino origin results in the automatic assumptions that, for example, interventions must be family based. Upon closer examination, studies have found that the Hispanic family unit is much more complex, and less unconditionally supportive, than it is often assumed to be, and in many cases, some Hispanic/Latino women prefer women-only group interventions without the inhibiting presence of family members, children, or spouses (<xref rid="B440" ref-type="bibr">440</xref>, <xref rid="B441" ref-type="bibr">441</xref>).</p><p>In both clinical and research programs, engagement of stakeholders, not only including the patient population and the healthcare provider team, but also administrative clinic and research staff, is critical for the success of health-promotion interventions. A bidirectional communication style, from clinicians/investigators to patients and community, is necessary to ensure the cultural coherence, accessibility, and sustainability of a program. Individuals who are thoroughly competent in the cultural, socioeconomic, and even geographic context of the target population can navigate cultural nuances of these heterogeneous populations and provide invaluable guidance in the design and implementation of both large- and small-scale preventive and treatment efforts.</p><p>Upon designing a research project or implementing a clinical program to prevent type 2 DM in Hispanics/Latinos in the US and in Latin America, other challenges need to be acknowledged. Insufficient institutional (government, academic, etc.) interest or commitment, lack of public awareness on the importance of prevention, insufficient financial and human resources, and political issues are some of the challenges faced across the continent (<xref rid="B442" ref-type="bibr">442</xref>&#x02013;<xref rid="B444" ref-type="bibr">444</xref>). Whereas out of the scope of this review, proposed models of an international collaborative initiative (<xref rid="B442" ref-type="bibr">442</xref>) and of an implementation cycle and a translatability scale for identifying and implementing effective solutions to address the rising burden of chronic diseases in low-middle income countries, specifically CVD (<xref rid="B444" ref-type="bibr">444</xref>), might set the stage for future type 2 DM prevention initiatives in the continent.</p><p>The progressive and sustained increase in type 2 DM among Hispanics/Latinos is a clear indicator that preventive efforts need to be seriously and urgently reframed. This will require a better understanding of the extent and etiology of the disease, creating solutions through multidisciplinary approaches, and a fundamentally radical transformation in our priorities as individuals and as communities.</p></sec><sec id="S6"><title>Author Contributions</title><p>MLAS conceptualized the manuscript. MLAS, UCR, FJP, JM, NML and CMP researched the literature, wrote different sections of the manuscript, reviewed the manuscript in its entirety, and approved its final version. MLAS and NML did the final review and editing of the manuscript.</p></sec><sec id="S7"><title>Disclaimer</title><p>The views expressed in this manuscript are those of the authors and do not necessarily represent the views of the National Heart, Lung, and Blood Institute; the National Institutes of Health; or the US Department of Health and Human Services.</p></sec><sec id="S8"><title>Conflict of Interest Statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><ack><p>The authors would like to acknowledge and thank Dr. Jean L. Olson and Ms. Jill A. Pope for their valuable comments and edits.</p></ack><ref-list><title>References</title><ref id="B1"><label>1</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Garc&#x000ed;a-M&#x000e1;rquez</surname><given-names>G</given-names></name></person-group>
<article-title>No one writes to the colonel</article-title>. <edition>1st ed</edition> In: <person-group person-group-type="editor"><name><surname>Garc&#x000ed;a-M&#x000e1;rquez</surname><given-names>G</given-names></name></person-group>, editor. <source>Collected Novellas</source>. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Harper Perennial</publisher-name> (<year>1991</year>). <fpage>152</fpage> p.</mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="webpage"><person-group person-group-type="author"><name><surname>Jacome Roca</surname><given-names>A</given-names></name></person-group>
<source>Diabetes en Colombia: Recuento Hist&#x000f3;rico y Bibliogr&#x000e1;fico</source>. (<year>2013</year>). Available from: <uri xlink:type="simple" xlink:href="http://encolombia.com/medicina/revistas-medicas/d-diabetes/d22/historia-y-bibliografia/">http://encolombia.com/medicina/revistas-medicas/d-diabetes/d22/historia-y-bibliografia/</uri></mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scolpini</surname><given-names>V</given-names></name></person-group>
<article-title>Historia de la diabetes en el Uruguay</article-title>. <source>Arch Pediatr Urug</source> (<year>1982</year>) <volume>53</volume>:<fpage>245</fpage>&#x02013;<lpage>59</lpage>.</mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="webpage"><collab>World Health Organization</collab>. <source>The Top 10 Causes of Death</source>. (<year>2017</year>). Available from: <uri xlink:type="simple" xlink:href="http://www.who.int/mediacentre/factsheets/fs310/en/">http://www.who.int/mediacentre/factsheets/fs310/en/</uri></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="webpage"><collab>United States Census Bureau</collab>. <source>Profile America Facts for Features, CB16-FF.16 Hispanic Heritage Month</source>. (<year>2016</year>). Available from: <uri xlink:type="simple" xlink:href="http://census.gov/newsroom/facts-for-features/2016/cb16-ff16.html">http://census.gov/newsroom/facts-for-features/2016/cb16-ff16.html</uri></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Colby</surname><given-names>SL</given-names></name><name><surname>Ortman</surname><given-names>JM</given-names></name></person-group>
<source>Projections of the Size and Composition of the US Population: 2014-2060, Current Population Reports 2015; P25-1143</source>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>US Census Bureau</publisher-name> (<year>2014</year>).</mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Patten</surname><given-names>E</given-names></name></person-group>
<source>The Nation&#x02019;s Latino Population Is Defined by Its Youth</source>. <publisher-name>Pew Research Center, Hispanic Trends</publisher-name> (<year>2016</year>). Available from: <uri xlink:type="simple" xlink:href="http://www.pewhispanic.org/2016/04/20/the-nations-latino-population-is-defined-by-its-youth/">http://www.pewhispanic.org/2016/04/20/the-nations-latino-population-is-defined-by-its-youth/</uri></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menke</surname><given-names>A</given-names></name><name><surname>Casagrande</surname><given-names>SS</given-names></name><name><surname>Geiss</surname><given-names>L</given-names></name><name><surname>Cowie</surname><given-names>CC</given-names></name></person-group>. <article-title>Prevalence of and trends in diabetes among adults in the United States, 1988-2012</article-title>. <source>JAMA</source> (<year>2015</year>) <volume>314</volume>:<fpage>1021</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1001/jama.2015.10029</pub-id><?supplied-pmid 26348752?><pub-id pub-id-type="pmid">26348752</pub-id></mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alegre-D&#x000ed;az</surname><given-names>J</given-names></name><name><surname>Herrington</surname><given-names>W</given-names></name><name><surname>L&#x000f3;pez-Cervantes</surname><given-names>M</given-names></name><name><surname>Gnautic</surname><given-names>L</given-names></name><name><surname>Ram&#x000ed;rez</surname><given-names>R</given-names></name><name><surname>Hill</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Diabetes and cause-specific mortality in Mexico City</article-title>. <source>N Engl J Med</source> (<year>2016</year>) <volume>375</volume>:<fpage>1961</fpage>&#x02013;<lpage>71</lpage>.<pub-id pub-id-type="doi">10.1056/NEJMoa1605368</pub-id><?supplied-pmid 27959614?><pub-id pub-id-type="pmid">27959614</pub-id></mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Col&#x000f3;n-Ramos</surname><given-names>U</given-names></name><name><surname>Rodr&#x000ed;guez-Ayuso</surname><given-names>I</given-names></name><name><surname>Gebrekristos</surname><given-names>HT</given-names></name><name><surname>Roess</surname><given-names>A</given-names></name><name><surname>P&#x000e9;rez</surname><given-names>CM</given-names></name><name><surname>Simonsen</surname><given-names>L</given-names></name></person-group>. <article-title>Transnational mortality comparisons between archipelago and mainland Puerto Ricans</article-title>. <source>J Immigr Minor Health</source> (<year>2017</year>) <volume>19</volume>:<fpage>1009</fpage>&#x02013;<lpage>17</lpage>.<pub-id pub-id-type="doi">10.1007/s10903-016-0448-5</pub-id><?supplied-pmid 27334006?><pub-id pub-id-type="pmid">27334006</pub-id></mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flegal</surname><given-names>KM</given-names></name><name><surname>Ezzati</surname><given-names>TM</given-names></name><name><surname>Harris</surname><given-names>MI</given-names></name><name><surname>Haynes</surname><given-names>SG</given-names></name><name><surname>Juarez</surname><given-names>RZ</given-names></name><name><surname>Knowler</surname><given-names>WC</given-names></name><etal/></person-group>
<article-title>Prevalence of diabetes in Mexican Americans, Cubans, and Puerto Ricans from the Hispanic Health and Nutrition Examination Survey, 1982-1984</article-title>. <source>Diabetes Care</source> (<year>1991</year>) <volume>14</volume>:<fpage>628</fpage>&#x02013;<lpage>38</lpage>.<pub-id pub-id-type="doi">10.2337/diacare.14.7.628</pub-id><pub-id pub-id-type="pmid">1914812</pub-id></mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneiderman</surname><given-names>N</given-names></name><name><surname>Llabre</surname><given-names>M</given-names></name><name><surname>Cowie</surname><given-names>CC</given-names></name><name><surname>Barnhart</surname><given-names>J</given-names></name><name><surname>Carnethon</surname><given-names>M</given-names></name><name><surname>Gallo</surname><given-names>LC</given-names></name><etal/></person-group>
<article-title>Prevalence of diabetes among Hispanics/Latinos from diverse backgrounds: the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)</article-title>. <source>Diabetes Care</source> (<year>2014</year>) <volume>37</volume>:<fpage>2233</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.2337/dc13-2939</pub-id><pub-id pub-id-type="pmid">25061138</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avil&#x000e9;s-Santa</surname><given-names>ML</given-names></name><name><surname>Schneiderman</surname><given-names>N</given-names></name><name><surname>Savage</surname><given-names>PJ</given-names></name><name><surname>Kaplan</surname><given-names>RC</given-names></name><name><surname>Teng</surname><given-names>Y</given-names></name><name><surname>P&#x000e9;rez</surname><given-names>CM</given-names></name><etal/></person-group>
<article-title>Identifying probable diabetes mellitus among Hispanics/Latinos from four U.S. cities: findings from the Hispanic Community Health Study/Study of Latinos</article-title>. <source>Endocr Pract</source> (<year>2016</year>) <volume>22</volume>:<fpage>1151</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="doi">10.4158/EP151144.OR</pub-id><pub-id pub-id-type="pmid">27295013</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="webpage"><person-group person-group-type="author"><name><surname>Humes</surname><given-names>KR</given-names></name><name><surname>Jones</surname><given-names>NA</given-names></name><name><surname>Ramirez</surname><given-names>RR</given-names></name></person-group>
<source>Overview of Race and Hispanic Origin: 2010; 2010 Census Briefs</source>. (<year>2011</year>). Available from: <uri xlink:type="simple" xlink:href="https://www.census.gov/prod/cen2010/briefs/c2010br-02.pdf">https://www.census.gov/prod/cen2010/briefs/c2010br-02.pdf</uri></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="webpage"><collab>Interim Report to the Office of Management and Budget</collab>. <source>Review of Standards for Maintaining, Collecting, and Presenting Federal Data on Race and Ethnicity</source>. (<year>2017</year>). Available from: <uri xlink:type="simple" xlink:href="https://www.whitehouse.gov/sites/whitehouse.gov/files/briefing-room/presidential-actions/related-omb-material/r_e_iwg_interim_report_022417.pdf">https://www.whitehouse.gov/sites/whitehouse.gov/files/briefing-room/presidential-actions/related-omb-material/r_e_iwg_interim_report_022417.pdf</uri></mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Ennis</surname><given-names>SR</given-names></name><name><surname>R&#x000ed;os-Vargas</surname><given-names>M</given-names></name><name><surname>Albert</surname><given-names>NG</given-names></name></person-group>
<source>The Hispanic Population: 2010, 2010 Census Briefs</source>. <publisher-loc>Suitland, MD</publisher-loc>: <publisher-name>U.S. Department of Commerce Economics and Statistics Administration, U.S. Census Bureau</publisher-name> (<year>2011</year>).</mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lopez</surname><given-names>MH</given-names></name></person-group>
<source>Hispanic or Latino? Many Don&#x02019;t Care, Except in Texas</source>. <publisher-name>Pew Research Center</publisher-name> (<year>2013</year>). Available from: <uri xlink:type="simple" xlink:href="http://www.pewresearch.org/fact-tank/2013/10/28/in-texas-its-hispanic-por-favor/">http://www.pewresearch.org/fact-tank/2013/10/28/in-texas-its-hispanic-por-favor/</uri></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lopez</surname><given-names>MH</given-names></name></person-group>
<source>Hispanic Identity</source>. <publisher-name>Pew Research Center Hispanic Trends</publisher-name> (<year>2013</year>). Available from: <uri xlink:type="simple" xlink:href="http://www.pewhispanic.org/2013/10/22/3-hispanic-identity/">http://www.pewhispanic.org/2013/10/22/3-hispanic-identity/</uri></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="webpage"><source>Diccionario de la Real Academia Espa&#x000f1;ola de la Lengua</source>. (<year>2017</year>). Available from: <uri xlink:type="simple" xlink:href="http://lema.rae.es/dpd/?key=hispanoamerica">http://lema.rae.es/dpd/?key=hispanoamerica</uri></mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Legorburu</surname><given-names>J</given-names></name></person-group>
<source>Lengua y Literatura II</source>. <publisher-loc>Madrid, Spain</publisher-loc>: <publisher-name>Ediciones S.M. Madrid</publisher-name> (<year>1980</year>). p. <fpage>24</fpage>&#x02013;<lpage>6</lpage>.</mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="webpage"><collab>U.S. Census Bureau</collab>. <source>American Community Survey 1-Year Estimates</source>. (<year>2015</year>). Available from: <uri xlink:type="simple" xlink:href="https://factfinder.census.gov/faces/nav/jsf/pages/community_facts.xhtml">https://factfinder.census.gov/faces/nav/jsf/pages/community_facts.xhtml</uri></mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="webpage"><person-group person-group-type="author"><name><surname>Stepler</surname><given-names>R</given-names></name><name><surname>Brown</surname><given-names>A</given-names></name></person-group>
<source>Statistical Portrait of Hispanics in the United States</source>. (<year>2017</year>). Available from: <uri xlink:type="simple" xlink:href="http://www.pewhispanic.org/2016/04/19/statistical-portrait-of-hispanics-in-the-united-states-trends/">http://www.pewhispanic.org/2016/04/19/statistical-portrait-of-hispanics-in-the-united-states-trends/</uri></mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="other"><collab>United States Census Bureau</collab>. <source>Facts for Figures: Hispanic Heritage Month 2016</source>. (<year>2016</year>). Release Number: CB16-FF.16.</mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Ortman</surname><given-names>JM</given-names></name><name><surname>Guarnieri</surname><given-names>CE</given-names></name></person-group>
<source>United States Population Projections: 2000-2050</source>. <publisher-name>National Population Projections</publisher-name> (<year>2009</year>). Available from: <uri xlink:type="simple" xlink:href="https://www.census.gov/library/working-papers/2009/demo/us-pop-proj-2000-2050.html">https://www.census.gov/library/working-papers/2009/demo/us-pop-proj-2000-2050.html</uri></mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="book"><collab>U.S. Census Bureau American FactFinder</collab>. <source>2011-2015 American Community Survey 5-Year Estimates</source>. <publisher-name>U.S. Census Bureau</publisher-name> (<year>2017</year>). Available from: <uri xlink:type="simple" xlink:href="https://factfinder.census.gov/faces/tableservices/jsf/pages/productview.xhtml?pid=ACS_15_5YR_S1501&#x00026;src=pt">https://factfinder.census.gov/faces/tableservices/jsf/pages/productview.xhtml?pid=ACS_15_5YR_S1501&#x00026;src=pt</uri></mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Proctor</surname><given-names>BD</given-names></name><name><surname>Semega</surname><given-names>JL</given-names></name><name><surname>Kollar</surname><given-names>MA</given-names></name></person-group>
<source>U.S. Census Bureau, Current Population Reports, P60-256(RV), Income and Poverty in the United States: 2015</source>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>U.S. Government Printing Office</publisher-name> (<year>2016</year>).</mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>J</given-names></name><name><surname>Medalia</surname><given-names>C</given-names></name></person-group>
<source>US Census Bureau, Current Population Reports, P 60-253 Health Insurance Coverage in the United States: 2014</source>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>US Government Printing Office</publisher-name> (<year>2015</year>).</mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>RA</given-names></name><name><surname>Martinez</surname><given-names>ME</given-names></name></person-group>
<source>Health Insurance Coverage: Early Release of Estimates from the National Health Interview Survey, January-March 2014</source>. <publisher-loc>Atlanta</publisher-loc>: <publisher-name>National Center for Health Statistics</publisher-name> (<year>2014</year>). Available from: <uri xlink:type="simple" xlink:href="https://www.cdc.gov/nchs/data/nhis/earlyrelease/insur201409.pdf">https://www.cdc.gov/nchs/data/nhis/earlyrelease/insur201409.pdf</uri></mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Penedo</surname><given-names>FJ</given-names></name><name><surname>Yanez</surname><given-names>B</given-names></name><name><surname>Casta&#x000f1;eda</surname><given-names>SF</given-names></name><name><surname>Gallo</surname><given-names>L</given-names></name><name><surname>Wortman</surname><given-names>K</given-names></name><name><surname>Gouskova</surname><given-names>N</given-names></name><etal/></person-group>
<article-title>Self-reported cancer prevalence among Hispanics in the US: results from the Hispanic Community Health Study/Study of Latinos</article-title>. <source>PLoS One</source> (<year>2016</year>) <volume>11</volume>:<fpage>e0146268</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0146268</pub-id><pub-id pub-id-type="pmid">26808047</pub-id></mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="book"><collab>United Nations Department of Economic and Social Affairs/Population Division</collab>. <source>World Population Prospects: The 2015 Revision, Key Findings and Advance Tables</source>. <publisher-loc>New York</publisher-loc> (<year>2015</year>). Available from: <uri xlink:type="simple" xlink:href="https://esa.un.org/unpd/wpp/publications/">https://esa.un.org/unpd/wpp/publications/</uri></mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="webpage"><collab>CEPAL (Comisi&#x000f3;n Econ&#x000f3;mica para Am&#x000e9;rica Latina y el Caribe/Economic Commission for Latin America and the Caribbean)</collab>. <source>Anuario estad&#x000ed;stico de America Latina y El Caribe/Statistical Yearbook for Latin America and the Caribbean</source>. (<year>2017</year>). Available from: <uri xlink:type="simple" xlink:href="https://www.cepal.org/en/publications/type/anuario-estadistico-america-latina-caribe-statistical-yearbook-latin-america-and">https://www.cepal.org/en/publications/type/anuario-estadistico-america-latina-caribe-statistical-yearbook-latin-america-and</uri></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="webpage"><collab>U.S. Commission on Civil Rights</collab>. <source>Counting the Forgotten: The 1970 Census Count of Persons of Spanish Speaking Background in the United States</source>. (<year>2017</year>). Available from: <uri xlink:type="simple" xlink:href="https://www.law.umaryland.edu/marshall/usccr/documents/cr12sp22970.pdf">https://www.law.umaryland.edu/marshall/usccr/documents/cr12sp22970.pdf</uri></mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moy</surname><given-names>CS</given-names></name></person-group>
<article-title>Determining ethnic origin in an interview survey: problems and recommendations</article-title>. <source>Public Health Rep</source> (<year>1977</year>) <volume>92</volume>:<fpage>414</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="pmid">910017</pub-id></mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldberg</surname><given-names>B</given-names></name></person-group>
<article-title>Tuberculosis in racial types with special reference to Mexicans</article-title>. <source>Am J Pub Health</source> (<year>1929</year>) <volume>19</volume>:<fpage>274</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="doi">10.2105/AJPH.19.3.274</pub-id></mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gregg</surname><given-names>R</given-names></name></person-group>
<article-title>Medical examination and vaccination of farm laborers recruited from Mexico</article-title>. <source>Public Health Rep</source> (<year>1950</year>) <volume>65</volume>:<fpage>807</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.2307/4587381</pub-id><pub-id pub-id-type="pmid">15424318</pub-id></mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keissman</surname><given-names>JJ</given-names></name></person-group>
<article-title>The curandero&#x02019;s apprentice: a therapeutic integration of folk and medical care</article-title>. <source>Am J Psychiatry</source> (<year>1975</year>) <volume>132</volume>:<fpage>81</fpage>&#x02013;<lpage>3</lpage>.<pub-id pub-id-type="doi">10.1176/ajp.132.1.81</pub-id><pub-id pub-id-type="pmid">1088843</pub-id></mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garrison</surname><given-names>V</given-names></name></person-group>. <article-title>Support systems of schizophrenic and nonschizophrenic Puerto Rican migrant women in New York City</article-title>. <source>Schizophr Bull</source> (<year>1978</year>) <volume>4</volume>:<fpage>561</fpage>&#x02013;<lpage>96</lpage>.<pub-id pub-id-type="doi">10.1093/schbul/4.4.561</pub-id><?supplied-pmid 734367?><pub-id pub-id-type="pmid">734367</pub-id></mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suffet</surname><given-names>F</given-names></name><name><surname>Brotman</surname><given-names>R</given-names></name></person-group>. <article-title>Employment and social disability among opiate addicts</article-title>. <source>Am J Drug Alcohol Abuse</source> (<year>1976</year>) <volume>3</volume>:<fpage>387</fpage>&#x02013;<lpage>95</lpage>.<pub-id pub-id-type="doi">10.3109/00952997609014281</pub-id><?supplied-pmid 1032752?><pub-id pub-id-type="pmid">1032752</pub-id></mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kline</surname><given-names>LY</given-names></name></person-group>
<article-title>Some factors in the psychiatric treatment of Spanish-Americans</article-title>. <source>Am J Psychiatry</source> (<year>1969</year>) <volume>125</volume>:<fpage>1674</fpage>&#x02013;<lpage>81</lpage>.<pub-id pub-id-type="doi">10.1176/ajp.125.12.1674</pub-id><pub-id pub-id-type="pmid">5770186</pub-id></mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mirowsky</surname><given-names>J</given-names><suffix>II</suffix></name><name><surname>Ross</surname><given-names>CE</given-names></name></person-group>
<article-title>Minority status, ethnic culture, and distress: a comparison of blacks, whites, Mexicans, and Mexican Americans</article-title>. <source>AJS</source> (<year>1980</year>) <volume>86</volume>:<fpage>479</fpage>&#x02013;<lpage>95</lpage>.<pub-id pub-id-type="pmid">7468905</pub-id></mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klerman</surname><given-names>LV</given-names></name><name><surname>Jones</surname><given-names>JG</given-names></name><name><surname>Hull</surname><given-names>MC</given-names></name></person-group>
<article-title>Puerto Ricans in a small U.S. city</article-title>. <source>Public Health Rep</source> (<year>1966</year>) <volume>81</volume>:<fpage>369</fpage>&#x02013;<lpage>76</lpage>.<pub-id pub-id-type="doi">10.2307/4592720</pub-id><pub-id pub-id-type="pmid">4956105</pub-id></mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoppe</surname><given-names>SK</given-names></name><name><surname>Leon</surname><given-names>RL</given-names></name></person-group>. <article-title>Coping in the barrio: case studies of Mexican-American families</article-title>. <source>Child Psychiatry Hum Dev</source> (<year>1977</year>) <volume>7</volume>:<fpage>264</fpage>&#x02013;<lpage>75</lpage>.<pub-id pub-id-type="doi">10.1007/BF01433935</pub-id><?supplied-pmid 913167?><pub-id pub-id-type="pmid">913167</pub-id></mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuttner</surname><given-names>RE</given-names></name><name><surname>Mailander</surname><given-names>JC</given-names></name></person-group>
<article-title>Serum pepsinogen in migrant Mexicans and stressed Caucasians</article-title>. <source>J Natl Med Assoc</source> (<year>1965</year>) <volume>57</volume>:<fpage>109</fpage>&#x02013;<lpage>11</lpage>.<pub-id pub-id-type="pmid">5325336</pub-id></mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drake</surname><given-names>G</given-names></name><name><surname>Carpenter</surname><given-names>CM</given-names></name><name><surname>Dunn</surname><given-names>JE</given-names></name></person-group>
<article-title>Further studies on the frequency of achlorydria among Mexicans in Los Angeles</article-title>. <source>J Natl Cancer Inst</source> (<year>1962</year>) <volume>28</volume>:<fpage>853</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">13887721</pub-id></mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carmel</surname><given-names>R</given-names></name><name><surname>Johnson</surname><given-names>CS</given-names></name></person-group>. <article-title>Racial patterns in pernicious anemia. Early age at onset and increased frequency of intrinsic-factor antibody in black women</article-title>. <source>N Engl J Med</source> (<year>1978</year>) <volume>298</volume>:<fpage>647</fpage>&#x02013;<lpage>50</lpage>.<pub-id pub-id-type="doi">10.1056/NEJM197803232981203</pub-id><?supplied-pmid 628388?><pub-id pub-id-type="pmid">628388</pub-id></mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schenk</surname><given-names>EA</given-names></name><name><surname>Kilpstein</surname><given-names>FA</given-names></name><name><surname>Tomasini</surname><given-names>JT</given-names></name></person-group>
<article-title>Morphologic characteristics of jejunal biopsies from asymptomatic Haitians and Puerto Ricans</article-title>. <source>Am J Clin Nutr</source> (<year>1972</year>) <volume>25</volume>:<fpage>1080</fpage>&#x02013;<lpage>3</lpage>.<pub-id pub-id-type="pmid">5078332</pub-id></mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winsberg</surname><given-names>GR</given-names></name><name><surname>Sonnenschein</surname><given-names>E</given-names></name><name><surname>Dyer</surname><given-names>AR</given-names></name><name><surname>Schnadig</surname><given-names>V</given-names></name><name><surname>Bonilla</surname><given-names>E</given-names></name></person-group>. <article-title>Prevalence of intestinal parasites in Latino residents of Chicago</article-title>. <source>Am J Epidemiol</source> (<year>1975</year>) <volume>102</volume>:<fpage>526</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="doi">10.1093/oxfordjournals.aje.a112190</pub-id><?supplied-pmid 1202954?><pub-id pub-id-type="pmid">1202954</pub-id></mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mascola</surname><given-names>L</given-names></name><name><surname>Pelosi</surname><given-names>R</given-names></name><name><surname>Blount</surname><given-names>JH</given-names></name><name><surname>Binkin</surname><given-names>NJ</given-names></name><name><surname>Alexander</surname><given-names>CE</given-names></name><name><surname>Cates</surname><given-names>W</given-names><suffix>Jr</suffix></name></person-group>. <article-title>Congenital syphilis. Why is it still occurring?</article-title>
<source>JAMA</source> (<year>1984</year>) <volume>5</volume>:<fpage>1719</fpage>&#x02013;<lpage>22</lpage>.<?supplied-pmid 6471297?><pub-id pub-id-type="pmid">6471297</pub-id></mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vandow</surname><given-names>JE</given-names></name></person-group>
<article-title>Venereal disease among Puerto Ricans in New York City</article-title>. <source>Public Health Rep</source> (<year>1955</year>) <volume>70</volume>:<fpage>1242</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.2307/4589333</pub-id><pub-id pub-id-type="pmid">13273580</pub-id></mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernandez</surname><given-names>A</given-names></name></person-group>
<article-title>Chicanas and the issue of involuntary sterilization: reforms needed to protect inform consent</article-title>. <source>Chicano Law Rev</source> (<year>1976</year>) <volume>3</volume>:<fpage>3</fpage>&#x02013;<lpage>37</lpage>.<pub-id pub-id-type="pmid">11662794</pub-id></mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dawber</surname><given-names>TR</given-names></name><name><surname>Meadors</surname><given-names>GF</given-names></name><name><surname>Moore</surname><given-names>FE</given-names></name></person-group>
<article-title>Epidemiological approaches to heart disease: the Framingham study</article-title>. <source>Am J Public Health Nations Health</source> (<year>1951</year>) <volume>41</volume>:<fpage>279</fpage>&#x02013;<lpage>81</lpage>.<pub-id pub-id-type="doi">10.2105/AJPH.41.3.279</pub-id><pub-id pub-id-type="pmid">14819398</pub-id></mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dawber</surname><given-names>TR</given-names></name><name><surname>Moore</surname><given-names>FE</given-names></name><name><surname>Mann</surname><given-names>GV</given-names></name></person-group>
<article-title>Coronary heart disease in the Framingham study</article-title>. <source>Am J Public Health Nations Health</source> (<year>1957</year>) <volume>47</volume>:<fpage>4</fpage>&#x02013;<lpage>24</lpage>.<pub-id pub-id-type="doi">10.2105/AJPH.47.4_Pt_2.4</pub-id></mixed-citation></ref><ref id="B53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dawber</surname><given-names>TR</given-names></name><name><surname>Kannel</surname><given-names>WB</given-names></name><name><surname>Revotskie</surname><given-names>N</given-names></name><name><surname>Stokes</surname><given-names>J</given-names><suffix>III</suffix></name><name><surname>Kagan</surname><given-names>A</given-names></name><name><surname>Gordon</surname><given-names>T</given-names></name></person-group>
<article-title>Some factors associated with the development of coronary heart disease: six years&#x02019; follow-up experience in the Framingham study</article-title>. <source>Am J Public Health Nations Health</source> (<year>1959</year>) <volume>49</volume>:<fpage>1349</fpage>&#x02013;<lpage>56</lpage>.<pub-id pub-id-type="doi">10.2105/AJPH.49.10.1349</pub-id><pub-id pub-id-type="pmid">13814552</pub-id></mixed-citation></ref><ref id="B54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cruz-Vidal</surname><given-names>M</given-names></name><name><surname>Costas</surname><given-names>R</given-names></name><name><surname>Garcia-Palmieri</surname><given-names>MR</given-names></name><name><surname>Sorlie</surname><given-names>PD</given-names></name><name><surname>Hertzmark</surname><given-names>E</given-names></name></person-group>. <article-title>Factors related to diabetes mellitus in Puerto Rican men</article-title>. <source>Diabetes</source> (<year>1979</year>) <volume>28</volume>:<fpage>300</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.2337/diab.28.4.300</pub-id><?supplied-pmid 437369?><pub-id pub-id-type="pmid">437369</pub-id></mixed-citation></ref><ref id="B55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cruz-Vidal</surname><given-names>M</given-names></name><name><surname>Garc&#x000ed;a-Palmieri</surname><given-names>MR</given-names></name><name><surname>Costas</surname><given-names>R</given-names></name><name><surname>Sorlie</surname><given-names>PD</given-names></name><name><surname>Havlik</surname><given-names>RJ</given-names></name></person-group>. <article-title>Abnormal blood glucose and coronary heart disease: the Puerto Rico Heart Health Program</article-title>. <source>Diabetes Care</source> (<year>1983</year>) <volume>6</volume>:<fpage>556</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="doi">10.2337/diacare.6.6.556</pub-id><?supplied-pmid 6606547?><pub-id pub-id-type="pmid">6606547</pub-id></mixed-citation></ref><ref id="B56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaskill</surname><given-names>SP</given-names></name><name><surname>Allen</surname><given-names>CR</given-names></name><name><surname>Garza</surname><given-names>V</given-names></name><name><surname>Gonzales</surname><given-names>JL</given-names></name><name><surname>Waldrop</surname><given-names>RH</given-names></name></person-group>. <article-title>Cardiovascular risk factors in Mexican Americans in Laredo, Texas: I. Prevalence of overweight and diabetes and distributions of serum lipids</article-title>. <source>Am J Epidemiol</source> (<year>1981</year>) <volume>113</volume>:<fpage>546</fpage>&#x02013;<lpage>55</lpage>.<pub-id pub-id-type="doi">10.1093/oxfordjournals.aje.a113131</pub-id><?supplied-pmid 7223735?><pub-id pub-id-type="pmid">7223735</pub-id></mixed-citation></ref><ref id="B57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gunby</surname><given-names>P</given-names></name></person-group>
<article-title>San Antonio Heart Study compares ethnic groups</article-title>. <source>JAMA</source> (<year>1980</year>) <volume>244</volume>:<fpage>225</fpage><pub-id pub-id-type="doi">10.1001/jama.244.3.225a</pub-id></mixed-citation></ref><ref id="B58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stern</surname><given-names>MP</given-names></name><name><surname>Pugh</surname><given-names>JA</given-names></name><name><surname>Gaskill</surname><given-names>SP</given-names></name><name><surname>Hazuda</surname><given-names>HP</given-names></name></person-group>. <article-title>Knowledge, attitudes, and behavior related to obesity and dieting in Mexican Americans and Anglos: the San Antonio Heart Study</article-title>. <source>Am J Epidemiol</source> (<year>1982</year>) <volume>115</volume>:<fpage>917</fpage>&#x02013;<lpage>28</lpage>.<pub-id pub-id-type="doi">10.1093/oxfordjournals.aje.a113379</pub-id><?supplied-pmid 7091149?><pub-id pub-id-type="pmid">7091149</pub-id></mixed-citation></ref><ref id="B59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delgado</surname><given-names>JL</given-names></name><name><surname>Johnson</surname><given-names>CL</given-names></name><name><surname>Trevi&#x000f1;o</surname><given-names>FM</given-names></name></person-group>
<article-title>Hispanic health nutrition and examination survey: methodological considerations</article-title>. <source>Am J Public Health</source> (<year>1990</year>) <volume>80</volume>(<issue>Suppl</issue>):<fpage>6</fpage>&#x02013;<lpage>10</lpage>.<pub-id pub-id-type="doi">10.2105/AJPH.80.Suppl.6</pub-id><pub-id pub-id-type="pmid">9187575</pub-id></mixed-citation></ref><ref id="B60"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crespo</surname><given-names>C</given-names></name><name><surname>Loria</surname><given-names>C</given-names></name><name><surname>Burt</surname><given-names>V</given-names></name></person-group>. <article-title>Hypertension and other cardiovascular disease risk factors among Mexican Americans, Cuban Americans, and Puerto Ricans from the Hispanic Health and Nutrition Examination Survey</article-title>. <source>Public Health Rep</source> (<year>1996</year>) <volume>111</volume>(<issue>Suppl 2</issue>):<fpage>7</fpage>&#x02013;<lpage>10</lpage>.<?supplied-pmid 8898761?><pub-id pub-id-type="pmid">8898761</pub-id></mixed-citation></ref><ref id="B61"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamman</surname><given-names>RF</given-names></name><name><surname>Marshall</surname><given-names>JA</given-names></name><name><surname>Baxter</surname><given-names>J</given-names></name><name><surname>Kahn</surname><given-names>LB</given-names></name><name><surname>Mayer</surname><given-names>EJ</given-names></name><name><surname>Orleans</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Methods and prevalence of non-insulin-dependent diabetes mellitus in a biethnic Colorado population, the San Luis Valley Diabetes Study</article-title>. <source>Am J Epidemiol</source> (<year>1989</year>) <volume>129</volume>:<fpage>295</fpage>&#x02013;<lpage>311</lpage>.<pub-id pub-id-type="doi">10.1093/oxfordjournals.aje.a115134</pub-id><pub-id pub-id-type="pmid">2912042</pub-id></mixed-citation></ref><ref id="B62"><label>62</label><mixed-citation publication-type="webpage"><source>Behavioral Risk Factor Surveillance System</source>. (<year>2017</year>). Available from: <uri xlink:type="simple" xlink:href="https://www.cdc.gov/brfss/">https://www.cdc.gov/brfss/</uri></mixed-citation></ref><ref id="B63"><label>63</label><mixed-citation publication-type="webpage"><collab>National Center for Health Statistics</collab>. <source>National Health and Nutrition Examination Survey</source>. (<year>2017</year>). Available from: <uri xlink:type="simple" xlink:href="https://www.cdc.gov/nchs/nhanes/">https://www.cdc.gov/nchs/nhanes/</uri></mixed-citation></ref><ref id="B64"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sorlie</surname><given-names>PD</given-names></name><name><surname>Avil&#x000e9;s-Santa</surname><given-names>ML</given-names></name><name><surname>Wassertheil-Smoller</surname><given-names>S</given-names></name><name><surname>Kaplan</surname><given-names>RC</given-names></name><name><surname>Daviglus</surname><given-names>ML</given-names></name><name><surname>Giachello</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Design and implementation of the Hispanic Community Health Study/Study of Latinos</article-title>. <source>Ann Epidemiol</source> (<year>2010</year>) <volume>20</volume>:<fpage>629</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="doi">10.1016/j.annepidem.2010.03.015</pub-id><?supplied-pmid 20609343?><pub-id pub-id-type="pmid">20609343</pub-id></mixed-citation></ref><ref id="B65"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LaVange</surname><given-names>LM</given-names></name><name><surname>Kalsbeek</surname><given-names>W</given-names></name><name><surname>Sorlie</surname><given-names>PD</given-names></name><name><surname>Avil&#x000e9;s-Santa</surname><given-names>ML</given-names></name><name><surname>Kaplan</surname><given-names>RC</given-names></name><name><surname>Barnhart</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Sample design and cohort selection in the Hispanic Community Health Study/Study of Latinos</article-title>. <source>Ann Epidemiol</source> (<year>2010</year>) <volume>20</volume>:<fpage>642</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/j.annepidem.2010.05.006</pub-id><?supplied-pmid 20609344?><pub-id pub-id-type="pmid">20609344</pub-id></mixed-citation></ref><ref id="B66"><label>66</label><mixed-citation publication-type="journal"><collab>American Diabetes Association</collab>. <article-title>Classification and diagnosis of diabetes</article-title>. <source>Diabetes Care</source> (<year>2017</year>) <volume>40</volume>(<issue>Suppl 1</issue>):<fpage>S11</fpage>&#x02013;<lpage>24</lpage>.<pub-id pub-id-type="doi">10.2337/dc17-S005</pub-id><pub-id pub-id-type="pmid">27979889</pub-id></mixed-citation></ref><ref id="B67"><label>67</label><mixed-citation publication-type="book"><collab>World Health Organization</collab>. <source>Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus. Abbreviated Report of a WHO Consultation</source>. <publisher-name>World Health Organization</publisher-name> (<year>2011</year>). Available from: <uri xlink:type="simple" xlink:href="http://www.who.int/diabetes/publications/report-hba1c_2011.pdf?ua=1">http://www.who.int/diabetes/publications/report-hba1c_2011.pdf?ua=1</uri></mixed-citation></ref><ref id="B68"><label>68</label><mixed-citation publication-type="book"><collab>World Health Organization</collab>. <source>Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia. Report of a WHO/IDF Consultation</source>. <publisher-name>World Health Organization</publisher-name> (<year>2006</year>). Available from: <uri xlink:type="simple" xlink:href="http://apps.who.int/iris/bitstream/10665/43588/1/9241594934_eng.pdf">http://apps.who.int/iris/bitstream/10665/43588/1/9241594934_eng.pdf</uri></mixed-citation></ref><ref id="B69"><label>69</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanis</surname><given-names>CL</given-names></name><name><surname>Ferrell</surname><given-names>RE</given-names></name><name><surname>Barton</surname><given-names>SA</given-names></name><name><surname>Aguilar</surname><given-names>L</given-names></name><name><surname>Garza-Ibarra</surname><given-names>A</given-names></name><name><surname>Tulloch</surname><given-names>BR</given-names></name><etal/></person-group>
<article-title>Diabetes among Mexican Americans in Starr County, Texas</article-title>. <source>Am J Epidemiol</source> (<year>1983</year>) <volume>118</volume>:<fpage>659</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="doi">10.1093/oxfordjournals.aje.a113677</pub-id><?supplied-pmid 6637993?><pub-id pub-id-type="pmid">6637993</pub-id></mixed-citation></ref><ref id="B70"><label>70</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samet</surname><given-names>JM</given-names></name><name><surname>Coultas</surname><given-names>DB</given-names></name><name><surname>Howard</surname><given-names>CA</given-names></name><name><surname>Skipper</surname><given-names>BJ</given-names></name><name><surname>Hanis</surname><given-names>CL</given-names></name></person-group>. <article-title>Diabetes, gallbladder disease, obesity, and hypertension among Hispanics in New Mexico</article-title>. <source>Am J Epidemiol</source> (<year>1988</year>) <volume>128</volume>:<fpage>1302</fpage>&#x02013;<lpage>11</lpage>.<pub-id pub-id-type="doi">10.1093/oxfordjournals.aje.a115083</pub-id><?supplied-pmid 3195569?><pub-id pub-id-type="pmid">3195569</pub-id></mixed-citation></ref><ref id="B71"><label>71</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamman</surname><given-names>RF</given-names></name><name><surname>Mayer</surname><given-names>EJ</given-names></name><name><surname>Moo-Young</surname><given-names>GA</given-names></name><name><surname>Hildebrandt</surname><given-names>W</given-names></name><name><surname>Marshall</surname><given-names>JA</given-names></name><name><surname>Baxter</surname><given-names>J</given-names></name></person-group>. <article-title>Prevalence and risk factors of diabetic retinopathy in non-Hispanic whites and Hispanics with NIDDM. San Luis Valley Diabetes Study</article-title>. <source>Diabetes</source> (<year>1989</year>) <volume>38</volume>:<fpage>1231</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.2337/diab.38.10.1231</pub-id><?supplied-pmid 2792575?><pub-id pub-id-type="pmid">2792575</pub-id></mixed-citation></ref><ref id="B72"><label>72</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>BD</given-names></name><name><surname>Stern</surname><given-names>MP</given-names></name><name><surname>Haffner</surname><given-names>SM</given-names></name><name><surname>Hazuda</surname><given-names>HP</given-names></name><name><surname>Patterson</surname><given-names>JK</given-names></name></person-group>
<article-title>Risk factors for cardiovascular mortality in Mexican Americans and non-Hispanic whites: the San Antonio Heart Study</article-title>. <source>Am J Epidemiol</source> (<year>1990</year>) <volume>131</volume>:<fpage>423</fpage>&#x02013;<lpage>33</lpage>.<pub-id pub-id-type="doi">10.1093/oxfordjournals.aje.a115517</pub-id><pub-id pub-id-type="pmid">2301352</pub-id></mixed-citation></ref><ref id="B73"><label>73</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haddock</surname><given-names>L</given-names></name><name><surname>de Conty</surname><given-names>IT</given-names></name></person-group>. <article-title>Prevalence rates for diabetes mellitus in Puerto Rico</article-title>. <source>Diabetes Care</source> (<year>1991</year>) <volume>14</volume>:<fpage>676</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="doi">10.2337/diacare.14.7.676</pub-id><?supplied-pmid 1914818?><pub-id pub-id-type="pmid">1914818</pub-id></mixed-citation></ref><ref id="B74"><label>74</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stern</surname><given-names>MP</given-names></name><name><surname>Gonzalez</surname><given-names>C</given-names></name><name><surname>Mitchell</surname><given-names>BD</given-names></name><name><surname>Villalpando</surname><given-names>E</given-names></name><name><surname>Haffner</surname><given-names>SM</given-names></name><name><surname>Hazuda</surname><given-names>HP</given-names></name></person-group>. <article-title>Genetic and environmental determinants of type II diabetes in Mexico City and San Antonio</article-title>. <source>Diabetes</source> (<year>1992</year>) <volume>41</volume>:<fpage>484</fpage>&#x02013;<lpage>92</lpage>.<pub-id pub-id-type="doi">10.2337/diab.41.4.484</pub-id><?supplied-pmid 1607073?><pub-id pub-id-type="pmid">1607073</pub-id></mixed-citation></ref><ref id="B75"><label>75</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>DE</given-names></name><name><surname>Cadwell</surname><given-names>BL</given-names></name><name><surname>Cheng</surname><given-names>YJ</given-names></name><name><surname>Cowie</surname><given-names>CC</given-names></name><name><surname>Gregg</surname><given-names>EW</given-names></name><name><surname>Geiss</surname><given-names>LS</given-names></name><etal/></person-group>
<article-title>Prevalence of impaired fasting glucose and its relationship with cardiovascular disease risk factors in US adolescents, 1999-2000</article-title>. <source>Pediatrics</source> (<year>2005</year>) <volume>116</volume>:<fpage>1122</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1542/peds.2004-2001</pub-id><?supplied-pmid 16263998?><pub-id pub-id-type="pmid">16263998</pub-id></mixed-citation></ref><ref id="B76"><label>76</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JM</given-names></name><name><surname>Okumura</surname><given-names>MJ</given-names></name><name><surname>Davis</surname><given-names>MM</given-names></name><name><surname>Herman</surname><given-names>WH</given-names></name><name><surname>Gurney</surname><given-names>JG</given-names></name></person-group>. <article-title>Prevalence and determinants of insulin resistance among U.S. adolescents: a population-based study</article-title>. <source>Diabetes Care</source> (<year>2006</year>) <volume>29</volume>:<fpage>2427</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="doi">10.2337/dc06-0709</pub-id><?supplied-pmid 17065679?><pub-id pub-id-type="pmid">17065679</pub-id></mixed-citation></ref><ref id="B77"><label>77</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ioannou</surname><given-names>GN</given-names></name><name><surname>Bryson</surname><given-names>CL</given-names></name><name><surname>Boyko</surname><given-names>EJ</given-names></name></person-group>
<article-title>Prevalence and trends of insulin resistance, impaired fasting glucose, and diabetes</article-title>. <source>J Diabetes Complications</source> (<year>2007</year>) <volume>21</volume>:<fpage>363</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="doi">10.1016/j.jdiacomp.2006.07.005</pub-id><pub-id pub-id-type="pmid">17967708</pub-id></mixed-citation></ref><ref id="B78"><label>78</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allison</surname><given-names>MA</given-names></name><name><surname>Budoff</surname><given-names>MJ</given-names></name><name><surname>Wong</surname><given-names>ND</given-names></name><name><surname>Blumenthal</surname><given-names>RS</given-names></name><name><surname>Schreiner</surname><given-names>PJ</given-names></name><name><surname>Criqui</surname><given-names>MH</given-names></name></person-group>. <article-title>Prevalence of and risk factors for subclinical cardiovascular disease in selected US Hispanic ethnic groups: the multi-ethnic study of atherosclerosis</article-title>. <source>Am J Epidemiol</source> (<year>2008</year>) <volume>167</volume>:<fpage>962</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1093/aje/kwm402</pub-id><?supplied-pmid 18283034?><pub-id pub-id-type="pmid">18283034</pub-id></mixed-citation></ref><ref id="B79"><label>79</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cowie</surname><given-names>CC</given-names></name><name><surname>Rust</surname><given-names>KF</given-names></name><name><surname>Ford</surname><given-names>ES</given-names></name><name><surname>Eberhardt</surname><given-names>MS</given-names></name><name><surname>Byrd-Holt</surname><given-names>DD</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006</article-title>. <source>Diabetes Care</source> (<year>2009</year>) <volume>32</volume>:<fpage>287</fpage>&#x02013;<lpage>94</lpage>.<pub-id pub-id-type="doi">10.2337/dc08-1296</pub-id><?supplied-pmid 19017771?><pub-id pub-id-type="pmid">19017771</pub-id></mixed-citation></ref><ref id="B80"><label>80</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Ford</surname><given-names>ES</given-names></name><name><surname>Zhao</surname><given-names>G</given-names></name><name><surname>Mokdad</surname><given-names>AH</given-names></name></person-group>. <article-title>Prevalence of pre-diabetes and its association with clustering of cardiometabolic risk factors and hyperinsulinemia among U.S. adolescents: National Health and Nutrition Examination Survey 2005-2006</article-title>. <source>Diabetes Care</source> (<year>2009</year>) <volume>32</volume>:<fpage>342</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.2337/dc08-1128</pub-id><?supplied-pmid 18957533?><pub-id pub-id-type="pmid">18957533</pub-id></mixed-citation></ref><ref id="B81"><label>81</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Derby</surname><given-names>CA</given-names></name><name><surname>Wildman</surname><given-names>RP</given-names></name><name><surname>McGinn</surname><given-names>AP</given-names></name><name><surname>Green</surname><given-names>RR</given-names></name><name><surname>Polotsky</surname><given-names>AJ</given-names></name><name><surname>Ram</surname><given-names>KT</given-names></name><etal/></person-group>
<article-title>Cardiovascular risk factor variation within a Hispanic cohort: SWAN, the Study of Women&#x02019;s Health Across the Nation</article-title>. <source>Ethn Dis</source> (<year>2010</year>) <volume>20</volume>:<fpage>396</fpage>&#x02013;<lpage>402</lpage>.<?supplied-pmid 21305828?><pub-id pub-id-type="pmid">21305828</pub-id></mixed-citation></ref><ref id="B82"><label>82</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x000ed;az-Apodaca</surname><given-names>BA</given-names></name><name><surname>Ebrahim</surname><given-names>S</given-names></name><name><surname>McCormack</surname><given-names>V</given-names></name><name><surname>de Cos&#x000ed;o</surname><given-names>FG</given-names></name><name><surname>Ruiz-Holgu&#x000ed;n</surname><given-names>R</given-names></name></person-group>. <article-title>Prevalence of type 2 diabetes and impaired fasting glucose: cross-sectional study of multiethnic adult population at the United States-Mexico border</article-title>. <source>Rev Panam Salud Publica</source> (<year>2010</year>) <volume>28</volume>:<fpage>174</fpage>&#x02013;<lpage>81</lpage>.<pub-id pub-id-type="doi">10.1590/S1020-49892010000900007</pub-id><?supplied-pmid 20963264?><pub-id pub-id-type="pmid">20963264</pub-id></mixed-citation></ref><ref id="B83"><label>83</label><mixed-citation publication-type="journal"><collab>Centers for Disease Control and Prevention (CDC)</collab>. <article-title>Increasing prevalence of diagnosed diabetes &#x02013; United States and Puerto Rico, 1995-2010</article-title>. <source>MMWR Morb Mortal Wkly Rep</source> (<year>2012</year>) <volume>61</volume>:<fpage>918</fpage>&#x02013;<lpage>21</lpage>.<pub-id pub-id-type="pmid">23151951</pub-id></mixed-citation></ref><ref id="B84"><label>84</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daviglus</surname><given-names>ML</given-names></name><name><surname>Talavera</surname><given-names>GA</given-names></name><name><surname>Avil&#x000e9;s-Santa</surname><given-names>ML</given-names></name><name><surname>Allison</surname><given-names>M</given-names></name><name><surname>Cai</surname><given-names>J</given-names></name><name><surname>Criqui</surname><given-names>MH</given-names></name><etal/></person-group>
<article-title>Prevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic/Latino individuals of diverse backgrounds in the United States</article-title>. <source>JAMA</source> (<year>2012</year>) <volume>308</volume>:<fpage>1775</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="doi">10.1001/jama.2012.14517</pub-id><pub-id pub-id-type="pmid">23117778</pub-id></mixed-citation></ref><ref id="B85"><label>85</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunt</surname><given-names>KJ</given-names></name><name><surname>Gebregziabher</surname><given-names>M</given-names></name><name><surname>Egede</surname><given-names>LE</given-names></name></person-group>. <article-title>Racial and ethnic differences in cardio-metabolic risk in individuals with undiagnosed diabetes: National Health and Nutrition Examination Survey 1999-2008</article-title>. <source>J Gen Intern Med</source> (<year>2012</year>) <volume>27</volume>:<fpage>893</fpage>&#x02013;<lpage>900</lpage>.<pub-id pub-id-type="doi">10.1007/s11606-012-2023-7</pub-id><?supplied-pmid 22415867?><pub-id pub-id-type="pmid">22415867</pub-id></mixed-citation></ref><ref id="B86"><label>86</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez</surname><given-names>F</given-names></name><name><surname>Hicks</surname><given-names>LS</given-names></name><name><surname>Lopez</surname><given-names>L</given-names></name></person-group>. <article-title>Association of acculturation and country of origin with self-reported hypertension and diabetes in a heterogeneous Hispanic population</article-title>. <source>BMC Public Health</source> (<year>2012</year>) <volume>12</volume>:<fpage>768</fpage>.<pub-id pub-id-type="doi">10.1186/1471-2458-12-768</pub-id><?supplied-pmid 22966844?><pub-id pub-id-type="pmid">22966844</pub-id></mixed-citation></ref><ref id="B87"><label>87</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bullard</surname><given-names>KM</given-names></name><name><surname>Saydah</surname><given-names>SH</given-names></name><name><surname>Imperatore</surname><given-names>G</given-names></name><name><surname>Cowie</surname><given-names>CC</given-names></name><name><surname>Gregg</surname><given-names>EW</given-names></name><name><surname>Geiss</surname><given-names>LS</given-names></name><etal/></person-group>
<article-title>Secular changes in U.S. Prediabetes prevalence defined by hemoglobin A1c and fasting plasma glucose: National Health and Nutrition Examination Surveys, 1999-2010</article-title>. <source>Diabetes Care</source> (<year>2013</year>) <volume>36</volume>:<fpage>2286</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="doi">10.2337/dc12-2563</pub-id><?supplied-pmid 23603918?><pub-id pub-id-type="pmid">23603918</pub-id></mixed-citation></ref><ref id="B88"><label>88</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dabelea</surname><given-names>D</given-names></name><name><surname>Mayer-Davis</surname><given-names>EJ</given-names></name><name><surname>Saydah</surname><given-names>S</given-names></name><name><surname>Imperatore</surname><given-names>G</given-names></name><name><surname>Linder</surname><given-names>B</given-names></name><name><surname>Divers</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009</article-title>. <source>JAMA</source> (<year>2014</year>) <volume>311</volume>:<fpage>1778</fpage>&#x02013;<lpage>86</lpage>.<pub-id pub-id-type="doi">10.1001/jama.2014.3201</pub-id><?supplied-pmid 24794371?><pub-id pub-id-type="pmid">24794371</pub-id></mixed-citation></ref><ref id="B89"><label>89</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pettitt</surname><given-names>DJ</given-names></name><name><surname>Talton</surname><given-names>J</given-names></name><name><surname>Dabelea</surname><given-names>D</given-names></name><name><surname>Divers</surname><given-names>J</given-names></name><name><surname>Imperatore</surname><given-names>G</given-names></name><name><surname>Lawrence</surname><given-names>JM</given-names></name><etal/></person-group>
<article-title>Prevalence of diabetes in U.S. youth in 2009: the SEARCH for diabetes in youth study</article-title>. <source>Diabetes Care</source> (<year>2014</year>) <volume>37</volume>:<fpage>402</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.2337/dc13-1838</pub-id><?supplied-pmid 24041677?><pub-id pub-id-type="pmid">24041677</pub-id></mixed-citation></ref><ref id="B90"><label>90</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selvin</surname><given-names>E</given-names></name><name><surname>Parrinello</surname><given-names>CM</given-names></name><name><surname>Sacks</surname><given-names>DB</given-names></name><name><surname>Coresh</surname><given-names>J</given-names></name></person-group>. <article-title>Trends in prevalence and control of diabetes in the United States, 1988-1994 and 1999-2010</article-title>. <source>Ann Intern Med</source> (<year>2014</year>) <volume>160</volume>:<fpage>517</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="doi">10.7326/M13-2411</pub-id><?supplied-pmid 24733192?><pub-id pub-id-type="pmid">24733192</pub-id></mixed-citation></ref><ref id="B91"><label>91</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arroyo-Johnson</surname><given-names>C</given-names></name><name><surname>Mincey</surname><given-names>KD</given-names></name><name><surname>Ackermann</surname><given-names>N</given-names></name><name><surname>Milam</surname><given-names>L</given-names></name><name><surname>Goodman</surname><given-names>MS</given-names></name><name><surname>Colditz</surname><given-names>GA</given-names></name></person-group>. <article-title>Racial and ethnic heterogeneity in self-reported diabetes prevalence trends across Hispanic subgroups, National Health Interview Survey, 1997-2012</article-title>. <source>Prev Chronic Dis</source> (<year>2016</year>) <volume>13</volume>:<fpage>E10</fpage>.<pub-id pub-id-type="doi">10.5888/pcd13.150260</pub-id><?supplied-pmid 26796518?><pub-id pub-id-type="pmid">26796518</pub-id></mixed-citation></ref><ref id="B92"><label>92</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isasi</surname><given-names>CR</given-names></name><name><surname>Parrinello</surname><given-names>CM</given-names></name><name><surname>Ayala</surname><given-names>GX</given-names></name><name><surname>Delamater</surname><given-names>AM</given-names></name><name><surname>Perreira</surname><given-names>KM</given-names></name><name><surname>Daviglus</surname><given-names>ML</given-names></name><etal/></person-group>
<article-title>Sex differences in cardiometabolic risk factors among Hispanic/Latino youth</article-title>. <source>J Pediatr</source> (<year>2016</year>) <volume>176</volume>:<fpage>121</fpage>&#x02013;<lpage>7.e1</lpage>.<pub-id pub-id-type="doi">10.1016/j.jpeds.2016.05.037</pub-id><pub-id pub-id-type="pmid">27344220</pub-id></mixed-citation></ref><ref id="B93"><label>93</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanis</surname><given-names>CL</given-names></name><name><surname>Redline</surname><given-names>S</given-names></name><name><surname>Cade</surname><given-names>BE</given-names></name><name><surname>Bell</surname><given-names>GI</given-names></name><name><surname>Cox</surname><given-names>NJ</given-names></name><name><surname>Below</surname><given-names>JE</given-names></name><etal/></person-group>
<article-title>Beyond type 2 diabetes, obesity and hypertension: an axis including sleep apnea, left ventricular hypertrophy, endothelial dysfunction, and aortic stiffness among Mexican Americans in Starr County, Texas</article-title>. <source>Cardiovasc Diabetol</source> (<year>2016</year>) <volume>15</volume>:<fpage>86</fpage>.<pub-id pub-id-type="doi">10.1186/s12933-016-0405-6</pub-id><?supplied-pmid 27266869?><pub-id pub-id-type="pmid">27266869</pub-id></mixed-citation></ref><ref id="B94"><label>94</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menke</surname><given-names>A</given-names></name><name><surname>Casagrande</surname><given-names>S</given-names></name><name><surname>Cowie</surname><given-names>CC</given-names></name></person-group>
<article-title>Prevalence of diabetes in adolescents aged 12 to 19 years in the United States, 2005-2014</article-title>. <source>JAMA</source> (<year>2016</year>) <volume>316</volume>:<fpage>344</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1001/jama.2016.8544</pub-id><pub-id pub-id-type="pmid">27434447</pub-id></mixed-citation></ref><ref id="B95"><label>95</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avil&#x000e9;s-Santa</surname><given-names>ML</given-names></name><name><surname>P&#x000e9;rez</surname><given-names>CM</given-names></name><name><surname>Schneiderman</surname><given-names>N</given-names></name><name><surname>Savage</surname><given-names>PJ</given-names></name><name><surname>Kaplan</surname><given-names>RC</given-names></name><name><surname>Teng</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>Detecting prediabetes among Hispanics/Latinos from diverse heritage groups: does the test matter? Findings from the Hispanic Community Health Study/Study of Latinos</article-title>. <source>Prev Med</source> (<year>2017</year>) <volume>95</volume>:<fpage>110</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/j.ypmed.2016.12.009</pub-id><pub-id pub-id-type="pmid">27956225</pub-id></mixed-citation></ref><ref id="B96"><label>96</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stark Casagrande</surname><given-names>S</given-names></name><name><surname>Fradkin</surname><given-names>JE</given-names></name><name><surname>Saydah</surname><given-names>SH</given-names></name><name><surname>Rust</surname><given-names>KF</given-names></name><name><surname>Cowie</surname><given-names>CC</given-names></name></person-group>. <article-title>The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010</article-title>. <source>Diabetes Care</source> (<year>2013</year>) <volume>36</volume>:<fpage>2271</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.2337/dc12-2258</pub-id><?supplied-pmid 23418368?><pub-id pub-id-type="pmid">23418368</pub-id></mixed-citation></ref><ref id="B97"><label>97</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneiderman</surname><given-names>N</given-names></name><name><surname>Llabre</surname><given-names>MM</given-names></name><name><surname>Chirinos</surname><given-names>DA</given-names></name><name><surname>Teng</surname><given-names>Y</given-names></name><name><surname>Cai</surname><given-names>J</given-names></name><name><surname>Cowie</surname><given-names>CC</given-names></name><etal/></person-group>
<article-title>Diversity in diabetes status and cardiovascular disease in the Longitudinal Hispanic Community Health Study</article-title>. <source>Circulation</source> (<year>2017</year>) <volume>135</volume>(<issue>Suppl 1</issue>):<fpage>A075</fpage>.</mixed-citation></ref><ref id="B98"><label>98</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menke</surname><given-names>A</given-names></name><name><surname>Casagrande</surname><given-names>SS</given-names></name><name><surname>Avil&#x000e9;s-Santa</surname><given-names>ML</given-names></name><name><surname>Cowie</surname><given-names>CC</given-names></name></person-group>
<article-title>Factors associated with being unaware of having diabetes</article-title>. <source>Diabetes Care</source> (<year>2017</year>) <volume>40</volume>:<fpage>e55</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.2337/dc16-2626</pub-id><pub-id pub-id-type="pmid">28289042</pub-id></mixed-citation></ref><ref id="B99"><label>99</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haffner</surname><given-names>SM</given-names></name><name><surname>Hazuda</surname><given-names>HP</given-names></name><name><surname>Mitchell</surname><given-names>BD</given-names></name><name><surname>Patterson</surname><given-names>JK</given-names></name><name><surname>Stern</surname><given-names>MP</given-names></name></person-group>. <article-title>Increased incidence of type II diabetes mellitus in Mexican Americans</article-title>. <source>Diabetes Care</source> (<year>1991</year>) <volume>14</volume>:<fpage>102</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.2337/diacare.14.7.665</pub-id><?supplied-pmid 2060411?><pub-id pub-id-type="pmid">2060411</pub-id></mixed-citation></ref><ref id="B100"><label>100</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baxter</surname><given-names>J</given-names></name><name><surname>Hamman</surname><given-names>RF</given-names></name><name><surname>Lopez</surname><given-names>TK</given-names></name><name><surname>Marshall</surname><given-names>JA</given-names></name><name><surname>Hoag</surname><given-names>S</given-names></name><name><surname>Swenson</surname><given-names>CJ</given-names></name></person-group>
<article-title>Excess incidence of known non-insulin-dependent diabetes mellitus (NIDDM) in Hispanics compared with non-Hispanic whites in the San Luis Valley, Colorado</article-title>. <source>Ethn Dis</source> (<year>1993</year>) <volume>3</volume>:<fpage>11</fpage>&#x02013;<lpage>21</lpage>.<pub-id pub-id-type="pmid">8508101</pub-id></mixed-citation></ref><ref id="B101"><label>101</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burke</surname><given-names>JP</given-names></name><name><surname>Williams</surname><given-names>K</given-names></name><name><surname>Gaskill</surname><given-names>SP</given-names></name><name><surname>Hazuda</surname><given-names>HP</given-names></name><name><surname>Haffner</surname><given-names>SM</given-names></name><name><surname>Stern</surname><given-names>MP</given-names></name></person-group>. <article-title>Rapid rise in the incidence of type 2 diabetes from 1987 to 1996: results from the San Antonio Heart Study</article-title>. <source>Arch Intern Med</source> (<year>1999</year>) <volume>159</volume>:<fpage>1450</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1001/archinte.159.13.1450</pub-id><?supplied-pmid 10399896?><pub-id pub-id-type="pmid">10399896</pub-id></mixed-citation></ref><ref id="B102"><label>102</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burke</surname><given-names>JP</given-names></name><name><surname>Williams</surname><given-names>K</given-names></name><name><surname>Haffner</surname><given-names>SM</given-names></name><name><surname>Villalpando</surname><given-names>CG</given-names></name><name><surname>Stern</surname><given-names>MP</given-names></name></person-group>. <article-title>Elevated incidence of type 2 diabetes in San Antonio, Texas, compared with that of Mexico City, Mexico</article-title>. <source>Diabetes Care</source> (<year>2001</year>) <volume>24</volume>:<fpage>1573</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.2337/diacare.24.9.1573</pub-id><?supplied-pmid 11522701?><pub-id pub-id-type="pmid">11522701</pub-id></mixed-citation></ref><ref id="B103"><label>103</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawrence</surname><given-names>JM</given-names></name><name><surname>Mayer-Davis</surname><given-names>EJ</given-names></name><name><surname>Reynolds</surname><given-names>K</given-names></name><name><surname>Beyer</surname><given-names>J</given-names></name><name><surname>Pettitt</surname><given-names>DJ</given-names></name><name><surname>D&#x02019;Agostino</surname><given-names>RB</given-names><suffix>Jr</suffix></name><etal/></person-group>
<article-title>Diabetes in Hispanic American youth: prevalence, incidence, demographics, and clinical characteristics: the SEARCH for diabetes in youth study</article-title>. <source>Diabetes Care</source> (<year>2009</year>) <volume>32</volume>(<issue>Suppl 2</issue>):<fpage>S123</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="doi">10.2337/dc09-S204</pub-id><pub-id pub-id-type="pmid">19246577</pub-id></mixed-citation></ref><ref id="B104"><label>104</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuhrman</surname><given-names>BJ</given-names></name><name><surname>Smit</surname><given-names>E</given-names></name><name><surname>Crespo</surname><given-names>CJ</given-names></name><name><surname>Garcia-Palmieri</surname><given-names>MR</given-names></name></person-group>. <article-title>Coffee intake and risk of incident diabetes in Puerto Rican men: results from the Puerto Rico Heart Health Program</article-title>. <source>Public Health Nutr</source> (<year>2009</year>) <volume>12</volume>:<fpage>842</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1017/S1368980008003303</pub-id><?supplied-pmid 18775084?><pub-id pub-id-type="pmid">18775084</pub-id></mixed-citation></ref><ref id="B105"><label>105</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tabaei</surname><given-names>BP</given-names></name><name><surname>Chamany</surname><given-names>S</given-names></name><name><surname>Driver</surname><given-names>CR</given-names></name><name><surname>Kerker</surname><given-names>B</given-names></name><name><surname>Silver</surname><given-names>L</given-names></name></person-group>. <article-title>Incidence of self-reported diabetes in New York city, 2002, 2004, and 2008</article-title>. <source>Prev Chronic Dis</source> (<year>2012</year>) <volume>9</volume>:<fpage>110320</fpage>.<pub-id pub-id-type="doi">10.5888/pcd9.110320</pub-id><?supplied-pmid 22698175?><pub-id pub-id-type="pmid">22698175</pub-id></mixed-citation></ref><ref id="B106"><label>106</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer-Davis</surname><given-names>EJ</given-names></name><name><surname>Lawrence</surname><given-names>JM</given-names></name><name><surname>Dabelea</surname><given-names>D</given-names></name><name><surname>Divers</surname><given-names>J</given-names></name><name><surname>Isom</surname><given-names>S</given-names></name><name><surname>Dolan</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>Incidence trends of type 1 and type 2 diabetes among youths, 2002-2012</article-title>. <source>N Engl J Med</source> (<year>2017</year>) <volume>376</volume>:<fpage>1419</fpage>&#x02013;<lpage>29</lpage>.<pub-id pub-id-type="doi">10.1056/NEJMoa1610187</pub-id><?supplied-pmid 28402773?><pub-id pub-id-type="pmid">28402773</pub-id></mixed-citation></ref><ref id="B107"><label>107</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berkowitz</surname><given-names>GS</given-names></name><name><surname>Lapinski</surname><given-names>RH</given-names></name><name><surname>Wein</surname><given-names>R</given-names></name><name><surname>Lee</surname><given-names>D</given-names></name></person-group>
<article-title>Race/ethnicity and other risk factors for gestational diabetes</article-title>. <source>Am J Epidemiol</source> (<year>1992</year>) <volume>135</volume>:<fpage>965</fpage>&#x02013;<lpage>73</lpage>.<pub-id pub-id-type="doi">10.1093/oxfordjournals.aje.a116408</pub-id><pub-id pub-id-type="pmid">1595695</pub-id></mixed-citation></ref><ref id="B108"><label>108</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solomon</surname><given-names>CG</given-names></name><name><surname>Willett</surname><given-names>WC</given-names></name><name><surname>Carey</surname><given-names>VJ</given-names></name><name><surname>Rich-Edwards</surname><given-names>J</given-names></name><name><surname>Hunter</surname><given-names>DJ</given-names></name><name><surname>Colditz</surname><given-names>GA</given-names></name><etal/></person-group>
<article-title>A prospective study of pregravid determinants of gestational diabetes mellitus</article-title>. <source>JAMA</source> (<year>1997</year>) <volume>278</volume>:<fpage>1078</fpage>&#x02013;<lpage>83</lpage>.<pub-id pub-id-type="doi">10.1001/jama.1997.03550130052036</pub-id><?supplied-pmid 9315766?><pub-id pub-id-type="pmid">9315766</pub-id></mixed-citation></ref><ref id="B109"><label>109</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrara</surname><given-names>A</given-names></name><name><surname>Kahn</surname><given-names>HS</given-names></name><name><surname>Quesenberry</surname><given-names>C</given-names></name><name><surname>Riley</surname><given-names>C</given-names></name><name><surname>Hedderson</surname><given-names>MM</given-names></name></person-group>
<article-title>An increase in the incidence of gestational diabetes mellitus: Northern California, 1991&#x02013;2000</article-title>. <source>Obstet Gynecol</source> (<year>2004</year>) <volume>103</volume>:<fpage>526</fpage>&#x02013;<lpage>33</lpage>.<pub-id pub-id-type="doi">10.1097/01.AOG.0000113623.18286.20</pub-id><pub-id pub-id-type="pmid">14990417</pub-id></mixed-citation></ref><ref id="B110"><label>110</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savitz</surname><given-names>DA</given-names></name><name><surname>Janevic</surname><given-names>TM</given-names></name><name><surname>Engel</surname><given-names>SM</given-names></name><name><surname>Kaufman</surname><given-names>JS</given-names></name><name><surname>Herring</surname><given-names>AH</given-names></name></person-group>. <article-title>Ethnicity and gestational diabetes in New York city, 1995-2003</article-title>. <source>BJOG</source> (<year>2008</year>) <volume>115</volume>:<fpage>969</fpage>&#x02013;<lpage>78</lpage>.<pub-id pub-id-type="doi">10.1111/j.1471-0528.2008.01763.x</pub-id><?supplied-pmid 18651880?><pub-id pub-id-type="pmid">18651880</pub-id></mixed-citation></ref><ref id="B111"><label>111</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>SY</given-names></name><name><surname>Abe</surname><given-names>K</given-names></name><name><surname>Hall</surname><given-names>LR</given-names></name><name><surname>Kim</surname><given-names>SY</given-names></name><name><surname>Njoroge</surname><given-names>T</given-names></name><name><surname>Qin</surname><given-names>C</given-names></name></person-group>. <article-title>Gestational diabetes mellitus: all Asians are not alike</article-title>. <source>Prev Med</source> (<year>2009</year>) <volume>49</volume>:<fpage>265</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/j.ypmed.2009.07.001</pub-id><?supplied-pmid 19596364?><pub-id pub-id-type="pmid">19596364</pub-id></mixed-citation></ref><ref id="B112"><label>112</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SY</given-names></name><name><surname>Saraiva</surname><given-names>C</given-names></name><name><surname>Curtis</surname><given-names>M</given-names></name><name><surname>Wilson</surname><given-names>HG</given-names></name><name><surname>Troyan</surname><given-names>J</given-names></name><name><surname>Sharma</surname><given-names>AJ</given-names></name></person-group>
<article-title>Fraction of gestational diabetes mellitus attributable to overweight and obesity by race/ethnicity, California, 2007-2009</article-title>. <source>Am J Public Health</source> (<year>2013</year>) <volume>103</volume>:<fpage>e65</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="doi">10.2105/AJPH.2013.301469</pub-id><pub-id pub-id-type="pmid">23947320</pub-id></mixed-citation></ref><ref id="B113"><label>113</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bardenheier</surname><given-names>BH</given-names></name><name><surname>Imperatore</surname><given-names>G</given-names></name><name><surname>Gilboa</surname><given-names>SM</given-names></name><name><surname>Geiss</surname><given-names>LS</given-names></name><name><surname>Saydah</surname><given-names>SH</given-names></name><name><surname>Devlin</surname><given-names>HM</given-names></name><etal/></person-group>
<article-title>Trends in gestational diabetes among hospital deliveries in 19 U.S. States, 2000-2010</article-title>. <source>Am J Prev Med</source> (<year>2015</year>) <volume>49</volume>:<fpage>12</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/j.amepre.2015.01.026</pub-id><pub-id pub-id-type="pmid">26094225</pub-id></mixed-citation></ref><ref id="B114"><label>114</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bardenheier</surname><given-names>BH</given-names></name><name><surname>Imperatore</surname><given-names>G</given-names></name><name><surname>Devlin</surname><given-names>HM</given-names></name><name><surname>Kim</surname><given-names>SY</given-names></name><name><surname>Cho</surname><given-names>P</given-names></name><name><surname>Geiss</surname><given-names>LS</given-names></name></person-group>. <article-title>Trends in pre-pregnancy diabetes among deliveries in 19 U.S. states, 2000-2010</article-title>. <source>Am J Prev Med</source> (<year>2015</year>) <volume>48</volume>:<fpage>154</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="doi">10.1016/j.amepre.2014.08.031</pub-id><?supplied-pmid 25326417?><pub-id pub-id-type="pmid">25326417</pub-id></mixed-citation></ref><ref id="B115"><label>115</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malerbi</surname><given-names>DA</given-names></name><name><surname>Franco</surname><given-names>LJ</given-names></name></person-group>. <article-title>Multicenter study of the prevalence of diabetes mellitus and impaired glucose tolerance in the urban Brazilian population aged 30-69 yr. The Brazilian Cooperative Group on the Study of Diabetes Prevalence</article-title>. <source>Diabetes Care</source> (<year>1992</year>) <volume>15</volume>:<fpage>1509</fpage>&#x02013;<lpage>16</lpage>.<pub-id pub-id-type="doi">10.2337/diacare.15.11.1509</pub-id><?supplied-pmid 1468278?><pub-id pub-id-type="pmid">1468278</pub-id></mixed-citation></ref><ref id="B116"><label>116</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliveira</surname><given-names>JE</given-names></name><name><surname>Milech</surname><given-names>A</given-names></name><name><surname>Franco</surname><given-names>LJ</given-names></name></person-group>. <article-title>The prevalence of diabetes in Rio de Janeiro, Brazil. The Cooperative Group for the Study of Diabetes Prevalence in Rio De Janeiro</article-title>. <source>Diabetes Care</source> (<year>1996</year>) <volume>19</volume>:<fpage>663</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.2337/diacare.19.6.663</pub-id><?supplied-pmid 8725870?><pub-id pub-id-type="pmid">8725870</pub-id></mixed-citation></ref><ref id="B117"><label>117</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barcel&#x000f3;</surname><given-names>A</given-names></name><name><surname>Daroca</surname><given-names>MC</given-names></name><name><surname>Ribera</surname><given-names>R</given-names></name><name><surname>Duarte</surname><given-names>E</given-names></name><name><surname>Zapata</surname><given-names>A</given-names></name><name><surname>Vohra</surname><given-names>M</given-names></name></person-group>. <article-title>Diabetes in Bolivia</article-title>. <source>Rev Panam Salud Publica</source> (<year>2001</year>) <volume>10</volume>:<fpage>318</fpage>&#x02013;<lpage>23</lpage>.<?supplied-pmid 11774803?><pub-id pub-id-type="pmid">11774803</pub-id></mixed-citation></ref><ref id="B118"><label>118</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torquato</surname><given-names>MT</given-names></name><name><surname>Montenegro J&#x000fa;nior</surname><given-names>RM</given-names></name><name><surname>Viana</surname><given-names>LA</given-names></name><name><surname>de Souza</surname><given-names>RA</given-names></name><name><surname>Lanna</surname><given-names>CM</given-names></name><name><surname>Lucas</surname><given-names>JC</given-names></name><etal/></person-group>
<article-title>Prevalence of diabetes mellitus and impaired glucose tolerance in the urban population aged 30-69 years in Ribeir&#x000e3;o Preto (S&#x000e3;o Paulo), Brazil</article-title>. <source>Sao Paulo Med J</source> (<year>2003</year>) <volume>121</volume>:<fpage>224</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="doi">10.1590/S1516-31802003000600002</pub-id><pub-id pub-id-type="pmid">14989137</pub-id></mixed-citation></ref><ref id="B119"><label>119</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aguilar-Salinas</surname><given-names>CA</given-names></name><name><surname>Velazquez Monroy</surname><given-names>O</given-names></name><name><surname>G&#x000f3;mez-P&#x000e9;rez</surname><given-names>FJ</given-names></name><name><surname>Gonzalez Ch&#x000e1;vez</surname><given-names>A</given-names></name><name><surname>Esqueda</surname><given-names>AL</given-names></name><name><surname>Molina Cuevas</surname><given-names>V</given-names></name><etal/></person-group>
<article-title>Characteristics of patients with type 2 diabetes in M&#x000e9;xico: results from a large population-based nationwide survey</article-title>. <source>Diabetes Care</source> (<year>2003</year>) <volume>26</volume>:<fpage>2021</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.2337/diacare.26.7.2021</pub-id><?supplied-pmid 12832306?><pub-id pub-id-type="pmid">12832306</pub-id></mixed-citation></ref><ref id="B120"><label>120</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sereday</surname><given-names>MS</given-names></name><name><surname>Gonzalez</surname><given-names>C</given-names></name><name><surname>Giorgini</surname><given-names>D</given-names></name><name><surname>De Loredo</surname><given-names>L</given-names></name><name><surname>Braguinsky</surname><given-names>J</given-names></name><name><surname>Cobe&#x000f1;as</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Prevalence of diabetes, obesity, hypertension and hyperlipidemia in the central area of Argentina</article-title>. <source>Diabetes Metab</source> (<year>2004</year>) <volume>30</volume>:<fpage>335</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/S1262-3636(07)70125-8</pub-id><?supplied-pmid 15525876?><pub-id pub-id-type="pmid">15525876</pub-id></mixed-citation></ref><ref id="B121"><label>121</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>S&#x000e1;nchez-Castillo</surname><given-names>CP</given-names></name><name><surname>Vel&#x000e1;squez-Monroy</surname><given-names>O</given-names></name><name><surname>Lara-Esqueda</surname><given-names>A</given-names></name><name><surname>Berber</surname><given-names>A</given-names></name><name><surname>Sepulveda</surname><given-names>J</given-names></name><name><surname>Tapia-Conyer</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Diabetes and hypertension increases in a society with abdominal obesity: results of the Mexican National Health Survey 2000</article-title>. <source>Public Health Nutr</source> (<year>2005</year>) <volume>8</volume>:<fpage>53</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="doi">10.1079/PHN2004659</pub-id><pub-id pub-id-type="pmid">15707539</pub-id></mixed-citation></ref><ref id="B122"><label>122</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albala</surname><given-names>C</given-names></name><name><surname>Lebr&#x000e3;o</surname><given-names>ML</given-names></name><name><surname>Le&#x000f3;n D&#x000ed;az</surname><given-names>EM</given-names></name><name><surname>Ham-Chande</surname><given-names>R</given-names></name><name><surname>Hennis</surname><given-names>AJ</given-names></name><name><surname>Palloni</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>The health, well-being, and aging (&#x0201c;SABE&#x0201d;) survey: methodology applied and profile of the study population</article-title>. <source>Rev Panam Salud Publica</source> (<year>2005</year>) <volume>17</volume>:<fpage>307</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="doi">10.1590/S1020-49892005000500003</pub-id><pub-id pub-id-type="pmid">16053641</pub-id></mixed-citation></ref><ref id="B123"><label>123</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barcel&#x000f3;</surname><given-names>A</given-names></name><name><surname>Pel&#x000e1;ez</surname><given-names>M</given-names></name><name><surname>Rodriguez-Wong</surname><given-names>L</given-names></name><name><surname>Pastor-Valero</surname><given-names>M</given-names></name></person-group>. <article-title>The prevalence of diagnosed diabetes among the elderly of seven cities in Latin America and the Caribbean: the health wellbeing and aging (SABE) project</article-title>. <source>J Aging Health</source> (<year>2006</year>) <volume>18</volume>:<fpage>224</fpage>&#x02013;<lpage>39</lpage>.<pub-id pub-id-type="doi">10.1177/0898264305285728</pub-id><?supplied-pmid 16614342?><pub-id pub-id-type="pmid">16614342</pub-id></mixed-citation></ref><ref id="B124"><label>124</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barcel&#x000f3;</surname><given-names>A</given-names></name><name><surname>Gregg</surname><given-names>EW</given-names></name><name><surname>Pastor-Valero</surname><given-names>M</given-names></name><name><surname>Robles</surname><given-names>SC</given-names></name></person-group>. <article-title>Waist circumference, BMI and the prevalence of self-reported diabetes among the elderly of the United States and six cities of Latin America and the Caribbean</article-title>. <source>Diabetes Res Clin Pract</source> (<year>2007</year>) <volume>78</volume>:<fpage>418</fpage>&#x02013;<lpage>27</lpage>.<pub-id pub-id-type="doi">10.1016/j.diabres.2007.06.008</pub-id><?supplied-pmid 17669541?><pub-id pub-id-type="pmid">17669541</pub-id></mixed-citation></ref><ref id="B125"><label>125</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meaney</surname><given-names>E</given-names></name><name><surname>Lara-Esqueda</surname><given-names>A</given-names></name><name><surname>Ceballos-Reyes</surname><given-names>GM</given-names></name><name><surname>Asbun</surname><given-names>J</given-names></name><name><surname>Vela</surname><given-names>A</given-names></name><name><surname>Mart&#x000ed;nez-Marroqu&#x000ed;n</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>Cardiovascular risk factors in the urban Mexican population: the FRIMEX study</article-title>. <source>Public Health</source> (<year>2007</year>) <volume>121</volume>:<fpage>378</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="doi">10.1016/j.puhe.2006.11.008</pub-id><?supplied-pmid 17292427?><pub-id pub-id-type="pmid">17292427</pub-id></mixed-citation></ref><ref id="B126"><label>126</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medina-Lezama</surname><given-names>J</given-names></name><name><surname>Morey-Vargas</surname><given-names>OL</given-names></name><name><surname>Zea-D&#x000ed;az</surname><given-names>H</given-names></name><name><surname>Bola&#x000f1;os-Salazar</surname><given-names>JF</given-names></name><name><surname>Corrales-Medina</surname><given-names>F</given-names></name><name><surname>Cuba-Bustinza</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Prevalence of lifestyle-related cardiovascular risk factors in Peru: the PREVENCION study</article-title>. <source>Rev Panam Salud Publica</source> (<year>2008</year>) <volume>24</volume>:<fpage>169</fpage>&#x02013;<lpage>79</lpage>.<pub-id pub-id-type="doi">10.1590/S1020-49892008000900003</pub-id><?supplied-pmid 19115544?><pub-id pub-id-type="pmid">19115544</pub-id></mixed-citation></ref><ref id="B127"><label>127</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Capilheira</surname><given-names>MF</given-names></name><name><surname>Santos</surname><given-names>IS</given-names></name><name><surname>Azevedo</surname><given-names>MR</given-names></name><name><surname>Reichert</surname><given-names>FF</given-names></name></person-group>. <article-title>Risk factors for chronic non-communicable diseases and the CARMEN initiative: a population-based study in the south of Brazil</article-title>. <source>Cad Sa&#x000fa;de P&#x000fa;blica</source> (<year>2008</year>) <volume>24</volume>:<fpage>2767</fpage>&#x02013;<lpage>74</lpage>.<pub-id pub-id-type="doi">10.1590/S0102-311X2008001200005</pub-id><?supplied-pmid 19082267?><pub-id pub-id-type="pmid">19082267</pub-id></mixed-citation></ref><ref id="B128"><label>128</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schargrodsky</surname><given-names>H</given-names></name><name><surname>Hern&#x000e1;ndez-Hern&#x000e1;ndez</surname><given-names>R</given-names></name><name><surname>Champagne</surname><given-names>BM</given-names></name><name><surname>Silva</surname><given-names>H</given-names></name><name><surname>Vinueza</surname><given-names>R</given-names></name><name><surname>Silva Ay&#x000e7;aguer</surname><given-names>LC</given-names></name><etal/></person-group>
<article-title>CARMELA: assessment of cardiovascular risk in seven Latin American cities</article-title>. <source>Am J Med</source> (<year>2008</year>) <volume>121</volume>:<fpage>58</fpage>&#x02013;<lpage>65</lpage>.<pub-id pub-id-type="doi">10.1016/j.amjmed.2007.08.038</pub-id><?supplied-pmid 18187074?><pub-id pub-id-type="pmid">18187074</pub-id></mixed-citation></ref><ref id="B129"><label>129</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Escobedo</surname><given-names>J</given-names></name><name><surname>Buitr&#x000f3;n</surname><given-names>LV</given-names></name><name><surname>Velasco</surname><given-names>MF</given-names></name><name><surname>Ram&#x000ed;rez</surname><given-names>JC</given-names></name><name><surname>Hern&#x000e1;ndez</surname><given-names>R</given-names></name><name><surname>Macchia</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>High prevalence of diabetes and impaired fasting glucose in urban Latin America: the CARMELA study</article-title>. <source>Diabet Med</source> (<year>2009</year>) <volume>26</volume>:<fpage>864</fpage>&#x02013;<lpage>71</lpage>.<pub-id pub-id-type="doi">10.1111/j.1464-5491.2009.02795.x</pub-id><?supplied-pmid 19719706?><pub-id pub-id-type="pmid">19719706</pub-id></mixed-citation></ref><ref id="B130"><label>130</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuri-Morales</surname><given-names>P</given-names></name><name><surname>Emberson</surname><given-names>J</given-names></name><name><surname>Alegre-D&#x000ed;az</surname><given-names>J</given-names></name><name><surname>Tapia-Conyer</surname><given-names>R</given-names></name><name><surname>Collins</surname><given-names>R</given-names></name><name><surname>Peto</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>The prevalence of chronic diseases and major disease risk factors at different ages among 150,000 men and women living in Mexico City: cross-sectional analyses of a prospective study</article-title>. <source>BMC Public Health</source> (<year>2009</year>) <volume>9</volume>:<fpage>9</fpage>.<pub-id pub-id-type="doi">10.1186/1471-2458-9-9</pub-id><?supplied-pmid 19134207?><pub-id pub-id-type="pmid">19134207</pub-id></mixed-citation></ref><ref id="B131"><label>131</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burrows</surname><given-names>RA</given-names></name><name><surname>Leiva</surname><given-names>LB</given-names></name><name><surname>Weisstaub</surname><given-names>G</given-names></name><name><surname>Lera</surname><given-names>LM</given-names></name><name><surname>Albala</surname><given-names>CB</given-names></name><name><surname>Blanco</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>High HOMA-IR, adjusted for puberty, relates to the metabolic syndrome in overweight and obese Chilean youths</article-title>. <source>Pediatr Diabetes</source> (<year>2011</year>) <volume>12</volume>:<fpage>212</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1111/j.1399-5448.2010.00685.x</pub-id><?supplied-pmid 21426454?><pub-id pub-id-type="pmid">21426454</pub-id></mixed-citation></ref><ref id="B132"><label>132</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bautista</surname><given-names>LE</given-names></name><name><surname>Casas</surname><given-names>JP</given-names></name><name><surname>Herrera</surname><given-names>VM</given-names></name><name><surname>Miranda</surname><given-names>JJ</given-names></name><name><surname>Perel</surname><given-names>P</given-names></name><name><surname>Pichardo</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>The Latin American consortium of studies in obesity (LASO)</article-title>. <source>Obes Rev</source> (<year>2009</year>) <volume>10</volume>:<fpage>364</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="doi">10.1111/j.1467-789X.2009.00591.x</pub-id><pub-id pub-id-type="pmid">19438980</pub-id></mixed-citation></ref><ref id="B133"><label>133</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miranda</surname><given-names>JJ</given-names></name><name><surname>Herrera</surname><given-names>VM</given-names></name><name><surname>Chirinos</surname><given-names>JA</given-names></name><name><surname>G&#x000f3;mez</surname><given-names>LF</given-names></name><name><surname>Perel</surname><given-names>P</given-names></name><name><surname>Pichardo</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Major cardiovascular risk factors in Latin America: a comparison with the United States. The Latin American consortium of studies in obesity (LASO)</article-title>. <source>PLoS One</source> (<year>2013</year>) <volume>8</volume>:<fpage>e54056</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0054056</pub-id><pub-id pub-id-type="pmid">23349785</pub-id></mixed-citation></ref><ref id="B134"><label>134</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aquino</surname><given-names>EM</given-names></name><name><surname>Barreto</surname><given-names>SM</given-names></name><name><surname>Bensenor</surname><given-names>IM</given-names></name><name><surname>Carvalho</surname><given-names>MS</given-names></name><name><surname>Chor</surname><given-names>D</given-names></name><name><surname>Duncan</surname><given-names>BB</given-names></name><etal/></person-group>
<article-title>Brazilian Longitudinal Study of Adult Health (ELSA-Brasil): objectives and design</article-title>. <source>Am J Epidemiol</source> (<year>2012</year>) <volume>175</volume>:<fpage>315</fpage>&#x02013;<lpage>24</lpage>.<pub-id pub-id-type="doi">10.1093/aje/kwr294</pub-id><?supplied-pmid 22234482?><pub-id pub-id-type="pmid">22234482</pub-id></mixed-citation></ref><ref id="B135"><label>135</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>MI</given-names></name><name><surname>Hoffman</surname><given-names>JF</given-names></name><name><surname>de F&#x000e1;tima Sander Diniz</surname><given-names>M</given-names></name><name><surname>Lotufo</surname><given-names>PA</given-names></name><name><surname>Griep</surname><given-names>RH</given-names></name><name><surname>Bensenor</surname><given-names>IM</given-names></name><etal/></person-group>
<article-title>High prevalence of diabetes and intermediate hyperglycemia &#x02013; the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)</article-title>. <source>Diabetol Metab Syndr</source> (<year>2014</year>) <volume>6</volume>:<fpage>123</fpage><pub-id pub-id-type="doi">10.1186/1758-5996-6-123</pub-id><pub-id pub-id-type="pmid">25788987</pub-id></mixed-citation></ref><ref id="B136"><label>136</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubinstein</surname><given-names>AL</given-names></name><name><surname>Irazola</surname><given-names>VE</given-names></name><name><surname>Calandrelli</surname><given-names>M</given-names></name><name><surname>Elorriaga</surname><given-names>N</given-names></name><name><surname>Gutierrez</surname><given-names>L</given-names></name><name><surname>Lanas</surname><given-names>F</given-names></name><etal/></person-group>
<article-title>Multiple cardiometabolic risk factors in the Southern Cone of Latin America: a population-based study in Argentina, Chile, and Uruguay</article-title>. <source>Int J Cardiol</source> (<year>2015</year>) <volume>183</volume>:<fpage>82</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/j.ijcard.2015.01.062</pub-id><?supplied-pmid 25662056?><pub-id pub-id-type="pmid">25662056</pub-id></mixed-citation></ref><ref id="B137"><label>137</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDonald Posso</surname><given-names>AJ</given-names></name><name><surname>Bradshaw Meza</surname><given-names>RA</given-names></name><name><surname>Mendoza Morales</surname><given-names>EA</given-names></name><name><surname>Jaen</surname><given-names>Y</given-names></name><name><surname>Cumbrera Ortega</surname><given-names>A</given-names></name><name><surname>Mendoza Posada</surname><given-names>EJ</given-names></name></person-group>. <article-title>Diabetes in Panama: epidemiology, risk factors, and clinical management</article-title>. <source>Ann Glob Health</source> (<year>2015</year>) <volume>81</volume>:<fpage>754</fpage>&#x02013;<lpage>64</lpage>.<pub-id pub-id-type="doi">10.1016/j.aogh.2015.12.014</pub-id><?supplied-pmid 27108143?><pub-id pub-id-type="pmid">27108143</pub-id></mixed-citation></ref><ref id="B138"><label>138</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>J</given-names></name><name><surname>Kondal</surname><given-names>D</given-names></name><name><surname>Rubinstein</surname><given-names>A</given-names></name><name><surname>Irazola</surname><given-names>V</given-names></name><name><surname>Gutierrez</surname><given-names>L</given-names></name><name><surname>Miranda</surname><given-names>JJ</given-names></name><etal/></person-group>
<article-title>A multiethnic study of pre-diabetes and diabetes in LMIC</article-title>. <source>Glob Heart</source> (<year>2016</year>) <volume>11</volume>:<fpage>61</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="doi">10.1016/j.gheart.2015.12.015</pub-id><?supplied-pmid 27102023?><pub-id pub-id-type="pmid">27102023</pub-id></mixed-citation></ref><ref id="B139"><label>139</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernab&#x000e9;-Ortiz</surname><given-names>A</given-names></name><name><surname>Carrillo-Larco</surname><given-names>RM</given-names></name><name><surname>Gilman</surname><given-names>RH</given-names></name><name><surname>Miele</surname><given-names>CH</given-names></name><name><surname>Checkley</surname><given-names>W</given-names></name><name><surname>Wells</surname><given-names>JC</given-names></name><etal/></person-group>
<article-title>Geographical variation in the progression of type 2 diabetes in Peru: the CRONICAS cohort study</article-title>. <source>Diabetes Res Clin Pract</source> (<year>2016</year>) <volume>121</volume>:<fpage>135</fpage>&#x02013;<lpage>45</lpage>.<pub-id pub-id-type="doi">10.1016/j.diabres.2016.09.007</pub-id><?supplied-pmid 27710820?><pub-id pub-id-type="pmid">27710820</pub-id></mixed-citation></ref><ref id="B140"><label>140</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aschner</surname><given-names>P</given-names></name><name><surname>Aguilar-Salinas</surname><given-names>C</given-names></name><name><surname>Aguirre</surname><given-names>L</given-names></name><name><surname>Franco</surname><given-names>L</given-names></name><name><surname>Gagliardino</surname><given-names>JJ</given-names></name><name><surname>de Lapertosa</surname><given-names>SG</given-names></name><etal/></person-group>
<article-title>Diabetes in South and Central America: an update</article-title>. <source>Diabetes Res Clin Pract</source> (<year>2014</year>) <volume>103</volume>:<fpage>238</fpage>&#x02013;<lpage>43</lpage>.<pub-id pub-id-type="doi">10.1016/j.diabres.2013.11.010</pub-id><?supplied-pmid 24439209?><pub-id pub-id-type="pmid">24439209</pub-id></mixed-citation></ref><ref id="B141"><label>141</label><mixed-citation publication-type="book"><collab>International Diabetes Federation</collab>. <source>Diabetes Atlas</source>. <edition>7th ed</edition>
<publisher-loc>Brussels, Belgium</publisher-loc> (<year>2015</year>). Available from: <uri xlink:type="simple" xlink:href="http://www.diabetesatlas.org">www.diabetesatlas.org</uri></mixed-citation></ref><ref id="B142"><label>142</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>MI</given-names></name><name><surname>Duncan</surname><given-names>BB</given-names></name><name><surname>Reichelt</surname><given-names>AJ</given-names></name><name><surname>Branchtein</surname><given-names>L</given-names></name><name><surname>Matos</surname><given-names>MC</given-names></name><name><surname>Costa e Forti</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Gestational diabetes mellitus diagnosed with a 2-h 75-g oral glucose tolerance test and adverse pregnancy outcomes</article-title>. <source>Diabetes Care</source> (<year>2001</year>) <volume>24</volume>:<fpage>1151</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.2337/diacare.24.7.1151</pub-id><?supplied-pmid 11423494?><pub-id pub-id-type="pmid">11423494</pub-id></mixed-citation></ref><ref id="B143"><label>143</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonz&#x000e1;lez-Villalpando</surname><given-names>C</given-names></name><name><surname>D&#x000e1;vila-Cervantes</surname><given-names>CA</given-names></name><name><surname>Zamora-Macorra</surname><given-names>M</given-names></name><name><surname>Trejo-Valdivia</surname><given-names>B</given-names></name><name><surname>Gonz&#x000e1;lez-Villalpando</surname><given-names>ME</given-names></name></person-group>. <article-title>Incidence of type 2 diabetes in Mexico: results of the Mexico City diabetes study after 18 years of follow-up</article-title>. <source>Salud Publica Mex</source> (<year>2014</year>) <volume>56</volume>:<fpage>11</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.21149/spm.v56i1.7318</pub-id><?supplied-pmid 24912516?><pub-id pub-id-type="pmid">24912516</pub-id></mixed-citation></ref><ref id="B144"><label>144</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flegal</surname><given-names>KM</given-names></name><name><surname>Kruszon-Moran</surname><given-names>D</given-names></name><name><surname>Carroll</surname><given-names>MD</given-names></name><name><surname>Fryar</surname><given-names>CD</given-names></name><name><surname>Ogden</surname><given-names>CL</given-names></name></person-group>
<article-title>Trends in obesity among adults in the United States, 2005-2014</article-title>. <source>JAMA</source> (<year>2016</year>) <volume>315</volume>:<fpage>2284</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="doi">10.1001/jama.2016.6458</pub-id><pub-id pub-id-type="pmid">27272580</pub-id></mixed-citation></ref><ref id="B145"><label>145</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogden</surname><given-names>CL</given-names></name><name><surname>Carroll</surname><given-names>MD</given-names></name><name><surname>Lawman</surname><given-names>HG</given-names></name><name><surname>Fryar</surname><given-names>CD</given-names></name><name><surname>Kruszon</surname><given-names>D</given-names></name><name><surname>Kit</surname><given-names>BK</given-names></name><etal/></person-group>
<article-title>Trends in obesity prevalence among children and adolescents in the United States, 1988-1994 through 2013-2014</article-title>. <source>JAMA</source> (<year>2016</year>) <volume>315</volume>:<fpage>2292</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1001/jama.2016.6361</pub-id><?supplied-pmid 27272581?><pub-id pub-id-type="pmid">27272581</pub-id></mixed-citation></ref><ref id="B146"><label>146</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heiss</surname><given-names>G</given-names></name><name><surname>Snyder</surname><given-names>ML</given-names></name><name><surname>Teng</surname><given-names>Y</given-names></name><name><surname>Schneiderman</surname><given-names>N</given-names></name><name><surname>Llabre</surname><given-names>MM</given-names></name><name><surname>Cowie</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Prevalence of metabolic syndrome among Hispanics/Latinos of diverse background: the Hispanic Community Health Study/Study of Latinos</article-title>. <source>Diabetes Care</source> (<year>2014</year>) <volume>37</volume>:<fpage>2391</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.2337/dc13-2505</pub-id><pub-id pub-id-type="pmid">25061141</pub-id></mixed-citation></ref><ref id="B147"><label>147</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x000e9;rez</surname><given-names>CM</given-names></name><name><surname>S&#x000e1;nchez</surname><given-names>H</given-names></name><name><surname>Ortiz</surname><given-names>AP</given-names></name></person-group>
<article-title>Prevalence of overweight and obesity and their cardiometabolic comorbidities in Hispanic adults living in Puerto Rico</article-title>. <source>J Community Health</source> (<year>2013</year>) <volume>38</volume>:<fpage>1140</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1007/s10900-013-9726-5</pub-id><pub-id pub-id-type="pmid">23846388</pub-id></mixed-citation></ref><ref id="B148"><label>148</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x000e9;rez</surname><given-names>CM</given-names></name><name><surname>Ortiz</surname><given-names>AP</given-names></name><name><surname>Guzm&#x000e1;n</surname><given-names>M</given-names></name><name><surname>Su&#x000e1;rez</surname><given-names>E</given-names></name></person-group>
<article-title>Distribution of the metabolic syndrome in adults living in the San Juan Metropolitan area of Puerto Rico</article-title>. <source>P R Health Sci J</source> (<year>2012</year>) <volume>31</volume>:<fpage>114</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="pmid">23038883</pub-id></mixed-citation></ref><ref id="B149"><label>149</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bense&#x000f1;or</surname><given-names>IM</given-names></name><name><surname>Guolart</surname><given-names>AC</given-names></name><name><surname>Santos</surname><given-names>IS</given-names></name><name><surname>Bittencourt</surname><given-names>MS</given-names></name><name><surname>Pereira</surname><given-names>AC</given-names></name><name><surname>Santos</surname><given-names>RD</given-names></name><etal/></person-group>
<article-title>Association between a healthy cardiovascular profile and coronary artery calcium score: results from the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)</article-title>. <source>Am Heart J</source> (<year>2016</year>) <volume>174</volume>:<fpage>51</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/j.ahj.2015.12.018</pub-id><pub-id pub-id-type="pmid">26995370</pub-id></mixed-citation></ref><ref id="B150"><label>150</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rivera</surname><given-names>JA</given-names></name><name><surname>De Cossio</surname><given-names>TG</given-names></name><name><surname>Pedraza</surname><given-names>LS</given-names></name><name><surname>Aburto</surname><given-names>TC</given-names></name><name><surname>S&#x000e1;nchez</surname><given-names>TG</given-names></name><name><surname>Martorell</surname><given-names>R</given-names></name></person-group>. <article-title>Childhood and adolescent overweight and obesity in Latin America: a systematic review</article-title>. <source>Lancet Diabetes Endocrinol</source> (<year>2014</year>) <volume>2</volume>:<fpage>321</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="doi">10.1016/S2213-8587(13)70173-6</pub-id><?supplied-pmid 24703050?><pub-id pub-id-type="pmid">24703050</pub-id></mixed-citation></ref><ref id="B151"><label>151</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hern&#x000e1;ndez-Cordero</surname><given-names>S</given-names></name><name><surname>Cuevas-Nasu</surname><given-names>L</given-names></name><name><surname>Mor&#x000e1;n-Ru&#x000e1;n</surname><given-names>MC</given-names></name><name><surname>M&#x000e9;ndez-G&#x000f3;mez Humar&#x000e1;n</surname><given-names>I</given-names></name><name><surname>Avila-Arcos</surname><given-names>MA</given-names></name><name><surname>Rivera-Dommarco</surname><given-names>JA</given-names></name></person-group>. <article-title>Overweight and obesity in Mexican children and adolescents during the last 25 years</article-title>. <source>Nutr Diabetes</source> (<year>2017</year>) <volume>7</volume>:<fpage>e247</fpage>.<pub-id pub-id-type="doi">10.1038/nutd.2016.52</pub-id><?supplied-pmid 28287630?><pub-id pub-id-type="pmid">28287630</pub-id></mixed-citation></ref><ref id="B152"><label>152</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parra</surname><given-names>DC</given-names></name><name><surname>Iannotti</surname><given-names>L</given-names></name><name><surname>G&#x000f3;mez</surname><given-names>LF</given-names></name><name><surname>Pach&#x000f3;n</surname><given-names>H</given-names></name><name><surname>Haire-Joshu</surname><given-names>D</given-names></name><name><surname>Sarmiento</surname><given-names>OL</given-names></name><etal/></person-group>
<article-title>The nutrition transition in Colombia over a decade: a novel household classification system of anthropometric measures</article-title>. <source>Arch Public Health</source> (<year>2015</year>) <volume>73</volume>:<fpage>12</fpage>.<pub-id pub-id-type="doi">10.1186/s13690-014-0057-5</pub-id><?supplied-pmid 25780562?><pub-id pub-id-type="pmid">25780562</pub-id></mixed-citation></ref><ref id="B153"><label>153</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>F</given-names></name><name><surname>He</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Walton</surname><given-names>RG</given-names></name></person-group>
<article-title>Trends in prevalence, awareness, management, and control of hypertension among United States adults, 1999-2010</article-title>. <source>J Am Coll Cardiol</source> (<year>2012</year>) <volume>60</volume>:<fpage>599</fpage>&#x02013;<lpage>606</lpage>.<pub-id pub-id-type="doi">10.1016/j.jacc.2012.04.026</pub-id><pub-id pub-id-type="pmid">22796254</pub-id></mixed-citation></ref><ref id="B154"><label>154</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sorlie</surname><given-names>PD</given-names></name><name><surname>Allison</surname><given-names>MA</given-names></name><name><surname>Avil&#x000e9;s-Santa</surname><given-names>ML</given-names></name><name><surname>Cai</surname><given-names>J</given-names></name><name><surname>Daviglus</surname><given-names>ML</given-names></name><name><surname>Howard</surname><given-names>AG</given-names></name><etal/></person-group>
<article-title>Prevalence of hypertension, awareness, treatment, and control in the Hispanic Community Health Study/Study of Latinos</article-title>. <source>Am J Hypertens</source> (<year>2014</year>) <volume>27</volume>:<fpage>793</fpage>&#x02013;<lpage>800</lpage>.<pub-id pub-id-type="doi">10.1093/ajh/hpu003</pub-id><pub-id pub-id-type="pmid">24627442</pub-id></mixed-citation></ref><ref id="B155"><label>155</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hern&#x000e1;ndez-Hern&#x000e1;ndez</surname><given-names>R</given-names></name><name><surname>Silva</surname><given-names>H</given-names></name><name><surname>Velasco</surname><given-names>M</given-names></name><name><surname>Pellegrini</surname><given-names>F</given-names></name><name><surname>Macchia</surname><given-names>A</given-names></name><name><surname>Escobedo</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Hypertension in seven Latin American cities: the cardiovascular risk factor multiple evaluation in Latin America (CARMELA) study</article-title>. <source>J Hypertens</source> (<year>2010</year>) <volume>28</volume>:<fpage>24</fpage>&#x02013;<lpage>34</lpage>.<pub-id pub-id-type="doi">10.1097/HJH.0b013e328332c353</pub-id><pub-id pub-id-type="pmid">19809362</pub-id></mixed-citation></ref><ref id="B156"><label>156</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carroll</surname><given-names>MD</given-names></name><name><surname>Kit</surname><given-names>BK</given-names></name><name><surname>Lacher</surname><given-names>DA</given-names></name><name><surname>Yoon</surname><given-names>SS</given-names></name></person-group>
<article-title>Total and high-density lipoprotein cholesterol in adults: National Health and Nutrition Examination Survey, 2011-2012</article-title>. <source>NHCS Data Brief</source> (<year>2013</year>) <volume>132</volume>:<fpage>1</fpage>&#x02013;<lpage>8</lpage>.</mixed-citation></ref><ref id="B157"><label>157</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez</surname><given-names>CJ</given-names></name><name><surname>Daviglus</surname><given-names>ML</given-names></name><name><surname>Swett</surname><given-names>K</given-names></name><name><surname>Gonzalez</surname><given-names>HM</given-names></name><name><surname>Gallo</surname><given-names>LC</given-names></name><name><surname>Wassertheil-Smoller</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Dyslipidemia patterns among Hispanics/Latinos of diverse background in the United States</article-title>. <source>Am J Med</source> (<year>2014</year>) <volume>127</volume>:<fpage>1186</fpage>&#x02013;<lpage>94</lpage>.<pub-id pub-id-type="doi">10.1016/j.amjmed.2014.07.026</pub-id><?supplied-pmid 25195188?><pub-id pub-id-type="pmid">25195188</pub-id></mixed-citation></ref><ref id="B158"><label>158</label><mixed-citation publication-type="webpage"><collab>Centers for Disease Control and Prevention</collab>. <source>Fast Facts and Fact Sheets: Current Cigarette Smoking among Adults in the United States</source>. (<year>2017</year>). Available from: <uri xlink:type="simple" xlink:href="https://www.cdc.gov/tobacco/data_statistics/fact_sheets/adult_data/cig_smoking/">https://www.cdc.gov/tobacco/data_statistics/fact_sheets/adult_data/cig_smoking/</uri></mixed-citation></ref><ref id="B159"><label>159</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaplan</surname><given-names>RC</given-names></name><name><surname>Bangdiwala</surname><given-names>SI</given-names></name><name><surname>Barnhart</surname><given-names>JM</given-names></name><name><surname>Casta&#x000f1;eda</surname><given-names>SF</given-names></name><name><surname>Gellman</surname><given-names>MD</given-names></name><name><surname>Lee</surname><given-names>DJ</given-names></name><etal/></person-group>
<article-title>Smoking among U.S. Hispanic/Latino adults: the Hispanic Community Health Study/Study of Latinos</article-title>. <source>Am J Prev Med</source> (<year>2014</year>) <volume>46</volume>:<fpage>496</fpage>&#x02013;<lpage>506</lpage>.<pub-id pub-id-type="doi">10.1016/j.amepre.2014.01.014</pub-id><?supplied-pmid 24745640?><pub-id pub-id-type="pmid">24745640</pub-id></mixed-citation></ref><ref id="B160"><label>160</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>Y</given-names></name><name><surname>Tucker</surname><given-names>P</given-names></name><name><surname>Okoro</surname><given-names>CA</given-names></name><name><surname>Giles</surname><given-names>WH</given-names></name><name><surname>Mokdad</surname><given-names>AH</given-names></name><name><surname>Harris</surname><given-names>VB</given-names></name><etal/></person-group>
<article-title>REACH 2010 surveillance for health status in minority communities &#x02013; United States, 2001&#x02013;2002</article-title>. <source>MMWR Surveill Summ</source> (<year>2004</year>) <volume>53</volume>:<fpage>1</fpage>&#x02013;<lpage>36</lpage>.</mixed-citation></ref><ref id="B161"><label>161</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merchant</surname><given-names>G</given-names></name><name><surname>Buelna</surname><given-names>C</given-names></name><name><surname>Casta&#x000f1;eda</surname><given-names>SF</given-names></name><name><surname>Arredondo</surname><given-names>EM</given-names></name><name><surname>Marshall</surname><given-names>SJ</given-names></name><name><surname>Strizich</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Accelerometer-measured sedentary time among Hispanic adults: results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)</article-title>. <source>Prev Med Rep</source> (<year>2015</year>) <volume>2</volume>:<fpage>845</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="doi">10.1016/j.pmedr.2015.09.019</pub-id><?supplied-pmid 26844159?><pub-id pub-id-type="pmid">26844159</pub-id></mixed-citation></ref><ref id="B162"><label>162</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siega-Riz</surname><given-names>AM</given-names></name><name><surname>Sotres-Alvarez</surname><given-names>D</given-names></name><name><surname>Ayala</surname><given-names>GX</given-names></name><name><surname>Ginsberg</surname><given-names>M</given-names></name><name><surname>Himes</surname><given-names>JH</given-names></name><name><surname>Liu</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Food-group and nutrient-density intakes by Hispanic and Latino backgrounds in the Hispanic Community Health Study/Study of Latinos</article-title>. <source>Am J Clin Nutr</source> (<year>2014</year>) <volume>99</volume>:<fpage>1487</fpage>&#x02013;<lpage>98</lpage>.<pub-id pub-id-type="doi">10.3945/ajcn.113.082685</pub-id><?supplied-pmid 24760972?><pub-id pub-id-type="pmid">24760972</pub-id></mixed-citation></ref><ref id="B163"><label>163</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattei</surname><given-names>J</given-names></name><name><surname>Sotres-Alvarez</surname><given-names>D</given-names></name><name><surname>Daviglus</surname><given-names>ML</given-names></name><name><surname>Gallo</surname><given-names>LC</given-names></name><name><surname>Gellman</surname><given-names>M</given-names></name><name><surname>Hu</surname><given-names>FB</given-names></name><etal/></person-group>
<article-title>Diet quality and its association with cardiometabolic risk factors vary by Hispanic and Latino ethnic background in the Hispanic Community Health Study/Study of Latinos</article-title>. <source>J Nutr</source> (<year>2016</year>) <volume>146</volume>:<fpage>2035</fpage>&#x02013;<lpage>44</lpage>.<pub-id pub-id-type="doi">10.3945/jn.116.231209</pub-id><?supplied-pmid 27605403?><pub-id pub-id-type="pmid">27605403</pub-id></mixed-citation></ref><ref id="B164"><label>164</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corsino</surname><given-names>L</given-names></name><name><surname>Sotres-Alvarez</surname><given-names>D</given-names></name><name><surname>Butera</surname><given-names>NM</given-names></name><name><surname>Siega-Riz</surname><given-names>AM</given-names></name><name><surname>Palacios</surname><given-names>C</given-names></name><name><surname>P&#x000e9;rez</surname><given-names>CM</given-names></name><etal/></person-group>
<article-title>Association of the DASH dietary pattern with insulin resistance and diabetes in U.S. Hispanic/Latino adults: results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)</article-title>. <source>BMJ Open Diabetes Res Care</source> (<year>2017</year>) <volume>5</volume>:<fpage>e000402</fpage><pub-id pub-id-type="doi">10.1136/bmjdrc-2017-000402</pub-id></mixed-citation></ref><ref id="B165"><label>165</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berm&#x000fa;dez</surname><given-names>OI</given-names></name><name><surname>Tucker</surname><given-names>KL</given-names></name></person-group>
<article-title>Trends in dietary patterns in Latin American populations</article-title>. <source>Cad Saude Publica</source> (<year>2003</year>) <volume>19</volume>(<issue>Suppl 1</issue>):<fpage>S87</fpage>&#x02013;<lpage>99</lpage>.<pub-id pub-id-type="doi">10.1590/S0102-311X2003000700010</pub-id><pub-id pub-id-type="pmid">12886439</pub-id></mixed-citation></ref><ref id="B166"><label>166</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattei</surname><given-names>J</given-names></name><name><surname>Malik</surname><given-names>V</given-names></name><name><surname>Wedick</surname><given-names>NM</given-names></name><name><surname>Hu</surname><given-names>FB</given-names></name><name><surname>Spiegelman</surname><given-names>D</given-names></name><name><surname>Willett</surname><given-names>WC</given-names></name><etal/></person-group>
<article-title>Reducing the global burden of type 2 diabetes by improving the quality of staple foods: the global nutrition and epidemiologic transition initiative</article-title>. <source>Global Health</source> (<year>2015</year>) <volume>11</volume>:<fpage>23</fpage>.<pub-id pub-id-type="doi">10.1186/s12992-015-0109-9</pub-id><?supplied-pmid 26040275?><pub-id pub-id-type="pmid">26040275</pub-id></mixed-citation></ref><ref id="B167"><label>167</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimmet</surname><given-names>P</given-names></name><name><surname>Alberti</surname><given-names>KG</given-names></name><name><surname>Shaw</surname><given-names>J</given-names></name></person-group>. <article-title>Global and societal implications of the diabetes epidemic</article-title>. <source>Nature</source> (<year>2001</year>) <volume>414</volume>:<fpage>782</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1038/414782a</pub-id><?supplied-pmid 11742409?><pub-id pub-id-type="pmid">11742409</pub-id></mixed-citation></ref><ref id="B168"><label>168</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carrera Boada</surname><given-names>CA</given-names></name><name><surname>Mart&#x000ed;nez-Moreno</surname><given-names>JM</given-names></name></person-group>
<article-title>Pathophysiology of diabetes mellitus type 2: beyond the duo &#x0201c;insulin resistance-secretion deficit&#x0201d;</article-title>. <source>Nutr Hosp</source> (<year>2013</year>) <volume>28</volume>(<issue>Suppl 2</issue>):<fpage>78</fpage>&#x02013;<lpage>87</lpage>.<pub-id pub-id-type="doi">10.3305/nh.2013.28.sup2.6717</pub-id></mixed-citation></ref><ref id="B169"><label>169</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeFronzo</surname><given-names>RA</given-names></name></person-group>
<article-title>Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus</article-title>. <source>Diabetes</source> (<year>2009</year>) <volume>58</volume>:<fpage>773</fpage>&#x02013;<lpage>95</lpage>.<pub-id pub-id-type="doi">10.2337/db09-9028</pub-id><pub-id pub-id-type="pmid">19336687</pub-id></mixed-citation></ref><ref id="B170"><label>170</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hotamisligil</surname><given-names>GS</given-names></name></person-group>. <article-title>Inflammation, metaflammation, and immunometabolic disorders</article-title>. <source>Nature</source> (<year>2017</year>) <volume>542</volume>:<fpage>177</fpage>&#x02013;<lpage>85</lpage>.<pub-id pub-id-type="doi">10.1038/nature21363</pub-id><?supplied-pmid 28179656?><pub-id pub-id-type="pmid">28179656</pub-id></mixed-citation></ref><ref id="B171"><label>171</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fonseca</surname><given-names>FA</given-names></name><name><surname>Izar</surname><given-names>MC</given-names></name></person-group>. <article-title>High-sensitivity C-reactive protein and cardiovascular disease across countries and ethnicities</article-title>. <source>Clinics (Sao Paulo)</source> (<year>2016</year>) <volume>71</volume>:<fpage>235</fpage>&#x02013;<lpage>42</lpage>.<pub-id pub-id-type="doi">10.6061/clinics/2016(04)11</pub-id><?supplied-pmid 27166776?><pub-id pub-id-type="pmid">27166776</pub-id></mixed-citation></ref><ref id="B172"><label>172</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stern</surname><given-names>MP</given-names></name><name><surname>Gaskill</surname><given-names>SP</given-names></name><name><surname>Hazuda</surname><given-names>HP</given-names></name><name><surname>Gardner</surname><given-names>LI</given-names></name><name><surname>Haffner</surname><given-names>SM</given-names></name></person-group>. <article-title>Does obesity explain excess prevalence of diabetes among Mexican Americans? Results of the San Antonio Heart Study</article-title>. <source>Diabetologia</source> (<year>1983</year>) <volume>24</volume>:<fpage>272</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1007/BF00282712</pub-id><?supplied-pmid 6862133?><pub-id pub-id-type="pmid">6862133</pub-id></mixed-citation></ref><ref id="B173"><label>173</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Everhart</surname><given-names>JE</given-names></name><name><surname>Pettitt</surname><given-names>DJ</given-names></name><name><surname>Bennett</surname><given-names>PH</given-names></name><name><surname>Knowler</surname><given-names>WC</given-names></name></person-group>. <article-title>Duration of obesity increases the incidence of NIDDM</article-title>. <source>Diabetes</source> (<year>1992</year>) <volume>41</volume>:<fpage>235</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="doi">10.2337/diabetes.41.2.235</pub-id><?supplied-pmid 1733815?><pub-id pub-id-type="pmid">1733815</pub-id></mixed-citation></ref><ref id="B174"><label>174</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janssen</surname><given-names>A</given-names></name><name><surname>Katzmarzyk</surname><given-names>PT</given-names></name><name><surname>Ross</surname><given-names>R</given-names></name></person-group>
<article-title>Duration of obesity and metabolic health risk in American men and women</article-title>. <source>Ann Epidemiol</source> (<year>2004</year>) <volume>14</volume>:<fpage>585</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="doi">10.1016/j.annepidem.2004.01.007</pub-id><pub-id pub-id-type="pmid">15350959</pub-id></mixed-citation></ref><ref id="B175"><label>175</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Attard</surname><given-names>SM</given-names></name><name><surname>Herring</surname><given-names>AH</given-names></name><name><surname>Howard</surname><given-names>AG</given-names></name><name><surname>Gordon-Larsen</surname><given-names>P</given-names></name></person-group>. <article-title>Longitudinal trajectories of BMI and cardiovascular disease risk: the National Longitudinal Study of Adolescent Health</article-title>. <source>Obesity</source> (<year>2013</year>) <volume>21</volume>:<fpage>2180</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1002/oby.20569</pub-id><?supplied-pmid 24136924?><pub-id pub-id-type="pmid">24136924</pub-id></mixed-citation></ref><ref id="B176"><label>176</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>L&#x000f3;pez-Vel&#x000e1;zquez</surname><given-names>JA</given-names></name><name><surname>Silva-Vidal</surname><given-names>KV</given-names></name><name><surname>Ponciano-Rodr&#x000ed;guez</surname><given-names>G</given-names></name><name><surname>Ch&#x000e1;vez-Tapia</surname><given-names>NC</given-names></name><name><surname>Arrese</surname><given-names>M</given-names></name><name><surname>Uribe</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>The prevalence of nonalcoholic fatty liver disease in the Americas</article-title>. <source>Ann Hepatol</source> (<year>2014</year>) <volume>13</volume>:<fpage>166</fpage>&#x02013;<lpage>78</lpage>.<?supplied-pmid 24552858?><pub-id pub-id-type="pmid">24552858</pub-id></mixed-citation></ref><ref id="B177"><label>177</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lazo</surname><given-names>M</given-names></name><name><surname>Bilal</surname><given-names>U</given-names></name><name><surname>Perez-Escamilla</surname><given-names>R</given-names></name></person-group>. <article-title>Epidemiology of NAFLD and type 2 diabetes: health disparities among persons of Hispanic origin</article-title>. <source>Curr Diab Rep</source> (<year>2015</year>) <volume>15</volume>:<fpage>116</fpage>.<pub-id pub-id-type="doi">10.1007/s11892-015-0674-6</pub-id><?supplied-pmid 26468154?><pub-id pub-id-type="pmid">26468154</pub-id></mixed-citation></ref><ref id="B178"><label>178</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorenzo</surname><given-names>C</given-names></name><name><surname>Hazuda</surname><given-names>HP</given-names></name><name><surname>Haffner</surname><given-names>SM</given-names></name></person-group>. <article-title>Insulin resistance and excess risk of diabetes in Mexican-Americans: the San Antonio Heart Study</article-title>. <source>J Clin Endocrinol Metab</source> (<year>2012</year>) <volume>97</volume>:<fpage>793</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1210/jc.2011-2272</pub-id><?supplied-pmid 22174423?><pub-id pub-id-type="pmid">22174423</pub-id></mixed-citation></ref><ref id="B179"><label>179</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunt</surname><given-names>KJ</given-names></name><name><surname>Williams</surname><given-names>K</given-names></name><name><surname>Resendez</surname><given-names>RG</given-names></name><name><surname>Hazuda</surname><given-names>HP</given-names></name><name><surname>Haffner</surname><given-names>SM</given-names></name><name><surname>Stern</surname><given-names>MP</given-names></name></person-group>
<article-title>All-cause and cardiovascular mortality among diabetic participants in the San Antonio Heart Study: evidence against the &#x0201c;Hispanic Paradox&#x0201d;</article-title>. <source>DiabetesCare</source> (<year>2002</year>) <volume>25</volume>:<fpage>1557</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="doi">10.2337/diacare.25.9.1557</pub-id></mixed-citation></ref><ref id="B180"><label>180</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caballero</surname><given-names>AE</given-names></name><name><surname>Bousquet-Santos</surname><given-names>K</given-names></name><name><surname>Robles-Osorio</surname><given-names>L</given-names></name><name><surname>Montagnani</surname><given-names>V</given-names></name><name><surname>Soodini</surname><given-names>G</given-names></name><name><surname>Porramatikul</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Overweight Latino children and adolescents have marked endothelial dysfunction and subclinical vascular inflammation in association with excess body fat and insulin resistance</article-title>. <source>Diabetes Care</source> (<year>2008</year>) <volume>31</volume>:<fpage>576</fpage>&#x02013;<lpage>82</lpage>.<pub-id pub-id-type="doi">10.2337/dc07-1540</pub-id><pub-id pub-id-type="pmid">18083792</pub-id></mixed-citation></ref><ref id="B181"><label>181</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendivil</surname><given-names>CO</given-names></name><name><surname>Robles-Osorio</surname><given-names>L</given-names></name><name><surname>Horton</surname><given-names>ES</given-names></name><name><surname>Hamdy</surname><given-names>O</given-names></name><name><surname>Caballero</surname><given-names>AE</given-names></name></person-group>. <article-title>Young Hispanics at risk of type 2 diabetes display endothelial activation, subclinical inflammation and alterations of coagulation and fibrinolysis</article-title>. <source>Diabetol MetabSyndr</source> (<year>2013</year>) <volume>5</volume>:<fpage>37</fpage>.<pub-id pub-id-type="doi">10.1186/1758-5996-5-37</pub-id><?supplied-pmid 23870459?><pub-id pub-id-type="pmid">23870459</pub-id></mixed-citation></ref><ref id="B182"><label>182</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Festa</surname><given-names>A</given-names></name><name><surname>Hanley</surname><given-names>AJ</given-names></name><name><surname>Tracy</surname><given-names>RP</given-names></name><name><surname>D&#x02019;Agostino</surname><given-names>R</given-names><suffix>Jr</suffix></name><name><surname>Haffner</surname><given-names>SM</given-names></name></person-group>. <article-title>Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion</article-title>. <source>Circulation</source> (<year>2003</year>) <volume>108</volume>:<fpage>1822</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="doi">10.1161/01.CIR.0000091339.70120.53</pub-id><?supplied-pmid 14517163?><pub-id pub-id-type="pmid">14517163</pub-id></mixed-citation></ref><ref id="B183"><label>183</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>RC</given-names></name><name><surname>Davy</surname><given-names>KP</given-names></name><name><surname>Hickey</surname><given-names>MS</given-names></name><name><surname>Melby</surname><given-names>CL</given-names></name></person-group>. <article-title>Circulating tumor necrosis factor alpha is higher in non-obese, non-diabetic Mexican Americans compared to non-Hispanic white adults</article-title>. <source>Cytokine</source> (<year>2005</year>) <volume>30</volume>:<fpage>14</fpage>&#x02013;<lpage>21</lpage>.<pub-id pub-id-type="doi">10.1016/j.cyto.2004.10.015</pub-id><?supplied-pmid 15784408?><pub-id pub-id-type="pmid">15784408</pub-id></mixed-citation></ref><ref id="B184"><label>184</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huffman</surname><given-names>FG</given-names></name><name><surname>Gomez</surname><given-names>GP</given-names></name><name><surname>Zarini</surname><given-names>GG</given-names></name></person-group>. <article-title>Metabolic syndrome and high-sensitivity C-reactive protein in Cubans</article-title>. <source>Ethn Dis</source> (<year>2009</year>) <volume>19</volume>:<fpage>115</fpage>&#x02013;<lpage>20</lpage>.<?supplied-pmid 19537220?><pub-id pub-id-type="pmid">19537220</pub-id></mixed-citation></ref><ref id="B185"><label>185</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reyes</surname><given-names>M</given-names></name><name><surname>Gahagan</surname><given-names>S</given-names></name><name><surname>D&#x000ed;az</surname><given-names>E</given-names></name><name><surname>Blanco</surname><given-names>E</given-names></name><name><surname>Leiva</surname><given-names>L</given-names></name><name><surname>Lera</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>Relationship of adiposity and insulin resistance mediated by inflammation in a group of overweight and obese Chilean adolescents</article-title>. <source>Nutr J</source> (<year>2011</year>) <volume>10</volume>:<fpage>4</fpage>.<pub-id pub-id-type="doi">10.1186/1475-2891-10-4</pub-id><?supplied-pmid 21235793?><pub-id pub-id-type="pmid">21235793</pub-id></mixed-citation></ref><ref id="B186"><label>186</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McFarlin</surname><given-names>BK</given-names></name><name><surname>Johnson</surname><given-names>CA</given-names></name><name><surname>Moreno</surname><given-names>JP</given-names></name><name><surname>Foreyt</surname><given-names>JP</given-names></name></person-group>. <article-title>Mexican American children have differential elevation of metabolic biomarkers proportional to obesity status</article-title>. <source>J Pediatr Gastroenterol Nutr</source> (<year>2013</year>) <volume>57</volume>:<fpage>718</fpage>&#x02013;<lpage>21</lpage>.<pub-id pub-id-type="doi">10.1097/MPG.0b013e3182a6993d</pub-id><?supplied-pmid 23945313?><pub-id pub-id-type="pmid">23945313</pub-id></mixed-citation></ref><ref id="B187"><label>187</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x000e9;rez</surname><given-names>CM</given-names></name><name><surname>Ortiz</surname><given-names>AP</given-names></name><name><surname>Fuentes-Mattei</surname><given-names>E</given-names></name><name><surname>Vel&#x000e1;zquez-Torres</surname><given-names>G</given-names></name><name><surname>Santiago</surname><given-names>D</given-names></name><name><surname>Giovannetti</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>High prevalence of cardiometabolic risk factors in Hispanic adolescents: correlations with adipocytokines and markers of inflammation</article-title>. <source>J Immigr Minor Health</source> (<year>2014</year>) <volume>16</volume>:<fpage>865</fpage>&#x02013;<lpage>73</lpage>.<pub-id pub-id-type="doi">10.1007/s10903-013-9866-9</pub-id><?supplied-pmid 23828626?><pub-id pub-id-type="pmid">23828626</pub-id></mixed-citation></ref><ref id="B188"><label>188</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weinstock</surname><given-names>RS</given-names></name><name><surname>Drews</surname><given-names>KL</given-names></name><name><surname>Caprio</surname><given-names>S</given-names></name><name><surname>Leibel</surname><given-names>NI</given-names></name><name><surname>McKay</surname><given-names>SV</given-names></name><name><surname>Zeitler</surname><given-names>PS</given-names></name><etal/></person-group>
<article-title>Metabolic syndrome is common and persistent in youth-onset type 2 diabetes: results from the TODAY clinical trial</article-title>. <source>Obesity</source> (<year>2015</year>) <volume>23</volume>:<fpage>1357</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="doi">10.1002/oby.21120</pub-id><?supplied-pmid 26047470?><pub-id pub-id-type="pmid">26047470</pub-id></mixed-citation></ref><ref id="B189"><label>189</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parrinello</surname><given-names>CM</given-names></name><name><surname>Hua</surname><given-names>S</given-names></name><name><surname>Carnethon</surname><given-names>MR</given-names></name><name><surname>Gallo</surname><given-names>LC</given-names></name><name><surname>Hudson</surname><given-names>BI</given-names></name><name><surname>Goldberg</surname><given-names>RB</given-names></name><etal/></person-group>
<article-title>Associations of hyperglycemia and insulin resistance with biomarkers of endothelial dysfunction in Hispanic/Latino youths: results from the Hispanic Community Children&#x02019;s Health Study/Study of Latino Youth (SOL Youth)</article-title>. <source>J Diabetes Complications</source> (<year>2017</year>) <volume>31</volume>:<fpage>836</fpage>&#x02013;<lpage>42</lpage>.<pub-id pub-id-type="doi">10.1016/j.jdiacomp.2017.01.019</pub-id><?supplied-pmid 28242270?><pub-id pub-id-type="pmid">28242270</pub-id></mixed-citation></ref><ref id="B190"><label>190</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kocarnik</surname><given-names>JM</given-names></name><name><surname>Pendergrass</surname><given-names>SA</given-names></name><name><surname>Carty</surname><given-names>CL</given-names></name><name><surname>Pankow</surname><given-names>JS</given-names></name><name><surname>Schumacher</surname><given-names>FR</given-names></name><name><surname>Cheng</surname><given-names>I</given-names></name><etal/></person-group>
<article-title>Multiancestral analysis of inflammation-related genetic variants and C-reactive protein in the population architecture using genomics and epidemiology study</article-title>. <source>Circ Cardiovasc Genet</source> (<year>2014</year>) <volume>7</volume>:<fpage>178</fpage>&#x02013;<lpage>88</lpage>.<pub-id pub-id-type="doi">10.1161/CIRCGENETICS.113.000173</pub-id><?supplied-pmid 24622110?><pub-id pub-id-type="pmid">24622110</pub-id></mixed-citation></ref><ref id="B191"><label>191</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kulick</surname><given-names>ER</given-names></name><name><surname>Moon</surname><given-names>YP</given-names></name><name><surname>Cheung</surname><given-names>K</given-names></name><name><surname>Willey</surname><given-names>JZ</given-names></name><name><surname>Sacco</surname><given-names>RL</given-names></name><name><surname>Elkind</surname><given-names>MS</given-names></name></person-group>. <article-title>Racial-ethnic disparities in the association between risk factors and diabetes: the Northern Manhattan Study</article-title>. <source>Prev Med</source> (<year>2016</year>) <volume>83</volume>:<fpage>31</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1016/j.ypmed.2015.11.023</pub-id><?supplied-pmid 26658025?><pub-id pub-id-type="pmid">26658025</pub-id></mixed-citation></ref><ref id="B192"><label>192</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenbaum</surname><given-names>M</given-names></name><name><surname>Fennoy</surname><given-names>I</given-names></name><name><surname>Accacha</surname><given-names>S</given-names></name><name><surname>Altshuler</surname><given-names>L</given-names></name><name><surname>Carey</surname><given-names>DE</given-names></name><name><surname>Holleran</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Racial/ethnic differences in clinical and biochemical type 2 diabetes mellitus risk factors in children</article-title>. <source>Obesity</source> (<year>2013</year>) <volume>21</volume>:<fpage>2081</fpage>&#x02013;<lpage>90</lpage>.<pub-id pub-id-type="doi">10.1002/oby.20483</pub-id><?supplied-pmid 23596082?><pub-id pub-id-type="pmid">23596082</pub-id></mixed-citation></ref><ref id="B193"><label>193</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avil&#x000e9;s-Santa</surname><given-names>ML</given-names></name><name><surname>Salinas</surname><given-names>K</given-names></name><name><surname>Huet-Adams</surname><given-names>K</given-names></name><name><surname>Raskin</surname><given-names>P</given-names></name></person-group>. <article-title>Insulin therapy, glycemic control, and cardiovascular risk factors in young Latin Americans with type 2 diabetes mellitus</article-title>. <source>J Investig Med</source> (<year>2006</year>) <volume>54</volume>:<fpage>20</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="doi">10.2310/6650.2005.05012</pub-id><?supplied-pmid 16409887?><pub-id pub-id-type="pmid">16409887</pub-id></mixed-citation></ref><ref id="B194"><label>194</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mirza</surname><given-names>S</given-names></name><name><surname>Hossain</surname><given-names>M</given-names></name><name><surname>Mathews</surname><given-names>C</given-names></name><name><surname>Martinez</surname><given-names>P</given-names></name><name><surname>Pino</surname><given-names>P</given-names></name><name><surname>Gay</surname><given-names>JL</given-names></name><etal/></person-group>
<article-title>Type 2-diabetes is associated with elevated levels of TNF-alpha, IL-6 and adiponectin and low levels of leptin in a population of Mexican Americans: a cross-sectional study</article-title>. <source>Cytokine</source> (<year>2012</year>) <volume>57</volume>:<fpage>136</fpage>&#x02013;<lpage>42</lpage>.<pub-id pub-id-type="doi">10.1016/j.cyto.2011.09.029</pub-id><?supplied-pmid 22035595?><pub-id pub-id-type="pmid">22035595</pub-id></mixed-citation></ref><ref id="B195"><label>195</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kayser</surname><given-names>BD</given-names></name><name><surname>Toledo-Corral</surname><given-names>CM</given-names></name><name><surname>Alderete</surname><given-names>TL</given-names></name><name><surname>Weigensberg</surname><given-names>MJ</given-names></name><name><surname>Goran</surname><given-names>MI</given-names></name></person-group>. <article-title>Temporal relationships between adipocytokines and diabetes risk in Hispanic adolescents with obesity</article-title>. <source>Obesity</source> (<year>2015</year>) <volume>23</volume>:<fpage>1479</fpage>&#x02013;<lpage>85</lpage>.<pub-id pub-id-type="doi">10.1002/oby.21128</pub-id><?supplied-pmid 26046253?><pub-id pub-id-type="pmid">26046253</pub-id></mixed-citation></ref><ref id="B196"><label>196</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pereira</surname><given-names>RI</given-names></name><name><surname>Low Wang</surname><given-names>CC</given-names></name><name><surname>Wolfe</surname><given-names>P</given-names></name><name><surname>Havranek</surname><given-names>EP</given-names></name><name><surname>Long</surname><given-names>CS</given-names></name><name><surname>Bessesen</surname><given-names>DH</given-names></name></person-group>. <article-title>Associations of adiponectin with adiposity, insulin sensitivity, and diet in young, healthy, Mexican Americans and non-Latino white adults</article-title>. <source>Int J EnvironRes Public Health</source> (<year>2015</year>) <volume>13</volume>:<fpage>ijerh13010054</fpage>.<pub-id pub-id-type="doi">10.3390/ijerph13010054</pub-id><?supplied-pmid 26703682?><pub-id pub-id-type="pmid">26703682</pub-id></mixed-citation></ref><ref id="B197"><label>197</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanley</surname><given-names>AJ</given-names></name><name><surname>Bowden</surname><given-names>D</given-names></name><name><surname>Wagenknecht</surname><given-names>LE</given-names></name><name><surname>Balasubramanyam</surname><given-names>A</given-names></name><name><surname>Langfeld</surname><given-names>C</given-names></name><name><surname>Saad</surname><given-names>MF</given-names></name><etal/></person-group>
<article-title>Associations of adiponectin with body fat distribution and insulin sensitivity in nondiabetic Hispanics and African-Americans</article-title>. <source>J Clin Endocrinol Metab</source> (<year>2007</year>) <volume>92</volume>:<fpage>2665</fpage>&#x02013;<lpage>71</lpage>.<pub-id pub-id-type="doi">10.1210/jc.2006-2614</pub-id><?supplied-pmid 17426091?><pub-id pub-id-type="pmid">17426091</pub-id></mixed-citation></ref><ref id="B198"><label>198</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koebnick</surname><given-names>C</given-names></name><name><surname>Roberts</surname><given-names>CK</given-names></name><name><surname>Shaibi</surname><given-names>GQ</given-names></name><name><surname>Kelly</surname><given-names>LA</given-names></name><name><surname>Lane</surname><given-names>CJ</given-names></name><name><surname>Toledo-Corral</surname><given-names>CM</given-names></name><etal/></person-group>
<article-title>Adiponectin and leptin are independently associated with insulin sensitivity, but not with insulin secretion or beta-cell function in overweight Hispanic adolescents</article-title>. <source>Horm Metab Res</source> (<year>2008</year>) <volume>40</volume>:<fpage>708</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="doi">10.1055/s-2008-1077097</pub-id><?supplied-pmid 18563679?><pub-id pub-id-type="pmid">18563679</pub-id></mixed-citation></ref><ref id="B199"><label>199</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanley</surname><given-names>AJ</given-names></name><name><surname>Wagenknecht</surname><given-names>LE</given-names></name><name><surname>Norris</surname><given-names>JM</given-names></name><name><surname>Bergman</surname><given-names>R</given-names></name><name><surname>Anderson</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>YI</given-names></name><etal/></person-group>
<article-title>Adiponectin and the incidence of type 2 diabetes in Hispanics and African Americans: the IRAS Family Study</article-title>. <source>Diabetes Care</source> (<year>2011</year>) <volume>34</volume>:<fpage>2231</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.2337/dc11-0531</pub-id><?supplied-pmid 21816973?><pub-id pub-id-type="pmid">21816973</pub-id></mixed-citation></ref><ref id="B200"><label>200</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gardener</surname><given-names>H</given-names></name><name><surname>Crisby</surname><given-names>M</given-names></name><name><surname>Sjoberg</surname><given-names>C</given-names></name><name><surname>Hudson</surname><given-names>B</given-names></name><name><surname>Goldberg</surname><given-names>R</given-names></name><name><surname>Mendez</surname><given-names>AJ</given-names></name><etal/></person-group>
<article-title>Serum adiponectin in relation to race-ethnicity and vascular risk factors in the Northern Manhattan Study</article-title>. <source>Metab Syndr Relat Disord</source> (<year>2013</year>) <volume>11</volume>:<fpage>46</fpage>&#x02013;<lpage>55</lpage>.<pub-id pub-id-type="doi">10.1089/met.2012.0065</pub-id><?supplied-pmid 23127161?><pub-id pub-id-type="pmid">23127161</pub-id></mixed-citation></ref><ref id="B201"><label>201</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arslanian</surname><given-names>S</given-names></name><name><surname>El Ghormli</surname><given-names>L</given-names></name><name><surname>Bacha</surname><given-names>F</given-names></name><name><surname>Caprio</surname><given-names>S</given-names></name><name><surname>Goland</surname><given-names>R</given-names></name><name><surname>Haymond</surname><given-names>MW</given-names></name><etal/></person-group>
<article-title>Adiponectin, insulin sensitivity, &#x003b2;-cell function, and racial/ethnic disparity in treatment failure rates in TODAY</article-title>. <source>Diabetes Care</source> (<year>2017</year>) <volume>40</volume>:<fpage>85</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="doi">10.2337/dc16-0455</pub-id><pub-id pub-id-type="pmid">27803118</pub-id></mixed-citation></ref><ref id="B202"><label>202</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butte</surname><given-names>NF</given-names></name><name><surname>Cai</surname><given-names>G</given-names></name><name><surname>Cole</surname><given-names>SA</given-names></name><name><surname>Wilson</surname><given-names>TA</given-names></name><name><surname>Fisher</surname><given-names>JO</given-names></name><name><surname>Zakeri</surname><given-names>IF</given-names></name><etal/></person-group>
<article-title>Metabolic and behavioral predictors of weight gain in Hispanic children: the Viva la Familia Study</article-title>. <source>Am J Clin Nutr</source> (<year>2007</year>) <volume>85</volume>:<fpage>1478</fpage>&#x02013;<lpage>85</lpage>.<?supplied-pmid 17556682?><pub-id pub-id-type="pmid">17556682</pub-id></mixed-citation></ref><ref id="B203"><label>203</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mardones</surname><given-names>F</given-names></name><name><surname>Arnaiz</surname><given-names>P</given-names></name><name><surname>Pacheco</surname><given-names>P</given-names></name><name><surname>Dominguez</surname><given-names>A</given-names></name><name><surname>Villaroel</surname><given-names>L</given-names></name><name><surname>Eriksson</surname><given-names>JG</given-names></name><etal/></person-group>
<article-title>Associations of prenatal growth with metabolic syndrome, insulin resistance, and nutritional status in Chilean children</article-title>. <source>Biomed Res Int</source> (<year>2014</year>) <volume>2014</volume>:<fpage>472017</fpage>.<pub-id pub-id-type="doi">10.1155/2014/472017</pub-id><?supplied-pmid 25025054?><pub-id pub-id-type="pmid">25025054</pub-id></mixed-citation></ref><ref id="B204"><label>204</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monteiro</surname><given-names>LJ</given-names></name><name><surname>Norman</surname><given-names>JE</given-names></name><name><surname>Rice</surname><given-names>GE</given-names></name><name><surname>Illanes</surname><given-names>SE</given-names></name></person-group>. <article-title>Fetal programming and gestational diabetes mellitus</article-title>. <source>Placenta</source> (<year>2016</year>) <volume>30</volume>:<fpage>S54</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="doi">10.1016/j.placenta.2015.11.015</pub-id><?supplied-pmid 26724985?><pub-id pub-id-type="pmid">26724985</pub-id></mixed-citation></ref><ref id="B205"><label>205</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanguru</surname><given-names>L</given-names></name><name><surname>Bezawada</surname><given-names>N</given-names></name><name><surname>Hussein</surname><given-names>J</given-names></name><name><surname>Bell</surname><given-names>J</given-names></name></person-group>
<article-title>The burden of diabetes mellitus during pregnancy in low- and middle-income countries: a systematic review</article-title>. <source>Glob Health Action</source> (<year>2014</year>) <volume>7</volume>:<fpage>23987</fpage><pub-id pub-id-type="doi">10.3402/gha.v7.23987</pub-id></mixed-citation></ref><ref id="B206"><label>206</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crume</surname><given-names>TL</given-names></name><name><surname>Ogden</surname><given-names>L</given-names></name><name><surname>Daniels</surname><given-names>S</given-names></name><name><surname>Hamman</surname><given-names>RF</given-names></name><name><surname>Norris</surname><given-names>JM</given-names></name><name><surname>Dabelea</surname><given-names>D</given-names></name></person-group>. <article-title>The impact of in utero exposure to diabetes on childhood body mass index growth trajectories: the EPOCH Study</article-title>. <source>J Pediatr</source> (<year>2011</year>) <volume>158</volume>:<fpage>941</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1016/j.jpeds.2010.12.007</pub-id><?supplied-pmid 21238981?><pub-id pub-id-type="pmid">21238981</pub-id></mixed-citation></ref><ref id="B207"><label>207</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>TR</given-names></name></person-group>. <article-title>Fetal exposure to gestational diabetes contributes to subsequent adult metabolic syndrome</article-title>. <source>Am J Obstet Gynecol</source> (<year>2010</year>) <volume>202</volume>:<fpage>643</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/j.ajog.2010.02.059</pub-id><?supplied-pmid 20430355?><pub-id pub-id-type="pmid">20430355</pub-id></mixed-citation></ref><ref id="B208"><label>208</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>P</given-names></name><name><surname>Liu</surname><given-names>E</given-names></name><name><surname>Qiao</surname><given-names>Y</given-names></name><name><surname>Katzmarzyk</surname><given-names>PT</given-names></name><name><surname>Chaput</surname><given-names>JP</given-names></name><name><surname>Fogelholm</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Maternal gestational diabetes and childhood obesity at age 9-11: results from a multinational study</article-title>. <source>Diabetologia</source> (<year>2016</year>) <volume>59</volume>:<fpage>2339</fpage>&#x02013;<lpage>48</lpage>.<pub-id pub-id-type="doi">10.1007/s00125-016-4062-9</pub-id><pub-id pub-id-type="pmid">27510911</pub-id></mixed-citation></ref><ref id="B209"><label>209</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jim&#x000e9;nez-Cruz</surname><given-names>A</given-names></name><name><surname>Ortega-Cisneros</surname><given-names>A</given-names></name><name><surname>Bacard&#x000ed;-Gasc&#x000f3;n</surname><given-names>M</given-names></name></person-group>
<article-title>Efecto de la diabetes gestacional sobre los indicadores de adiposidad en los primeros 18 a&#x000f1;os: Revisi&#x000f3;n sistem&#x000e1;tica</article-title>. <source>Nutr Hosp</source> (<year>2014</year>) <volume>29</volume>:<fpage>397</fpage>&#x02013;<lpage>401</lpage>.<pub-id pub-id-type="doi">10.3305/nh.2014.29.2.7042</pub-id><pub-id pub-id-type="pmid">24528360</pub-id></mixed-citation></ref><ref id="B210"><label>210</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>JN</given-names></name><name><surname>Gunderson</surname><given-names>EP</given-names></name><name><surname>Gyllenhammer</surname><given-names>LE</given-names></name><name><surname>Goran</surname><given-names>MI</given-names></name></person-group>. <article-title>Impact of gestational diabetes mellitus on pubertal changes in adiposity and metabolic profiles in Latino offspring</article-title>. <source>J Pediatr</source> (<year>2013</year>) <volume>162</volume>:<fpage>741</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1016/j.jpeds.2012.10.001</pub-id><?supplied-pmid 23149173?><pub-id pub-id-type="pmid">23149173</pub-id></mixed-citation></ref><ref id="B211"><label>211</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egeland</surname><given-names>GM</given-names></name><name><surname>Meltzer</surname><given-names>SJ</given-names></name></person-group>. <article-title>Following in mother&#x02019;s footsteps? Mother-daughter risks for insulin resistance and cardiovascular disease 15 years after gestational diabetes</article-title>. <source>Diabet Med</source> (<year>2010</year>) <volume>27</volume>:<fpage>257</fpage>&#x02013;<lpage>65</lpage>.<pub-id pub-id-type="doi">10.1111/j.1464-5491.2010.02944.x</pub-id><?supplied-pmid 20536487?><pub-id pub-id-type="pmid">20536487</pub-id></mixed-citation></ref><ref id="B212"><label>212</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Page</surname><given-names>KA</given-names></name><name><surname>Romero</surname><given-names>A</given-names></name><name><surname>Buchanan</surname><given-names>TA</given-names></name><name><surname>Xiang</surname><given-names>AH</given-names></name></person-group>. <article-title>Gestational diabetes mellitus, maternal obesity, and adiposity in offspring</article-title>. <source>J Pediatr</source> (<year>2014</year>) <volume>164</volume>:<fpage>807</fpage>&#x02013;<lpage>10</lpage>.<pub-id pub-id-type="doi">10.1016/j.jpeds.2013.11.063</pub-id><?supplied-pmid 24388326?><pub-id pub-id-type="pmid">24388326</pub-id></mixed-citation></ref><ref id="B213"><label>213</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silverman</surname><given-names>BL</given-names></name><name><surname>Metzger</surname><given-names>BE</given-names></name><name><surname>Cho</surname><given-names>NH</given-names></name><name><surname>Loeb</surname><given-names>CA</given-names></name></person-group>. <article-title>Impaired glucose tolerance in adolescent offspring of diabetic mothers: relationship to fetal hyperinsulinism</article-title>. <source>Diabetes Care</source> (<year>1995</year>) <volume>18</volume>:<fpage>611</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.2337/diacare.18.5.611</pub-id><?supplied-pmid 8585997?><pub-id pub-id-type="pmid">8585997</pub-id></mixed-citation></ref><ref id="B214"><label>214</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaarasmaki</surname><given-names>M</given-names></name><name><surname>Pouta</surname><given-names>A</given-names></name><name><surname>Elliot</surname><given-names>P</given-names></name><name><surname>Tapanainen</surname><given-names>P</given-names></name><name><surname>Sovio</surname><given-names>U</given-names></name><name><surname>Ruokonen</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Adolescent manifestations of metabolic syndrome among children born to women with gestational diabetes in a general-population birth cohort</article-title>. <source>Am J Epidemiol</source> (<year>2009</year>) <volume>169</volume>:<fpage>1209</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="doi">10.1093/aje/kwp020</pub-id><?supplied-pmid 19363101?><pub-id pub-id-type="pmid">19363101</pub-id></mixed-citation></ref><ref id="B215"><label>215</label><mixed-citation publication-type="journal"><collab>The HAPO Study Cooperative Research Group</collab>. <article-title>Hyperglycemia and adverse pregnancy outcomes</article-title>. <source>N Engl J Med</source> (<year>2008</year>) <volume>358</volume>:<fpage>1991</fpage>&#x02013;<lpage>2002</lpage>.<pub-id pub-id-type="doi">10.1056/NEJMoa0707943</pub-id><pub-id pub-id-type="pmid">18463375</pub-id></mixed-citation></ref><ref id="B216"><label>216</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moreli</surname><given-names>JB</given-names></name><name><surname>Corr&#x000ea;a-Silva</surname><given-names>S</given-names></name><name><surname>Damasceno</surname><given-names>DC</given-names></name><name><surname>Sinzato</surname><given-names>YK</given-names></name><name><surname>Lorenzon-Ojea</surname><given-names>AR</given-names></name><name><surname>Borbely</surname><given-names>AU</given-names></name><etal/></person-group>
<article-title>Changes in the TNF-alpha/IL-10 ratio in hyperglycemia-associated pregnancies</article-title>. <source>Diabetes Res Clin Pract</source> (<year>2015</year>) <volume>107</volume>:<fpage>362</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/j.diabres.2015.01.005</pub-id><?supplied-pmid 25648390?><pub-id pub-id-type="pmid">25648390</pub-id></mixed-citation></ref><ref id="B217"><label>217</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sobrevia</surname><given-names>L</given-names></name><name><surname>Salsoso</surname><given-names>R</given-names></name><name><surname>S&#x000e1;ez</surname><given-names>T</given-names></name><name><surname>Sanhueza</surname><given-names>C</given-names></name><name><surname>Pardo</surname><given-names>F</given-names></name><name><surname>Leiva</surname><given-names>A</given-names></name></person-group>. <article-title>Insulin therapy and fetoplacental vascular function in gestational diabetes mellitus</article-title>. <source>Exp Physiol</source> (<year>2015</year>) <volume>100</volume>:<fpage>231</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1113/expphysiol.2014.082743</pub-id><?supplied-pmid 25581778?><pub-id pub-id-type="pmid">25581778</pub-id></mixed-citation></ref><ref id="B218"><label>218</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salom&#x000f3;n</surname><given-names>C</given-names></name><name><surname>Westermeier</surname><given-names>F</given-names></name><name><surname>Puebla</surname><given-names>C</given-names></name><name><surname>Arroyo</surname><given-names>P</given-names></name><name><surname>Guzm&#x000e1;n-Guti&#x000e9;rrez</surname><given-names>E</given-names></name><name><surname>Pardo</surname><given-names>F</given-names></name><etal/></person-group>
<article-title>Gestational diabetes reduces adenosine transport in human placental microvascular endothelium, an effect reversed by insulin</article-title>. <source>PLoS One</source> (<year>2012</year>) <volume>7</volume>:<fpage>e40578</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0040578</pub-id><?supplied-pmid 22808198?><pub-id pub-id-type="pmid">22808198</pub-id></mixed-citation></ref><ref id="B219"><label>219</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hara Cde</surname><given-names>C</given-names></name><name><surname>Fran&#x000e7;a</surname><given-names>EL</given-names></name><name><surname>Fagundes</surname><given-names>DL</given-names></name><name><surname>de Queiroz</surname><given-names>AA</given-names></name><name><surname>Rudge</surname><given-names>MV</given-names></name><name><surname>Honorio-Fran&#x000e7;a</surname><given-names>AC</given-names></name><etal/></person-group>
<article-title>Characterization of natural killer cells and cytokines in maternal placenta and fetus of diabetic mothers</article-title>. <source>J Immunol Res</source> (<year>2016</year>) <volume>2016</volume>:<fpage>7154524</fpage>.<pub-id pub-id-type="doi">10.1155/2016/7154524</pub-id><?supplied-pmid 27294162?><pub-id pub-id-type="pmid">27294162</pub-id></mixed-citation></ref><ref id="B220"><label>220</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gallardo</surname><given-names>JM</given-names></name><name><surname>G&#x000f3;mez-L&#x000f3;pez</surname><given-names>J</given-names></name><name><surname>Medina-Bravo</surname><given-names>P</given-names></name><name><surname>Ju&#x000e1;rez-S&#x000e1;nchez</surname><given-names>F</given-names></name><name><surname>Contreras-Ramos</surname><given-names>A</given-names></name><name><surname>Galicia-Esquivel</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Maternal obesity increases oxidative stress in the newborn</article-title>. <source>Obesity</source> (<year>2015</year>) <volume>23</volume>:<fpage>1650</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1002/oby.21159</pub-id><?supplied-pmid 26193060?><pub-id pub-id-type="pmid">26193060</pub-id></mixed-citation></ref><ref id="B221"><label>221</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olmos</surname><given-names>PR</given-names></name><name><surname>Rigotti</surname><given-names>A</given-names></name><name><surname>Busso</surname><given-names>D</given-names></name><name><surname>Berkowitz</surname><given-names>L</given-names></name><name><surname>Santos</surname><given-names>JL</given-names></name><name><surname>Borzone</surname><given-names>GR</given-names></name><etal/></person-group>
<article-title>Maternal hypertriglyceridemia: a link between maternal overweight-obesity and macrosomia in gestational diabetes</article-title>. <source>Obesity</source> (<year>2014</year>) <volume>22</volume>:<fpage>2156</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="doi">10.1002/oby.20816</pub-id><?supplied-pmid 24957884?><pub-id pub-id-type="pmid">24957884</pub-id></mixed-citation></ref><ref id="B222"><label>222</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gelaleti</surname><given-names>RB</given-names></name><name><surname>Damasceno</surname><given-names>DC</given-names></name><name><surname>Lima</surname><given-names>PH</given-names></name><name><surname>Salvadori</surname><given-names>DM</given-names></name><name><surname>Calderon Ide</surname><given-names>M</given-names></name><name><surname>Pera&#x000e7;oli</surname><given-names>JC</given-names></name><etal/></person-group>
<article-title>Oxidative DNA damage in diabetic and mild gestational hyperglycemic pregnant women</article-title>. <source>Diabetol Metab Syndr</source> (<year>2015</year>) <volume>7</volume>:<fpage>1</fpage>.<pub-id pub-id-type="doi">10.1186/1758-5996-7-1</pub-id><?supplied-pmid 25810781?><pub-id pub-id-type="pmid">25810781</pub-id></mixed-citation></ref><ref id="B223"><label>223</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moreli</surname><given-names>JB</given-names></name><name><surname>Santos</surname><given-names>JH</given-names></name><name><surname>Lorenzon-Ojea</surname><given-names>AR</given-names></name><name><surname>Corr&#x000ea;a-Silva</surname><given-names>S</given-names></name><name><surname>Fortunato</surname><given-names>RS</given-names></name><name><surname>Rocha</surname><given-names>CR</given-names></name><etal/></person-group>
<article-title>Hyperglycemia differentially affects maternal and fetal DNA integrity and DNA damage response</article-title>. <source>Int J Biol Sci</source> (<year>2016</year>) <volume>12</volume>:<fpage>466</fpage>&#x02013;<lpage>77</lpage>.<pub-id pub-id-type="doi">10.7150/ijbs.12815</pub-id><?supplied-pmid 27019630?><pub-id pub-id-type="pmid">27019630</pub-id></mixed-citation></ref><ref id="B224"><label>224</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uwaezuoke</surname><given-names>SN</given-names></name></person-group>
<article-title>Childhood diabetes mellitus and the &#x0201c;double burden of malnutrition&#x0201d;: an emerging public health challenge in developing countries</article-title>. <source>J Diabetes Metab</source> (<year>2015</year>) <volume>6</volume>:<fpage>1000597</fpage><pub-id pub-id-type="doi">10.4172/2155-6156.1000597</pub-id></mixed-citation></ref><ref id="B225"><label>225</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hales</surname><given-names>CN</given-names></name><name><surname>Barker</surname><given-names>DJ</given-names></name></person-group>
<article-title>Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis</article-title>. <source>Diabetologia</source> (<year>1992</year>) <volume>35</volume>:<fpage>595</fpage>&#x02013;<lpage>601</lpage>.<pub-id pub-id-type="doi">10.1007/BF00400248</pub-id><pub-id pub-id-type="pmid">1644236</pub-id></mixed-citation></ref><ref id="B226"><label>226</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>AA</given-names></name><name><surname>Santos</surname><given-names>CJ</given-names></name><name><surname>Amigo</surname><given-names>H</given-names></name><name><surname>Barbieri</surname><given-names>MA</given-names></name><name><surname>Bustos</surname><given-names>P</given-names></name><name><surname>Bettiol</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>Birth weight, current body mass index, and insulin sensitivity and secretion in young adults in two Latin American populations</article-title>. <source>Nutr Metab Cardiovasc Dis</source> (<year>2012</year>) <volume>22</volume>:<fpage>533</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/j.numecd.2010.09.012</pub-id><?supplied-pmid 21543197?><pub-id pub-id-type="pmid">21543197</pub-id></mixed-citation></ref><ref id="B227"><label>227</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez-Barranco</surname><given-names>J</given-names></name><name><surname>Rios-Torres</surname><given-names>JM</given-names></name><name><surname>Castillo-Martinez</surname><given-names>L</given-names></name><name><surname>Lopez-Alvarenga</surname><given-names>JC</given-names></name><name><surname>Aguilar-Salinas</surname><given-names>CA</given-names></name><name><surname>Bouchard</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Effect of malnutrition during the first year of life on adult plasma insulin and glucose tolerance</article-title>. <source>Metabolism</source> (<year>2003</year>) <volume>52</volume>:<fpage>1005</fpage>&#x02013;<lpage>11</lpage>.<pub-id pub-id-type="doi">10.1016/S0026-0495(03)00151-3</pub-id><?supplied-pmid 12898465?><pub-id pub-id-type="pmid">12898465</pub-id></mixed-citation></ref><ref id="B228"><label>228</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Escaffi Fonseca</surname><given-names>MJ</given-names></name><name><surname>Moreira Carrasco</surname><given-names>L</given-names></name><name><surname>Rodr&#x000ed;guez Osiac</surname><given-names>L</given-names></name><name><surname>Pizarro Quevedo</surname><given-names>T</given-names></name><name><surname>Cavada Chac&#x000f3;n</surname><given-names>G</given-names></name><name><surname>Villaroel del Pino</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>Efectos de la desnutrici&#x000f3;n cal&#x000f3;rico-proteica temprana en el estado nutricional y atributos del s&#x000ed;ndrome metab&#x000f3;lico en una cohorte de adultos j&#x000f3;venes</article-title>. <source>Nutr Hosp</source> (<year>2015</year>) <volume>32</volume>:<fpage>1116</fpage>&#x02013;<lpage>21</lpage>.<pub-id pub-id-type="doi">10.3305/nh.2015.32.3.9395</pub-id><pub-id pub-id-type="pmid">26319828</pub-id></mixed-citation></ref><ref id="B229"><label>229</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sapunar</surname><given-names>J</given-names></name><name><surname>Bustos</surname><given-names>P</given-names></name><name><surname>S&#x000e1;ez</surname><given-names>K</given-names></name><name><surname>Mu&#x000f1;oz</surname><given-names>S</given-names></name><name><surname>Asenjo</surname><given-names>S</given-names></name></person-group>
<article-title>Efecto del estado nutricional neonatal en el riesgo de s&#x000ed;ndrome metab&#x000f3;lico en ni&#x000f1;os obesos de 2 comunas de la regi&#x000f3;n del B&#x000ed;o-B&#x000ed;o</article-title>. <source>Rev Med Chile</source> (<year>2014</year>) <volume>142</volume>:<fpage>1523</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.4067/S0034-98872014001200005</pub-id><pub-id pub-id-type="pmid">25693434</pub-id></mixed-citation></ref><ref id="B230"><label>230</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ram&#x000ed;rez-Silva</surname><given-names>I</given-names></name><name><surname>Rivera</surname><given-names>JA</given-names></name><name><surname>Trejo-Valdivia</surname><given-names>B</given-names></name><name><surname>Martorell</surname><given-names>R</given-names></name><name><surname>Stein</surname><given-names>AD</given-names></name><name><surname>Romieu</surname><given-names>I</given-names></name><etal/></person-group>
<article-title>Breastfeeding status at age 3 months is associated with adiposity and cardiometabolic markers at age 4 years in Mexican children</article-title>. <source>J Nutr</source> (<year>2015</year>) <volume>145</volume>:<fpage>1295</fpage>&#x02013;<lpage>302</lpage>.<pub-id pub-id-type="doi">10.3945/jn.114.198366</pub-id><?supplied-pmid 25926414?><pub-id pub-id-type="pmid">25926414</pub-id></mixed-citation></ref><ref id="B231"><label>231</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>da Luz Santos</surname><given-names>CD</given-names></name><name><surname>Clemente</surname><given-names>AP</given-names></name><name><surname>Martins</surname><given-names>VJ</given-names></name><name><surname>Albuquerque</surname><given-names>MP</given-names></name><name><surname>Sawaya</surname><given-names>AL</given-names></name></person-group>. <article-title>Adolescents with mild stunting show alterations in glucose and insulin metabolism</article-title>. <source>J Nutr Metab</source> (<year>2010</year>) <volume>2010</volume>:<fpage>943070</fpage>.<pub-id pub-id-type="doi">10.1155/2010/943070</pub-id><?supplied-pmid 21318152?><pub-id pub-id-type="pmid">21318152</pub-id></mixed-citation></ref><ref id="B232"><label>232</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Eko&#x000e9;</surname><given-names>JM</given-names></name><name><surname>Shipp</surname><given-names>J</given-names></name></person-group>
<article-title>Malnutrition-related diabetes mellitus: myth or reality</article-title>. In: <person-group person-group-type="editor"><name><surname>Eko&#x000e9;</surname><given-names>JM</given-names></name><name><surname>Zimmet</surname><given-names>P</given-names></name><name><surname>Williams</surname><given-names>R</given-names></name></person-group>, editors. <source>The Epidemiology of Diabetes Mellitus: An International Perspective</source>. <publisher-loc>Chichester, New York</publisher-loc>: <publisher-name>John Wiley</publisher-name> (<year>2001</year>). p. <fpage>263</fpage>&#x02013;<lpage>72</lpage>.</mixed-citation></ref><ref id="B233"><label>233</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>RH</given-names></name></person-group>. <article-title>The role of undernutrition in the pathogenesis of diabetes mellitus</article-title>. <source>Diabetes Care</source> (<year>1984</year>) <volume>7</volume>:<fpage>595</fpage>&#x02013;<lpage>601</lpage>.<pub-id pub-id-type="doi">10.2337/diacare.7.6.595</pub-id><?supplied-pmid 6439534?><pub-id pub-id-type="pmid">6439534</pub-id></mixed-citation></ref><ref id="B234"><label>234</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chattopadhyay</surname><given-names>PS</given-names></name><name><surname>Gupta</surname><given-names>SK</given-names></name><name><surname>Chattopadhyay</surname><given-names>R</given-names></name><name><surname>Kundu</surname><given-names>PK</given-names></name><name><surname>Chakraborti</surname><given-names>R</given-names></name></person-group>
<article-title>Malnutrition-related diabetes mellitus (MRDM), not diabetes-related malnutrition</article-title>. <source>Diabetes Care</source> (<year>1995</year>) <volume>18</volume>:<fpage>276</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.2337/diacare.18.2.276</pub-id><pub-id pub-id-type="pmid">7729313</pub-id></mixed-citation></ref><ref id="B235"><label>235</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoet</surname><given-names>JJ</given-names></name><name><surname>Tripathy</surname><given-names>BB</given-names></name></person-group>
<article-title>Report of the international workshop on types of diabetes peculiar to the tropics</article-title>. <source>Diabetes Care</source> (<year>1996</year>) <volume>19</volume>:<fpage>1014</fpage>.</mixed-citation></ref><ref id="B236"><label>236</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>RH</given-names></name><name><surname>Yajnik</surname><given-names>CS</given-names></name></person-group>
<article-title>Commentary: time to rethink malnutrition and diabetes in the tropics</article-title>. <source>Diabetes Care</source> (<year>1996</year>) <volume>19</volume>:<fpage>1014</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.2337/diacare.19.9.1014</pub-id></mixed-citation></ref><ref id="B237"><label>237</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>CC</given-names></name><name><surname>Watkins</surname><given-names>SM</given-names></name><name><surname>Lorenzo</surname><given-names>C</given-names></name><name><surname>Wagenknecht</surname><given-names>LE</given-names></name><name><surname>Il&#x02019;yasova</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>YD</given-names></name><etal/></person-group>
<article-title>Branched-chain amino acids and insulin metabolism: the Insulin Resistance Atherosclerosis Study (IRAS)</article-title>. <source>Diabetes Care</source> (<year>2016</year>) <volume>39</volume>:<fpage>582</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.2337/dc15-2284</pub-id><?supplied-pmid 26895884?><pub-id pub-id-type="pmid">26895884</pub-id></mixed-citation></ref><ref id="B238"><label>238</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Umpi&#x000e9;rrez</surname><given-names>GE</given-names></name><name><surname>Smiley</surname><given-names>D</given-names></name><name><surname>Kitabchi</surname><given-names>AE</given-names></name></person-group>. <article-title>Narrative review: ketosis-prone type 2 diabetes mellitus</article-title>. <source>Ann Intern Med</source> (<year>2006</year>) <volume>144</volume>:<fpage>350</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.7326/0003-4819-144-5-200603070-00011</pub-id><?supplied-pmid 16520476?><pub-id pub-id-type="pmid">16520476</pub-id></mixed-citation></ref><ref id="B239"><label>239</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pi&#x000f1;ero-Pilo&#x000f1;a</surname><given-names>A</given-names></name><name><surname>Litonjua</surname><given-names>P</given-names></name><name><surname>Avil&#x000e9;s-Santa</surname><given-names>L</given-names></name><name><surname>Raskin</surname><given-names>P</given-names></name></person-group>. <article-title>Idiopathic type 1 diabetes in Dallas, Texas: a 5-year experience</article-title>. <source>Diabetes Care</source> (<year>2001</year>) <volume>24</volume>:<fpage>1014</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.2337/diacare.24.6.1014</pub-id><?supplied-pmid 11375362?><pub-id pub-id-type="pmid">11375362</pub-id></mixed-citation></ref><ref id="B240"><label>240</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balasubramanyam</surname><given-names>A</given-names></name><name><surname>Nalini</surname><given-names>R</given-names></name><name><surname>Hampe</surname><given-names>CS</given-names></name><name><surname>Maldonado</surname><given-names>M</given-names></name></person-group>. <article-title>Syndromes of ketosis-prone diabetes mellitus</article-title>. <source>Endocr Rev</source> (<year>2008</year>) <volume>29</volume>:<fpage>292</fpage>&#x02013;<lpage>302</lpage>.<pub-id pub-id-type="doi">10.1210/er.2007-0026</pub-id><?supplied-pmid 18292467?><pub-id pub-id-type="pmid">18292467</pub-id></mixed-citation></ref><ref id="B241"><label>241</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feres</surname><given-names>MC</given-names></name><name><surname>Fonseca</surname><given-names>FAH</given-names></name><name><surname>Cintra</surname><given-names>FD</given-names></name><name><surname>Mello-Fujita</surname><given-names>L</given-names></name><name><surname>de Souza</surname><given-names>AL</given-names></name><name><surname>De Martino</surname><given-names>MC</given-names></name><etal/></person-group>
<article-title>An assessment of oxidized LDL in the lipid profiles of patients with obstructive sleep apnea and its association with both hypertension and dyslipidemia, and the impact of treatment with CPAP</article-title>. <source>Atherosclerosis</source> (<year>2015</year>) <volume>241</volume>:<fpage>342</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2015.05.008</pub-id><?supplied-pmid 26071656?><pub-id pub-id-type="pmid">26071656</pub-id></mixed-citation></ref><ref id="B242"><label>242</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cintra</surname><given-names>F</given-names></name><name><surname>Tufik</surname><given-names>S</given-names></name><name><surname>de Paola</surname><given-names>A</given-names></name><name><surname>Feres</surname><given-names>MC</given-names></name><name><surname>Mello-Fujita</surname><given-names>L</given-names></name><name><surname>Oliveira</surname><given-names>W</given-names></name><etal/></person-group>
<article-title>Cardiovascular profile in patients with obstructive sleep apnea</article-title>. <source>Arq Bras Cardiol</source> (<year>2011</year>) <volume>96</volume>:<fpage>293</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1590/S0066-782X2011005000030</pub-id><?supplied-pmid 21437515?><pub-id pub-id-type="pmid">21437515</pub-id></mixed-citation></ref><ref id="B243"><label>243</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grandner</surname><given-names>MA</given-names></name><name><surname>Chakravorty</surname><given-names>S</given-names></name><name><surname>Perlis</surname><given-names>ML</given-names></name><name><surname>Oliver</surname><given-names>L</given-names></name><name><surname>Gurubhagavatula</surname><given-names>I</given-names></name></person-group>. <article-title>Habitual sleep duration associated with self-reported and objectively determined cardiometabolic risk factors</article-title>. <source>Sleep Med</source> (<year>2014</year>) <volume>15</volume>:<fpage>42</fpage>&#x02013;<lpage>50</lpage>.<pub-id pub-id-type="doi">10.1016/j.sleep.2013.09.012</pub-id><?supplied-pmid 24333222?><pub-id pub-id-type="pmid">24333222</pub-id></mixed-citation></ref><ref id="B244"><label>244</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shechter</surname><given-names>A</given-names></name></person-group>
<article-title>Obstructive sleep apnea and energy balance regulation: a systematic review</article-title>. <source>Sleep Med Rev</source> (<year>2016</year>) <volume>34</volume>:<fpage>59</fpage>&#x02013;<lpage>69</lpage>.<pub-id pub-id-type="doi">10.1016/j.smrv.2016.07.001</pub-id><pub-id pub-id-type="pmid">27818084</pub-id></mixed-citation></ref><ref id="B245"><label>245</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ip</surname><given-names>MS</given-names></name><name><surname>Lam</surname><given-names>B</given-names></name><name><surname>Ng</surname><given-names>MM</given-names></name><name><surname>Lam</surname><given-names>WK</given-names></name><name><surname>Tsang</surname><given-names>KW</given-names></name><name><surname>Lam</surname><given-names>KS</given-names></name></person-group>. <article-title>Obstructive sleep apnea is independently associated with insulin resistance</article-title>. <source>Am J Respir CritCare Med</source> (<year>2002</year>) <volume>165</volume>:<fpage>670</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1164/ajrccm.165.5.2103001</pub-id><?supplied-pmid 11874812?><pub-id pub-id-type="pmid">11874812</pub-id></mixed-citation></ref><ref id="B246"><label>246</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kendzerska</surname><given-names>T</given-names></name><name><surname>Gershon</surname><given-names>AS</given-names></name><name><surname>Hawker</surname><given-names>G</given-names></name><name><surname>Tomlinson</surname><given-names>G</given-names></name><name><surname>Leung</surname><given-names>RS</given-names></name></person-group>
<article-title>Obstructive sleep apnea and incident diabetes. A historical cohort study</article-title>. <source>Am J Respir CritCare Med</source> (<year>2014</year>) <volume>190</volume>:<fpage>218</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="doi">10.1164/rccm.201312-2209OC</pub-id></mixed-citation></ref><ref id="B247"><label>247</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Redline</surname><given-names>S</given-names></name><name><surname>Sotres-Alvarez</surname><given-names>D</given-names></name><name><surname>Loredo</surname><given-names>J</given-names></name><name><surname>Hall</surname><given-names>M</given-names></name><name><surname>Patel</surname><given-names>SR</given-names></name><name><surname>Ramos</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Sleep-disordered breathing in Hispanic/Latino individuals of diverse backgrounds: the Hispanic Community Health Study/Study of Latinos</article-title>. <source>Am JRespir Crit Care Med</source> (<year>2014</year>) <volume>189</volume>:<fpage>335</fpage>&#x02013;<lpage>44</lpage>.<pub-id pub-id-type="doi">10.1164/rccm.201309-1735OC</pub-id><?supplied-pmid 24392863?><pub-id pub-id-type="pmid">24392863</pub-id></mixed-citation></ref><ref id="B248"><label>248</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knutson</surname><given-names>KL</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Patel</surname><given-names>SR</given-names></name><name><surname>Loredo</surname><given-names>JS</given-names></name><name><surname>Redline</surname><given-names>S</given-names></name><name><surname>Cai</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Association between sleep timing, obesity, diabetes: the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) cohort study</article-title>. <source>Sleep</source> (<year>2017</year>) <volume>40</volume>(<issue>4</issue>):<fpage>zsx014</fpage><pub-id pub-id-type="doi">10.1093/sleep/zsx014</pub-id></mixed-citation></ref><ref id="B249"><label>249</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cespedes</surname><given-names>EM</given-names></name><name><surname>Dudley</surname><given-names>KA</given-names></name><name><surname>Sotres-Alvarez</surname><given-names>D</given-names></name><name><surname>Zee</surname><given-names>PC</given-names></name><name><surname>Daviglus</surname><given-names>ML</given-names></name><name><surname>Shah</surname><given-names>NA</given-names></name><etal/></person-group>
<article-title>Joint associations of insomnia and sleep duration with prevalent diabetes: the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)</article-title>. <source>J Diabetes</source> (<year>2016</year>) <volume>8</volume>:<fpage>387</fpage>&#x02013;<lpage>97</lpage>.<pub-id pub-id-type="doi">10.1111/1753-0407.12308</pub-id><pub-id pub-id-type="pmid">25952169</pub-id></mixed-citation></ref><ref id="B250"><label>250</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cade</surname><given-names>BE</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Stilp</surname><given-names>AM</given-names></name><name><surname>Gleason</surname><given-names>KJ</given-names></name><name><surname>Sofer</surname><given-names>T</given-names></name><name><surname>Ancoli-Israel</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Genetic associations with obstructive sleep apnea traits in Hispanic/Latino Americans</article-title>. <source>Am J Respir Crit Care Med</source> (<year>2016</year>) <volume>194</volume>:<fpage>886</fpage>&#x02013;<lpage>97</lpage>.<pub-id pub-id-type="doi">10.1164/rccm.201512-2431OC</pub-id><?supplied-pmid 26977737?><pub-id pub-id-type="pmid">26977737</pub-id></mixed-citation></ref><ref id="B251"><label>251</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakker</surname><given-names>JP</given-names></name><name><surname>Weng</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Redline</surname><given-names>S</given-names></name><name><surname>Punjabi</surname><given-names>NM</given-names></name><name><surname>Patel</surname><given-names>SR</given-names></name></person-group>
<article-title>Associations between obstructive sleep apnea, sleep duration, and abnormal fasting glucose. The multi-ethnic study of atherosclerosis</article-title>. <source>Am J Respir Crit Care Med</source> (<year>2015</year>) <volume>192</volume>:<fpage>745</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="doi">10.1164/rccm.201502-0366OC</pub-id><pub-id pub-id-type="pmid">26084035</pub-id></mixed-citation></ref><ref id="B252"><label>252</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de la Monte</surname><given-names>SM</given-names></name></person-group>
<article-title>Type 3 diabetes is sporadic Alzheimer&#x02019;s disease: mini-review</article-title>. <source>Eur Neuropsychopharmacol</source> (<year>2014</year>) <volume>24</volume>:<fpage>1954</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="doi">10.1016/j.euroneuro.2014.06.008</pub-id><pub-id pub-id-type="pmid">25088942</pub-id></mixed-citation></ref><ref id="B253"><label>253</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steen</surname><given-names>E</given-names></name><name><surname>Terry</surname><given-names>BM</given-names></name><name><surname>Rivera</surname><given-names>EJ</given-names></name><name><surname>Cannon</surname><given-names>JL</given-names></name><name><surname>Neely</surname><given-names>TR</given-names></name><name><surname>Tavares</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer&#x02019;s disease &#x02013; is this type 3 diabetes?</article-title>
<source>J Alzheimers Dis</source> (<year>2005</year>) <volume>7</volume>:<fpage>63</fpage>&#x02013;<lpage>80</lpage>.<pub-id pub-id-type="doi">10.3233/JAD-2005-7107</pub-id><pub-id pub-id-type="pmid">15750215</pub-id></mixed-citation></ref><ref id="B254"><label>254</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayeda</surname><given-names>ER</given-names></name><name><surname>Haan</surname><given-names>MN</given-names></name><name><surname>Kanaya</surname><given-names>AM</given-names></name><name><surname>Yaffe</surname><given-names>K</given-names></name><name><surname>Nuehaus</surname><given-names>J</given-names></name></person-group>. <article-title>Type 2 diabetes and 10-year risk of dementia and cognitive impairment among older Mexican Americans</article-title>. <source>Diabetes Care</source> (<year>2013</year>) <volume>36</volume>:<fpage>2600</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.2337/dc12-2158</pub-id><?supplied-pmid 23514732?><pub-id pub-id-type="pmid">23514732</pub-id></mixed-citation></ref><ref id="B255"><label>255</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayeda</surname><given-names>ER</given-names></name><name><surname>Haan</surname><given-names>MN</given-names></name><name><surname>Yaffe</surname><given-names>K</given-names></name><name><surname>Kanaya</surname><given-names>AM</given-names></name><name><surname>Neuhaus</surname><given-names>J</given-names></name></person-group>. <article-title>Does type 2 diabetes increase rate of cognitive decline in older Mexican Americans?</article-title>
<source>Alzheimer DisAssoc Disord</source> (<year>2015</year>) <volume>29</volume>:<fpage>206</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="doi">10.1097/WAD.0000000000000083</pub-id><?supplied-pmid 25650694?><pub-id pub-id-type="pmid">25650694</pub-id></mixed-citation></ref><ref id="B256"><label>256</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>WHW</given-names></name><name><surname>Kitai</surname><given-names>T</given-names></name><name><surname>Hazen</surname><given-names>SL</given-names></name></person-group>
<article-title>Gut microbiota in cardiovascular health and disease</article-title>. <source>Circ Res</source> (<year>2017</year>) <volume>120</volume>:<fpage>1183</fpage>&#x02013;<lpage>96</lpage>.<pub-id pub-id-type="doi">10.1161/CIRCRESAHA.117.309715</pub-id><pub-id pub-id-type="pmid">28360349</pub-id></mixed-citation></ref><ref id="B257"><label>257</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lambeth</surname><given-names>SM</given-names></name><name><surname>Carson</surname><given-names>T</given-names></name><name><surname>Lowe</surname><given-names>J</given-names></name><name><surname>Ramaraj</surname><given-names>T</given-names></name><name><surname>Leff</surname><given-names>JW</given-names></name><name><surname>Luo</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>Composition, diversity and abundance of gut microbiome in prediabetes and type 2 diabetes</article-title>. <source>J Diabetes Obes</source> (<year>2015</year>) <volume>2</volume>:<fpage>1</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.15436/2376-0949.15.031</pub-id><?supplied-pmid 26756039?><pub-id pub-id-type="pmid">26756039</pub-id></mixed-citation></ref><ref id="B258"><label>258</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brunkwall</surname><given-names>L</given-names></name><name><surname>Orho-Melander</surname><given-names>M</given-names></name></person-group>
<article-title>The gut microbiome as a target for prevention and treatment of hyperglycemia in type 2 diabetes: from current human evidence to future possibilities</article-title>. <source>Diabetologia</source> (<year>2017</year>) <volume>60</volume>:<fpage>943</fpage>&#x02013;<lpage>51</lpage>.<pub-id pub-id-type="doi">10.1007/s00125-017-4278-3</pub-id><pub-id pub-id-type="pmid">28434033</pub-id></mixed-citation></ref><ref id="B259"><label>259</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ed;a-Monz&#x000f3;n</surname><given-names>C</given-names></name><name><surname>Vargas-Castrill&#x000f3;n</surname><given-names>J</given-names></name><name><surname>Porrero</surname><given-names>JL</given-names></name><name><surname>Alonso</surname><given-names>MT</given-names></name><name><surname>Bonachia</surname><given-names>O</given-names></name><name><surname>Castillo</surname><given-names>MJ</given-names></name><etal/></person-group>
<article-title>Prevalence and risk factors for biopsy-proven non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in a prospective cohort of adult patients with gallstones</article-title>. <source>Liver Int</source> (<year>2015</year>) <volume>35</volume>:<fpage>1983</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="doi">10.1111/liv.12813</pub-id><?supplied-pmid 25708133?><pub-id pub-id-type="pmid">25708133</pub-id></mixed-citation></ref><ref id="B260"><label>260</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>EM</given-names></name><name><surname>Styblo</surname><given-names>M</given-names></name><name><surname>Fry</surname><given-names>RC</given-names></name></person-group>. <article-title>Genetic and epigenetic mechanisms underlying arsenic-associated diabetes mellitus: a perspective of the current evidence</article-title>. <source>Epigenomics</source> (<year>2017</year>) <volume>9</volume>:<fpage>701</fpage>&#x02013;<lpage>10</lpage>.<pub-id pub-id-type="doi">10.2217/epi-2016-0097</pub-id><?supplied-pmid 28470093?><pub-id pub-id-type="pmid">28470093</pub-id></mixed-citation></ref><ref id="B261"><label>261</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Magueresse-Battistoni</surname><given-names>B</given-names></name><name><surname>Vidal</surname><given-names>H</given-names></name><name><surname>Naville</surname><given-names>D</given-names></name></person-group>
<article-title>Impact of in utero exposure to pollutants on metabolic health in adults</article-title>. <source>Med Sci</source> (<year>2016</year>) <volume>32</volume>:<fpage>51</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1051/medsci/20163201009</pub-id></mixed-citation></ref><ref id="B262"><label>262</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chevalier</surname><given-names>N</given-names></name><name><surname>Fenichel</surname><given-names>P</given-names></name></person-group>. <article-title>Bisphenol A: targeting metabolic tissues</article-title>. <source>Rev EndocrMetab Disord</source> (<year>2015</year>) <volume>16</volume>:<fpage>299</fpage>&#x02013;<lpage>309</lpage>.<pub-id pub-id-type="doi">10.1007/s11154-016-9333-8</pub-id><?supplied-pmid 26820262?><pub-id pub-id-type="pmid">26820262</pub-id></mixed-citation></ref><ref id="B263"><label>263</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shearrer</surname><given-names>GE</given-names></name><name><surname>O&#x02019;Reilly</surname><given-names>GA</given-names></name><name><surname>Belcher</surname><given-names>BR</given-names></name><name><surname>Daniels</surname><given-names>MJ</given-names></name><name><surname>Goran</surname><given-names>MI</given-names></name><name><surname>Spruijt-Metz</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>The impact of sugar sweetened beverage intake on hunger and satiety in minority adolescents</article-title>. <source>Appetite</source> (<year>2016</year>) <volume>97</volume>:<fpage>43</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/j.appet.2015.11.015</pub-id><?supplied-pmid 26606887?><pub-id pub-id-type="pmid">26606887</pub-id></mixed-citation></ref><ref id="B264"><label>264</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Below</surname><given-names>JE</given-names></name><name><surname>Parra</surname><given-names>EJ</given-names></name></person-group>. <article-title>Genome-wide studies of type 2 diabetes and lipid traits in Hispanics</article-title>. <source>Curr Diab Rep</source> (<year>2016</year>) <volume>16</volume>:<fpage>41</fpage>.<pub-id pub-id-type="doi">10.1007/s11892-016-0737-3</pub-id><?supplied-pmid 27007718?><pub-id pub-id-type="pmid">27007718</pub-id></mixed-citation></ref><ref id="B265"><label>265</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyssenko</surname><given-names>V</given-names></name><name><surname>Lupi</surname><given-names>R</given-names></name><name><surname>Marchetti</surname><given-names>P</given-names></name><name><surname>Del Guerra</surname><given-names>S</given-names></name><name><surname>Orho-Melander</surname><given-names>M</given-names></name><name><surname>Almgren</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes</article-title>. <source>J Clin Invest</source> (<year>2007</year>) <volume>117</volume>:<fpage>2155</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="doi">10.1172/JCI30706</pub-id><?supplied-pmid 17671651?><pub-id pub-id-type="pmid">17671651</pub-id></mixed-citation></ref><ref id="B266"><label>266</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Florez</surname><given-names>JC</given-names></name><name><surname>Jablonski</surname><given-names>KA</given-names></name><name><surname>Bayley</surname><given-names>N</given-names></name><name><surname>Pollin</surname><given-names>TI</given-names></name><name><surname>de Bakker</surname><given-names>PI</given-names></name><name><surname>Shuldiner</surname><given-names>AR</given-names></name><etal/></person-group>
<article-title>TCF7L2 polymorphisms and progression to diabetes in the diabetes prevention program</article-title>. <source>N Engl J Med</source> (<year>2006</year>) <volume>355</volume>:<fpage>241</fpage>&#x02013;<lpage>50</lpage>.<pub-id pub-id-type="doi">10.1056/NEJMoa062418</pub-id><?supplied-pmid 16855264?><pub-id pub-id-type="pmid">16855264</pub-id></mixed-citation></ref><ref id="B267"><label>267</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>RM</given-names></name><name><surname>Allayee</surname><given-names>H</given-names></name><name><surname>Xiang</surname><given-names>AH</given-names></name><name><surname>Trigo</surname><given-names>E</given-names></name><name><surname>Hartiala</surname><given-names>J</given-names></name><name><surname>Lawrence</surname><given-names>JM</given-names></name><etal/></person-group>
<article-title>Transcription factor 7-like 2 (TCF7L2) is associated with gestational diabetes mellitus and interacts with adiposity to alter insulin secretion in Mexican Americans</article-title>. <source>Diabetes</source> (<year>2007</year>) <volume>56</volume>:<fpage>1481</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.2337/db06-1682</pub-id><?supplied-pmid 17317761?><pub-id pub-id-type="pmid">17317761</pub-id></mixed-citation></ref><ref id="B268"><label>268</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez-Gomez</surname><given-names>LE</given-names></name><name><surname>Cruz</surname><given-names>M</given-names></name><name><surname>Martinez-Nava</surname><given-names>GA</given-names></name><name><surname>Madrid-Marina</surname><given-names>V</given-names></name><name><surname>Parra</surname><given-names>E</given-names></name><name><surname>Garcia-Mena</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>A replication study of the IRS1, CAPN10, TCF7L2, and PPARG gene polymorphisms associated with type 2 diabetes in two different populations of Mexico</article-title>. <source>Ann Hum Genet</source> (<year>2011</year>) <volume>75</volume>:<fpage>612</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1111/j.1469-1809.2011.00668.x</pub-id><pub-id pub-id-type="pmid">21834909</pub-id></mixed-citation></ref><ref id="B269"><label>269</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palmer</surname><given-names>ND</given-names></name><name><surname>Lehtinen</surname><given-names>AB</given-names></name><name><surname>Langefeld</surname><given-names>CD</given-names></name><name><surname>Campbell</surname><given-names>JK</given-names></name><name><surname>Haffner</surname><given-names>SM</given-names></name><name><surname>Norris</surname><given-names>JM</given-names></name><etal/></person-group>
<article-title>Association of TCF7L2 gene polymorphisms with reduced acute insulin response in Hispanic Americans</article-title>. <source>J Clin Endocrinol Metab</source> (<year>2008</year>) <volume>93</volume>:<fpage>304</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1210/jc.2007-1225</pub-id><?supplied-pmid 17971425?><pub-id pub-id-type="pmid">17971425</pub-id></mixed-citation></ref><ref id="B270"><label>270</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qi</surname><given-names>Q</given-names></name><name><surname>Stilp</surname><given-names>AM</given-names></name><name><surname>Sofer</surname><given-names>T</given-names></name><name><surname>Moon</surname><given-names>JY</given-names></name><name><surname>Hidalgo</surname><given-names>B</given-names></name><name><surname>Szpiro</surname><given-names>AA</given-names></name><etal/></person-group>
<article-title>Genetics of type 2 diabetes in U.S. Hispanic/Latino individuals: results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)</article-title>. <source>Diabetes</source> (<year>2017</year>) <volume>66</volume>:<fpage>1419</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="doi">10.2337/db16-1150</pub-id><?supplied-pmid 28254843?><pub-id pub-id-type="pmid">28254843</pub-id></mixed-citation></ref><ref id="B271"><label>271</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sousa</surname><given-names>AG</given-names></name><name><surname>Marquezine</surname><given-names>GF</given-names></name><name><surname>Lemos</surname><given-names>PA</given-names></name><name><surname>Martinez</surname><given-names>E</given-names></name><name><surname>Lopes</surname><given-names>N</given-names></name><name><surname>Hueb</surname><given-names>WA</given-names></name><etal/></person-group>
<article-title>TCF7L2 polymorphism rs7903146 is associated with coronary artery disease severity and mortality</article-title>. <source>PLoS One</source> (<year>2009</year>) <volume>4</volume>:<fpage>e7697</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0007697</pub-id><?supplied-pmid 19924244?><pub-id pub-id-type="pmid">19924244</pub-id></mixed-citation></ref><ref id="B272"><label>272</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muendlein</surname><given-names>A</given-names></name><name><surname>Saely</surname><given-names>CH</given-names></name><name><surname>Geller-Rhomberg</surname><given-names>S</given-names></name><name><surname>Sonderegger</surname><given-names>G</given-names></name><name><surname>Rein</surname><given-names>P</given-names></name><name><surname>Winder</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>Single nucleotide polymorphisms of TCF7L2 are linked to diabetic coronary atherosclerosis</article-title>. <source>PLoS One</source> (<year>2011</year>) <volume>6</volume>:<fpage>e17978</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0017978</pub-id><?supplied-pmid 21423583?><pub-id pub-id-type="pmid">21423583</pub-id></mixed-citation></ref><ref id="B273"><label>273</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>HJ</given-names></name><name><surname>Lee</surname><given-names>DH</given-names></name><name><surname>Jeon</surname><given-names>HJ</given-names></name><name><surname>Kim</surname><given-names>DS</given-names></name><name><surname>Lee</surname><given-names>YH</given-names></name><name><surname>Oh</surname><given-names>T</given-names></name></person-group>. <article-title>Transcription factor 7-like 2 (TCF7L2) gene polymorphism rs7903146 is associated with stroke in type 2 diabetes patients with long disease duration</article-title>. <source>Diabetes Res Clin Pract</source> (<year>2014</year>) <volume>103</volume>:<fpage>e3</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1016/j.diabres.2013.12.051</pub-id><?supplied-pmid 24529562?><pub-id pub-id-type="pmid">24529562</pub-id></mixed-citation></ref><ref id="B274"><label>274</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>AL</given-names></name><name><surname>Jacobs</surname><given-names>SB</given-names></name><name><surname>Moreno-Macias</surname><given-names>H</given-names></name><name><surname>Huerta-Chagoya</surname><given-names>A</given-names></name><name><surname>Churchhouse</surname><given-names>C</given-names></name><name><surname>Marquez-Luna</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico</article-title>. <source>Nature</source> (<year>2014</year>) <volume>506</volume>:<fpage>97</fpage>&#x02013;<lpage>101</lpage>.<pub-id pub-id-type="doi">10.1038/nature12828</pub-id><?supplied-pmid 24390345?><pub-id pub-id-type="pmid">24390345</pub-id></mixed-citation></ref><ref id="B275"><label>275</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Travers</surname><given-names>ME</given-names></name><name><surname>Mackay</surname><given-names>DJ</given-names></name><name><surname>Dekker Nitert</surname><given-names>M</given-names></name><name><surname>Morris</surname><given-names>AP</given-names></name><name><surname>Lindgren</surname><given-names>CM</given-names></name><name><surname>Berry</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Insights into the molecular mechanism for type 2 diabetes susceptibility at the KCNQ1 locus from temporal changes in imprinting status in human islets</article-title>. <source>Diabetes</source> (<year>2013</year>) <volume>62</volume>:<fpage>987</fpage>&#x02013;<lpage>92</lpage>.<pub-id pub-id-type="doi">10.2337/db12-0819</pub-id><?supplied-pmid 23139357?><pub-id pub-id-type="pmid">23139357</pub-id></mixed-citation></ref><ref id="B276"><label>276</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Estrada</surname><given-names>K</given-names></name><name><surname>Aukrust</surname><given-names>I</given-names></name><name><surname>Bjorkhaug</surname><given-names>L</given-names></name><name><surname>Burtt</surname><given-names>NP</given-names></name><name><surname>Mercader</surname><given-names>JM</given-names></name><name><surname>Garcia-Ortiz</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>Association of a low-frequency variant in HNF1A with type 2 diabetes in a Latino population</article-title>. <source>JAMA</source> (<year>2014</year>) <volume>311</volume>:<fpage>2305</fpage>&#x02013;<lpage>14</lpage>.<pub-id pub-id-type="doi">10.1001/jama.2014.6511</pub-id><?supplied-pmid 24915262?><pub-id pub-id-type="pmid">24915262</pub-id></mixed-citation></ref><ref id="B277"><label>277</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palmer</surname><given-names>ND</given-names></name><name><surname>Goodarzi</surname><given-names>MO</given-names></name><name><surname>Langefeld</surname><given-names>CD</given-names></name><name><surname>Wang</surname><given-names>N</given-names></name><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Taylor</surname><given-names>KD</given-names></name><etal/></person-group>
<article-title>Genetic variants associated with quantitative glucose homeostasis traits translate to type 2 diabetes in Mexican Americans: the GUARDIAN (genetics underlying diabetes in Hispanics) consortium</article-title>. <source>Diabetes</source> (<year>2015</year>) <volume>64</volume>:<fpage>1853</fpage>&#x02013;<lpage>66</lpage>.<pub-id pub-id-type="doi">10.2337/db14-0732</pub-id><?supplied-pmid 25524916?><pub-id pub-id-type="pmid">25524916</pub-id></mixed-citation></ref><ref id="B278"><label>278</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frigeri</surname><given-names>HR</given-names></name><name><surname>Martins</surname><given-names>LT</given-names></name><name><surname>Auwerter</surname><given-names>NC</given-names></name><name><surname>dos Santos-Weiss</surname><given-names>ICR</given-names></name><name><surname>Pedrosa</surname><given-names>FO</given-names></name><name><surname>de Souza</surname><given-names>EM</given-names></name><etal/></person-group>
<article-title>The polymorphism rs2268574 in glucokinase gene is associated with gestational diabetes mellitus</article-title>. <source>Clin Biochem</source> (<year>2014</year>) <volume>47</volume>:<fpage>499</fpage>&#x02013;<lpage>500</lpage>.<pub-id pub-id-type="doi">10.1016/j.clinbiochem.2014.01.024</pub-id><pub-id pub-id-type="pmid">24495862</pub-id></mixed-citation></ref><ref id="B279"><label>279</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Junior</surname><given-names>JP</given-names></name><name><surname>Frigeri</surname><given-names>HR</given-names></name><name><surname>Dos Santos-Weiss</surname><given-names>IC</given-names></name><name><surname>Rego</surname><given-names>FG</given-names></name><name><surname>Pitcheth</surname><given-names>G</given-names></name><name><surname>Alberton</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>The MTNR1B gene polymorphism rs10830963 is associated with gestational diabetes in a Brazilian population</article-title>. <source>Gene</source> (<year>2015</year>) <volume>568</volume>:<fpage>114</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1016/j.gene.2015.05.024</pub-id><pub-id pub-id-type="pmid">25982863</pub-id></mixed-citation></ref><ref id="B280"><label>280</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blois</surname><given-names>SM</given-names></name><name><surname>Gueuvoghlanian-Silva</surname><given-names>BY</given-names></name><name><surname>Tirado-Gonz&#x000e1;lez</surname><given-names>I</given-names></name><name><surname>Torloni</surname><given-names>MR</given-names></name><name><surname>Freitag</surname><given-names>N</given-names></name><name><surname>Mattar</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Getting too sweet: galectin-1 dysregulation in gestational diabetes</article-title>. <source>Mol Hum Reprod</source> (<year>2014</year>) <volume>20</volume>:<fpage>644</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1093/molehr/gau021</pub-id><pub-id pub-id-type="pmid">24637109</pub-id></mixed-citation></ref><ref id="B281"><label>281</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gelaleti</surname><given-names>RB</given-names></name><name><surname>Damasceno</surname><given-names>DC</given-names></name><name><surname>Salvadori</surname><given-names>DM</given-names></name><name><surname>Marcondes</surname><given-names>JP</given-names></name><name><surname>Lima</surname><given-names>PH</given-names></name><name><surname>Morceli</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>IRS-1 gene polymorphism and DNA damage in pregnant women with diabetes or mild gestational hyperglycemia</article-title>. <source>Diabetol Metab Syndr</source> (<year>2015</year>) <volume>7</volume>:<fpage>30</fpage>.<pub-id pub-id-type="doi">10.1186/s13098-015-0026-3</pub-id><?supplied-pmid 25859280?><pub-id pub-id-type="pmid">25859280</pub-id></mixed-citation></ref><ref id="B282"><label>282</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>S&#x000e1;nchez Monroy</surname><given-names>V</given-names></name><name><surname>Gonz&#x000e1;lez D&#x000ed;az</surname><given-names>A</given-names></name><name><surname>Lozano Trenado</surname><given-names>LM</given-names></name><name><surname>Campos Peralta</surname><given-names>JM</given-names></name><name><surname>Polo Soto</surname><given-names>S</given-names></name></person-group>
<article-title>Thr130lle polymorphism of HNF4A gene is associated with gestational diabetes mellitus in Mexican population</article-title>. <source>J Investig Med</source> (<year>2014</year>) <volume>62</volume>:<fpage>632</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="doi">10.2310/JIM.0000000000000045</pub-id></mixed-citation></ref><ref id="B283"><label>283</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guzm&#x000e1;n-Flores</surname><given-names>JM</given-names></name><name><surname>Escalante</surname><given-names>M</given-names></name><name><surname>S&#x000e1;nchez-Corona</surname><given-names>J</given-names></name><name><surname>Garc&#x000ed;a-Zapi&#x000e9;n</surname><given-names>AG</given-names></name><name><surname>Cruz-Quevedo</surname><given-names>EG</given-names></name><name><surname>Mu&#x000f1;oz-Valle</surname><given-names>JF</given-names></name><etal/></person-group>
<article-title>Association analysis between -308G/A and -238G/A TNF-alpha gene promoter polymorphisms and insulin resistance in Mexican women with gestational diabetes mellitus</article-title>. <source>J InvestigMed</source> (<year>2013</year>) <volume>61</volume>:<fpage>265</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.2310/JIM.0b013e31827b98c9</pub-id><?supplied-pmid 23254337?><pub-id pub-id-type="pmid">23254337</pub-id></mixed-citation></ref><ref id="B284"><label>284</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huerta-Chagoya</surname><given-names>A</given-names></name><name><surname>V&#x000e1;zquez-C&#x000e1;rdenas</surname><given-names>P</given-names></name><name><surname>Moreno-Mac&#x000ed;as</surname><given-names>H</given-names></name><name><surname>Tapia-Maruri</surname><given-names>L</given-names></name><name><surname>Rodr&#x000ed;guez-Guill&#x000e9;n</surname><given-names>R</given-names></name><name><surname>L&#x000f3;pez-Vite</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Genetic determinants of gestational diabetes mellitus and related metabolic traits in Mexican women</article-title>. <source>PLoS One</source> (<year>2015</year>) <volume>10</volume>:<fpage>e0126408</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0126408</pub-id><pub-id pub-id-type="pmid">25973943</pub-id></mixed-citation></ref><ref id="B285"><label>285</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reyes-L&#x000f3;pez</surname><given-names>R</given-names></name><name><surname>P&#x000e9;rez-Luque</surname><given-names>E</given-names></name><name><surname>Malacara</surname><given-names>JM</given-names></name></person-group>. <article-title>Metabolic, hormonal characteristics and genetic variants of TCF7L2 associated with development of gestational diabetes mellitus in Mexican women</article-title>. <source>Diabetes Metab Res Rev</source> (<year>2014</year>) <volume>30</volume>:<fpage>701</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1002/dmrr.2538</pub-id><?supplied-pmid 24639413?><pub-id pub-id-type="pmid">24639413</pub-id></mixed-citation></ref><ref id="B286"><label>286</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Melo</surname><given-names>SF</given-names></name><name><surname>Frigeri</surname><given-names>HR</given-names></name><name><surname>dos Santos-Weiss</surname><given-names>IC</given-names></name><name><surname>R&#x000e9;a</surname><given-names>RR</given-names></name><name><surname>de Souza</surname><given-names>EM</given-names></name><name><surname>Alberton</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>Polymorphisms in FTO and TCF7L2 genes of Euro-Brazilian women with gestational diabetes</article-title>. <source>Biochemistry</source> (<year>2015</year>) <volume>48</volume>:<fpage>1064</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1016/j.clinbiochem.2015.06.013</pub-id><?supplied-pmid 26102344?><pub-id pub-id-type="pmid">26102344</pub-id></mixed-citation></ref><ref id="B287"><label>287</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kulkarni</surname><given-names>H</given-names></name><name><surname>Kos</surname><given-names>MZ</given-names></name><name><surname>Neary</surname><given-names>J</given-names></name><name><surname>Dyer</surname><given-names>TD</given-names></name><name><surname>Kent</surname><given-names>JW</given-names><suffix>Jr</suffix></name><name><surname>Goring</surname><given-names>HH</given-names></name><etal/></person-group>
<article-title>Novel epigenetic determinants of type 2 diabetes in Mexican-American families</article-title>. <source>Hum Mol Genet</source> (<year>2015</year>) <volume>24</volume>:<fpage>5330</fpage>&#x02013;<lpage>44</lpage>.<pub-id pub-id-type="doi">10.1093/hmg/ddv232</pub-id><?supplied-pmid 26101197?><pub-id pub-id-type="pmid">26101197</pub-id></mixed-citation></ref><ref id="B288"><label>288</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mamtani</surname><given-names>M</given-names></name><name><surname>Kulkarni</surname><given-names>H</given-names></name><name><surname>Dyer</surname><given-names>TD</given-names></name><name><surname>G&#x000f6;ring</surname><given-names>HH</given-names></name><name><surname>Neary</surname><given-names>JL</given-names></name><name><surname>Cole</surname><given-names>SA</given-names></name><etal/></person-group>
<article-title>Genome- and epigenome-wide association study of hypertriglyceridemic waist in Mexican American families</article-title>. <source>Clin Epigenetics</source> (<year>2016</year>) <volume>8</volume>:<fpage>6</fpage>.<pub-id pub-id-type="doi">10.1186/s13148-016-0173-x</pub-id><?supplied-pmid 26798409?><pub-id pub-id-type="pmid">26798409</pub-id></mixed-citation></ref><ref id="B289"><label>289</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbieiri</surname><given-names>P</given-names></name><name><surname>Nunes</surname><given-names>JC</given-names></name><name><surname>Torres</surname><given-names>AG</given-names></name><name><surname>Nishimura</surname><given-names>RY</given-names></name><name><surname>Zuccolotto</surname><given-names>DC</given-names></name><name><surname>Crivellenti</surname><given-names>LC</given-names></name><etal/></person-group>
<article-title>Indices of dietary fat quality during midpregnancy is associated with gestational diabetes</article-title>. <source>Nutrition</source> (<year>2016</year>) <volume>32</volume>:<fpage>656</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="doi">10.1016/j.nut.2015.12.002</pub-id><?supplied-pmid 26876000?><pub-id pub-id-type="pmid">26876000</pub-id></mixed-citation></ref><ref id="B290"><label>290</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ram&#x000ed;rez-V&#x000e9;lez</surname><given-names>R</given-names></name><name><surname>Bustamante</surname><given-names>J</given-names></name><name><surname>Czerniczyniec</surname><given-names>A</given-names></name><name><surname>Aguilar de Plata</surname><given-names>AC</given-names></name><name><surname>Lores-Arnaiz</surname><given-names>S</given-names></name></person-group>. <article-title>Effect of exercise training on eNOS expression, NO production and oxygen metabolism in human placenta</article-title>. <source>PLoS One</source> (<year>2013</year>) <volume>8</volume>:<fpage>e80225</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0080225</pub-id><?supplied-pmid 24244656?><pub-id pub-id-type="pmid">24244656</pub-id></mixed-citation></ref><ref id="B291"><label>291</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ram&#x000ed;rez-V&#x000e9;lez</surname><given-names>R</given-names></name><name><surname>Aguilar de Plata</surname><given-names>AC</given-names></name><name><surname>Escudero</surname><given-names>MM</given-names></name><name><surname>Echeverry</surname><given-names>I</given-names></name><name><surname>Ortega</surname><given-names>JG</given-names></name><name><surname>Salazar</surname><given-names>B</given-names></name><etal/></person-group>
<article-title>Influence of regular aerobic exercise on endothelium-dependent vasodilation and cardiorespiratory fitness in pregnant women</article-title>. <source>J Obstet Gynaecol Res</source> (<year>2011</year>) <volume>37</volume>:<fpage>1601</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1111/j.1447-0756.2011.01582.x</pub-id><?supplied-pmid 21733037?><pub-id pub-id-type="pmid">21733037</pub-id></mixed-citation></ref><ref id="B292"><label>292</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ram&#x000ed;rez-V&#x000e9;lez</surname><given-names>R</given-names></name></person-group>
<article-title>Aerobic exercise training during pregnancy increases antioxidant status in nulliparous women: secondary data analysis of a controlled clinical trial</article-title>. <source>Endocrinol Nutr</source> (<year>2013</year>) <volume>60</volume>:<fpage>279</fpage>&#x02013;<lpage>81</lpage>.<pub-id pub-id-type="doi">10.1016/j.endonu.2012.05.012</pub-id><pub-id pub-id-type="pmid">22840511</pub-id></mixed-citation></ref><ref id="B293"><label>293</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cid</surname><given-names>M</given-names></name><name><surname>Gonz&#x000e1;lez</surname><given-names>M</given-names></name></person-group>
<article-title>Potential benefits of physical activity during pregnancy for the reduction of gestational diabetes prevalence and oxidative stress</article-title>. <source>Early Hum Dev</source> (<year>2016</year>) <volume>94</volume>:<fpage>57</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1016/j.earlhumdev.2016.01.007</pub-id><pub-id pub-id-type="pmid">26833143</pub-id></mixed-citation></ref><ref id="B294"><label>294</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perales</surname><given-names>M</given-names></name><name><surname>Santos-Lozano</surname><given-names>A</given-names></name><name><surname>Ruiz</surname><given-names>JR</given-names></name><name><surname>Lucia</surname><given-names>A</given-names></name><name><surname>Barakat</surname><given-names>R</given-names></name></person-group>
<article-title>Benefits of aerobic or resistance training during pregnancy on maternal health and perinatal outcomes: a systematic review</article-title>. <source>Early Hum Dev</source> (<year>2016</year>) <volume>94</volume>:<fpage>43</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/j.earlhumdev.2016.01.004</pub-id><pub-id pub-id-type="pmid">26850782</pub-id></mixed-citation></ref><ref id="B295"><label>295</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chasan-Taber</surname><given-names>L</given-names></name><name><surname>Silveira</surname><given-names>M</given-names></name><name><surname>Marcus</surname><given-names>BH</given-names></name><name><surname>Braun</surname><given-names>B</given-names></name><name><surname>Stanek</surname><given-names>E</given-names></name><name><surname>Markenson</surname><given-names>G</given-names></name></person-group>
<article-title>Feasibility and efficacy of a physical activity intervention among pregnant women: the Behaviors Affecting Baby and You (B.A.B.Y.) Study</article-title>. <source>J Phys ActHealth</source> (<year>2011</year>) <volume>8</volume>(<issue>Suppl 2</issue>):<fpage>S228</fpage>&#x02013;<lpage>38</lpage>.<pub-id pub-id-type="doi">10.1123/jpah.8.s2.s228</pub-id></mixed-citation></ref><ref id="B296"><label>296</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehrlich</surname><given-names>SF</given-names></name><name><surname>Hedderson</surname><given-names>MM</given-names></name><name><surname>Quesenberry</surname><given-names>CP</given-names><suffix>Jr</suffix></name><name><surname>Feng</surname><given-names>J</given-names></name><name><surname>Brown</surname><given-names>SD</given-names></name><name><surname>Crites</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>Post-partum weight loss and glucose metabolism in women with gestational diabetes: the DEBI study</article-title>. <source>Diabet Med</source> (<year>2014</year>) <volume>31</volume>:<fpage>862</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1111/dme.12425</pub-id><?supplied-pmid 24597974?><pub-id pub-id-type="pmid">24597974</pub-id></mixed-citation></ref><ref id="B297"><label>297</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrara</surname><given-names>A</given-names></name><name><surname>Hedderson</surname><given-names>MM</given-names></name><name><surname>Brown</surname><given-names>SD</given-names></name><name><surname>Albright</surname><given-names>CL</given-names></name><name><surname>Enrlich</surname><given-names>SF</given-names></name><name><surname>Tsai</surname><given-names>AL</given-names></name><etal/></person-group>
<article-title>The comparative effectiveness of diabetes prevention strategies to reduce postpartum weight retention in women with gestational diabetes mellitus: the gestational diabetes&#x02019; effects on moms (GEM) cluster randomized controlled trial</article-title>. <source>Diabetes Care</source> (<year>2016</year>) <volume>39</volume>:<fpage>65</fpage>&#x02013;<lpage>74</lpage>.<pub-id pub-id-type="doi">10.2337/dc15-1254</pub-id><pub-id pub-id-type="pmid">26657945</pub-id></mixed-citation></ref><ref id="B298"><label>298</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendelson</surname><given-names>SG</given-names></name><name><surname>McNeese-Smith</surname><given-names>D</given-names></name><name><surname>Koniak-Griffin</surname><given-names>D</given-names></name><name><surname>Nyamathi</surname><given-names>A</given-names></name><name><surname>Lu</surname><given-names>MC</given-names></name></person-group>. <article-title>A community-based parish nurse intervention program for Mexican American women with gestational diabetes</article-title>. <source>J Obstet Gynecol Neonatal Nurs</source> (<year>2008</year>) <volume>37</volume>:<fpage>415</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="doi">10.1111/j.1552-6909.2008.00262.x</pub-id><?supplied-pmid 18754979?><pub-id pub-id-type="pmid">18754979</pub-id></mixed-citation></ref><ref id="B299"><label>299</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Philis-Tsimikas</surname><given-names>A</given-names></name><name><surname>Fortmann</surname><given-names>AL</given-names></name><name><surname>Dharkar-Surber</surname><given-names>S</given-names></name><name><surname>Euyoque</surname><given-names>JA</given-names></name><name><surname>Ruiz</surname><given-names>M</given-names></name><name><surname>Schultz</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Dulce mothers: an intervention to reduce diabetes and cardiovascular risk in Latinas after gestational diabetes</article-title>. <source>Transl Behav Med</source> (<year>2014</year>) <volume>4</volume>:<fpage>18</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="doi">10.1007/s13142-014-0253-4</pub-id><?supplied-pmid 24653773?><pub-id pub-id-type="pmid">24653773</pub-id></mixed-citation></ref><ref id="B300"><label>300</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hawkins</surname><given-names>M</given-names></name><name><surname>Hosker</surname><given-names>M</given-names></name><name><surname>Marcus</surname><given-names>BH</given-names></name><name><surname>Rosal</surname><given-names>MC</given-names></name><name><surname>Braun</surname><given-names>B</given-names></name><name><surname>Stanek</surname><given-names>EJ</given-names></name><etal/></person-group>
<article-title>A pregnancy lifestyle intervention to prevent gestational diabetes risk factors in overweight Hispanic women: a feasibility randomized controlled trial</article-title>. <source>Diabet Med</source> (<year>2015</year>) <volume>32</volume>:<fpage>108</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="doi">10.1111/dme.12601</pub-id><?supplied-pmid 25306925?><pub-id pub-id-type="pmid">25306925</pub-id></mixed-citation></ref><ref id="B301"><label>301</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Athavale</surname><given-names>P</given-names></name><name><surname>Thomas</surname><given-names>M</given-names></name><name><surname>Delgadillo-Duenas</surname><given-names>AT</given-names></name><name><surname>Leong</surname><given-names>K</given-names></name><name><surname>Najmabadi</surname><given-names>A</given-names></name><name><surname>Harleman</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Linking high risk postpartum women with a technology enabled health coaching program to reduce diabetes risk and improve wellbeing: program description, case studies, and recommendations for community health coaching programs</article-title>. <source>J Diabetes Res</source> (<year>2016</year>) <volume>2016</volume>:<fpage>4353956</fpage><pub-id pub-id-type="doi">10.1155/2016/4353956</pub-id><pub-id pub-id-type="pmid">27830157</pub-id></mixed-citation></ref><ref id="B302"><label>302</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chasan-Taber</surname><given-names>L</given-names></name><name><surname>Marcus</surname><given-names>BH</given-names></name><name><surname>Rosal</surname><given-names>MC</given-names></name><name><surname>Tucker</surname><given-names>KL</given-names></name><name><surname>Hartnan</surname><given-names>SJ</given-names></name><name><surname>Pekow</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Estudio Parto: postpartum diabetes prevention program for Hispanic women with abnormal glucose tolerance in pregnancy: a randomized controlled trial &#x02013; study protocol</article-title>. <source>BMC Pregnancy Childbirth</source> (<year>2014</year>) <volume>14</volume>:<fpage>100</fpage><pub-id pub-id-type="doi">10.1186/1471-2393-14-100</pub-id><pub-id pub-id-type="pmid">24606590</pub-id></mixed-citation></ref><ref id="B303"><label>303</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haemer</surname><given-names>MA</given-names></name><name><surname>Grow</surname><given-names>HM</given-names></name><name><surname>Fernandez</surname><given-names>C</given-names></name><name><surname>Lukasiewicz</surname><given-names>GJ</given-names></name><name><surname>Rhodes</surname><given-names>ET</given-names></name><name><surname>Shaffer</surname><given-names>LA</given-names></name><etal/></person-group>
<article-title>Addressing prediabetes in childhood obesity treatment programs: support from research and current practice</article-title>. <source>Child Obes</source> (<year>2014</year>) <volume>10</volume>:<fpage>292</fpage>&#x02013;<lpage>303</lpage>.<pub-id pub-id-type="doi">10.1089/chi.2013.0158</pub-id><?supplied-pmid 25055134?><pub-id pub-id-type="pmid">25055134</pub-id></mixed-citation></ref><ref id="B304"><label>304</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Branscum</surname><given-names>P</given-names></name><name><surname>Sharma</surname><given-names>M</given-names></name></person-group>. <article-title>A systematic analysis of childhood obesity prevention interventions targeting Hispanic children: lessons learned from the previous decade</article-title>. <source>Obes Rev</source> (<year>2011</year>) <volume>12</volume>:<fpage>e151</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1111/j.1467-789X.2010.00809.x</pub-id><?supplied-pmid 20977600?><pub-id pub-id-type="pmid">20977600</pub-id></mixed-citation></ref><ref id="B305"><label>305</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>T</given-names></name><name><surname>Summerbell</surname><given-names>C</given-names></name></person-group>. <article-title>Systematic review of school-based interventions that focus on changing dietary intake and physical activity levels to prevent childhood obesity: an update to the obesity guidance produced by the National Institute for Health and Clinical Excellence</article-title>. <source>Obes Rev</source> (<year>2009</year>) <volume>10</volume>:<fpage>110</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="doi">10.1111/j.1467-789X.2008.00515.x</pub-id><?supplied-pmid 18673306?><pub-id pub-id-type="pmid">18673306</pub-id></mixed-citation></ref><ref id="B306"><label>306</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dietz</surname><given-names>WH</given-names></name><name><surname>Gortmaker</surname><given-names>SL</given-names></name></person-group>. <article-title>Preventing obesity in children and adolescents</article-title>. <source>Annu Rev Public Health</source> (<year>2001</year>) <volume>22</volume>:<fpage>337</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="doi">10.1146/annurev.publhealth.22.1.337</pub-id><?supplied-pmid 11274525?><pub-id pub-id-type="pmid">11274525</pub-id></mixed-citation></ref><ref id="B307"><label>307</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loveman</surname><given-names>E</given-names></name><name><surname>Al-Khudairy</surname><given-names>L</given-names></name><name><surname>Johnson</surname><given-names>RE</given-names></name><name><surname>Robertson</surname><given-names>W</given-names></name><name><surname>Colquitt</surname><given-names>JL</given-names></name><name><surname>Mead</surname><given-names>EL</given-names></name><etal/></person-group>
<article-title>Parent-only interventions for childhood overweight or obesity in children aged 5 to 11 years</article-title>. <source>Cochrane Database Syst Rev</source> (<year>2015</year>) <volume>12</volume>:<fpage>CD012008</fpage>.<pub-id pub-id-type="doi">10.1002/14651858.CD012008</pub-id><?supplied-pmid 26690844?><pub-id pub-id-type="pmid">26690844</pub-id></mixed-citation></ref><ref id="B308"><label>308</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x000e9;rez-Morales</surname><given-names>ME</given-names></name><name><surname>Bacard&#x000ed;-Gasc&#x000f3;n</surname><given-names>M</given-names></name><name><surname>Jim&#x000e9;nez-Cruz</surname><given-names>A</given-names></name></person-group>. <article-title>Childhood overweight and obesity prevention interventions among Hispanic children in the United States: systematic review</article-title>. <source>Nutr Hosp</source> (<year>2012</year>) <volume>27</volume>:<fpage>1415</fpage>&#x02013;<lpage>21</lpage>.<pub-id pub-id-type="doi">10.3305/nh.2012.27.5.5973</pub-id><?supplied-pmid 23478686?><pub-id pub-id-type="pmid">23478686</pub-id></mixed-citation></ref><ref id="B309"><label>309</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stice</surname><given-names>E</given-names></name><name><surname>Shaw</surname><given-names>H</given-names></name><name><surname>Marti</surname><given-names>CN</given-names></name></person-group>. <article-title>A meta-analytic review of obesity prevention programs for children and adolescents: the skinny on interventions that work</article-title>. <source>Psychol Bull</source> (<year>2006</year>) <volume>132</volume>:<fpage>667</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="doi">10.1037/0033-2909.132.5.667</pub-id><?supplied-pmid 16910747?><pub-id pub-id-type="pmid">16910747</pub-id></mixed-citation></ref><ref id="B310"><label>310</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Cai</surname><given-names>L</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Wilson</surname><given-names>RF</given-names></name><name><surname>Weston</surname><given-names>C</given-names></name><name><surname>Fawole</surname><given-names>O</given-names></name><etal/></person-group>
<article-title>What childhood obesity prevention programmes work? A systematic review and meta-analysis</article-title>. <source>Obes Rev</source> (<year>2015</year>) <volume>16</volume>:<fpage>547</fpage>&#x02013;<lpage>65</lpage>.<pub-id pub-id-type="doi">10.1111/obr.12277</pub-id><?supplied-pmid 25893796?><pub-id pub-id-type="pmid">25893796</pub-id></mixed-citation></ref><ref id="B311"><label>311</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Whitlock</surname><given-names>EP</given-names></name><name><surname>O&#x02019;Connor</surname><given-names>EA</given-names></name><name><surname>Williams</surname><given-names>SB</given-names></name><name><surname>Beil</surname><given-names>TL</given-names></name><name><surname>Lutz</surname><given-names>KW</given-names></name></person-group>
<article-title>(Oregon Evidence-Based Practice Center, Center for Health Research, Portland, OR)</article-title>. <source>Effectiveness of Primary Care Interventions for Weight Management in Children and Adolescents: An Updated, Targeted Systematic Review for the USPSTF</source>. <publisher-loc>Rockville, MD</publisher-loc>: <publisher-name>Agency for Healthcare Research and Quality (US)</publisher-name> (<year>2010</year>). <fpage>168</fpage> p.</mixed-citation></ref><ref id="B312"><label>312</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whitlock</surname><given-names>EP</given-names></name><name><surname>O&#x02019;Connor</surname><given-names>EA</given-names></name><name><surname>Williams</surname><given-names>SB</given-names></name><name><surname>Beil</surname><given-names>TL</given-names></name><name><surname>Lutz</surname><given-names>KW</given-names></name></person-group>. <article-title>Effectiveness of weight management interventions in children: a targeted systematic review for the USPSTF</article-title>. <source>Pediatrics</source> (<year>2010</year>) <volume>125</volume>:<fpage>e396</fpage>&#x02013;<lpage>418</lpage>.<pub-id pub-id-type="doi">10.1542/peds.2009-1955</pub-id><?supplied-pmid 20083531?><pub-id pub-id-type="pmid">20083531</pub-id></mixed-citation></ref><ref id="B313"><label>313</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>LA</given-names></name><name><surname>Lane</surname><given-names>CJ</given-names></name><name><surname>Weigensberg</surname><given-names>MJ</given-names></name><name><surname>Toledo-Corral</surname><given-names>CM</given-names></name><name><surname>Goran</surname><given-names>MI</given-names></name></person-group>
<article-title>Pubertal changes of insulin sensitivity, acute insulin response, and &#x003b2;-cell function in overweight Latino youth</article-title>. <source>J Pediatr</source> (<year>2011</year>) <volume>158</volume>:<fpage>442</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1016/j.jpeds.2010.08.046</pub-id><pub-id pub-id-type="pmid">20888012</pub-id></mixed-citation></ref><ref id="B314"><label>314</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marshall</surname><given-names>WA</given-names></name><name><surname>Tanner</surname><given-names>JM</given-names></name></person-group>
<article-title>Variations in pattern of pubertal changes in girls</article-title>. <source>Arch Dis Child</source> (<year>1969</year>) <volume>44</volume>:<fpage>291</fpage>&#x02013;<lpage>303</lpage>.<pub-id pub-id-type="doi">10.1136/adc.44.235.291</pub-id><pub-id pub-id-type="pmid">5785179</pub-id></mixed-citation></ref><ref id="B315"><label>315</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marshall</surname><given-names>WA</given-names></name><name><surname>Tanner</surname><given-names>JM</given-names></name></person-group>
<article-title>Variations in the pattern of pubertal changes in boys</article-title>. <source>Arch Dis Child</source> (<year>1970</year>) <volume>45</volume>:<fpage>13</fpage>&#x02013;<lpage>23</lpage>.<pub-id pub-id-type="doi">10.1136/adc.45.239.13</pub-id><pub-id pub-id-type="pmid">5440182</pub-id></mixed-citation></ref><ref id="B316"><label>316</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wells</surname><given-names>JC</given-names></name><name><surname>Cole</surname><given-names>TJ</given-names></name></person-group>. <article-title>Height, adiposity and hormonal cardiovascular risk markers in childhood: how to partition the associations?</article-title>
<source>Int J Obes</source> (<year>2014</year>) <volume>38</volume>:<fpage>930</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1038/ijo.2014.24</pub-id><?supplied-pmid 24509503?><pub-id pub-id-type="pmid">24509503</pub-id></mixed-citation></ref><ref id="B317"><label>317</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yajnik</surname><given-names>CS</given-names></name></person-group>. <article-title>Nutrition, growth, and body size in relation to insulin resistance and type 2 diabetes</article-title>. <source>Curr Diab Rep</source> (<year>2003</year>) <volume>3</volume>:<fpage>108</fpage>&#x02013;<lpage>14</lpage>.<pub-id pub-id-type="doi">10.1007/s11892-003-0033-x</pub-id><?supplied-pmid 12728636?><pub-id pub-id-type="pmid">12728636</pub-id></mixed-citation></ref><ref id="B318"><label>318</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berkowitz</surname><given-names>RI</given-names></name><name><surname>Wadden</surname><given-names>TA</given-names></name><name><surname>Gehrman</surname><given-names>CA</given-names></name><name><surname>Bishop-Gilyard</surname><given-names>CT</given-names></name><name><surname>Moore</surname><given-names>RH</given-names></name><name><surname>Womble</surname><given-names>LG</given-names></name><etal/></person-group>
<article-title>Meal replacements in the treatment of adolescent obesity: a randomized controlled trial</article-title>. <source>Obesity</source> (<year>2011</year>) <volume>19</volume>:<fpage>1193</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1038/oby.2010.288</pub-id><?supplied-pmid 21151016?><pub-id pub-id-type="pmid">21151016</pub-id></mixed-citation></ref><ref id="B319"><label>319</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berkowitz</surname><given-names>RI</given-names></name><name><surname>Wadden</surname><given-names>TA</given-names></name><name><surname>Tershakovec</surname><given-names>AM</given-names></name><name><surname>Cronquist</surname><given-names>JL</given-names></name></person-group>. <article-title>Behavior therapy and sibutramine for the treatment of adolescent obesity: a randomized controlled trial</article-title>. <source>JAMA</source> (<year>2003</year>) <volume>289</volume>:<fpage>1805</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="doi">10.1001/jama.289.14.1805</pub-id><?supplied-pmid 12684359?><pub-id pub-id-type="pmid">12684359</pub-id></mixed-citation></ref><ref id="B320"><label>320</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fox</surname><given-names>CK</given-names></name><name><surname>Kaizer</surname><given-names>AM</given-names></name><name><surname>Rudser</surname><given-names>KD</given-names></name><name><surname>Nathan</surname><given-names>BM</given-names></name><name><surname>Gross</surname><given-names>AC</given-names></name><name><surname>Sunni</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Meal replacements followed by topiramate for the treatment of adolescent severe obesity: a pilot randomized controlled trial</article-title>. <source>Obesity</source> (<year>2016</year>) <volume>24</volume>:<fpage>2553</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="doi">10.1002/oby.21633</pub-id><?supplied-pmid 27807925?><pub-id pub-id-type="pmid">27807925</pub-id></mixed-citation></ref><ref id="B321"><label>321</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jelalian</surname><given-names>E</given-names></name><name><surname>Lloyd-Richardson</surname><given-names>EE</given-names></name><name><surname>Mehlenbeck</surname><given-names>RS</given-names></name><name><surname>Hart</surname><given-names>CN</given-names></name><name><surname>Flynn-O&#x02019;Brien</surname><given-names>K</given-names></name><name><surname>Kaplan</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Behavioral weight control treatment with supervised exercise or peer-enhanced adventure for overweight adolescents</article-title>. <source>J Pediatr</source> (<year>2010</year>) <volume>157</volume>:<fpage>923</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/j.jpeds.2010.05.047</pub-id><pub-id pub-id-type="pmid">20655544</pub-id></mixed-citation></ref><ref id="B322"><label>322</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lloyd-Richardson</surname><given-names>EE</given-names></name><name><surname>Jelalian</surname><given-names>E</given-names></name><name><surname>Sato</surname><given-names>AF</given-names></name><name><surname>Hart</surname><given-names>CN</given-names></name><name><surname>Mehlenbeck</surname><given-names>R</given-names></name><name><surname>Wing</surname><given-names>RR</given-names></name></person-group>. <article-title>Two-year follow-up of an adolescent behavioral weight control intervention</article-title>. <source>Pediatrics</source> (<year>2012</year>) <volume>130</volume>:<fpage>e281</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1542/peds.2011-3283</pub-id><?supplied-pmid 22753560?><pub-id pub-id-type="pmid">22753560</pub-id></mixed-citation></ref><ref id="B323"><label>323</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parillo</surname><given-names>M</given-names></name><name><surname>Licenziati</surname><given-names>MR</given-names></name><name><surname>Vacca</surname><given-names>M</given-names></name><name><surname>De Marco</surname><given-names>D</given-names></name><name><surname>Iannuzzi</surname><given-names>A</given-names></name></person-group>. <article-title>Metabolic changes after a hypocaloric, low-glycemic-index diet in obese children</article-title>. <source>J Endocrinol Invest</source> (<year>2012</year>) <volume>35</volume>:<fpage>629</fpage>&#x02013;<lpage>33</lpage>.<pub-id pub-id-type="doi">10.3275/7909</pub-id><?supplied-pmid 21897113?><pub-id pub-id-type="pmid">21897113</pub-id></mixed-citation></ref><ref id="B324"><label>324</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reinehr</surname><given-names>T</given-names></name><name><surname>Kiess</surname><given-names>W</given-names></name><name><surname>Kapellen</surname><given-names>T</given-names></name><name><surname>Andler</surname><given-names>W</given-names></name></person-group>. <article-title>Insulin sensitivity among obese children and adolescents, according to degree of weight loss</article-title>. <source>Pediatrics</source> (<year>2004</year>) <volume>114</volume>:<fpage>1569</fpage>&#x02013;<lpage>73</lpage>.<pub-id pub-id-type="doi">10.1542/peds.2003-0649-F</pub-id><?supplied-pmid 15574616?><pub-id pub-id-type="pmid">15574616</pub-id></mixed-citation></ref><ref id="B325"><label>325</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ventura</surname><given-names>E</given-names></name><name><surname>Davis</surname><given-names>J</given-names></name><name><surname>Byrd-Williams</surname><given-names>C</given-names></name><name><surname>Alexander</surname><given-names>K</given-names></name><name><surname>McClain</surname><given-names>A</given-names></name><name><surname>Lane</surname><given-names>CJ</given-names></name><etal/></person-group>
<article-title>Reduction in risk factors for type 2 diabetes mellitus in response to a low-sugar, high-fiber dietary intervention in overweight Latino adolescents</article-title>. <source>ArchPediatr Adolesc Med</source> (<year>2009</year>) <volume>163</volume>:<fpage>320</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1001/archpediatrics.2009.11</pub-id><?supplied-pmid 19349560?><pub-id pub-id-type="pmid">19349560</pub-id></mixed-citation></ref><ref id="B326"><label>326</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holub</surname><given-names>CK</given-names></name><name><surname>Elder</surname><given-names>JP</given-names></name><name><surname>Arredondo</surname><given-names>EM</given-names></name><name><surname>Barquera</surname><given-names>S</given-names></name><name><surname>Eisenberg</surname><given-names>CM</given-names></name><name><surname>S&#x000e1;nchez Romero</surname><given-names>LM</given-names></name><etal/></person-group>
<article-title>Obesity control in Latin American and U.S. Latinos: a systematic review</article-title>. <source>Am J Prev Med</source> (<year>2013</year>) <volume>44</volume>:<fpage>529</fpage>&#x02013;<lpage>37</lpage>.<pub-id pub-id-type="doi">10.1016/j.amepre.2013.01.023</pub-id><?supplied-pmid 23597819?><pub-id pub-id-type="pmid">23597819</pub-id></mixed-citation></ref><ref id="B327"><label>327</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindberg</surname><given-names>NM</given-names></name><name><surname>Stevens</surname><given-names>VJ</given-names></name></person-group>. <article-title>Review: weight-loss interventions with Hispanic populations</article-title>. <source>Ethn Dis</source> (<year>2007</year>) <volume>17</volume>:<fpage>397</fpage>&#x02013;<lpage>402</lpage>.<?supplied-pmid 17682376?><pub-id pub-id-type="pmid">17682376</pub-id></mixed-citation></ref><ref id="B328"><label>328</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lobelo</surname><given-names>F</given-names></name><name><surname>Garcia de Quevedo</surname><given-names>I</given-names></name><name><surname>Holub</surname><given-names>CK</given-names></name><name><surname>Nagle</surname><given-names>BJ</given-names></name><name><surname>Arredondo</surname><given-names>EM</given-names></name><name><surname>Barquera</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>School-based programs aimed at the prevention and treatment of obesity: evidence-based interventions for youth in Latin America</article-title>. <source>J Sch Health</source> (<year>2013</year>) <volume>83</volume>:<fpage>668</fpage>&#x02013;<lpage>77</lpage>.<pub-id pub-id-type="doi">10.1111/josh.12080</pub-id><?supplied-pmid 23879787?><pub-id pub-id-type="pmid">23879787</pub-id></mixed-citation></ref><ref id="B329"><label>329</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagle</surname><given-names>BJ</given-names></name><name><surname>Holub</surname><given-names>CK</given-names></name><name><surname>Barquera</surname><given-names>S</given-names></name><name><surname>S&#x000e1;nchez-Romero</surname><given-names>LM</given-names></name><name><surname>Eisenberg</surname><given-names>CM</given-names></name><name><surname>Rivera-Dommarco</surname><given-names>JA</given-names></name><etal/></person-group>
<article-title>Interventions for the treatment of obesity among children and adolescents in Latin America: a systematic review</article-title>. <source>Salud Publica Mex</source> (<year>2013</year>) <volume>55</volume>(<issue>Suppl 3</issue>):<fpage>434</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="doi">10.21149/spm.v55s3.5145</pub-id><?supplied-pmid 24643493?><pub-id pub-id-type="pmid">24643493</pub-id></mixed-citation></ref><ref id="B330"><label>330</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eisenberg</surname><given-names>CM</given-names></name><name><surname>S&#x000e1;nchez-Romero</surname><given-names>LM</given-names></name><name><surname>Rivera-Dommarco</surname><given-names>JA</given-names></name><name><surname>Holub</surname><given-names>CK</given-names></name><name><surname>Arredondo</surname><given-names>EM</given-names></name><name><surname>Elder</surname><given-names>JP</given-names></name><etal/></person-group>
<article-title>Interventions to increase physical activity and healthy eating among overweight and obese children in Mexico</article-title>. <source>SaludPublica Mex</source> (<year>2013</year>) <volume>55</volume>(<issue>Suppl 3</issue>):<fpage>441</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.21149/spm.v55s3.5146</pub-id></mixed-citation></ref><ref id="B331"><label>331</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ayala</surname><given-names>GX</given-names></name><name><surname>Ibarra</surname><given-names>L</given-names></name><name><surname>Binggeli-Vallarta</surname><given-names>A</given-names></name><name><surname>Moody</surname><given-names>J</given-names></name><name><surname>McKenzie</surname><given-names>TL</given-names></name><name><surname>Angulo</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Our choice/Nuestra opci&#x000f3;n: the Imperial County, California, childhood obesity research demonstration study (CA-CORD)</article-title>. <source>Child Obes</source> (<year>2015</year>) <volume>11</volume>:<fpage>37</fpage>&#x02013;<lpage>47</lpage>.<pub-id pub-id-type="doi">10.1089/chi.2014.0080</pub-id><pub-id pub-id-type="pmid">25584664</pub-id></mixed-citation></ref><ref id="B332"><label>332</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dooyema</surname><given-names>CA</given-names></name><name><surname>Belay</surname><given-names>B</given-names></name><name><surname>Foltz</surname><given-names>JL</given-names></name><name><surname>Williams</surname><given-names>N</given-names></name><name><surname>Blanck</surname><given-names>HM</given-names></name></person-group>
<article-title>The childhood obesity research demonstration project: a comprehensive community approach to reduce childhood obesity</article-title>. <source>Child Obes</source> (<year>2013</year>) <volume>9</volume>:<fpage>454</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1089/chi.2013.0060</pub-id><pub-id pub-id-type="pmid">24094146</pub-id></mixed-citation></ref><ref id="B333"><label>333</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Connor</surname><given-names>DP</given-names></name><name><surname>Lee</surname><given-names>RE</given-names></name><name><surname>Mehta</surname><given-names>P</given-names></name><name><surname>Thompson</surname><given-names>D</given-names></name><name><surname>Bhargava</surname><given-names>A</given-names></name><name><surname>Carlson</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Childhood obesity research demonstration project: cross-site evaluation methods</article-title>. <source>Child Obes</source> (<year>2015</year>) <volume>11</volume>:<fpage>92</fpage>&#x02013;<lpage>103</lpage>.<pub-id pub-id-type="doi">10.1089/chi.2014.0061</pub-id><?supplied-pmid 25679060?><pub-id pub-id-type="pmid">25679060</pub-id></mixed-citation></ref><ref id="B334"><label>334</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>N</given-names></name><name><surname>Dooyema</surname><given-names>CA</given-names></name><name><surname>Foltz</surname><given-names>JL</given-names></name><name><surname>Belay</surname><given-names>B</given-names></name><name><surname>Blanck</surname><given-names>HM</given-names></name></person-group>. <article-title>The childhood obesity research demonstration project: a team approach for supporting a multisite, multisector intervention</article-title>. <source>Child Obes</source> (<year>2015</year>) <volume>1</volume>:<fpage>104</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1089/chi.2014.0063</pub-id><?supplied-pmid 25325835?><pub-id pub-id-type="pmid">25325835</pub-id></mixed-citation></ref><ref id="B335"><label>335</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Epstein</surname><given-names>LH</given-names></name><name><surname>Gordy</surname><given-names>CC</given-names></name><name><surname>Raynor</surname><given-names>HA</given-names></name><name><surname>Beddome</surname><given-names>M</given-names></name><name><surname>Kilanowski</surname><given-names>CK</given-names></name><name><surname>Paluch</surname><given-names>R</given-names></name></person-group>. <article-title>Increasing fruit and vegetable intake and decreasing fat and sugar intake in families at risk for childhood obesity</article-title>. <source>Obes Res</source> (<year>2001</year>) <volume>9</volume>:<fpage>171</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1038/oby.2001.18</pub-id><?supplied-pmid 11323442?><pub-id pub-id-type="pmid">11323442</pub-id></mixed-citation></ref><ref id="B336"><label>336</label><mixed-citation publication-type="book"><collab>American Diabetes Association</collab>. <source>Preventing Type 2 Diabetes [Internet]</source>. <publisher-loc>Arlington, VA</publisher-loc>: <publisher-name>American Diabetes Association</publisher-name> (<year>2014</year>). Available from: <uri xlink:type="simple" xlink:href="http://www.diabetes.org/living-with-diabetes/parents-and-kids/children-and-type-2/preventing-type-2-in-children.html">http://www.diabetes.org/living-with-diabetes/parents-and-kids/children-and-type-2/preventing-type-2-in-children.html</uri></mixed-citation></ref><ref id="B337"><label>337</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gow</surname><given-names>ML</given-names></name><name><surname>Garnett</surname><given-names>SP</given-names></name><name><surname>Baur</surname><given-names>LA</given-names></name><name><surname>Lister</surname><given-names>NB</given-names></name></person-group>. <article-title>The effectiveness of different diet strategies to reduce type 2 diabetes risk in youth</article-title>. <source>Nutrients</source> (<year>2016</year>) <volume>8</volume>:<fpage>486</fpage>.<pub-id pub-id-type="doi">10.3390/nu8080486</pub-id><?supplied-pmid 27517953?><pub-id pub-id-type="pmid">27517953</pub-id></mixed-citation></ref><ref id="B338"><label>338</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fajcsak</surname><given-names>Z</given-names></name><name><surname>Gabor</surname><given-names>A</given-names></name><name><surname>Kovacs</surname><given-names>V</given-names></name><name><surname>Martos</surname><given-names>E</given-names></name></person-group>
<article-title>The effects of 6-week low glycemic load diet based on low glycemic index foods in overweight/obese children &#x02013; pilot study</article-title>. <source>J Am Coll Nutr</source> (<year>2008</year>) <volume>27</volume>:<fpage>12</fpage>&#x02013;<lpage>21</lpage>.<pub-id pub-id-type="doi">10.1080/07315724.2008.10719670</pub-id><pub-id pub-id-type="pmid">18460477</pub-id></mixed-citation></ref><ref id="B339"><label>339</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gellar</surname><given-names>L</given-names></name><name><surname>Nansel</surname><given-names>TR</given-names></name></person-group>. <article-title>High and low glycemic index mixed meals and blood glucose in youth with type 2 diabetes or impaired glucose tolerance</article-title>. <source>J Pediatr</source> (<year>2009</year>) <volume>154</volume>:<fpage>455</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/j.jpeds.2008.09.040</pub-id><?supplied-pmid 19874764?><pub-id pub-id-type="pmid">19874764</pub-id></mixed-citation></ref><ref id="B340"><label>340</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iannuzzi</surname><given-names>A</given-names></name><name><surname>Licenziati</surname><given-names>MR</given-names></name><name><surname>Vacca</surname><given-names>M</given-names></name><name><surname>De Marco</surname><given-names>D</given-names></name><name><surname>Cinquegrana</surname><given-names>G</given-names></name><name><surname>Laccetti</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Comparison of two diets of varying glycemic index on carotid subclinical atherosclerosis in obese children</article-title>. <source>Heart Vessels</source> (<year>2009</year>) <volume>24</volume>:<fpage>419</fpage>&#x02013;<lpage>24</lpage>.<pub-id pub-id-type="doi">10.1007/s00380-008-1138-6</pub-id><?supplied-pmid 20108073?><pub-id pub-id-type="pmid">20108073</pub-id></mixed-citation></ref><ref id="B341"><label>341</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krebs</surname><given-names>NF</given-names></name><name><surname>Gao</surname><given-names>D</given-names></name><name><surname>Gralla</surname><given-names>J</given-names></name><name><surname>Collins</surname><given-names>JS</given-names></name><name><surname>Johnson</surname><given-names>SL</given-names></name></person-group>. <article-title>Efficacy and safety of a high protein, low carbohydrate diet for weight loss in severely obese adolescents</article-title>. <source>J Pediatr</source> (<year>2010</year>) <volume>157</volume>:<fpage>252</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/j.jpeds.2010.02.010</pub-id><?supplied-pmid 20304413?><pub-id pub-id-type="pmid">20304413</pub-id></mixed-citation></ref><ref id="B342"><label>342</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebbeling</surname><given-names>CB</given-names></name><name><surname>Leidig</surname><given-names>MM</given-names></name><name><surname>Sinclair</surname><given-names>KB</given-names></name><name><surname>Hangen</surname><given-names>JP</given-names></name><name><surname>Ludwig</surname><given-names>DS</given-names></name></person-group>
<article-title>A reduced-glycemic load diet in the treatment of adolescent obesity</article-title>. <source>Arch Pediatr Adolesc Med</source> (<year>2003</year>) <volume>157</volume>:<fpage>773</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1001/archpedi.157.8.773</pub-id><pub-id pub-id-type="pmid">12912783</pub-id></mixed-citation></ref><ref id="B343"><label>343</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boule</surname><given-names>NG</given-names></name><name><surname>Haddad</surname><given-names>E</given-names></name><name><surname>Kenny</surname><given-names>GP</given-names></name><name><surname>Wells</surname><given-names>GA</given-names></name><name><surname>Sigal</surname><given-names>RJ</given-names></name></person-group>. <article-title>Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials</article-title>. <source>JAMA</source> (<year>2001</year>) <volume>286</volume>:<fpage>1218</fpage>&#x02013;<lpage>27</lpage>.<pub-id pub-id-type="doi">10.1001/jama.286.10.1218</pub-id><?supplied-pmid 11559268?><pub-id pub-id-type="pmid">11559268</pub-id></mixed-citation></ref><ref id="B344"><label>344</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bunt</surname><given-names>JC</given-names></name><name><surname>Salbe</surname><given-names>AD</given-names></name><name><surname>Harper</surname><given-names>IT</given-names></name><name><surname>Hanson</surname><given-names>RL</given-names></name><name><surname>Tataranni</surname><given-names>PA</given-names></name></person-group>. <article-title>Weight, adiposity, and physical activity as determinants of an insulin sensitivity index in Pima Indian children</article-title>. <source>Diabetes Care</source> (<year>2003</year>) <volume>26</volume>:<fpage>2524</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="doi">10.2337/diacare.26.9.2524</pub-id><?supplied-pmid 12941713?><pub-id pub-id-type="pmid">12941713</pub-id></mixed-citation></ref><ref id="B345"><label>345</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duncan</surname><given-names>GE</given-names></name></person-group>
<article-title>The &#x0201c;fit but fat&#x0201d; concept revisited: population-based estimates using NHANES</article-title>. <source>Int J Behav Nutr Phys Act</source> (<year>2010</year>) <volume>7</volume>:<fpage>47</fpage><pub-id pub-id-type="doi">10.1186/1479-5868-7-47</pub-id><pub-id pub-id-type="pmid">20497579</pub-id></mixed-citation></ref><ref id="B346"><label>346</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Kuk</surname><given-names>JL</given-names></name><name><surname>Davidson</surname><given-names>LE</given-names></name><name><surname>Hudson</surname><given-names>R</given-names></name><name><surname>Kilpatrick</surname><given-names>K</given-names></name><name><surname>Graham</surname><given-names>TE</given-names></name><etal/></person-group>
<article-title>Exercise without weight loss is an effective strategy for obesity reduction in obese individuals with and without type 2 diabetes</article-title>. <source>J Appl Physiol</source> (<year>2005</year>) <volume>99</volume>:<fpage>1220</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1152/japplphysiol.00053.2005</pub-id><?supplied-pmid 15860689?><pub-id pub-id-type="pmid">15860689</pub-id></mixed-citation></ref><ref id="B347"><label>347</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macias-Cervantes</surname><given-names>MH</given-names></name><name><surname>Malacara</surname><given-names>JM</given-names></name><name><surname>Garay-Sevilla</surname><given-names>ME</given-names></name><name><surname>D&#x000ed;az-Cisneros</surname><given-names>FJ</given-names></name></person-group>. <article-title>Effect of recreational physical activity on insulin levels in Mexican/Hispanic children</article-title>. <source>Eur J Pediatr</source> (<year>2009</year>) <volume>168</volume>:<fpage>1195</fpage>&#x02013;<lpage>202</lpage>.<pub-id pub-id-type="doi">10.1007/s00431-008-0907-7</pub-id><?supplied-pmid 19142662?><pub-id pub-id-type="pmid">19142662</pub-id></mixed-citation></ref><ref id="B348"><label>348</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ross</surname><given-names>R</given-names></name><name><surname>Janssen</surname><given-names>I</given-names></name><name><surname>Dawson</surname><given-names>J</given-names></name><name><surname>Kungl</surname><given-names>AM</given-names></name><name><surname>Kuk</surname><given-names>JL</given-names></name><name><surname>Wong</surname><given-names>SL</given-names></name><etal/></person-group>
<article-title>Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial</article-title>. <source>Obes Res</source> (<year>2004</year>) <volume>12</volume>:<fpage>789</fpage>&#x02013;<lpage>98</lpage>.<pub-id pub-id-type="doi">10.1038/oby.2004.95</pub-id><?supplied-pmid 15166299?><pub-id pub-id-type="pmid">15166299</pub-id></mixed-citation></ref><ref id="B349"><label>349</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugiura</surname><given-names>H</given-names></name><name><surname>Sugiura</surname><given-names>H</given-names></name><name><surname>Kajima</surname><given-names>K</given-names></name><name><surname>Mirbod</surname><given-names>SM</given-names></name><name><surname>Iwata</surname><given-names>H</given-names></name><name><surname>Matsuoka</surname><given-names>T</given-names></name></person-group>. <article-title>Effects of long-term moderate exercise and increase in number of daily steps on serum lipids in women: randomised controlled trial [ISRCTN21921919]</article-title>. <source>BMC Womens Health</source> (<year>2002</year>) <volume>2</volume>:<fpage>3</fpage>.<pub-id pub-id-type="doi">10.1186/1472-6874-2-3</pub-id><?supplied-pmid 11846892?><pub-id pub-id-type="pmid">11846892</pub-id></mixed-citation></ref><ref id="B350"><label>350</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aires</surname><given-names>L</given-names></name><name><surname>Silva</surname><given-names>G</given-names></name><name><surname>Martins</surname><given-names>C</given-names></name><name><surname>Marques</surname><given-names>E</given-names></name><name><surname>Lagoa</surname><given-names>MJ</given-names></name><name><surname>Ribeiro</surname><given-names>JC</given-names></name><etal/></person-group>
<article-title>Exercise intervention and cardiovascular risk factors in obese children. Comparison between obese youngsters taking part in a physical activity school-based programme with and without individualised diet counselling: the ACORDA project</article-title>. <source>Ann Hum Biol</source> (<year>2016</year>) <volume>43</volume>:<fpage>183</fpage>&#x02013;<lpage>90</lpage>.<pub-id pub-id-type="doi">10.3109/03014460.2015.1059889</pub-id><?supplied-pmid 26193775?><pub-id pub-id-type="pmid">26193775</pub-id></mixed-citation></ref><ref id="B351"><label>351</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobbins</surname><given-names>M</given-names></name><name><surname>Husson</surname><given-names>H</given-names></name><name><surname>DeCorby</surname><given-names>K</given-names></name><name><surname>LaRocca</surname><given-names>RL</given-names></name></person-group>
<article-title>School-based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18</article-title>. <source>Cochrane Database Syst Rev</source> (<year>2013</year>) <volume>2</volume>:<fpage>CD007651</fpage><pub-id pub-id-type="doi">10.1002/14651858.CD007651.pub2</pub-id></mixed-citation></ref><ref id="B352"><label>352</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janssen</surname><given-names>I</given-names></name><name><surname>Leblanc</surname><given-names>AG</given-names></name></person-group>. <article-title>Systematic review of the health benefits of physical activity and fitness in school-aged children and youth</article-title>. <source>Int J Behav Nutr Phys Act</source> (<year>2010</year>) <volume>7</volume>:<fpage>40</fpage>.<pub-id pub-id-type="doi">10.1186/1479-5868-7-40</pub-id><?supplied-pmid 20459784?><pub-id pub-id-type="pmid">20459784</pub-id></mixed-citation></ref><ref id="B353"><label>353</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neumark-Sztainer</surname><given-names>DR</given-names></name><name><surname>Friend</surname><given-names>SE</given-names></name><name><surname>Flattum</surname><given-names>CF</given-names></name><name><surname>Hannan</surname><given-names>PJ</given-names></name><name><surname>Story</surname><given-names>MT</given-names></name><name><surname>Bauer</surname><given-names>KW</given-names></name><etal/></person-group>
<article-title>New moves &#x02013; preventing weight-related problems in adolescent girls: a group-randomized study</article-title>. <source>Am J Prev Med</source> (<year>2010</year>) <volume>39</volume>:<fpage>421</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="doi">10.1016/j.amepre.2010.07.017</pub-id><?supplied-pmid 20965379?><pub-id pub-id-type="pmid">20965379</pub-id></mixed-citation></ref><ref id="B354"><label>354</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grey</surname><given-names>M</given-names></name><name><surname>Jaser</surname><given-names>SS</given-names></name><name><surname>Holl</surname><given-names>MG</given-names></name><name><surname>Jefferson</surname><given-names>V</given-names></name><name><surname>Dziura</surname><given-names>J</given-names></name><name><surname>Northrup</surname><given-names>V</given-names></name></person-group>. <article-title>A multifaceted school-based intervention to reduce risk for type 2 diabetes in at-risk youth</article-title>. <source>Prev Med</source> (<year>2009</year>) <volume>49</volume>:<fpage>122</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/j.ypmed.2009.07.014</pub-id><?supplied-pmid 19643125?><pub-id pub-id-type="pmid">19643125</pub-id></mixed-citation></ref><ref id="B355"><label>355</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trevi&#x000f1;o</surname><given-names>RP</given-names></name><name><surname>Yin</surname><given-names>Z</given-names></name><name><surname>Hernandez</surname><given-names>A</given-names></name><name><surname>Hale</surname><given-names>DE</given-names></name><name><surname>Garcia</surname><given-names>OA</given-names></name><name><surname>Mobley</surname><given-names>C</given-names></name></person-group>
<article-title>Impact of the Bienestar school-based diabetes mellitus prevention program on fasting capillary glucose levels: a randomized controlled trial</article-title>. <source>Arch Pediatr AdolescMed</source> (<year>2004</year>) <volume>158</volume>:<fpage>911</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1001/archpedi.158.9.911</pub-id></mixed-citation></ref><ref id="B356"><label>356</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenbaum</surname><given-names>M</given-names></name><name><surname>Nonas</surname><given-names>C</given-names></name><name><surname>Weil</surname><given-names>R</given-names></name><name><surname>Horlick</surname><given-names>M</given-names></name><name><surname>Fennoy</surname><given-names>I</given-names></name><name><surname>Vargas</surname><given-names>I</given-names></name><etal/></person-group>
<article-title>School-based intervention acutely improves insulin sensitivity and decreases inflammatory markers and body fatness in junior high school students</article-title>. <source>J ClinEndocrinol Metab</source> (<year>2007</year>) <volume>92</volume>:<fpage>504</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1210/jc.2006-1516</pub-id><?supplied-pmid 17090635?><pub-id pub-id-type="pmid">17090635</pub-id></mixed-citation></ref><ref id="B357"><label>357</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnston</surname><given-names>CA</given-names></name><name><surname>Moreno</surname><given-names>JP</given-names></name><name><surname>Foreyt</surname><given-names>JP</given-names></name></person-group>. <article-title>Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes</article-title>. <source>Curr Atheroscler Rep</source> (<year>2014</year>) <volume>16</volume>:<fpage>457</fpage>.<pub-id pub-id-type="doi">10.1007/s11883-014-0457-6</pub-id><?supplied-pmid 25288176?><pub-id pub-id-type="pmid">25288176</pub-id></mixed-citation></ref><ref id="B358"><label>358</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foster</surname><given-names>GD</given-names></name><name><surname>Linder</surname><given-names>B</given-names></name><name><surname>Baranowski</surname><given-names>T</given-names></name><name><surname>Cooper</surname><given-names>DM</given-names></name><name><surname>Goldberg</surname><given-names>L</given-names></name><name><surname>Harrell</surname><given-names>JS</given-names></name><etal/></person-group>
<article-title>A school-based intervention for diabetes risk reduction</article-title>. <source>N Engl J Med</source> (<year>2010</year>) <volume>363</volume>:<fpage>443</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="doi">10.1056/NEJMoa1001933</pub-id><?supplied-pmid 20581420?><pub-id pub-id-type="pmid">20581420</pub-id></mixed-citation></ref><ref id="B359"><label>359</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willi</surname><given-names>SM</given-names></name><name><surname>Hirst</surname><given-names>K</given-names></name><name><surname>Jago</surname><given-names>R</given-names></name><name><surname>Buse</surname><given-names>J</given-names></name><name><surname>Kaufman</surname><given-names>F</given-names></name><name><surname>El Ghormli</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>Cardiovascular risk factors in multi-ethnic middle school students: the HEALTHY primary prevention trial</article-title>. <source>Pediatr Obes</source> (<year>2012</year>) <volume>7</volume>:<fpage>230</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1111/j.2047-6310.2011.00042.x</pub-id><?supplied-pmid 22461375?><pub-id pub-id-type="pmid">22461375</pub-id></mixed-citation></ref><ref id="B360"><label>360</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>HJ</given-names></name><name><surname>Andersen</surname><given-names>LB</given-names></name><name><surname>Lofrano-Prado</surname><given-names>MC</given-names></name><name><surname>Barros</surname><given-names>MV</given-names></name><name><surname>Freitas</surname><given-names>IF</given-names><suffix>Jr</suffix></name><name><surname>Hill</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Improvements on cardiovascular diseases risk factors in obese adolescents: a randomized exercise intervention study</article-title>. <source>J Phys Act Health</source> (<year>2015</year>) <volume>12</volume>:<fpage>553</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="doi">10.1123/jpah.2013-0199</pub-id><?supplied-pmid 24778268?><pub-id pub-id-type="pmid">24778268</pub-id></mixed-citation></ref><ref id="B361"><label>361</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryder</surname><given-names>JR</given-names></name><name><surname>Vega-Lopez</surname><given-names>S</given-names></name><name><surname>Ortega</surname><given-names>R</given-names></name><name><surname>Konopken</surname><given-names>Y</given-names></name><name><surname>Shaibi</surname><given-names>GQ</given-names></name></person-group>. <article-title>Lifestyle intervention improves lipoprotein particle size and distribution without weight loss in obese Latino adolescents</article-title>. <source>Pediatr Obes</source> (<year>2013</year>) <volume>8</volume>:<fpage>e59</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="doi">10.1111/j.2047-6310.2013.00162.x</pub-id><?supplied-pmid 23576420?><pub-id pub-id-type="pmid">23576420</pub-id></mixed-citation></ref><ref id="B362"><label>362</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaibi</surname><given-names>GQ</given-names></name><name><surname>Konopken</surname><given-names>Y</given-names></name><name><surname>Hoppin</surname><given-names>E</given-names></name><name><surname>Keller</surname><given-names>CS</given-names></name><name><surname>Ortega</surname><given-names>R</given-names></name><name><surname>Castro</surname><given-names>FG</given-names></name></person-group>. <article-title>Effects of a culturally grounded community-based diabetes prevention program for obese Latino adolescents</article-title>. <source>Diabetes Educ</source> (<year>2012</year>) <volume>38</volume>:<fpage>504</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="doi">10.1177/0145721712446635</pub-id><?supplied-pmid 22585870?><pub-id pub-id-type="pmid">22585870</pub-id></mixed-citation></ref><ref id="B363"><label>363</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vel&#x000e1;zquez-L&#x000f3;pez</surname><given-names>L</given-names></name><name><surname>Rico Ramos</surname><given-names>JM</given-names></name><name><surname>Torres Tamayo</surname><given-names>M</given-names></name><name><surname>Medina Bravo</surname><given-names>P</given-names></name><name><surname>Toca Porraz</surname><given-names>LE</given-names></name><name><surname>Escobedo de la Pe&#x000f1;a</surname><given-names>J</given-names></name></person-group>
<article-title>Impacto de la educaci&#x000f3;n nutricional sobre alteraciones metab&#x000f3;licas en ni&#x000f1;os y adolescentes con obesidad</article-title>. <source>Endocrinol Nutr</source> (<year>2009</year>) <volume>56</volume>:<fpage>441</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1016/S1575-0922(09)73311-X</pub-id><pub-id pub-id-type="pmid">20114013</pub-id></mixed-citation></ref><ref id="B364"><label>364</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knowler</surname><given-names>WC</given-names></name><name><surname>Barrett-Connor</surname><given-names>E</given-names></name><name><surname>Fowler</surname><given-names>SE</given-names></name><name><surname>Hamman</surname><given-names>RF</given-names></name><name><surname>Lachin</surname><given-names>JM</given-names></name><name><surname>Walker</surname><given-names>EA</given-names></name><etal/></person-group>
<article-title>Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin</article-title>. <source>N Engl J Med</source> (<year>2002</year>) <volume>346</volume>:<fpage>393</fpage>&#x02013;<lpage>403</lpage>.<pub-id pub-id-type="doi">10.1056/NEJMoa012512</pub-id><?supplied-pmid 11832527?><pub-id pub-id-type="pmid">11832527</pub-id></mixed-citation></ref><ref id="B365"><label>365</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubin</surname><given-names>RR</given-names></name><name><surname>Fujimoto</surname><given-names>WY</given-names></name><name><surname>Marrero</surname><given-names>DG</given-names></name><name><surname>Brenneman</surname><given-names>T</given-names></name><name><surname>Charleston</surname><given-names>JB</given-names></name><name><surname>Edelstein</surname><given-names>SL</given-names></name><etal/></person-group>
<article-title>The diabetes prevention program: recruitment methods and results</article-title>. <source>Control Clin Trials</source> (<year>2002</year>) <volume>23</volume>:<fpage>157</fpage>&#x02013;<lpage>71</lpage>.<pub-id pub-id-type="doi">10.1016/S0197-2456(01)00184-2</pub-id><?supplied-pmid 11943442?><pub-id pub-id-type="pmid">11943442</pub-id></mixed-citation></ref><ref id="B366"><label>366</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>West</surname><given-names>DS</given-names></name><name><surname>Prewitt</surname><given-names>TE</given-names></name><name><surname>Bursac</surname><given-names>Z</given-names></name><name><surname>Felix</surname><given-names>HC</given-names></name></person-group>. <article-title>Weight loss of black, white, and Hispanic men and women in the diabetes prevention program</article-title>. <source>Obesity</source> (<year>2008</year>) <volume>16</volume>:<fpage>1413</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1038/oby.2008.224</pub-id><?supplied-pmid 18421273?><pub-id pub-id-type="pmid">18421273</pub-id></mixed-citation></ref><ref id="B367"><label>367</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Brien</surname><given-names>MJ</given-names></name><name><surname>Perez</surname><given-names>A</given-names></name><name><surname>Alos</surname><given-names>VA</given-names></name><name><surname>Whitaker</surname><given-names>RC</given-names></name><name><surname>Ciolino</surname><given-names>JD</given-names></name><name><surname>Mohr</surname><given-names>DC</given-names></name><etal/></person-group>
<article-title>The feasibility, acceptability, and preliminary effectiveness of a promotora-led diabetes prevention program (PL-DPP) in Latinas: a pilot study</article-title>. <source>Diabetes Educ</source> (<year>2015</year>) <volume>41</volume>:<fpage>485</fpage>&#x02013;<lpage>94</lpage>.<pub-id pub-id-type="doi">10.1177/0145721715586576</pub-id><?supplied-pmid 26023095?><pub-id pub-id-type="pmid">26023095</pub-id></mixed-citation></ref><ref id="B368"><label>368</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ockene</surname><given-names>IS</given-names></name><name><surname>Tellez</surname><given-names>TL</given-names></name><name><surname>Rosal</surname><given-names>MC</given-names></name><name><surname>Reed</surname><given-names>GW</given-names></name><name><surname>Mordes</surname><given-names>J</given-names></name><name><surname>Merriam</surname><given-names>PA</given-names></name><etal/></person-group>
<article-title>Outcomes of a Latino community-based intervention for the prevention of diabetes: the Lawrence Latino diabetes prevention project</article-title>. <source>Am J Public Health</source> (<year>2012</year>) <volume>102</volume>:<fpage>336</fpage>&#x02013;<lpage>42</lpage>.<pub-id pub-id-type="doi">10.2105/AJPH.2011.300357</pub-id><?supplied-pmid 22390448?><pub-id pub-id-type="pmid">22390448</pub-id></mixed-citation></ref><ref id="B369"><label>369</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruggiero</surname><given-names>L</given-names></name><name><surname>Oros</surname><given-names>S</given-names></name><name><surname>Choi</surname><given-names>YK</given-names></name></person-group>. <article-title>Community-based translation of the diabetes prevention program&#x02019;s lifestyle intervention in an underserved Latino population</article-title>. <source>Diabetes Educ</source> (<year>2011</year>) <volume>37</volume>:<fpage>564</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="doi">10.1177/0145721711411107</pub-id><?supplied-pmid 21690435?><pub-id pub-id-type="pmid">21690435</pub-id></mixed-citation></ref><ref id="B370"><label>370</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Name</surname><given-names>MA</given-names></name><name><surname>Camp</surname><given-names>AW</given-names></name><name><surname>Magenheimer</surname><given-names>EA</given-names></name><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Dziura</surname><given-names>JD</given-names></name><name><surname>Montosa</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Effective translation of an intensive lifestyle intervention for Hispanic women with prediabetes in a community health center setting</article-title>. <source>Diabetes Care</source> (<year>2016</year>) <volume>39</volume>:<fpage>525</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="doi">10.2337/dc15-1899</pub-id><pub-id pub-id-type="pmid">26908915</pub-id></mixed-citation></ref><ref id="B371"><label>371</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vincent</surname><given-names>D</given-names></name><name><surname>McEwen</surname><given-names>MM</given-names></name><name><surname>Hepworth</surname><given-names>JT</given-names></name><name><surname>Stump</surname><given-names>CS</given-names></name></person-group>. <article-title>The effects of a community-based, culturally tailored diabetes prevention intervention for high-risk adults of Mexican descent</article-title>. <source>Diabetes Educ</source> (<year>2014</year>) <volume>40</volume>:<fpage>202</fpage>&#x02013;<lpage>13</lpage>.<pub-id pub-id-type="doi">10.1177/0145721714521020</pub-id><?supplied-pmid 24510942?><pub-id pub-id-type="pmid">24510942</pub-id></mixed-citation></ref><ref id="B372"><label>372</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>West-Pollak</surname><given-names>A</given-names></name><name><surname>Then</surname><given-names>EP</given-names></name><name><surname>Podesta</surname><given-names>C</given-names></name><name><surname>Hedelt</surname><given-names>A</given-names></name><name><surname>Perry</surname><given-names>ML</given-names></name><name><surname>Izarnotegui</surname><given-names>WV</given-names></name><etal/></person-group>
<article-title>Impact of a novel community-based lifestyle intervention program on type 2 diabetes and cardiovascular risk in a resource-poor setting in the Dominican Republic</article-title>. <source>Int Health</source> (<year>2014</year>) <volume>6</volume>:<fpage>118</fpage>&#x02013;<lpage>24</lpage>.<pub-id pub-id-type="doi">10.1093/inthealth/iht039</pub-id><?supplied-pmid 24497608?><pub-id pub-id-type="pmid">24497608</pub-id></mixed-citation></ref><ref id="B373"><label>373</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fain</surname><given-names>JA</given-names></name></person-group>
<article-title>The diabetes prevention program: replicating/translating the results</article-title>. <source>Diabetes Educ</source> (<year>2009</year>) <volume>35</volume>:<fpage>179</fpage><pub-id pub-id-type="doi">10.1177/01457217090350020301</pub-id><pub-id pub-id-type="pmid">19321804</pub-id></mixed-citation></ref><ref id="B374"><label>374</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giese</surname><given-names>KK</given-names></name><name><surname>Cook</surname><given-names>PF</given-names></name></person-group>
<article-title>Reducing obesity among employees of a manufacturing plant: translating the diabetes prevention program to the workplace</article-title>. <source>Workplace Health Saf</source> (<year>2014</year>) <volume>62</volume>:<fpage>136</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="doi">10.3928/21650799-20140305-02</pub-id><pub-id pub-id-type="pmid">24702680</pub-id></mixed-citation></ref><ref id="B375"><label>375</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>L</given-names></name></person-group>. <article-title>Translating the diabetes prevention program into practice: a review of community interventions</article-title>. <source>Diabetes Educ</source> (<year>2009</year>) <volume>35</volume>:<fpage>309</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1177/0145721708330153</pub-id><?supplied-pmid 19321809?><pub-id pub-id-type="pmid">19321809</pub-id></mixed-citation></ref><ref id="B376"><label>376</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krame</surname><given-names>MK</given-names></name><name><surname>Kriska</surname><given-names>AM</given-names></name><name><surname>Venditti</surname><given-names>EM</given-names></name><name><surname>Miller</surname><given-names>RG</given-names></name><name><surname>Brooks</surname><given-names>MM</given-names></name><name><surname>Burke</surname><given-names>LE</given-names></name><etal/></person-group>
<article-title>Translating the diabetes prevention program: a comprehensive model for prevention training and program delivery</article-title>. <source>Am J Prev Med</source> (<year>2009</year>) <volume>37</volume>:<fpage>505</fpage>&#x02013;<lpage>11</lpage>.<pub-id pub-id-type="doi">10.1016/j.amepre.2009.07.020</pub-id><?supplied-pmid 19944916?><pub-id pub-id-type="pmid">19944916</pub-id></mixed-citation></ref><ref id="B377"><label>377</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seidel</surname><given-names>MC</given-names></name><name><surname>Powell</surname><given-names>RO</given-names></name><name><surname>Zgibor</surname><given-names>JC</given-names></name><name><surname>Siminerio</surname><given-names>LM</given-names></name><name><surname>Piatt</surname><given-names>GA</given-names></name></person-group>. <article-title>Translating the diabetes prevention program into an urban medically underserved community: a nonrandomized prospective intervention study</article-title>. <source>Diabetes Care</source> (<year>2008</year>) <volume>31</volume>:<fpage>684</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.2337/dc07-1869</pub-id><?supplied-pmid 18252904?><pub-id pub-id-type="pmid">18252904</pub-id></mixed-citation></ref><ref id="B378"><label>378</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whittemor</surname><given-names>R</given-names></name><name><surname>Melkus</surname><given-names>G</given-names></name><name><surname>Wagner</surname><given-names>J</given-names></name><name><surname>Dziura</surname><given-names>J</given-names></name><name><surname>Northrup</surname><given-names>V</given-names></name><name><surname>Grey</surname><given-names>M</given-names></name></person-group>. <article-title>Translating the diabetes prevention program to primary care: a pilot study</article-title>. <source>Nurs Res</source> (<year>2009</year>) <volume>58</volume>:<fpage>2</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="doi">10.1097/NNR.0b013e31818fcef3</pub-id><?supplied-pmid 19092550?><pub-id pub-id-type="pmid">19092550</pub-id></mixed-citation></ref><ref id="B379"><label>379</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ali</surname><given-names>MK</given-names></name><name><surname>Echouffo-Tcheugui</surname><given-names>J</given-names></name><name><surname>Williamson</surname><given-names>DF</given-names></name></person-group>
<article-title>How effective were lifestyle interventions in real-world settings that were modeled on the diabetes prevention program?</article-title>
<source>Health Aff</source> (<year>2012</year>) <volume>31</volume>:<fpage>67</fpage>&#x02013;<lpage>75</lpage>.<pub-id pub-id-type="doi">10.1377/hlthaff.2011.1009</pub-id></mixed-citation></ref><ref id="B380"><label>380</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCurley</surname><given-names>JL</given-names></name><name><surname>Gutierrez</surname><given-names>AP</given-names></name><name><surname>Gallo</surname><given-names>LC</given-names></name></person-group>. <article-title>Diabetes prevention in U.S. Hispanic adults: a systematic review of culturally tailored interventions</article-title>. <source>Am J Prev Med</source> (<year>2017</year>) <volume>52</volume>:<fpage>519</fpage>&#x02013;<lpage>29</lpage>.<pub-id pub-id-type="doi">10.1016/j.amepre.2016.10.028</pub-id><?supplied-pmid 27989451?><pub-id pub-id-type="pmid">27989451</pub-id></mixed-citation></ref><ref id="B381"><label>381</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosas</surname><given-names>LG</given-names></name><name><surname>Lv</surname><given-names>N</given-names></name><name><surname>Xiao</surname><given-names>L</given-names></name><name><surname>Lewis</surname><given-names>MA</given-names></name><name><surname>Zavella</surname><given-names>P</given-names></name><name><surname>Kramer</surname><given-names>MK</given-names></name><etal/></person-group>
<article-title>Evaluation of a culturally-adapted lifestyle intervention to treat elevated cardiometabolic risk of Latino adults in primary care (Vida Sana): a randomized controlled trial</article-title>. <source>Contemp Clin Trials</source> (<year>2016</year>) <volume>48</volume>:<fpage>30</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="doi">10.1016/j.cct.2016.03.003</pub-id><?supplied-pmid 26995280?><pub-id pub-id-type="pmid">26995280</pub-id></mixed-citation></ref><ref id="B382"><label>382</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Col&#x000f3;n-Ramos</surname><given-names>U</given-names></name><name><surname>Thompson</surname><given-names>FE</given-names></name><name><surname>Yaroch</surname><given-names>AL</given-names></name><name><surname>Moser</surname><given-names>RP</given-names></name><name><surname>McNeel</surname><given-names>TS</given-names></name><name><surname>Dodd</surname><given-names>KW</given-names></name><etal/></person-group>
<article-title>Differences in fruit and vegetable intake among Hispanic subgroups in California: results from the 2005 California Health Interview Survey</article-title>. <source>J Am Diet Assoc</source> (<year>2009</year>) <volume>109</volume>:<fpage>1878</fpage>&#x02013;<lpage>85</lpage>.<pub-id pub-id-type="doi">10.1016/j.jada.2009.08.015</pub-id><?supplied-pmid 19857629?><pub-id pub-id-type="pmid">19857629</pub-id></mixed-citation></ref><ref id="B383"><label>383</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>TM</given-names></name><name><surname>Col&#x000f3;n-Ramos</surname><given-names>U</given-names></name><name><surname>Pinard</surname><given-names>CA</given-names></name><name><surname>Yaroch</surname><given-names>AL</given-names></name></person-group>. <article-title>Household food insecurity as a determinant of overweight and obesity among low-income Hispanic subgroups: data from the 2011-2012 California Health Interview Survey</article-title>. <source>Appetite</source> (<year>2016</year>) <volume>97</volume>:<fpage>37</fpage>&#x02013;<lpage>42</lpage>.<pub-id pub-id-type="doi">10.1016/j.appet.2015.11.009</pub-id><?supplied-pmid 26603573?><pub-id pub-id-type="pmid">26603573</pub-id></mixed-citation></ref><ref id="B384"><label>384</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heisler</surname><given-names>M</given-names></name><name><surname>Kaselitz</surname><given-names>E</given-names></name><name><surname>Rana</surname><given-names>GK</given-names></name><name><surname>Piette</surname><given-names>JD</given-names></name></person-group>
<article-title>Diabetes prevention interventions in Latin American countries: a scoping review</article-title>. <source>Curr Diab Rep</source> (<year>2016</year>) <volume>16</volume>:<fpage>80</fpage><pub-id pub-id-type="doi">10.1007/s11892-016-0778-7</pub-id><pub-id pub-id-type="pmid">27424069</pub-id></mixed-citation></ref><ref id="B385"><label>385</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Svetkey</surname><given-names>LP</given-names></name><name><surname>Simons-Morton</surname><given-names>D</given-names></name><name><surname>Vollmer</surname><given-names>WM</given-names></name><name><surname>Appel</surname><given-names>LJ</given-names></name><name><surname>Conlin</surname><given-names>PR</given-names></name><name><surname>Ryan</surname><given-names>DH</given-names></name><etal/></person-group>
<article-title>Effects of dietary patterns on blood pressure: subgroup analysis of the dietary approaches to stop hypertension (DASH) randomized clinical trial</article-title>. <source>Arch Intern Med</source> (<year>1999</year>) <volume>159</volume>:<fpage>285</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="doi">10.1001/archinte.159.3.285</pub-id><?supplied-pmid 9989541?><pub-id pub-id-type="pmid">9989541</pub-id></mixed-citation></ref><ref id="B386"><label>386</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lima</surname><given-names>ST</given-names></name><name><surname>da Silva Nalin de Souza</surname><given-names>B</given-names></name><name><surname>Franca</surname><given-names>AK</given-names></name><name><surname>Salgado Filho</surname><given-names>N</given-names></name><name><surname>Sichieri</surname><given-names>R</given-names></name></person-group>. <article-title>Dietary approach to hypertension based on low glycaemic index and principles of DASH (dietary approaches to stop hypertension): a randomised trial in a primary care service</article-title>. <source>Br J Nutr</source> (<year>2013</year>) <volume>110</volume>:<fpage>1472</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1017/S0007114513000718</pub-id><?supplied-pmid 23632203?><pub-id pub-id-type="pmid">23632203</pub-id></mixed-citation></ref><ref id="B387"><label>387</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sartorelli</surname><given-names>DS</given-names></name><name><surname>Sciarra</surname><given-names>EC</given-names></name><name><surname>Franco</surname><given-names>LJ</given-names></name><name><surname>Cardoso</surname><given-names>MA</given-names></name></person-group>. <article-title>Beneficial effects of short-term nutritional counselling at the primary health-care level among Brazilian adults</article-title>. <source>Public Health Nutr</source> (<year>2005</year>) <volume>8</volume>:<fpage>820</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1079/PHN2005737</pub-id><?supplied-pmid 16277797?><pub-id pub-id-type="pmid">16277797</pub-id></mixed-citation></ref><ref id="B388"><label>388</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Assun&#x000e7;&#x000e3;o</surname><given-names>MC</given-names></name><name><surname>Gigante</surname><given-names>DP</given-names></name><name><surname>Cardoso</surname><given-names>MA</given-names></name><name><surname>Sartorelli</surname><given-names>DS</given-names></name><name><surname>Santos</surname><given-names>IS</given-names></name></person-group>. <article-title>Randomized, controlled trial promotes physical activity and reduces consumption of sweets and sodium among overweight and obese adults</article-title>. <source>Nutr Res</source> (<year>2010</year>) <volume>30</volume>:<fpage>541</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/j.nutres.2010.07.006</pub-id><?supplied-pmid 20851308?><pub-id pub-id-type="pmid">20851308</pub-id></mixed-citation></ref><ref id="B389"><label>389</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindg&#x000e4;rde</surname><given-names>F</given-names></name><name><surname>Ahr&#x000e9;n</surname><given-names>B</given-names></name></person-group>
<article-title>Improved metabolic risk markers following two 6-month physical activity programs among socioeconomic marginalized women of Native American ancestry in Lima, Peru</article-title>. <source>Diabetes Care</source> (<year>2007</year>) <volume>30</volume>:<fpage>2230</fpage>&#x02013;<lpage>2</lpage>.<pub-id pub-id-type="doi">10.2337/dc06-2633</pub-id><pub-id pub-id-type="pmid">17540957</pub-id></mixed-citation></ref><ref id="B390"><label>390</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pimentel</surname><given-names>GD</given-names></name><name><surname>Portero-McLellan</surname><given-names>KC</given-names></name><name><surname>Oliveira</surname><given-names>EP</given-names></name><name><surname>Spada</surname><given-names>AP</given-names></name><name><surname>Oshiiwa</surname><given-names>M</given-names></name><name><surname>Zemdegs</surname><given-names>JC</given-names></name><etal/></person-group>
<article-title>Long-term nutrition education reduces several risk factors for type 2 diabetes mellitus in Brazilians with impaired glucose tolerance</article-title>. <source>Nutr Res</source> (<year>2010</year>) <volume>30</volume>:<fpage>186</fpage>&#x02013;<lpage>90</lpage>.<pub-id pub-id-type="doi">10.1016/j.nutres.2010.03.003</pub-id><?supplied-pmid 20417879?><pub-id pub-id-type="pmid">20417879</pub-id></mixed-citation></ref><ref id="B391"><label>391</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buchanan</surname><given-names>TA</given-names></name><name><surname>Xiang</surname><given-names>AH</given-names></name><name><surname>Peters</surname><given-names>RK</given-names></name><name><surname>Kjos</surname><given-names>SL</given-names></name><name><surname>Marroquin</surname><given-names>A</given-names></name><name><surname>Goico</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Preservation of pancreatic &#x003b2;-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women</article-title>. <source>Diabetes</source> (<year>2002</year>) <volume>51</volume>:<fpage>2796</fpage>&#x02013;<lpage>803</lpage>.<pub-id pub-id-type="doi">10.2337/diabetes.51.9.2796</pub-id><pub-id pub-id-type="pmid">12196473</pub-id></mixed-citation></ref><ref id="B392"><label>392</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiang</surname><given-names>AH</given-names></name><name><surname>Peters</surname><given-names>RK</given-names></name><name><surname>Kjos</surname><given-names>SL</given-names></name><name><surname>Marroquin</surname><given-names>A</given-names></name><name><surname>Goico</surname><given-names>J</given-names></name><name><surname>Ochoa</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Effect of pioglitazone on pancreatic &#x003b2;-cell function and diabetes risk in Hispanic women with prior gestational diabetes</article-title>. <source>Diabetes</source> (<year>2006</year>) <volume>55</volume>:<fpage>517</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="doi">10.2337/diabetes.55.02.06.db05-1066</pub-id><pub-id pub-id-type="pmid">16443789</pub-id></mixed-citation></ref><ref id="B393"><label>393</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyko</surname><given-names>EJ</given-names></name><name><surname>Gerstein</surname><given-names>HC</given-names></name><name><surname>Mohan</surname><given-names>V</given-names></name><name><surname>Yusuf</surname><given-names>S</given-names></name><name><surname>Sheridan</surname><given-names>P</given-names></name><name><surname>Anand</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Effects of ethnicity on diabetes incidence and prevention: results of the diabetes reduction assessment with ramipril and rosiglitazone medication (DREAM) trial</article-title>. <source>Diabet Med</source> (<year>2010</year>) <volume>27</volume>:<fpage>1226</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="doi">10.1111/j.1464-5491.2010.03064.x</pub-id><?supplied-pmid 20950379?><pub-id pub-id-type="pmid">20950379</pub-id></mixed-citation></ref><ref id="B394"><label>394</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeFronzo</surname><given-names>RA</given-names></name><name><surname>Tripathy</surname><given-names>D</given-names></name><name><surname>Schwenke</surname><given-names>DC</given-names></name><name><surname>Banerji</surname><given-names>MA</given-names></name><name><surname>Bray</surname><given-names>GA</given-names></name><name><surname>Buchanan</surname><given-names>TA</given-names></name><etal/></person-group>
<article-title>Pioglitazone for diabetes prevention in impaired glucose tolerance</article-title>. <source>N Engl J Med</source> (<year>2011</year>) <volume>364</volume>:<fpage>1104</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="doi">10.1056/NEJMoa1010949</pub-id><?supplied-pmid 21428766?><pub-id pub-id-type="pmid">21428766</pub-id></mixed-citation></ref><ref id="B395"><label>395</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Brien</surname><given-names>MJ</given-names></name><name><surname>Perez</surname><given-names>A</given-names></name><name><surname>Scanlan</surname><given-names>AB</given-names></name><name><surname>Alos</surname><given-names>VA</given-names></name><name><surname>Whitaker</surname><given-names>RC</given-names></name><name><surname>Foster</surname><given-names>GD</given-names></name><etal/></person-group>
<article-title>PREVENT-DM comparative effective trial of lifestyle intervention and metformin</article-title>. <source>Am J Prev Med</source> (<year>2017</year>) <volume>52</volume>:<fpage>788</fpage>&#x02013;<lpage>97</lpage>.<pub-id pub-id-type="doi">10.1016/j.amepre.2017.01.008</pub-id><pub-id pub-id-type="pmid">28237635</pub-id></mixed-citation></ref><ref id="B396"><label>396</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewin</surname><given-names>AJ</given-names></name><name><surname>Kereiakes</surname><given-names>DJ</given-names></name><name><surname>Chrysant</surname><given-names>SG</given-names></name><name><surname>Izzo</surname><given-names>JL</given-names></name><name><surname>Oparil</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Triple-combination treatment with olmesartan medoxomil/amlodipine/hydrochlorothiazide in Hispanic/Latino patients with hypertension: the TRINITY study</article-title>. <source>Ethn Dis</source> (<year>2014</year>) <volume>24</volume>:<fpage>41</fpage>&#x02013;<lpage>7</lpage>.<?supplied-pmid 24620447?><pub-id pub-id-type="pmid">24620447</pub-id></mixed-citation></ref><ref id="B397"><label>397</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper-DeHoff</surname><given-names>RM</given-names></name><name><surname>Aranda</surname><given-names>JM</given-names></name><name><surname>Gaxiola</surname><given-names>E</given-names></name><name><surname>Cangiano</surname><given-names>JL</given-names></name><name><surname>Garcia-Barreto</surname><given-names>D</given-names></name><name><surname>Conti</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Blood pressure control and cardiovascular outcomes in high-risk Hispanic patients &#x02013; findings from the INternational VErapamil SR/Trandolapril STudy (INVEST)</article-title>. <source>Am Heart J</source> (<year>2006</year>) <volume>151</volume>:<fpage>1072</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/j.ahj.2005.05.024</pub-id><pub-id pub-id-type="pmid">16644338</pub-id></mixed-citation></ref><ref id="B398"><label>398</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper-DeHoff</surname><given-names>RM</given-names></name><name><surname>Cohen</surname><given-names>JD</given-names></name><name><surname>Bakris</surname><given-names>GL</given-names></name><name><surname>Messerli</surname><given-names>FH</given-names></name><name><surname>Erdine</surname><given-names>S</given-names></name><name><surname>Hewkin</surname><given-names>AC</given-names></name><etal/></person-group>
<article-title>Predictors of development of diabetes mellitus in patients with coronary artery disease taking antihypertensive medications (findings from the International Verapamil SR-Trandolapril Study [INVEST])</article-title>. <source>Am J Cardiol</source> (<year>2006</year>) <volume>98</volume>:<fpage>890</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1016/j.amjcard.2006.04.030</pub-id><?supplied-pmid 16996868?><pub-id pub-id-type="pmid">16996868</pub-id></mixed-citation></ref><ref id="B399"><label>399</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Margolis</surname><given-names>KL</given-names></name><name><surname>Piller</surname><given-names>LB</given-names></name><name><surname>Ford</surname><given-names>CE</given-names></name><name><surname>Henriquez</surname><given-names>MA</given-names></name><name><surname>Cushman</surname><given-names>WC</given-names></name><name><surname>Einhorn</surname><given-names>PT</given-names></name><etal/></person-group>
<article-title>Blood pressure control in Hispanics in the antihypertensive and lipid-lowering treatment to prevent heart attack trial</article-title>. <source>Hypertension</source> (<year>2007</year>) <volume>50</volume>:<fpage>854</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.107.092650</pub-id><?supplied-pmid 17846352?><pub-id pub-id-type="pmid">17846352</pub-id></mixed-citation></ref><ref id="B400"><label>400</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wright</surname><given-names>JT</given-names></name><name><surname>Lacourciere</surname><given-names>Y</given-names></name><name><surname>Samuel</surname><given-names>R</given-names></name><name><surname>Zappe</surname><given-names>D</given-names></name><name><surname>Purkayastha</surname><given-names>D</given-names></name><name><surname>Black</surname><given-names>HR</given-names></name></person-group>
<article-title>24-hr ambulatory blood pressure response to combination valsartan/hydrochlorothiazide and amlodipine/hydrochlorothiazide in stage 2 hypertension by ethnicity: the EVALUATE study</article-title>. <source>J Clin Hypertens</source> (<year>2010</year>) <volume>12</volume>:<fpage>833</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="doi">10.1111/j.1751-7176.2010.00372.x</pub-id></mixed-citation></ref><ref id="B401"><label>401</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yusuf</surname><given-names>S</given-names></name><name><surname>Gerstein</surname><given-names>H</given-names></name><name><surname>Hoogwerf</surname><given-names>B</given-names></name><name><surname>Pogue</surname><given-names>J</given-names></name><name><surname>Bosch</surname><given-names>J</given-names></name><name><surname>Wolffenbuttel</surname><given-names>BHR</given-names></name><etal/></person-group>
<article-title>Ramipril and the development of diabetes</article-title>. <source>JAMA</source> (<year>2001</year>) <volume>286</volume>:<fpage>1882</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1001/jama.286.15.1882</pub-id><pub-id pub-id-type="pmid">11597291</pub-id></mixed-citation></ref><ref id="B402"><label>402</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elliott</surname><given-names>WJ</given-names></name><name><surname>Meyer</surname><given-names>PM</given-names></name></person-group>. <article-title>Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis</article-title>. <source>Lancet</source> (<year>2007</year>) <volume>369</volume>:<fpage>201</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1016/S0140-6736(07)60108-1</pub-id><?supplied-pmid 17240286?><pub-id pub-id-type="pmid">17240286</pub-id></mixed-citation></ref><ref id="B403"><label>403</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper-DeHoff</surname><given-names>RM</given-names></name><name><surname>Zhou</surname><given-names>Q</given-names></name><name><surname>Gaxiola</surname><given-names>E</given-names></name><name><surname>Cangiano</surname><given-names>JL</given-names></name><name><surname>Garcia-Barreto</surname><given-names>D</given-names></name><name><surname>Handberg</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Influence of Hispanic ethnicity on blood pressure control and cardiovascular outcomes in women with CAD and hypertension: findings from INVEST</article-title>. <source>J Womens Health</source> (<year>2007</year>) <volume>16</volume>:<fpage>632</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="doi">10.1089/jwh.2006.0086</pub-id><?supplied-pmid 17627399?><pub-id pub-id-type="pmid">17627399</pub-id></mixed-citation></ref><ref id="B404"><label>404</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Punzi</surname><given-names>H</given-names></name><name><surname>Lewin</surname><given-names>A</given-names></name><name><surname>Lukic</surname><given-names>T</given-names></name><name><surname>Goodin</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name></person-group>. <article-title>Efficacy and safety of nebivolol in Hispanics with stage I-II hypertension: a randomized placebo-controlled trial</article-title>. <source>Ther Adv Cardiovasc Dis</source> (<year>2010</year>) <volume>4</volume>:<fpage>349</fpage>&#x02013;<lpage>57</lpage>.<pub-id pub-id-type="doi">10.1177/1753944710387629</pub-id><?supplied-pmid 21088095?><pub-id pub-id-type="pmid">21088095</pub-id></mixed-citation></ref><ref id="B405"><label>405</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aranda</surname><given-names>JM</given-names><suffix>Jr</suffix></name><name><surname>Calderon</surname><given-names>R</given-names></name><name><surname>Aranda</surname><given-names>JM</given-names><suffix>Sr</suffix></name></person-group>. <article-title>Clinical characteristics and outcomes in hypertensive patients of Hispanic descent</article-title>. <source>Prev Cardiol</source> (<year>2008</year>) <volume>11</volume>:<fpage>116</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1111/j.1751-7141.2008.08008.x</pub-id><?supplied-pmid 18401240?><pub-id pub-id-type="pmid">18401240</pub-id></mixed-citation></ref><ref id="B406"><label>406</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yi</surname><given-names>SS</given-names></name><name><surname>Tabaei</surname><given-names>BP</given-names></name><name><surname>Angell</surname><given-names>SY</given-names></name><name><surname>Rapin</surname><given-names>A</given-names></name><name><surname>Buck</surname><given-names>MD</given-names></name><name><surname>Pagano</surname><given-names>WG</given-names></name><etal/></person-group>
<article-title>Self-blood pressure monitoring in an urban, ethnically diverse population: a randomized clinical trial utilizing the electronic health record</article-title>. <source>Circ Cardiovasc Qual Outcomes</source> (<year>2015</year>) <volume>8</volume>:<fpage>138</fpage>&#x02013;<lpage>45</lpage>.<pub-id pub-id-type="doi">10.1161/CIRCOUTCOMES.114.000950</pub-id><pub-id pub-id-type="pmid">25737487</pub-id></mixed-citation></ref><ref id="B407"><label>407</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pearson</surname><given-names>TA</given-names></name><name><surname>Denke</surname><given-names>MA</given-names></name><name><surname>McBride</surname><given-names>PE</given-names></name><name><surname>Battisti</surname><given-names>WP</given-names></name><name><surname>Brady</surname><given-names>WE</given-names></name><name><surname>Palmisano</surname><given-names>J</given-names></name></person-group>. <article-title>A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial</article-title>. <source>Mayo Clin Proc</source> (<year>2005</year>) <volume>80</volume>:<fpage>587</fpage>&#x02013;<lpage>95</lpage>.<pub-id pub-id-type="doi">10.4065/80.5.587</pub-id><?supplied-pmid 15887425?><pub-id pub-id-type="pmid">15887425</pub-id></mixed-citation></ref><ref id="B408"><label>408</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albert</surname><given-names>MA</given-names></name><name><surname>Glynn</surname><given-names>RJ</given-names></name><name><surname>Fonseca</surname><given-names>FAH</given-names></name><name><surname>Lorenzatti</surname><given-names>AJ</given-names></name><name><surname>Ferdinand</surname><given-names>KC</given-names></name><name><surname>MacFayden</surname><given-names>JG</given-names></name><etal/></person-group>
<article-title>Race, ethnicity, and the efficacy of rosuvastatin in primary prevention: the justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER) trial</article-title>. <source>Am Heart J</source> (<year>2011</year>) <volume>162</volume>:<fpage>106</fpage>&#x02013;<lpage>14</lpage>.<pub-id pub-id-type="doi">10.1016/j.ahj.2011.03.032</pub-id><?supplied-pmid 21742096?><pub-id pub-id-type="pmid">21742096</pub-id></mixed-citation></ref><ref id="B409"><label>409</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lloret</surname><given-names>R</given-names></name><name><surname>Ycas</surname><given-names>J</given-names></name><name><surname>Stein</surname><given-names>M</given-names></name><name><surname>Haffner</surname><given-names>SM</given-names></name><collab>STARSHIP Study Group</collab></person-group>. <article-title>Comparison of rosuvastatin versus atorvastatin in Hispanic-Americans with hypercholesterolemia (from the STARSHIP trial)</article-title>. <source>Am J Cardiol</source> (<year>2006</year>) <volume>98</volume>:<fpage>769</fpage>&#x02013;<lpage>73</lpage>.<pub-id pub-id-type="doi">10.1016/j.amjcard.2006.04.014</pub-id><?supplied-pmid 16950182?><pub-id pub-id-type="pmid">16950182</pub-id></mixed-citation></ref><ref id="B410"><label>410</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenstock</surname><given-names>J</given-names></name><name><surname>Hernandez-Triana</surname><given-names>E</given-names></name><name><surname>Handelsman</surname><given-names>Y</given-names></name><name><surname>Misir</surname><given-names>S</given-names></name><name><surname>Jones</surname><given-names>MR</given-names></name></person-group>. <article-title>Clinical effects of colesevelam in Hispanic subjects with primary hyperlipidemia and prediabetes</article-title>. <source>Postgrad Med</source> (<year>2012</year>) <volume>124</volume>:<fpage>14</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="doi">10.3810/pgm.2012.07.2564</pub-id><?supplied-pmid 22913890?><pub-id pub-id-type="pmid">22913890</pub-id></mixed-citation></ref><ref id="B411"><label>411</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guzm&#x000e1;n</surname><given-names>JR</given-names></name><name><surname>Lyra</surname><given-names>R</given-names></name><name><surname>Aguilar-Salinas</surname><given-names>CA</given-names></name><name><surname>Cavalcanti</surname><given-names>S</given-names></name><name><surname>Esca&#x000f1;o</surname><given-names>F</given-names></name><name><surname>Tambasia</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Treatment of type 2 diabetes in Latin America: a consensus statement by the medical associations of 17 Latin American countries</article-title>. <source>Rev PanamSalud Publica</source> (<year>2010</year>) <volume>28</volume>:<fpage>463</fpage>&#x02013;<lpage>71</lpage>.<pub-id pub-id-type="doi">10.1590/S1020-49892010001200008</pub-id></mixed-citation></ref><ref id="B412"><label>412</label><mixed-citation publication-type="book"><collab>Pan American Health Organization</collab>. <source>Diabetes in the Americas [Internet]</source>. <publisher-loc>Twenty-third Street, N.W (DC)</publisher-loc> (<year>2016</year>). Available from: <uri xlink:type="simple" xlink:href="http://www2.paho.org/hq/index.php?option=com_content&#x00026;view=article&#x00026;id=12126%3Adiabetes-in-the-americas&#x00026;catid=6648%3Afact-sheets&#x00026;Itemid=40721&#x00026;lang=en">http://www2.paho.org/hq/index.php?option=com_content&#x00026;view=article&#x00026;id=12126%3Adiabetes-in-the-americas&#x00026;catid=6648%3Afact-sheets&#x00026;Itemid=40721&#x00026;lang=en</uri></mixed-citation></ref><ref id="B413"><label>413</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Popkin</surname><given-names>BM</given-names></name><name><surname>Hawkes</surname><given-names>C</given-names></name></person-group>. <article-title>Sweetening of the global diet, particularly beverages: patterns, trends, and policy responses</article-title>. <source>Lancet Diabetes Endocrinol</source> (<year>2016</year>) <volume>4</volume>:<fpage>174</fpage>&#x02013;<lpage>86</lpage>.<pub-id pub-id-type="doi">10.1016/S2213-8587(15)00419-2</pub-id><?supplied-pmid 26654575?><pub-id pub-id-type="pmid">26654575</pub-id></mixed-citation></ref><ref id="B414"><label>414</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Col&#x000f3;n-Ramos</surname><given-names>U</given-names></name><name><surname>Monge-Rojas</surname><given-names>R</given-names></name><name><surname>Campos</surname><given-names>H</given-names></name></person-group>. <article-title>Impact of WHO recommendations to eliminate industrial trans-fatty acids from the food supply in Latin America and the Caribbean</article-title>. <source>Health Policy Plan</source> (<year>2014</year>) <volume>29</volume>:<fpage>529</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="doi">10.1093/heapol/czt034</pub-id><?supplied-pmid 24150503?><pub-id pub-id-type="pmid">24150503</pub-id></mixed-citation></ref><ref id="B415"><label>415</label><mixed-citation publication-type="book"><collab>Argentina, Ministerio de Salud de la Naci&#x000f3;n [Ministry of Health of the Nation, Argentina]</collab>. <source>Iniciativa Menos Sal, M&#x000e1;s Vida [Less Salt, More Life Initiative] [Homepage on the Internet]</source>. <publisher-loc>Buenos Aires, Argentina</publisher-loc>: <publisher-name>Ministerio de Salud, Presidencia de la Naci&#x000f3;n</publisher-name> (<year>2017</year>). Available from: <uri xlink:type="simple" xlink:href="http://www.msal.gob.ar/ent/index.php/informacion-para-ciudadanos/menos-sal--vida">http://www.msal.gob.ar/ent/index.php/informacion-para-ciudadanos/menos-sal--vida</uri></mixed-citation></ref><ref id="B416"><label>416</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Buitrago Gonz&#x000e1;ez</surname><given-names>AR</given-names></name><name><surname>Escobar</surname><given-names>NP</given-names></name><name><surname>Hern&#x000e1;ndez Torres</surname><given-names>BC</given-names></name><name><surname>Moreno Barrera</surname><given-names>CP</given-names></name></person-group>
<source>Estrategia nacional para la reducci&#x000f3;n del consumo de sal/sodio en Colombia 2012&#x02013;2021 [National Strategy for the Reduction of Salt/Sodium Consumption in Colombia 2012&#x02013;2021]</source>. <publisher-loc>Bogot&#x000e1;, Colombia</publisher-loc>: <publisher-name>Ministry of Health and Social Protection</publisher-name> (<year>2015</year>). <fpage>37</fpage> p. Spanish. Available from: <uri xlink:type="simple" xlink:href="https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/PP/SNA/Estrategia-reduccion-sal-2012-2021.pdf">https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/PP/SNA/Estrategia-reduccion-sal-2012-2021.pdf</uri></mixed-citation></ref><ref id="B417"><label>417</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nilson</surname><given-names>EA</given-names></name></person-group>. <article-title>The strides to reduce salt intake in Brazil: have we done enough?</article-title>
<source>Cardiovasc Diagn Ther</source> (<year>2015</year>) <volume>5</volume>:<fpage>243</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.3978/j.issn.2223-3652.2015.04.03</pub-id><?supplied-pmid 26090336?><pub-id pub-id-type="pmid">26090336</pub-id></mixed-citation></ref><ref id="B418"><label>418</label><mixed-citation publication-type="book"><collab>Pan American Health Organization</collab>. <source>Policy Statement: Preventing Cardiovascular Disease in the Americas by Reducing Dietary Salt Intake Population-Wide [Internet]</source>. <publisher-loc>Twenty Third Street, N.W (DC)</publisher-loc> (<year>2017</year>). Available from: <uri xlink:type="simple" xlink:href="http://www1.paho.org/hq/dmdocuments/2010/red-salt-policy-statement-eng.pdf">http://www1.paho.org/hq/dmdocuments/2010/red-salt-policy-statement-eng.pdf</uri></mixed-citation></ref><ref id="B419"><label>419</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valenzuela</surname><given-names>K</given-names></name><name><surname>Quitral</surname><given-names>V</given-names></name><name><surname>Villanueva</surname><given-names>AB</given-names></name><name><surname>Zavala</surname><given-names>F</given-names></name><name><surname>Atalah</surname><given-names>E</given-names></name></person-group>
<article-title>Evaluaci&#x000f3;n del programa piloto de reducci&#x000f3;n de sal/sodio en el pan en Santiago de Chile</article-title>. <source>Rev Chil Nutr</source> (<year>2013</year>) <volume>40</volume>:<fpage>119</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="doi">10.4067/S0717-75182013000200004</pub-id></mixed-citation></ref><ref id="B420"><label>420</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>G&#x000f3;mez</surname><given-names>LF</given-names></name><name><surname>Mosquera</surname><given-names>J</given-names></name><name><surname>G&#x000f3;mez</surname><given-names>OL</given-names></name><name><surname>Moreno</surname><given-names>J</given-names></name><name><surname>Pinz&#x000f3;n</surname><given-names>JD</given-names></name><name><surname>Jacoby</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Social conditions and urban environment associated with participation in the Ciclov&#x000ed;a program among adults from Cali, Colombia</article-title>. <source>Cad Saude Publica</source> (<year>2015</year>) <volume>31</volume>(<issue>Suppl 1</issue>):<fpage>257</fpage>&#x02013;<lpage>66</lpage>.<pub-id pub-id-type="doi">10.1590/0102-311X00086814</pub-id></mixed-citation></ref><ref id="B421"><label>421</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gill</surname><given-names>C</given-names></name><name><surname>Vatcheva</surname><given-names>KP</given-names></name><name><surname>Pan</surname><given-names>JJ</given-names></name><name><surname>Smulevitz</surname><given-names>B</given-names></name><name><surname>McPherson</surname><given-names>DD</given-names></name><name><surname>Fallon</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Frequency of nonalcoholic fatty liver disease and subclinical atherosclerosis among young Mexican Americans</article-title>. <source>Am J Cardiol</source> (<year>2017</year>) <volume>119</volume>:<fpage>1717</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="doi">10.1016/j.amjcard.2017.03.010</pub-id><?supplied-pmid 28395890?><pub-id pub-id-type="pmid">28395890</pub-id></mixed-citation></ref><ref id="B422"><label>422</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kallwitz</surname><given-names>ER</given-names></name><name><surname>Daviglus</surname><given-names>ML</given-names></name><name><surname>Allison</surname><given-names>MA</given-names></name><name><surname>Emory</surname><given-names>KT</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>Kuniholm</surname><given-names>MH</given-names></name><etal/></person-group>
<article-title>Prevalence of suspected nonalcoholic fatty liver disease in Hispanic/Latino individuals differs by heritage</article-title>. <source>Clin Gastroenterol Hepatol</source> (<year>2015</year>) <volume>13</volume>:<fpage>569</fpage>&#x02013;<lpage>76</lpage>.<pub-id pub-id-type="doi">10.1016/j.cgh.2014.08.037</pub-id><?supplied-pmid 25218670?><pub-id pub-id-type="pmid">25218670</pub-id></mixed-citation></ref><ref id="B423"><label>423</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szczepaniak</surname><given-names>LS</given-names></name><name><surname>Victor</surname><given-names>RG</given-names></name><name><surname>Mathur</surname><given-names>R</given-names></name><name><surname>Nelson</surname><given-names>MD</given-names></name><name><surname>Szczepaniak</surname><given-names>EW</given-names></name><name><surname>Tyer</surname><given-names>N</given-names></name><etal/></person-group>
<article-title>Pancreatic steatosis and its relationship to &#x003b2;-cell dysfunction in humans: racial and ethnic variations</article-title>. <source>Diabetes Care</source> (<year>2012</year>) <volume>35</volume>:<fpage>2377</fpage>&#x02013;<lpage>83</lpage>.<pub-id pub-id-type="doi">10.2337/dc12-0701</pub-id><pub-id pub-id-type="pmid">22968187</pub-id></mixed-citation></ref><ref id="B424"><label>424</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McAuley</surname><given-names>PA</given-names></name><name><surname>Hsu</surname><given-names>FC</given-names></name><name><surname>Loman</surname><given-names>KK</given-names></name><name><surname>Carr</surname><given-names>JJ</given-names></name><name><surname>Budoff</surname><given-names>MJ</given-names></name><name><surname>Szlo</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Liver attenuation, pericardial adipose tissue, obesity, and insulin resistance: the multi-ethnic study of atherosclerosis (MESA)</article-title>. <source>Obesity</source> (<year>2011</year>) <volume>19</volume>:<fpage>1855</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="doi">10.1038/oby.2011.191</pub-id><?supplied-pmid 21720430?><pub-id pub-id-type="pmid">21720430</pub-id></mixed-citation></ref><ref id="B425"><label>425</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Troncoso Sawyer</surname><given-names>M</given-names></name><name><surname>Deines</surname><given-names>CK</given-names></name></person-group>. <article-title>Missing the mark with Latina women with type 2 diabetes: implications for educators</article-title>. <source>Diabetes Educ</source> (<year>2013</year>) <volume>39</volume>:<fpage>671</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1177/0145721713495716</pub-id><?supplied-pmid 23897919?><pub-id pub-id-type="pmid">23897919</pub-id></mixed-citation></ref><ref id="B426"><label>426</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pyatak</surname><given-names>EA</given-names></name><name><surname>Florindez</surname><given-names>D</given-names></name><name><surname>Peters</surname><given-names>AL</given-names></name><name><surname>Weigensberg</surname><given-names>MJ</given-names></name></person-group>
<article-title>&#x0201c;We are all gonna get diabetic these days&#x0201d;: the impact of a living legacy of type 2 diabetes on Hispanic young adults&#x02019; diabetes care</article-title>. <source>Diabetes Educ</source> (<year>2014</year>) <volume>40</volume>:<fpage>648</fpage>&#x02013;<lpage>58</lpage>.<pub-id pub-id-type="doi">10.1177/0145721714535994</pub-id><pub-id pub-id-type="pmid">24867918</pub-id></mixed-citation></ref><ref id="B427"><label>427</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scollan-Koliopoulos</surname><given-names>M</given-names></name><name><surname>Walker</surname><given-names>EA</given-names></name><name><surname>Rapp</surname><given-names>KJ</given-names></name></person-group>. <article-title>Self-regulation theory and the multigenerational legacy of diabetes</article-title>. <source>Diabetes Educ</source> (<year>2011</year>) <volume>37</volume>:<fpage>669</fpage>&#x02013;<lpage>79</lpage>.<pub-id pub-id-type="doi">10.1177/0145721711416133</pub-id><?supplied-pmid 21918205?><pub-id pub-id-type="pmid">21918205</pub-id></mixed-citation></ref><ref id="B428"><label>428</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buckley</surname><given-names>J</given-names></name><name><surname>Yekta</surname><given-names>S</given-names></name><name><surname>Joseph</surname><given-names>V</given-names></name><name><surname>Johnson</surname><given-names>H</given-names></name><name><surname>Oliverio</surname><given-names>S</given-names></name><name><surname>De Groot</surname><given-names>AS</given-names></name></person-group>. <article-title>Vida Sana: a lifestyle intervention for uninsured, predominantly Spanish-speaking immigrants improves metabolic syndrome indicators</article-title>. <source>J Community Health</source> (<year>2015</year>) <volume>40</volume>:<fpage>116</fpage>&#x02013;<lpage>23</lpage>.<pub-id pub-id-type="doi">10.1007/s10900-014-9905-z</pub-id><?supplied-pmid 24984599?><pub-id pub-id-type="pmid">24984599</pub-id></mixed-citation></ref><ref id="B429"><label>429</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gutierrez</surname><given-names>J</given-names></name><name><surname>Devia</surname><given-names>C</given-names></name><name><surname>Weiss</surname><given-names>L</given-names></name><name><surname>Chantarat</surname><given-names>T</given-names></name><name><surname>Ruddock</surname><given-names>C</given-names></name><name><surname>Linnell</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Health, community, and spirituality: evaluation of a multicultural faith-based diabetes prevention program</article-title>. <source>Diabetes Educ</source> (<year>2014</year>) <volume>40</volume>:<fpage>214</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="doi">10.1177/0145721714521872</pub-id><?supplied-pmid 24518138?><pub-id pub-id-type="pmid">24518138</pub-id></mixed-citation></ref><ref id="B430"><label>430</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parikh</surname><given-names>P</given-names></name><name><surname>Simon</surname><given-names>EP</given-names></name><name><surname>Fei</surname><given-names>K</given-names></name><name><surname>Looker</surname><given-names>H</given-names></name><name><surname>Goytia</surname><given-names>C</given-names></name><name><surname>Horowitz</surname><given-names>CR</given-names></name></person-group>. <article-title>Results of a pilot diabetes prevention intervention in East Harlem, New York city: project HEED</article-title>. <source>Am J Public Health</source> (<year>2010</year>) <volume>100</volume>(<issue>Suppl 1</issue>):<fpage>S232</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.2105/AJPH.2009.170910</pub-id><?supplied-pmid 20147680?><pub-id pub-id-type="pmid">20147680</pub-id></mixed-citation></ref><ref id="B431"><label>431</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Billimek</surname><given-names>J</given-names></name><name><surname>Sorkin</surname><given-names>DH</given-names></name></person-group>. <article-title>Food insecurity, processes of care, and self-reported medication underuse in patients with type 2 diabetes: results from the California Health Interview Survey</article-title>. <source>Health Serv Res</source> (<year>2012</year>) <volume>47</volume>:<fpage>2159</fpage>&#x02013;<lpage>68</lpage>.<pub-id pub-id-type="doi">10.1111/j.1475-6773.2012.01463.x</pub-id><?supplied-pmid 22998155?><pub-id pub-id-type="pmid">22998155</pub-id></mixed-citation></ref><ref id="B432"><label>432</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haffner</surname><given-names>SM</given-names></name><name><surname>Stern</surname><given-names>MP</given-names></name><name><surname>Hazuda</surname><given-names>HP</given-names></name><name><surname>Mitchell</surname><given-names>BD</given-names></name><name><surname>Patterson</surname><given-names>JK</given-names></name></person-group>. <article-title>Cardiovascular risk factors in confirmed prediabetic individuals: does the clock for coronary heart disease start ticking before the onset of clinical diabetes?</article-title>
<source>JAMA</source> (<year>1990</year>) <volume>263</volume>:<fpage>2893</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1001/jama.263.21.2893</pub-id><?supplied-pmid 2338751?><pub-id pub-id-type="pmid">2338751</pub-id></mixed-citation></ref><ref id="B433"><label>433</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x000e9;rez</surname><given-names>CM</given-names></name><name><surname>Soto-Salgado</surname><given-names>M</given-names></name><name><surname>Su&#x000e1;rez</surname><given-names>E</given-names></name><name><surname>Guzm&#x000e1;n</surname><given-names>M</given-names></name><name><surname>Ortiz</surname><given-names>AP</given-names></name></person-group>. <article-title>High prevalence of diabetes and prediabetes and their coexistence with cardiovascular risk factors in a Hispanic community</article-title>. <source>J Immigr Minor Health</source> (<year>2015</year>) <volume>17</volume>:<fpage>1002</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1007/s10903-014-0025-8</pub-id><?supplied-pmid 24781780?><pub-id pub-id-type="pmid">24781780</pub-id></mixed-citation></ref><ref id="B434"><label>434</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Handelsman</surname><given-names>Y</given-names></name><name><surname>Bloomgarden</surname><given-names>ZT</given-names></name><name><surname>Grunberger</surname><given-names>G</given-names></name><name><surname>Umpierrez</surname><given-names>G</given-names></name><name><surname>Zimmerman</surname><given-names>RS</given-names></name><name><surname>Bailey</surname><given-names>TS</given-names></name><etal/></person-group>
<article-title>American Association of Clinical Endocrinologists and American College of Endocrinology &#x02013; clinical practice guidelines for developing a diabetes mellitus comprehensive care plan &#x02013; 2015</article-title>. <source>Endocr Pract</source> (<year>2015</year>) <volume>21</volume>(<issue>Suppl 1</issue>):<fpage>1</fpage>&#x02013;<lpage>87</lpage>.<pub-id pub-id-type="doi">10.4158/EP15672.GL</pub-id><pub-id pub-id-type="pmid">25869408</pub-id></mixed-citation></ref><ref id="B435"><label>435</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamman</surname><given-names>RF</given-names></name><name><surname>Horton</surname><given-names>E</given-names></name><name><surname>Barrett-Connor</surname><given-names>E</given-names></name><name><surname>Bray</surname><given-names>GA</given-names></name><name><surname>Christophi</surname><given-names>CA</given-names></name><name><surname>Crandall</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Factors affecting the decline in incidence of diabetes in the diabetes prevention program outcomes study (DPPOS)</article-title>. <source>Diabetes</source> (<year>2015</year>) <volume>64</volume>:<fpage>989</fpage>&#x02013;<lpage>98</lpage>.<pub-id pub-id-type="doi">10.2337/db14-0333</pub-id><?supplied-pmid 25277389?><pub-id pub-id-type="pmid">25277389</pub-id></mixed-citation></ref><ref id="B436"><label>436</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hiver</surname><given-names>MF</given-names></name><name><surname>Jablonski</surname><given-names>KA</given-names></name><name><surname>Perreault</surname><given-names>L</given-names></name><name><surname>Saxena</surname><given-names>R</given-names></name><name><surname>McAteer</surname><given-names>JB</given-names></name><name><surname>Franks</surname><given-names>PW</given-names></name><etal/></person-group>
<article-title>Updated genetic scores based on 34 confirmed type 2 diabetes loci is associated with diabetes incidence and regression to normoglycemia in the diabetes prevention program</article-title>. <source>Diabetes</source> (<year>2011</year>) <volume>60</volume>:<fpage>1340</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.2337/db10-1119</pub-id><pub-id pub-id-type="pmid">21378175</pub-id></mixed-citation></ref><ref id="B437"><label>437</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Resnicow</surname><given-names>K</given-names></name><name><surname>Baranowski</surname><given-names>T</given-names></name><name><surname>Ahluwalia</surname><given-names>JS</given-names></name><name><surname>Braithwaite</surname><given-names>RL</given-names></name></person-group>. <article-title>Cultural sensitivity in public health: defined and demystified</article-title>. <source>Ethn Dis</source> (<year>1999</year>) <volume>9</volume>:<fpage>10</fpage>&#x02013;<lpage>21</lpage>.<?supplied-pmid 10355471?><pub-id pub-id-type="pmid">10355471</pub-id></mixed-citation></ref><ref id="B438"><label>438</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glazier</surname><given-names>RH</given-names></name><name><surname>Bajcar</surname><given-names>J</given-names></name><name><surname>Kennie</surname><given-names>NR</given-names></name><name><surname>Willson</surname><given-names>K</given-names></name></person-group>. <article-title>A systematic review of interventions to improve diabetes care in socially disadvantaged populations</article-title>. <source>Diabetes Care</source> (<year>2006</year>) <volume>29</volume>:<fpage>1675</fpage>&#x02013;<lpage>88</lpage>.<pub-id pub-id-type="doi">10.2337/dc05-1942</pub-id><?supplied-pmid 16801602?><pub-id pub-id-type="pmid">16801602</pub-id></mixed-citation></ref><ref id="B439"><label>439</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anker</surname><given-names>AE</given-names></name><name><surname>Feeley</surname><given-names>TH</given-names></name><name><surname>McCracken</surname><given-names>B</given-names></name><name><surname>Lagoe</surname><given-names>CA</given-names></name></person-group>. <article-title>Measuring the effectiveness of mass-mediated health campaigns through meta-analysis</article-title>. <source>J Health Commun</source> (<year>2016</year>) <volume>21</volume>:<fpage>439</fpage>&#x02013;<lpage>56</lpage>.<pub-id pub-id-type="doi">10.1080/10810730.2015.1095820</pub-id><?supplied-pmid 26953782?><pub-id pub-id-type="pmid">26953782</pub-id></mixed-citation></ref><ref id="B440"><label>440</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindberg</surname><given-names>NM</given-names></name><name><surname>Stevens</surname><given-names>VJ</given-names></name></person-group>
<article-title>Immigration and weight gain: Mexican-American women&#x02019;s perspectives</article-title>. <source>J Immigr Minor Health</source> (<year>2011</year>) <volume>13</volume>:<fpage>155</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="doi">10.1007/s10903-009-9298-8</pub-id><pub-id pub-id-type="pmid">19859807</pub-id></mixed-citation></ref><ref id="B441"><label>441</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindberg</surname><given-names>NM</given-names></name><name><surname>Stevens</surname><given-names>VJ</given-names></name><name><surname>Halperin</surname><given-names>RO</given-names></name></person-group>
<article-title>Weight loss interventions for Hispanic populations: the role of culture</article-title>. <source>J Obes</source> (<year>2013</year>) <volume>2013</volume>:<fpage>1</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1155/2013/542736</pub-id></mixed-citation></ref><ref id="B442"><label>442</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chomsky-Higgins</surname><given-names>K</given-names></name><name><surname>Miclau</surname><given-names>TA</given-names></name><name><surname>Mackechnie</surname><given-names>MC</given-names></name><name><surname>Aguilar</surname><given-names>D</given-names></name><name><surname>Rubio Avila</surname><given-names>J</given-names></name><name><surname>Baldy dos Reis</surname><given-names>F</given-names></name><etal/></person-group>
<article-title>Barriers to clinical research in Latin America</article-title>. <source>FrontPublic Health</source> (<year>2017</year>) <volume>5</volume>:<fpage>57</fpage>.<pub-id pub-id-type="doi">10.3389/fpubh.2017.00057</pub-id><?supplied-pmid 28459047?><pub-id pub-id-type="pmid">28459047</pub-id></mixed-citation></ref><ref id="B443"><label>443</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cardenas</surname><given-names>MK</given-names></name><name><surname>Miranda</surname><given-names>JJ</given-names></name><name><surname>Beran</surname><given-names>D</given-names></name></person-group>
<article-title>Delivery of type 2 diabetes care in low- and middle-income countries: lessons from Lima, Peru</article-title>. <source>Diabet Med</source> (<year>2016</year>) <volume>33</volume>:<fpage>752</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="doi">10.1111/dme.13099</pub-id><pub-id pub-id-type="pmid">27194174</pub-id></mixed-citation></ref><ref id="B444"><label>444</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Owolabi</surname><given-names>M</given-names></name><name><surname>Miranda</surname><given-names>JJ</given-names></name><name><surname>Yaria</surname><given-names>J</given-names></name><name><surname>Ovbiagele</surname><given-names>B</given-names></name></person-group>
<article-title>Controlling cardiovascular diseases in low and middle-income countries by placing proof in pragmatism</article-title>. <source>BMJ Glob Health</source> (<year>2016</year>) <volume>1</volume>:<fpage>e000105</fpage><pub-id pub-id-type="doi">10.1136/bmjgh-2016-000105</pub-id></mixed-citation></ref></ref-list><app-group><app id="A1"><title>Appendix</title><table-wrap id="d35e26507" position="anchor"><table frame="hsides" rules="groups"><tbody><tr><td align="left" valign="top" colspan="2" rowspan="1"><bold>Abbreviations</bold></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">AA(s)</td><td align="left" valign="top" rowspan="1" colspan="1">African American(s)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ACE inhibitor</td><td align="left" valign="top" rowspan="1" colspan="1">angiotensin-converting enzyme inhibitor</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">AD</td><td align="left" valign="top" rowspan="1" colspan="1">Alzheimer&#x02019;s disease</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ARB</td><td align="left" valign="top" rowspan="1" colspan="1">angiotensin II receptor blocker</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ADA</td><td align="left" valign="top" rowspan="1" colspan="1">American Diabetes Association</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">AHEI</td><td align="left" valign="top" rowspan="1" colspan="1">alternate health eating index</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BCAAs</td><td align="left" valign="top" rowspan="1" colspan="1">branched-chain amino acids</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BMI</td><td align="left" valign="top" rowspan="1" colspan="1">body mass index</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BRFSS</td><td align="left" valign="top" rowspan="1" colspan="1">Behavioral Risk Factor Surveillance Survey</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BW</td><td align="left" valign="top" rowspan="1" colspan="1">birth weight</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CARMELA</td><td align="left" valign="top" rowspan="1" colspan="1">cardiovascular risk factor multiple evaluation in Latin America</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CESCAS I</td><td align="left" valign="top" rowspan="1" colspan="1"><italic>Centro de Excelencia en Salud Cardiovascular para el Cono Sur I</italic></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CRONICAS</td><td align="left" valign="top" rowspan="1" colspan="1"><italic>Centro de Excelencia de Enfermedades Cr&#x000f3;nicas</italic></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CRP</td><td align="left" valign="top" rowspan="1" colspan="1">C reactive protein</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CV</td><td align="left" valign="top" rowspan="1" colspan="1">cardiovascular</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CVD</td><td align="left" valign="top" rowspan="1" colspan="1">cardiovascular disease</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">DASH</td><td align="left" valign="top" rowspan="1" colspan="1">dietary approaches to stop hypertension</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">DEBI</td><td align="left" valign="top" rowspan="1" colspan="1">diet exercise and breastfeeding intervention</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">DM</td><td align="left" valign="top" rowspan="1" colspan="1">diabetes mellitus</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">DNA</td><td align="left" valign="top" rowspan="1" colspan="1">deoxyribonucleic acid</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">DPP</td><td align="left" valign="top" rowspan="1" colspan="1">Diabetes Prevention Program</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ELSA-Brasil</td><td align="left" valign="top" rowspan="1" colspan="1"><italic>Estudo Longitudinal de Sa&#x000fa;de do Adulto</italic></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FFA</td><td align="left" valign="top" rowspan="1" colspan="1">free fatty acids</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FBG</td><td align="left" valign="top" rowspan="1" colspan="1">fasting blood glucose</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FPG</td><td align="left" valign="top" rowspan="1" colspan="1">fasting plasma glucose</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FSIGT</td><td align="left" valign="top" rowspan="1" colspan="1">frequently sampled intravenous glucose tolerance test</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FTO</td><td align="left" valign="top" rowspan="1" colspan="1">alpha-ketoglutarate dependent dioxygenase</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GDM</td><td align="left" valign="top" rowspan="1" colspan="1">gestational diabetes mellitus</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GEM</td><td align="left" valign="top" rowspan="1" colspan="1">gestational diabetes&#x02019; effects on moms</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GRS</td><td align="left" valign="top" rowspan="1" colspan="1">genetic risk score</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GUARDIAN</td><td align="left" valign="top" rowspan="1" colspan="1">genetics underlying diabetes in Hispanics</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GWAS</td><td align="left" valign="top" rowspan="1" colspan="1">genome wide association studies</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HbA1c</td><td align="left" valign="top" rowspan="1" colspan="1">hemoglobin A1c</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HCHS/SOL</td><td align="left" valign="top" rowspan="1" colspan="1">Hispanic Community Health Study/Study of Latinos</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HDL-C</td><td align="left" valign="top" rowspan="1" colspan="1">high-density lipoprotein cholesterol</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hispanic HANES</td><td align="left" valign="top" rowspan="1" colspan="1">Hispanic Health and Nutrition Examination Survey</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HOMA-IR</td><td align="left" valign="top" rowspan="1" colspan="1">homeostasis model assessment for insulin resistance</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IDF</td><td align="left" valign="top" rowspan="1" colspan="1">International Diabetes Federation</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IGT</td><td align="left" valign="top" rowspan="1" colspan="1">impaired glucose tolerance</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IL-6</td><td align="left" valign="top" rowspan="1" colspan="1">interleukin 6</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">KPD</td><td align="left" valign="top" rowspan="1" colspan="1">ketosis prone diabetes</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">LASO</td><td align="left" valign="top" rowspan="1" colspan="1">Latin American Consortium of Studies in Obesity</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">LDL-C</td><td align="left" valign="top" rowspan="1" colspan="1">low-density lipoprotein cholesterol</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MCP-1</td><td align="left" valign="top" rowspan="1" colspan="1">macrophage chemoattractant protein 1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MESA</td><td align="left" valign="top" rowspan="1" colspan="1">Multi-Ethnic Study of Atherosclerosis</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NCEP</td><td align="left" valign="top" rowspan="1" colspan="1">National Cholesterol Education Program</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NHANES</td><td align="left" valign="top" rowspan="1" colspan="1">National Health and Nutrition Examination Survey</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NHIS</td><td align="left" valign="top" rowspan="1" colspan="1">National Health Interview Survey</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NHB(s)</td><td align="left" valign="top" rowspan="1" colspan="1">non-Hispanic black(s)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NHW(s)</td><td align="left" valign="top" rowspan="1" colspan="1">non-Hispanic white(s)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">OGTT</td><td align="left" valign="top" rowspan="1" colspan="1">oral glucose tolerance test</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">OMB</td><td align="left" valign="top" rowspan="1" colspan="1">office of management and budget</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">OSA</td><td align="left" valign="top" rowspan="1" colspan="1">obstructive sleep apnea</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PA</td><td align="left" valign="top" rowspan="1" colspan="1">physical activity</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PAHO</td><td align="left" valign="top" rowspan="1" colspan="1">Pan American Health Organization</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PPAR</td><td align="left" valign="top" rowspan="1" colspan="1">peroxisome proliferator-activated receptor</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">RCT(s)</td><td align="left" valign="top" rowspan="1" colspan="1">randomized clinical trial(s)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">REACH</td><td align="left" valign="top" rowspan="1" colspan="1">racial and ethnic approaches to community health</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">SAHS</td><td align="left" valign="top" rowspan="1" colspan="1">San Antonio Heart Study</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">SNPs</td><td align="left" valign="top" rowspan="1" colspan="1">single-nucleotide polymorphisms</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Type 1 DM</td><td align="left" valign="top" rowspan="1" colspan="1">Type 1 diabetes mellitus</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Type 2 DM</td><td align="left" valign="top" rowspan="1" colspan="1">Type 2 diabetes mellitus</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">TGs</td><td align="left" valign="top" rowspan="1" colspan="1">triglycerides</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">TCF7L2</td><td align="left" valign="top" rowspan="1" colspan="1">transcription factor 7-like 2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">TNF-&#x003b1;</td><td align="left" valign="top" rowspan="1" colspan="1">tumor necrosis factor alpha</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">US</td><td align="left" valign="top" rowspan="1" colspan="1">United States</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">WHO</td><td align="left" valign="top" rowspan="1" colspan="1">World Health Organization</td></tr></tbody></table></table-wrap></app></app-group></back></article>